SMILES,GENERIC_NAME,SYNONYMS,clinical_phase,moa,target,disease_area,indication,matched_name,similarity_score
CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O,Bivalirudin,Bivalirudin; Bivalirudina; Bivalirudinum,Launched,thrombin inhibitor,F2,cardiology,angina pectoris,bivalirudin,
CC(C)C[C@@H](NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCO)C(C)C)C(C)C)C(C)C,Gramicidin D,Bacillus brevis gramicidin D; Gramicidin; Gramicidin A; Gramicidin B; Gramicidin C; Gramicidina; Gramicidine,Launched,bacterial permeability inducer,,infectious disease,first-aid antibiotic,gramicidin,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,Cetrorelix,Cetrorelix; Cetrorelixum,Launched,gonadotropin releasing factor hormone receptor antagonist,GNRHR|LHCGR,endocrinology,premature luteinizing hormone surges,cetrorelix,
CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,Daptomycin,Daptomicina; Daptomycin; Daptomycine; Daptomycinum,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections|endocarditis,daptomycin,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,Abarelix,Abarelix,Phase 3,gonadotropin releasing factor hormone receptor antagonist,GNRHR,,,abarelix,
C/C1=C2/N=C(/C=C3\N=C(/C(C)=C4/[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@](C)([C@@H]5N=C1[C@](C)(CCC(=O)NC[C@@H](C)OP(=O)([O-])O[C@@H]1[C@@H](CO)O[C@H](n6cnc7cc(C)c(C)cc76)[C@@H]1O)[C@H]5CC(N)=O)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]2CCC(N)=O,Cyanocobalamin,Cianocobalamina; Cyanocob(III)alamin; Cyanocobalamin; Cyanocobalamine; Cyanocobalaminum; Vitamin B12; Vitamin B12 complex; Vitamin B12 NOS,Launched,methylmalonyl CoA mutase stimulant|vitamin B,MUT,hematology|infectious disease|gastroenterology,anemia|fish tapeworm infestation|celiac disease,cyanocobalamin,
C[S+](CC[C@H](N)C(=O)[O-])C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,Ademetionine,Ademetionine; AdoMet; L-S-Adenosylmethionine; S-Adenosylmethionine; SAM; SAM-e; SAMe,Launched,methyltransferase stimulant|phosphodiesterase inhibitor,,neurology/psychiatry,depression|attention-deficit/hyperactivity disorder (ADHD),ademetionine,
CC(=O)C(=O)O,Pyruvic acid,2-ketopropionic acid; 2-oxopropanoic acid; 2-Oxopropansäure; 2-Oxopropionsäure; a-Ketopropionic acid; Acetylformic acid; acide pyruvique; alpha-ketopropionic acid; Brenztraubensäure; BTS; Pyroracemic acid; α-ketopropionic acid; α-Oxopropionsäure,Preclinical,,,,,BTS,
N[C@@H](Cc1ccccc1)C(=O)O,Phenylalanine,(S)-2-Amino-3-phenylpropionic acid; (S)-alpha-Amino-beta-phenylpropionic acid; 3-phenyl-L-alanine; beta-Phenyl-L-alanine; F; Fenilalanina; L-Phenylalanine; Phe; Phenylalanine; Phenylalaninum; β-phenyl-L-alanine,Preclinical,enkephalinase inhibitor,CCBL1|CRH|HCAR3,,,D-phenylalanine,
O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12,Biotin,"(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid; (3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-valeric acid; 5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid; Biotin; Biotina; Biotine; Biotinum; cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid; cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid; cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid; Coenzyme R; D-(+)-biotin; D-Biotin; Vitamin B7; Vitamin H",Launched,vitamin B,ACACA|ACACB|HLCS|MCCC1|MCCC2|PC|PCCA|PCCB|SLC5A6,,,biotin,
C[N+](C)(C)CCO,Choline,"Bilineurine; Choline ion; N-trimethylethanolamine; N,N,N-trimethylethanol-ammonium; trimethylethanolamine; Vitamin J",Phase 3,acetylcholine precursor,ACHE|BCHE|CHRNA2|PCYT1A|PCYT1B|PHOSPHO1|PLD1|PLD2,,,choline,
NCCCC[C@H](N)C(=O)O,Lysine,"(S)-2,6-diaminohexanoic acid; (S)-lysine; (S)-α,ε-diaminocaproic acid; 6-ammonio-L-norleucine; L-2,6-Diaminocaproic acid; L-lys; L-Lysin; L-Lysine; LYS; Lysina; Lysine; Lysine acid; Lysinum",Phase 2,serotonin receptor agonist,GPRC6A|KARS|SLC7A1|SLC7A2|SLC7A3|SLC7A4,,,L-lysine,
NCCC[C@H](N)C(=O)O,Ornithine,"(S)-2,5-Diaminopentanoate; (S)-2,5-Diaminopentanoic acid; (S)-2,5-diaminovaleric acid; (S)-ornithine; (S)-α,δ-diaminovaleric acid; L-Ornithine; levo-ornithine; Ornithine; Ornithinum; Ornitina",Launched,NFkB pathway modulator,GPRC6A,,,ornithine,
NC(=O)CC[C@H](N)C(=O)O,L-Glutamine,"(2S)-2-amino-4-carbamoylbutanoic acid; (2S)-2,5-diamino-5-oxopentanoic acid; (S)-2,5-diamino-5-oxopentanoic acid; Glutamic acid 5-amide; Glutamic acid amide; Glutamina; Glutamine; L-(+)-glutamine; L-2-aminoglutaramic acid; L-glutamic acid γ-amide; L-Glutamin; L-Glutamine; L-Glutaminsäure-5-amid; Levoglutamide; Q",Launched,,CTPS1|GLUL|GPRC6A|PPAT,gastroenterology|dental|neurology/psychiatry|rheumatology,diarrhea|mucositis|muscle pain|joint pain|peptic ulcer disease (PUD)|ulcerative colitis|Crohn's disease|anxiety|insomnia,L-glutamine,
CSCC[C@H](N)C(=O)O,Methionine,(2S)-2-amino-4-(methylsulfanyl)butanoic acid; (S)-2-amino-4-(methylthio)butanoic acid; (S)-2-amino-4-(methylthio)butyric acid; (S)-methionine; L-(−)-methionine; L-a-Amino-g-methylthiobutyric acid; L-Methionin; L-Methionine; L-α-amino-γ-methylmercaptobutyric acid; M; Met; Methionine,Launched,voltage-gated calcium channel ligand,BHMT|BHMT2|METAP2|MTR|MTRR,pulmonary|allergy|neurology/psychiatry,asthma|allergic rhinitis|depression|Parkinson's Disease|schizophrenia,L-methionine,
C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O,Calcitriol,"(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10-triene-1,3,25-triol; (1α,3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol; (5Z,7E)-(1S,3R)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol; 1-alpha-25-Dihydroxyvitamin D3; 1,25-DHCC; 1,25-dihydroxycholecalciferol; 1α,25-dihydroxycholecalciferol; 1α,25-dihydroxyvitamin D3; 1α,25(OH)2D3; Calcitriol; Calcitriolum",Launched,vitamin D receptor agonist,VDR,endocrinology|orthopedics,hypocalcemia|hypoparathyroidism|osteoporosis,calcitriol,
CC1=C[C@H](O)CC(C)(C)[C@H]1/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,Lutein,Xanthophyll; Xantofyl,Launched,antioxidant,,ophthalmology,macular degeneration|cataracts|retinitis pigmentosa (RP),lutein,
N[C@@H](CSSC[C@H](N)C(=O)O)C(=O)O,Cystine,"(R,R)-3,3'-dithiobis(2-aminopropanoic acid); Cistina; Cystine; L-alpha-Diamino-beta-dithiolactic acid; L-Cystine; L-Dicysteine; β,β'-dithiodialanine",Launched,,CTNS|SLC3A1|SLC7A11|SLC7A9,,,L-cystine,
Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C,Riboflavin,"1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol; 6,7-Dimethyl-9-D-ribitylisoalloxazine; 7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine; 7,8-Dimethyl-10-ribitylisoalloxazine; Lactoflavin; Lactoflavine; Riboflavin; Riboflavina; Riboflavine; Riboflavinum; Vitamin B2; Vitamin Bi; Vitamin G",Launched,vitamin B,BLVRB|RFK,gastroenterology,jaundice,riboflavin,
CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO,N-Acetylglucosamine,2-Acetamido-2-deoxy-D-glucose; aldehydo-N-acetyl-D-glucosamine; D-GlcNAc; N-Acetyl-D-glucosamine; N-Acetylchitosamine,Phase 2/Phase 3,,B4GALT1|B4GALT2|B4GALT3|B4GALT4|NAGK|NAGLU|NAGPA|RENBP,,,N-acetyl-D-glucosamine,
N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O,Glutathione,"5-L-Glutamyl-L-cysteinylglycine; AEC GLUTATHIONE; gamma-L-Glutamyl-L-cysteinyl-glycine; Glutathion; Glutathione; Glutathione-SH; GLYCINE, L-.GAMMA.-GLUTAMYL-L-CYSTEINYL-; GSH; L-GLUTATHIONE REDUCED; Liposomal glutathione; N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine; Reduced glutathione; REDUCED L-GLUTATHIONE",Phase 3,antioxidant,ESD|GGT1|GLO1|GLRX|GLRX2|GPX1|GPX2|GPX3|GPX4|GPX5|GPX6|GPX7|GPX8|GSR|GSS|GSTA1|GSTA2|GSTA3|GSTA4|GSTA5|GSTK1|GSTM1|GSTM2|GSTM3|GSTM4|GSTM5|GSTO1|GSTO2|GSTP1|GSTT1|GSTZ1|HAGH|HPGDS|LTC4S|MGST1|MGST2|MGST3|TXNDC12,,,glutathione,
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)(C)O,Calcifediol,"(3S,5Z,7E)-9,10-secocholesta-5,7,10-triene-3,25-diol; (3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol; (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol; 25-hydroxycholecalciferol; 25-Hydroxyvitamin D3; Calcidiol; Calcifédiol; Calcifediol; Calcifediol anhydrous; Calcifediolum",Launched,vitamin D receptor agonist,VDR,endocrinology,hyperparathyroidism,calcifediol,
CN(CC(=O)O)C(=N)N,Creatine,((amino(Imino)methyl)(methyl)amino)acetic acid; (alpha-Methylguanido)acetic acid; (N-methylcarbamimidamido)acetic acid; (α-methylguanido)acetic acid; alpha-Methylguanidino acetic acid; Creatin; Creatine; Kreatin; Methylglycocyamine; N-(aminoiminomethyl)-N-methylglycine; N-amidinosarcosine; N-carbamimidoyl-N-methylglycine; N-methyl-N-guanylglycine,Launched,,CKB|CKM|CKMT1A|CKMT2|GAMT|SLC6A8,,,creatine,
N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,Tryptophan,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; (S)-alpha-Amino-beta-(3-indolyl)-propionic acid; (S)-Tryptophan; (S)-α-amino-1H-indole-3-propanoic acid; L-(-)-Tryptophan; L-(−)-tryptophan; L-Tryptophan; L-β-3-indolylalanine; Triptofano; Trp; Tryptophan; Tryptophane; Tryptophanum; W,Launched,serotonin receptor partial agonist,CASR|IDO1|SLC36A1|WARS|WARS2,neurology/psychiatry|gastroenterology,anxiety|bloating|constipation|fatigue|sleeplessness,tryptophan,
N[C@@H](CS)C(=O)O,Cysteine,(2R)-2-amino-3-mercaptopropanoic acid; (2R)-2-amino-3-sulfanylpropanoic acid; (R)-2-Amino-3-mercaptopropanoic acid; Cisteina; Cisteinum; Cys; Cysteine; Cysteinum; Free Cysteine; L-2-Amino-3-mercaptopropionic acid; L-Cys; L-Cystein; L-cysteine; L-Zystein,Launched,,CARS|CARS2|CBS|CDO-1|CDO1|CSAD|CTH|GCLC|GCLM|GOT1|GSS|MGMT|NFS1|SLC19A3,rheumatology,osteoarthritis|rheumatoid arthritis,L-cysteine,
Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1,Thiamine,Aneurin; Antiberiberi factor; Thiamin; Thiamine; thiamine(1+); thiamine(1+) ion; thiaminium; Thiaminum; Tiamina; Vitamin B1,Launched,vitamin B,SLC19A2|SLC19A3|TPK1,metabolism,thiamine deficiency,thiamine,
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C,Ergocalciferol,"(3β,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol; (5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol; (5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol; Activated ergosterol; Ercalciol; Ergocalciférol; Ergocalciferol; Ergocalciferolum; Oleovitamin D2; Viosterol; Vitamin D-2; Vitamin D2; Vitamina D2",Launched,vitamin analog,VDR,endocrinology|orthopedics,hypoparathyroidism|rickets|hypophosphatemia,ergocalciferol,
C[C@@H](O)[C@H](N)C(=O)O,Threonine,"(2S,3R)-(-)-Threonine; (2S)-threonine; 2-Amino-3-hydroxybutyric acid; L-(-)-Threonine; L-2-Amino-3-hydroxybutyric acid; L-alpha-amino-beta-hydroxybutyric acid; L-Threonin; L-Threonine; L-α-amino-β-hydroxybutyric acid; Thr; Threonine; Threoninum; Treonina",Phase 2,,TARS|TARS2|THNSL1,,,L-threonine,
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,Icosapent,"(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate; (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid; (all-Z)-5,8,11,14,17-eicosapentaenoic acid; 5,8,11,14,17-eicosapentaenoic acid; 5,8,11,14,17-Icosapentaenoic acid; all-cis-5,8,11,14,17-eicosapentaenoic acid; all-cis-5,8,11,14,17-icosapentaenoic acid; all-cis-icosa-5,8,11,14,17-pentaenoic acid; cis-5,8,11,14,17-eicosapentaenoic acid; cis-5,8,11,14,17-EPA; cis-delta(5,8,11,14,17)-Eicosapentaenoic acid; Eicosapentaenoic acid; EPA; Icosapent; Icosapentaenoic acid; Icosapento; Icosapentum; Timnodonic acid",Launched,platelet aggregation inhibitor,ACSL3|ACSL4|FADS1|FFAR1|PPARD|PPARG|PTGS1|PTGS2|SLC8A1|TRPV1,endocrinology,hypertriglyceridemia,icosapent,
CC(C)[C@H](N)C(=O)O,Valine,(2S)-2-Amino-3-methylbutanoic acid; (S)-Valine; 2-Amino-3-methylbutyric acid; L-(+)-alpha-Aminoisovaleric acid; L-alpha-Amino-beta-methylbutyric acid; L-valin; L-valine; Val; Valine,Phase 2,,,,,L-valine,
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1,Vitamin A,"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol; all-trans-retinol; all-trans-retinyl alcohol; all-trans-vitamin A alcohol; Retinol; Retinolum; Vitamin A1",Launched,retinoid receptor ligand,ALDH1A1|ALDH1A2|ALDH1A3|DHRS3|DHRS4|LRAT|NR2C2|RBP1|RBP3|RDH11|RDH12|RDH13|RDH14|RDH5|RDH8|RETSAT|RHO|RLBP1|RXRA|RXRB|RXRG,dermatology,cosmetic|acne vulgaris (AV)|keratosis,retinol,
Cc1ncc(CO)c(CO)c1O,Pyridoxine,"2-methyl-3-hydroxy-4,5-dihydroxymethylpyridine; 3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine; 3-hydroxy-4,5-dimethylol-α-picoline; 5-hydroxy-6-methyl-3,4-pyridinedimethanol; Piridoxina; Pyridoxine; Pyridoxinum; Pyridoxol; Vitamin B6",Launched,vitamin B,DDC|PDXK,metabolism,vitamin B6 deficiency,pyridoxine,
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C,Cholecalciferol,"(+)-vitamin D3; (3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol; (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol; Activated 7-dehydrocholesterol; Calciol; CC; Cholecalciferol; Cholecalciferolum; Colecalciferol; Colecalciferolum; Oleovitamin D3; Vitamin D-3; Vitamin D3",Launched,,VDR,endocrinology,vitamin D deficiency,cholecalciferol,
CC1=CC(=O)c2ccccc2C1=O,Menadione,"2-Methyl-1,4-Naphthalenedione; 2-Methyl-1,4-naphthochinon; 2-Methyl-1,4-naphthoquinone; Menadione; Vitamin K 3; Vitamin K3",Launched,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor,AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1,gastroenterology|neurology/psychiatry|dermatology|rheumatology,ulcerative colitis|diarrhea|headache|varicose veins|rheumatoid arthritis,menadione,
Nc1ncnc2nc[nH]c12,Adenine,6-Aminopurine; Adenin; Adenine; Vitamin B4,Preclinical,protein synthesis stimulant,ACACB|ACP1|APRT|MTAP|PECR|SRPK2,,,adenine,
NC(=O)C[C@H](N)C(=O)O,Asparagine,"(2S)-2-amino-3-carbamoylpropanoic acid; (2S)-2,4-diamino-4-oxobutanoic acid; (S)-2-amino-3-carbamoylpropanoic acid; (S)-Asparagine; 2-Aminosuccinamic acid; alpha-aminosuccinamic acid; Asn; Asparagine; Aspartamic acid; L-2-aminosuccinamic acid; L-Asparagine; L-aspartic acid beta-amide; L-aspartic acid β-amide; α-aminosuccinamic acid",Phase 3,,ASNS|ASRGL1|NARS|NARS2|SLC1A5|SLC38A3,,,L-asparagine,
CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,Pravastatin,"(+)-(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acid; Pravastatin; Pravastatin acid; Pravastatina; Pravastatine; Pravastatinum",Launched,HMGCR inhibitor,HMGCR|SLCO1B1,endocrinology|cardiology,hypercholesterolemia|myocardial infarction|hyperlipidemia,pravastatin,
COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1,Fluvoxamine,Fluvoxamina; Fluvoxamine; Fluvoxaminum,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4,neurology/psychiatry,obsessive compulsive disorder (OCD),fluvoxamine,
CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)O)C(C)C,Valsartan,(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine; Valsartan,Launched,angiotensin receptor antagonist,AGTR1,cardiology,hypertension|congestive heart failure|congestive heart failure,valsartan,
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,Ramipril,"(2S-(1(R*(R*)),2alpha,3abeta,6abeta))-1-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid; Ramipril; Ramiprilum",Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension,ramipril,
C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1,Masoprocol,"erythro-nordihydroguaiaretic acid; Masoprocol; Masoprocolum; meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane; meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane; meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol; meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol); meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol; meso-NDGA; meso-nordihydroguaiaretic acid; meso-β,γ-dimethyl-α,δ-bis(3,4-dihydroxyphenyl)butan; Nordihydroguaiaretic acid",Launched,lipoxygenase inhibitor,ALOX5,dermatology,actinic keratosis (AK),masoprocol,
CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,Flunisolide,Flunisolida; Flunisolide; Flunisolide anhydrous; Flunisolidum,Launched,cytochrome P450 inhibitor,NR3C1,allergy,allergic rhinitis,flunisolide,
NCC(CC(=O)O)c1ccc(Cl)cc1,Baclofen,(+-)-Baclofen; 4-Amino-3-(4-chlorophenyl)butyric acid; Baclofen; Baclofène; Baclofeno; Baclofenum; beta-(4-Chlorophenyl)gaba; beta-(Aminomethyl)-4-chlorobenzenepropanoic acid; beta-(Aminomethyl)-p-chlorohydrocinnamic acid; beta-(p-Chlorophenyl)-gamma-aminobutyric acid; DL-4-Amino-3-p-chlorophenylbutanoic acid; DL-Baclofen; gamma-Amino-beta-(p-chlorophenyl)butyric acid,Launched,benzodiazepine receptor agonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,neurology/psychiatry,multiple sclerosis|spasms,baclofen,
CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,Pentagastrin,Pentagastrin,Launched,CCK receptor agonist,CCKBR,gastroenterology,anacidity diagnostic|gastric hypersecretion diagnostic,pentagastrin,
CN1CCC[C@H]1c1cccnc1,Nicotine,(−)-nicotine; (S)-(−)-nicotine; (S)-3-(1-methylpyrrolidin-2-yl)pyridine; (S)-3-(N-methylpyrrolidin-2-yl)pyridine; (S)-Nicotine; 3-(2-(N-methylpyrrolidinyl))pyridine; 3-(N-methylpyrollidino)pyridine; L(−)-nicotine; Nicotina; Nicotine; Nicotine betadex; Nicotine polacrilex; Nikotin; Nikotyna,Launched,acetylcholine receptor agonist,CHAT|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB2|CHRNB3|CHRNB4|CYP19A1|TBXAS1|TRPA1,neurology/psychiatry,smoking cessation,nicotine,
CC1O[C@@]2(CS1)CN1CCC2CC1,Cevimeline,"2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine; Cevimelina; Cévimèline; Cevimeline; Cevimelinum",Launched,acetylcholine receptor agonist,CHRM3,rheumatology,sjogren's syndrome,cevimeline,
COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,Esmolol,(±)-esmolol; (±)-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate; 3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester; Esmolol; Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate; methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate,Launched,adrenergic receptor antagonist,ADRB1,cardiology,ventricular tachycardia (VT)|hypertension,esmolol,
CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,Bortezomib,[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid; Bortezomib; N-[(1R)-1-(DIHYDROXYBORYL)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide,Launched,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,hematologic malignancy,multiple myeloma|mantle cell lymphoma (MCL),bortezomib,
C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O,Carbidopa,"(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate; (S)-(−)-carbidopa; (S)-carbidopa; (αS)-α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid; Carbidopa; Carbidopa (anhydrous); Carbidopa anhydrous; Carbidopum; L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid; L-α-methyldopahydrazine",Launched,aromatic L-amino acid decarboxylase inhibitor,DDC,neurology/psychiatry,Parkinson's Disease,carbidopa,
Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,Vidarabine,9-beta-D-arabinofuranosyl-9H-purin-6-amine; 9-beta-D-arabinofuranosyl-adenine; 9-beta-D-Arabinofuranosyladenine; 9-β-D-arabinofuranosyl-9H-purin-6-amine; 9-β-D-arabinofuranosyladenine; Spongoadenosine; Vidarabine; Vidarabinum,Launched,antiviral,ADA,infectious disease,virus herpes simplex (HSV)|varicella-zoster virus (VZV),vidarabine,
CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,Betaxolol,1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol; 1-(isopropylamino)-3-[p-(cyclopropylmethoxyethyl)phenoxy]-2-propanol; Betaxolol; Bétaxolol; Betaxololum,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,ophthalmology,intraocular pressure|glaucoma|ocular hypertension,betaxolol,
OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,Fluconazole,Diflucan; Difluconazole; Fluconazol; Fluconazole; Fluconazolum; Triflucan,Launched,sterol demethylase inhibitor,CYP51A1,infectious disease,esophageal candidiasis|meningitis,fluconazole,
Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,Troglitazone,Troglitazona; Troglitazone,Withdrawn,insulin sensitizer|PPAR receptor agonist,CYP2C8|PPARG|TRPM3,,,troglitazone,
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Erythromycin,3''-O-demethylerythromycin; Abomacetin; Eritromicina; Erythromycin; Erythromycin A; Erythromycin C; érythromycine; Erythromycinum,Launched,NFkB pathway inhibitor,MLNR,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,erythromycin,
CC1=C2[N+]3=C(C=C4[N+]5=C(C(C)=C6N7[C@@H]8[C@H](CC(N)=O)[C@@]6(C)CCC(=O)NC[C@@H](C)OP(=O)([O-])O[C@@H]6[C@@H](CO)O[C@@H]([C@@H]6O)n6c[n+](c9cc(C)c(C)cc96)[Co-3]753(O)[N+]3=C1[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@]83C)[C@@H](CCC(N)=O)C4(C)C)[C@@H](CCC(N)=O)[C@]2(C)CC(N)=O,Hydroxocobalamin,Hydroxocobalamin; Hydroxocobalamin anhydrous; Hydroxocobalamine; Hydroxocobalaminum anhydrous; Hydroxycobalamin; OH-Cbl; Vitamin B-12b,Launched,vitamin B,,,,hydroxocobalamin,
Cn1c(=O)c2c(ncn2C)n(C)c1=O,Caffeine,"1-methyltheobromine; 1,3,7-trimethyl-2,6-dioxopurine; 1,3,7-trimethylpurine-2,6-dione; 1,3,7-trimethylxanthine; 3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion; 7-methyltheophylline; Anhydrous caffeine; Cafeína; Caféine; Caffeine; Caffeinum; Coffein; Coffeinum; Guaranine; Koffein; Mateína; Methyltheobromine; Teína; Thein; Theine",Launched,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3,neurology/psychiatry,fatigue|drowsiness,caffeine,
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,Sildenafil,"1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine; Sildenafil; Sildenafilo",Launched,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3,urology,erectile dysfunction,sildenafil,
CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,Dofetilide,beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide; Dofetilida; Dofetilide; Dofetilidum,Withdrawn,potassium channel blocker,KCNH1|KCNH2|KCNJ12|KCNK2,,,dofetilide,
CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,Pyrimethamine,"2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine; 2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine; 2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine; 5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine; 5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine; 5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine; CD; Chloridine; Chloridyn; Diaminopyritamin; Ethylpyrimidine; Pirimetamina; Primethamine; Pyriméthamine; Pyrimethamine; Pyrimethaminum",Launched,dihydrofolate reductase inhibitor,DHFR|SLC47A1,infectious disease,malaria,pyrimethamine,
COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC,Reserpine,"(−)-reserpine; (3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester; 3,4,5-trimethoxybenzoyl methyl reserpate; Reserpin; Reserpine",Launched,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,cardiology,hypertension,reserpine,
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,Azithromycin,Azithromycin; Azithromycine; Azithromycinum; Azitromicina,Launched,bacterial 50S ribosomal subunit inhibitor,MLNR,infectious disease,pelvic inflammatory disease|pneumonia,azithromycin,
Clc1ccccc1CN1CCc2sccc2C1,Ticlopidine,Ticlopidina; Ticlopidine; Ticlopidinum,Launched,purinergic receptor antagonist,P2RY12,hematology|neurology/psychiatry,thrombosis|stroke,ticlopidine,
O=C(O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,Trospium,,Launched,acetylcholine receptor antagonist,CHRM1,urology,urinary incontinence|urinary frequency,trospium,
COc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2,Adapalene,6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid; Adapalene; Adapalène; Adapaleno; Adapalenum,Launched,retinoid receptor agonist,RARA|RARB|RARG|RXRA|RXRB|RXRG,dermatology,acne vulgaris (AV),adapalene,
COc1ccc(OC)c(C(O)CNC(=O)CN)c1,Midodrine,"(±)-2-amino-N-(β-hydroxy-2,5-dimethoxyphenethyl)acetamide; 1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol; 2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide; DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid; Midodrin; Midodrina; Midodrine; Midodrinum",Launched,adrenergic receptor agonist,,cardiology,hypotension,midodrine,
COc1ccnc(CS(=O)c2nc3ccc(OC(F)F)cc3[nH]2)c1OC,Pantoprazole,Pantoprazol; Pantoprazole; Pantoprazolum,Launched,ATPase inhibitor,ATP4A,gastroenterology,gastroesophageal reflux disease (GERD)|erosive esophagitis (EE)|Zollinger-Ellison syndrome,pantoprazole,
Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,Torasemide,1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea; N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide; Torasemida; Torasemide; Torasémide; Torasemidum; Torsemide,Launched,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,SLC12A1,cardiology,edema|congestive heart failure|hypertension,torasemide,
CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,Citalopram,Citalopram; Citalopramum; Nitalapram,Launched,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,depression,citalopram,
CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12,Eletriptan,élétriptan; Eletriptán; Eletriptan; Eletriptanum,Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,neurology/psychiatry,migraine headache,eletriptan,
COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Moxifloxacin,"1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid; Moxifloxacin; Moxifloxacino",Launched,bacterial DNA gyrase inhibitor,TOP2A,otolaryngology|pulmonary|infectious disease,sinusitis|bronchitis|pneumonia|skin infections|intra-abdominal infections,moxifloxacin,
CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,Oxyphenonium,Oxyphenonium cation; Oxyphenonium ion,Launched,cholinergic receptor antagonist,CHRM1|CHRM3,gastroenterology,peptic ulcer disease (PUD),oxyphenonium,
Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,Nelfinavir,Nelfinavir,Launched,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4|CYP3A7,infectious disease,human immunodeficiency virus (HIV-1),nelfinavir,
CCC(NC(C)C)C(O)c1ccc(O)c(O)c1,Isoetharine,Isoetarina; Isoetarine; Isoetarinum; Isoetharine,Launched,adrenergic receptor agonist,,pulmonary,bronchospasm|asthma,isoetharine,
CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O,Glimepiride,Glimepirida; Glimepiride; Glimépiride; Glimepiridum,Launched,insulin secretagogue,ABCC8|KCNJ1|KCNJ11,endocrinology,diabetes mellitus,glimepiride,
CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,Indinavir,"(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide; Indinavir; Indinavir anhydrous",Launched,HIV protease inhibitor,CYP3A4|CYP3A5|CYP3A7,infectious disease,human immunodeficiency virus (HIV-1),indinavir,
CNC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)NC)CC(=O)[O-])CC(=O)[O-].[Gd+3],Gadodiamide,Gadodiamida; Gadodiamide; Gadodiamide anhydrous,Launched,radiopaque medium,,radiology,MRI contrast agent,gadodiamide,
NC(N)=NCC1COC2(CCCCC2)O1,Guanadrel,Guanadrel; Guanadrelum,Launched,adrenergic inhibitor,,cardiology,hypertension,guanadrel,
CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,Lovastatin,"(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate; 2β,6α-dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone; 6-alpha-methylcompactin; 6alpha-methylcompactin; 6α-methylcompactin; Lovastatin; Lovastatina; Lovastatine; Lovastatinum; Mevinolin",Launched,HMGCR inhibitor,HDAC2|HMGCR|ITGAL|NR1I2,cardiology|endocrinology,coronary heart disease|myocardial infarction|hypercholesterolemia,lovastatin,
FC(F)OC(F)(F)C(F)Cl,Enflurane,"2-chloro-1,1,2-trifluoroethyl difluoromethyl ether; Alyrane; Efrane; Enflurane; Enflurano; Enfluranum; Methylflurether",Launched,membrane permeability inhibitor,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9,neurology/psychiatry,anesthetic,enflurane,
CN(C)CCn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3csc(N)n3)[C@H]2SC1,Cefotiam,"(6R,7R)-7-[2-(2-Amino-thiazol-4-yl)-acetylamino]-3-[1-(2-dimethylamino-ethyl)-1H-tetrazol-5-ylsulfanylmethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefotiam; Cefotiamum; CTM",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,bacterial septicemia|bone and joint infections|respiratory tract infections|skin infections|urinary tract infections,cefotiam,
CCOc1ccccc1O[C@H](c1ccccc1)[C@H]1CNCCO1,Reboxetine,Reboxetina; Reboxetine,Launched,adrenergic receptor antagonist,SLC6A2,neurology/psychiatry,depression,reboxetine,
Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1,Milrinone,"1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile; Milrinona; Milrinone; Milrinonum",Launched,phosphodiesterase inhibitor,PDE2A|PDE3A|PDE3B|PDE5A,cardiology,congestive heart failure,milrinone,
O=C(CCBr)N1CCN(C(=O)CCBr)CC1,Pipobroman,"1,4-bis(3-bromopropionyl)piperazine; N,N-bis-(3-bromopropionyl)-piperazine; Pipobroman; Pipobromanum",Launched,DNA alkylating agent,,hematology,polycythemia vera|thrombocythemia,pipobroman,
Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,Nevirapine,"11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one; NEV; Nevirapina; Nevirapine; Nevirapine anhydrous; Nevirapine, anhydrous; NVP",Launched,non-nucleoside reverse transcriptase inhibitor,CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5,infectious disease,human immunodeficiency virus (HIV-1),nevirapine,
Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,Oxiconazole,"2',4'-Dichloro-2-imidazol-1-ylacetophenone (Z)-[O-(2,4-dichlorobenzyl)oxime]; Oxiconazol; Oxiconazole; Oxiconazolum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,tinea pedis|tinea cruris|tinea corporis,oxiconazole,
C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,Butalbital,"5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione; 5-allyl-5-(2-methylpropyl)barbituric acid; 5-allyl-5-(2'-methyl-n-propyl) barbituric acid; 5-allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione; 5-allyl-5-isobutylbarbituric acid; 5-isobutyl-5-allylbarbituric acid; Allylbarbital; Allylbarbitone; Allylbarbituric acid; Butalbarbital; Butalbital; Butalbitalum; iso-butylallylbarbituric acid; Itobarbital; Tetrallobarbital",Launched,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2,neurology/psychiatry,headache|muscle relaxant,butalbital,
Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,Cladribine,"(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2-CdA; 2-Chloro-2'-deoxy-beta-adenosine; 2-Chloro-2'-deoxyadenosine; 2-chloro-2′-deoxy-adenosine; 2-chloro-6-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine; 2-chloro-deoxyadenosine; 2-Chlorodeoxyadenosine; 2ClAdo; Cladribina; Cladribine; Cladribinum; CldAdo",Launched,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B,hematologic malignancy,hairy cell leukemia,cladribine,
COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1,Ranolazine,Ranolazina; Ranolazine,Launched,sodium channel blocker,SCN10A|SCN9A,cardiology,chronic stable angina,ranolazine,
Nc1ccc(O)c(C(=O)O)c1,Mesalazine,3-carboxy-4-hydroxyaniline; 5-aminosalicylic acid; 5-ASA; m-Aminosalicylic acid; Mesalamine; Mesalazina; Mésalazine; Mesalazine; Mesalazinum; p-Aminosalicylsaeure,Launched,cyclooxygenase inhibitor|lipoxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CHUK|IKBKB|MPO|PPARG|PTGS1|PTGS2,gastroenterology,ulcerative colitis|inflammatory bowel disease,mesalazine,
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,Ziprasidone,Ziprasidona; Ziprasidone; Ziprasidonum,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4,neurology/psychiatry,schizophrenia|bipolar disorder,ziprasidone,
CCC(CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1,Methysergide,"(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8β-carboxamide; (+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide; 1-Methyl-D-lysergic acid butanolamide; 1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide; 1-Methyllysergic acid butanolamide; 1-Methylmethylergonovine; 9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide; Méthysergide; Methysergide; Methysergidum; Metisergida; Metisergido; N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide",Launched,serotonin receptor antagonist,HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,neurology/psychiatry,headache,methysergide,
C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,Cabergoline,(8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide; (8β)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide; 1-((6-allylergolin-8β-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea; 1-[(6-allylergoline-8β-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea; 1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'β-carbonyl)urea; Cabergolina; Cabergoline; Cabergolinum,Launched,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7,endocrinology,hyperprolactinemia,cabergoline,
O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I,Idoxuridine,(+)-5-Iodo-2'-deoxyuridine; 1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil; 1-beta-D-2'-Deoxyribofuranosyl-5-iodouracil; 1beta-D-2'-Deoxyribofuranosyl-5-iodouracil; 2'-Deoxy-5-iodouridine; 5-iodo-2'-deoxyuridine; 5-Iododeoxyuridine; 5-Iodouracil deoxyriboside; Idoxuridin; Idoxuridina; Idoxuridine; Idoxuridinum; IdU; Iododeoxyridine; Iodoxuridine; Joddeoxiuridin,Launched,DNA directed DNA polymerase inhibitor|DNA synthesis inhibitor,,infectious disease,virus herpes simplex (HSV),idoxuridine,
Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1,Dapsone,"1,1'-sulfonylbis(4-aminobenzene); 1,1'-Sulfonylbis[4-aminobenzene]; 4-(4-amino-benzenesulfonyl)-phenylamine; 4-(4-aminophenylsulfonyl)aniline; 4-(4-aminophenylsulfonyl)benzenamine; 4-aminophenyl sulfone; 4,4'-dapsone; 4,4'-diaminodiphenyl sulfone; 4,4'-Diaminodiphenyl sulphone; 4,4'-Diaminodiphenylsulfone; 4,4'-sulfonylbisaniline; 4,4'-Sulfonylbisbenzenamine; 4,4'-Sulfonylbisbenzeneamine; 4,4'-Sulfonyldianilin; 4,4'-sulfonyldianiline; bis(4-aminophenyl)sulfone; Bis(p-aminophenyl) sulfone; DADPS; Dapsona; Dapsone; Dapsonum; DDS; Diaphenylsulfone; p-aminophenyl sulfone; p,p-sulphonylbisbenzamine; p,p-sulphonylbisbenzenamine; p,p'-diaminodiphenyl sulfone",Launched,bacterial antifolate,DHFR,dermatology|infectious disease,dermatitis herpetiformis (DH)|leprosy,dapsone,
CC(C)N1CCN(c2ccc(OC[C@@H]3CO[C@@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,Terconazole,Terconazole,Launched,sterol demethylase inhibitor,,infectious disease,vulvovaginal candidiasis,terconazole,
O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,Phenytoin,"5,5-Diphenyl-imidazolidine-2,4-dione; 5,5-diphenylimidazolidine-2,4-dione; 5,5-diphenyltetrahydro-1H-2,4-imidazoledione	; 5,5-Diphenyltetrahydro-1H-2,4-imidazoledione; Diphenylhydantoin; Fenitoina; Phentytoin; Phenytoin; Phenytoine; Phenytoinum; PR-122 (redox-phenytoin); Redox-phenytoin",Launched,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures,phenytoin,
CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,Medrysone,"11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione; Medrisona; Medrysone; Medrysonum",Launched,glucocorticoid receptor agonist,NR3C1,ophthalmology,conjunctivitis|episcleritis,medrysone,
C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,Doxycycline,5-hydroxy-α-6-deoxytetracycline; 6-alpha-deoxy-5-oxytetracycline; 6alpha-deoxy-5-oxytetracycline; 6α-deoxy-5-oxytetracycline; Anhydrous doxycycline; Doxiciclina; Doxycyclin; Doxycycline; Doxycycline (anhydrous); Doxycycline anhydrous; Doxycyclinum,Launched,bacterial 30S ribosomal subunit inhibitor|metalloproteinase inhibitor,MMP8,dental,periodontitis,doxycycline,
CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1,Diethylstilbestrol,"(E)-3,4-bis(4-hydroxyphenyl)-3-hexene; (E)-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol; 4,4'-dihydroxy-α,β-diethylstilbene; DES; Diéthylstilbestrol; Diethylstilbestrol; Diethylstilbestrolum; Dietilestilbestrol; Stilboestrol; trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol; trans-Diethylstilbesterol; trans-Diethylstilbestrol; trans-Diethylstilboesterol; α,α'-diethyl-(E)-4,4'-stilbenediol",Withdrawn,estrogen receptor agonist,ESR1|ESR2|ESRRB|ESRRG,,,diethylstilbestrol,
CN(C)[C@@H]1C(O)=C(C(=O)NCNCCCC[C@H](N)C(=O)O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,Lymecycline,"(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide; Limeciclina; Lymecycline; Lymecyclinum; N-Lysinomethyltetracycline; N2-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline; N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine; Tetracycline-L-methylene lysine; Tetracycline-L-methylenelysine",Launched,bacterial 50S ribosomal subunit inhibitor,,dermatology,acne vulgaris (AV),lymecycline,
Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,Clotrimazole,"1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole; 1-(o-Chloro-α,α-diphenylbenzyl)imidazole; 1-(o-Chlorotrityl)imidazole; 1-(α-(2-Chlorophenyl)benzhydryl)imidazole; Clotrimazol; Clotrimazole; Clotrimazolum",Launched,cytochrome P450 inhibitor|imidazoline receptor ligand,CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8,infectious disease,vulvovaginal candidiasis|oropharyngeal candidiasis,clotrimazole,
Nc1ccc(S(N)(=O)=O)cc1,Sulfanilamide,4-aminobenzene sulfonic acid amide; 4-azanylbenzenesulfonamide; p-aminobenzenesulfamide; p-aminobenzenesulfonamide; para-aminobenzenesulfonamide; Prontosil album; SA; Streptocide; Sulfamine; Sulfanilamida; Sulfanilamide; Sulfanilamidum; Sulphanilamide,Launched,carbonic anhydrase inhibitor,CYP2C19|CYP2C9|CYP2D6|CYP2E1|CYP3A4,infectious disease,vulvovaginal candidiasis,sulfanilamide,
O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1,Anagrelide,Anagrelida; Anagrelide; Anagrelidum,Launched,phosphodiesterase inhibitor,PDE3A,hematology|hematologic malignancy,thrombocythemia|myeloproliferative neoplasms,anagrelide,
O=NN(CCCl)C(=O)NCCCl,Carmustine,"BCNU; bis-chloroethylnitrosourea; Bischloroethyl nitrosourea; Carmustina; Carmustine; Carmustinum; N,N'-Bis(2-chloroethyl)-N-nitrosourea",Launched,DNA alkylating agent|DNA inhibitor,GSR,hematologic malignancy|oncology,non-Hodgkin lymphoma (NHL)|Hodgkin's lymphoma|multiple myeloma|glioblastoma|brainstem glioma|medulloblastoma|astrocytoma|ependymoma,carmustine,
Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C,Sulfisoxazole,"3,4-Dimethyl-5-sulfanilamidoisoxazole; 3,4-Dimethyl-5-sulfonamidoisoxazole; 3,4-Dimethyl-5-sulphanilamidoisoxazole; 3,4-Dimethyl-5-sulphonamidoisoxazole; 3,4-Dimethylisoxazole-5-sulfanilamide; 3,4-Dimethylisoxazole-5-sulphanilamide; 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide; 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide; 5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole; 5-(p-Aminobenzenesulfonamido)-3,4-dimethylisoxazole; 5-(p-Aminobenzenesulphonamido)-3,4-dimethylisoxazole; 5-Sulfanilamido-3,4-dimethylisoxazole; 5-Sulphanilamido-3,4-dimethyl-isoxazole; N'-(3,4)Dimethylisoxazol-5-yl-sulphanilamide; N1-(3,4-dimethyl-5-isoxazolyl)sulfanilamide; N1-(3,4-dimethyl-5-isoxazolyl)sulphanilamide; Sulfadimethylisoxazole; Sulfafurazol; Sulfafurazole; Sulfafurazolum; Sulfaisoxazole; Sulfasoxazole; Sulfisonazole; Sulfisoxasole; Sulfisoxazol; Sulfisoxazole; Sulfofurazole; Sulphadimethylisoxazole; Sulphafurazol; Sulphafurazole; Sulphaisoxazole; Sulphisoxazol; Sulphofurazole",Launched,bacterial antifolate,,infectious disease,urinary tract infections,sulfafurazole,
COCCc1ccc(OCC(O)CNC(C)C)cc1,Metoprolol,(RS)-Metoprolol; 1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol; DL-metoprolol; Metoprolol,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,cardiology,hypertension|angina pectoris|myocardial infarction,metoprolol,
CC=CC(=O)N(CC)c1ccccc1C,Crotamiton,Crotamiton,Launched,antipruritic,,infectious disease,scabies,crotamiton,
O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O,Dicoumarol,"3,3'-methylen-bis(4-hydroxy-cumarin); 3,3'-methylene-bis(4-hydroxycoumarine); 3,3'-methylenebis(4-hydroxy-1,2-benzopyrone); 3,3'-methylenebis(4-hydroxy-2H-1-benzopyran-2-one); 3,3'-methylenebis(4-hydroxycoumarin); bis-3,3'-(4-hydroxycoumarinyl)methane; bis-hydroxycoumarin; bis(4-hydroxycoumarin-3-yl)methane; di-(4-hydroxy-3-coumarinyl)methane; Dicoumarol; Dicoumarolum; Dicumarol",Launched,NADPH inhibitor,CRYZ|NQO1|VKORC1,hematology,deep vein thrombosis (DVT),dicoumarol,
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@H]12)c1csc(N)n1,Cefmenoxime,"(6R,7R)-7-((Z)-2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-((1-methyl-1H-5-tetraazolylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefmenoxima; Cefmenoxime; Cefmenoximum; CMX",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,cefmenoxime,
CCCN(CCC)CCc1cccc2c1CC(=O)N2,Ropinirole,Ropinirol; Ropinirole; Ropinirolum,Launched,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,neurology/psychiatry,Parkinson's Disease|restless leg syndrome,ropinirole,
COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12,Isradipine,Isradipine; Isradipino; Isradipinum,Launched,calcium channel blocker,CACNA1D|CACNA1F|CACNA2D1,cardiology,hypertension,isradipine,
NCCc1ccn[nH]1,Betazole,1H-pyrazole-3-ethanamine; 2-(1H-pyrazol-5-yl)ethanamine; 2-(3-pyrazolyl)ethylamine; 3-(2-aminoethyl)pyrazole; 3-(beta-aminoethyl)pyrazole; 3-(β-aminoethyl)pyrazole; Ametazole; Betazol; Betazole; Betazolum,Launched,histamine receptor agonist,HRH2,gastroenterology,gastric hypersecretion diagnostic,betazole,
CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,Topiramate,"2,3:4,5-bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate; 2,3:4,5-di-O-isopropylidene-β-D-fructopyranose sulfamate; Tipiramate; Tipiramato; Topiramate; Topiramato; Topiramatum; TPM",Launched,carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist,CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,epilepsy|migraine headache,topiramate,
CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21,Cefmetazole,"(6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefmetazole; Cefmetazolo; Cefmetazolum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,urinary tract infections|skin infections,cefmetazole,
CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,Olmesartan,"4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid; 4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid; Olmesartan",Launched,angiotensin receptor antagonist,AGTR1,cardiology,hypertension,olmesartan,
COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12,Amsacrine,4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide; 4'-(9-Acridinylamino)methanesulfon-m-anisidide; 4'-(9-Acridinylamino)methanesulfon-meta-anisidide; 4'-(9-Acridinylamino)methanesulphon-m-anisidide; Acridinyl anisidide; Amsacrina; Amsacrine; Amsacrinum; m-AMSA; mAMSA,Launched,topoisomerase inhibitor,KCNH2|TOP2A,hematologic malignancy,acute lymphoblastic leukemia (ALL),amsacrine,
CC1CNc2c(cccc2S(=O)(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CC[C@@H](C)C[C@@H]2C(=O)O)C1,Argatroban,Argatroban; Argatroban anhydrous,Launched,thrombin inhibitor,F2,hematology,heparin-induced thrombocytopenia (HIT),argatroban,
N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,Liothyronine,"3,3',5-triiodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-Triiodothyronine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; L-3,5,3'-Triiodothyronine; L-T3; Liothyronine; Liothyroninum; Liotironina; O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; T3; Triiodothyronine",Launched,thyroid hormone stimulant,THRA|THRB,endocrinology,hypothyroidism|myxedema coma,liothyronine,
CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,Disopyramide,Disopiramida; Disopyramide; Disopyramidum,Launched,sodium channel blocker,CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A,cardiology,ventricular tachycardia (VT)|ventricular arrhythmias,disopyramide,
CCN(CC)CC(=O)Nc1c(C)cccc1C,Lidocaine,"2-(Diethylamino)-2',6'-acetoxylidide; 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide; alpha-diethylamino-2,6-dimethylacetanilide; Lidocaina; Lidocaína; Lidocaine; Lidocainum; Lignocaine; α-diethylamino-2,6-dimethylacetanilide",Launched,histamine receptor agonist,EGFR|SCN10A|SCN5A|SCN9A,neurology/psychiatry|dermatology|hematology,itching|eczema|hemorrhage,lidocaine,
NCCC(O)(P(=O)(O)O)P(=O)(O)O,Pamidronic acid,Acide pamidronique; Acido pamidronico; Acidum pamidronicum; Pamidronate; Pamidronic acid,Launched,bone resorption inhibitor,FDPS,endocrinology|oncology|hematologic malignancy,hypercalcemia|Paget's disease|breast cancer|multiple myeloma,pamidronate,
CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1,Clemastine,(+)-(2R)-2-(2-(((R)-p-chloro-α-methyl-α-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine; (+)-(2R)-2-[2-[[(R)-p-chloro-α-methyl-α-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine; Clemastina; Clemastine; Clemastinum,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis|urticaria,clemastine,
C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,Acarbose,Acarbosa; Acarbose; Acarbosum,Launched,glucosidase inhibitor,AMY2A|MGAM,endocrinology,diabetes mellitus,acarbose,
COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,Venlafaxine,Venlafaxina; Venlafaxine; Venlafaxinum,Launched,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin–norepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,venlafaxine,
CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1,Travoprost,"(1R-(1.ALPHA.(Z),2.BETA.(1E,3R*),3.ALPHA.,5.ALPHA.))-7-(3,5-DIHYDROXY-2-(3-HYDROXY-4-(3-(TRIFLUOROMETHYL)PHENOXY)-1-BUTENYL)CYCLOPENTYL)-5-HEPTENOIC ACID, 1-METHYLETHYL ESTER; ISOPROPYL (Z)-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-((1E,3R)-3-HYDROXY-4-((.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-M-TOLYL)OXY)-1-BUTENYL)CYCLOPENTYL)-5-HEPTENOATE; isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[(α,α,α-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate; OTX-TP; Travoprost; TRAVOPROST COMPONENT OF DUOTRAV; Travoprostum",Launched,prostanoid receptor agonist,PTGFR,ophthalmology,ocular hypertension|glaucoma,travoprost,
CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,Amcinonide,Amcinónida; Amcinonide; Amcinonidum; Triamcinolonacetatcyclopentanonid,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,amcinonide,
CNCC[C@@H](Oc1ccccc1C)c1ccccc1,Atomoxetine,(-)-Tomoxetine; Atomoxetina; Atomoxetine; Tomoxetina; Tomoxetine; Tomoxetinum,Launched,norepinephrine transporter inhibitor,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,attention-deficit/hyperactivity disorder (ADHD),atomoxetine,
Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)c1c[nH]cn1,Bleomycin,Bleocin; Bleomicin; Bleomicina; Bleomycin; Bleomycine; Bleomycinum,Launched,DNA synthesis inhibitor,,hematologic malignancy|pulmonary|oncology,non-Hodgkin lymphoma (NHL)|Hodgkin's lymphoma|pleural effusion|testicular carcinoma|squamous cell carcinoma,bleomycin,
O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1,Chlorambucil,"4-(p-bis(beta-chloroethyl)aminophenyl)butyric acid; 4-(p-bis(β-chloroethyl)aminophenyl)butyric acid; 4-[p-[bis(2-chloroethyl)amino]phenyl]butyric acid; Ambochlorin; Chlorambucil; Chloraminophen; Clorambucilo; gamma-[p-di(2-chloroethyl)aminophenyl]butyric acid; N,N-di-2-chloroethyl-gamma-p-aminophenylbutyric acid; N,N-di-2-chloroethyl-γ-p-aminophenylbutyric acid; Phenylbutyric acid nitrogen mustard; γ-[p-di(2-chloroethyl)aminophenyl]butyric acid",Launched,DNA inhibitor,,hematologic malignancy,chronic lymphocytic leukemia (CLL)|Hodgkin's lymphoma,chlorambucil,
CCOC(=O)c1cncn1[C@H](C)c1ccccc1,Etomidate,(+)-ethyl 1-(α-methylbenzyl)imidazole-5-carboxylate; (+)-etomidate; (R)-(+)-1-(α-methylbenzyl)imidazole-5-carboxylic acid ethyl ester; (R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester; 3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester; Etomidate; Etomidato; Etomidatum; R-(+)-ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate,Launched,GABA receptor modulator,ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,neurology/psychiatry,general anaesthetic,etomidate,
Cc1nc(=O)c2cc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)ccc2[nH]1,Raltitrexed,Raltitrexed,Launched,thymidylate synthase inhibitor,FPGS|TYMS,oncology,mesothelioma,raltitrexed,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC,Etonogestrel,3-Ketodesogestrel; 3-Oxodesogestrel; Etonogestrel; étonogestrel; Etonogestrelum,Launched,progesterone receptor agonist,ESR1|PGR,endocrinology,contraceptive,etonogestrel,
CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C,Ropivacaine,"(S)-(−)-1-propyl-2',6'-pipecoloxylidide; (S)-ropivacaine; L-N-n-propylpipecolic acid-2,6-xylidide; Ropivacaina; Ropivacaine; Ropivacainum",Launched,sodium channel blocker,SCN10A,neurology/psychiatry,anesthetic,ropivacaine,
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,Bupivacaine,"(±)-bupivacaine; (RS)-bupivacaine; 1-Butyl-2',6'-pipecoloxylidide; 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide; Bupivacaina; Bupivacaine; Bupivacainum; dl-1-Butyl-2',6'-pipecoloxylidide; DL-Bupivacaine; Racemic bupivacaine",Launched,sodium channel blocker,KCNA5|SCN10A,neurology/psychiatry,peripheral nerve block|caudal epidural block|lumbar epidural block,bupivacaine,
Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1,Dapiprazole,"5,6,7,8-Tetrahydro-3-(2-(4-(o-tolyl)-1-piperazinyl)ethyl)-s-triazolo(4,3-a)pyridine; Dapiprazol; Dapiprazole; Dapiprazolum",Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,ophthalmology,mydriasis,dapiprazole,
Nc1nc(=O)c2ncn(CCC(CO)CO)c2[nH]1,Penciclovir,9-(4-hydroxy-3-(hydroxymethyl)butyl)guanine; 9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine; 9-[2-hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine; 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine; PCV; PE2; Penciclovir; Penciclovirum,Launched,DNA directed DNA polymerase inhibitor,,dental,cold sore,penciclovir,
Cc1onc(-c2c(F)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,Flucloxacillin,"(2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolylpenicillin; Floxacillin; Flucloxacilina; Flucloxacillin; Flucloxacilline; Flucloxacillinum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease|otolaryngology|dermatology|gastroenterology,gram-positive bacterial infections|tonsillitis|sinusitis|pneumonia|eczema|endocarditis|meningitis|enteritis|bacterial septicemia,flucloxacillin,
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)Nc4cccc(C(=O)O)c4)C3)[C@H](C)[C@H]12,Ertapenem,"(1R,5S,6S,8R,2'S,4'S)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; (4R,5S,6S)-3-((3S,5S)-5-((3-carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid; Ertapenem",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,intra-abdominal infections|skin infections|pneumonia|urinary tract infections|gynecologic infections|postpartum endomyometritis,ertapenem,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3C(=C)C[C@@]21CC,Desogestrel,"13-Ethyl-11-methylene-18,19-dinor-17α-pregn-4-en-20-yn-17-ol; Desogestrel; Désogestrel; Desogestrelum",Launched,progesterone receptor agonist,ESR1|PGR,endocrinology,contraceptive,desogestrel,
CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,Mitomycin,7-Amino-9alpha-methoxymitosane; Ametycine; Mitamycin; Mitocin-C; Mitomycin; Mitomycin C; Mitomycin-C; MMC,Launched,DNA alkylating agent|DNA synthesis inhibitor,,oncology,pancreatic cancer|gastric adenocarcinoma,mitomycin-C,
C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,Bexarotene,"4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid; 4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid; Bexaroten; Bexarotène; Bexarotene; Bexaroteno; Bexarotenum; p-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid",Launched,retinoid receptor agonist,RXRA|RXRB|RXRG,hematologic malignancy,cutaneous T-cell lymphoma (CTCL),bexarotene,
CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1,Ibutilide,Ibutilid; Ibutilida; Ibutilide; Ibutilidum; N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide,Launched,potassium channel blocker,CACNA1C|KCNH2,cardiology,atrial fibrillation (AF),ibutilide,
CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,Vindesine,3-(aminocarbonyl)-O4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine; 3-carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine; Desacetylvinblastine amide; Vindesina; Vindesine; Vindesinum,Launched,tubulin polymerization inhibitor,TUBB|TUBB1,oncology,breast cancer|non-small cell lung cancer (NSCLC)|melanoma,vindesine,
NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,Chlorthalidone,"1-keto-3-(3'-sulfamyl-4'-chlorophenyl)-3-hydroxyisoindoline; 1-oxo-3-(3-sulfamyl-4-chlorophenyl)-3-hydroxyisoindoline; 2-chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide; 2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulfonamide; 3-(4'-chloro-3'-sulfamoylphenyl)-3-hydroxyphthalimidine; 3-hydroxy-3-(4-chloro-3-sulfamylphenyl)phthalimidine; Chlorphthalidolone; Chlortalidone; Chlortalidonum; Chlorthalidone; Clortalidona; Phthalamodine; Phthalamudine",Launched,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7|SLC12A1,cardiology|gastroenterology|rheumatology|nephrology,hypertension|edema|congestive heart failure|hepatic cirrhosis|nephrotic syndrome|acute glomerulonephritis (AGN)|chronic renal failure,chlorthalidone,
C[C@@H]1NC(=O)[C@@H](N)CNC(=O)[C@H]([C@H]2CCN=C(N)N2)NC(=O)/C(=C\NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC1=O.NCCC[C@H](N)CC(=O)NC[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC(=O)[C@H]([C@H]2CCN=C(N)N2)NC(=O)/C(=C\NC(N)=O)NC1=O,Capreomycin,Capreomicina; Capreomycin,Launched,protein synthesis inhibitor,,infectious disease,tuberculosis,capreomycin,
CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12,Zolmitriptan,"(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one; 4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one; Zolmitriptan; Zolmitriptán; Zolmitriptanum",Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,neurology/psychiatry,migraine headache,zolmitriptan,
CC(=O)Nc1ccc(O)cc1,Acetaminophen,4-(Acetylamino)phenol; 4-acetamidophenol; 4'-hydroxyacetanilide; Acenol; Acetaminofén; Acetaminophen; Acétaminophène; APAP; N-acetyl-p-aminophenol; p-acetamidophenol; p-acetaminophenol; p-Acetylaminophenol; p-hydroxy-acetanilid; p-hydroxyacetanilide; p-hydroxyphenolacetamide; Paracetamol; Paracétamol; Paracetamolum,Launched,cyclooxygenase inhibitor,FAAH|PTGS1|PTGS2|TRPV1,neurology/psychiatry|endocrinology,pain relief|fever,paracetamol,
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,Gefitinib,4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; Gefitinib; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine,Launched,EGFR inhibitor,EGFR,oncology,non-small cell lung cancer (NSCLC),gefitinib,
CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O,Piperacillin,"(2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Piperacilina; Piperacillin; Piperacillin anhydrous; Piperacillina; Pipéracilline; Piperacillinum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,intra-abdominal infections|skin infections|pelvic inflammatory disease|pneumonia,piperacillin,
CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,Dihydroergotamine,"(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide; 5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman; 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione; 9,10-dihydroergotamine; Dihidroergotamina; Dihydroergotamin; Dihydroergotamine; Dihydroergotaminum; Diidroergotamina",Launched,serotonin receptor agonist,ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,neurology/psychiatry,migraine headache,dihydroergotamine,
CN(C)CCC=C1c2ccccc2CCc2ccccc21,Amitriptyline,"10,11-dihydro-5-(γ-dimethylaminopropylidene)-5H-dibenzo(a,d)cycloheptene; 10,11-dihydro-N,N-dimethyl-5H-dibenzo(a,d)heptalene-Δ5,γ-propylamine; 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine; 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine; 5-(3-dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptatriene; 5-(3-dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene; 5-(γ-dimethylaminopropylidene)-5H-dibenzo[a,d][1,4]cycloheptadiene; Amitriptilina; Amitriptylin; Amitriptyline; Amitriptylinum",Launched,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin–norepinephrine reuptake inhibitor (SNRI),ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4,neurology/psychiatry,depression,amitriptyline,
O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F,Floxuridine,1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil; 1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil; 1beta-D-2'-Deoxyribofuranosyl-5-flurouracil; 2'-Deoxy-5-fluorouridine; 5-Fluoro-2-desoxyuridine; 5-fluoro-2'-deoxyuridine; 5-Fluorodeoxyuridine; 5-Fluorouracil 2'-deoxyriboside; 5-Fluorouracil deoxyriboside; 5FDU; beta-5-Fluoro-2'-deoxyuridine; Deoxyfluorouridine; FdU; Floxiridina; Floxuridin; Floxuridine; Floxuridinum; Fluorodeoxyuridine; Fluoruridine deoxyribose,Launched,DNA synthesis inhibitor,TYMS,oncology,colorectal cancer,floxuridine,
Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1,Tolcapone,"(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone; 3,4-dihydroxy-4'-methyl-5-nitrobenzophenone; 3,4-dihydroxy-5-nitro-4'-methylbenzophenone; 4'-methyl-3,4-dihydroxy-5-nitrobenzophenone; Tolcapon; Tolcapona; Tolcapone; Tolcaponum",Withdrawn,catechol O methyltransferase inhibitor,COMT,,,tolcapone,
CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,Fluorometholone,"(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one; 9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione; Fluorometholon; Fluorométholone; Fluorometholone; Fluorometholonum; Fluorometolona",Launched,glucocorticoid receptor agonist,NR3C1,ophthalmology,eye inflammation,fluorometholone,
COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,Indomethacin,{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid; 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid; Indometacin; Indometacina; Indometacine; Indometacinum; Indomethacin,Launched,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,rheumatology|orthopedics,rheumatoid arthritis|ankylosing spondylitis|osteoarthritis|bursitis|tendinitis,indomethacin,
CC[C@@H](CO)NCCN[C@@H](CC)CO,Ethambutol,"(+)-2,2'-(ethylenediimino)di-1-butanol; (+)-ethambutol; (+)-N,N'-bis(1-(hydroxymethyl)propyl)ethylenediamine; (+)-S,S-ethambutol; (2S,7S)-2,7-diethyl-3,6-diazaoctane-1,8-diol; (S,S)-ethambutol; EMB; Etambutol; Etambutolo; Ethambutol; Ethambutolum; S,S-Ethambutol",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,tuberculosis,ethambutol,
CN(C)C(=N)NC(=N)N,Metformin,"1,1-Dimethylbiguanide; Dimethylbiguanid; Metformin; Metformina; Metformine; Metforminum",Launched,insulin sensitizer,ACACB|PRKAB1,endocrinology,diabetes mellitus,metformin,
CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2,Ipratropium,bromuro de ipratropio; Ipratropium cation; Ipratropium ion,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,pulmonary,bronchospasm|chronic obstructive pulmonary disease (COPD)|bronchitis|emphysema,ipratropium,
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,Olanzapine,"2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; Olanzapin; Olanzapina; Olanzapine; Olanzapinum",Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,neurology/psychiatry,schizophrenia|bipolar disorder,olanzapine,
NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1,Nitrofural,5-Nitro-2-furaldehyde semicarbazone; Furacilin; Nitrofural; Nitrofurazone,Launched,bacterial DNA inhibitor,,infectious disease,first-aid antibiotic,nitrofurazone,
CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@H](Cl)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,Pimecrolimus,33-Epi-chloro-33-desoxyascomycin; Pimecrolimus; Pimecrolimusum,Launched,calcineurin inhibitor,,dermatology,eczema,pimecrolimus,
COc1ccc2nc(S(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1,Omeprazole,OMEP; Omeprazol; Omeprazole; Omeprazolum,Launched,ATPase inhibitor,ATP4A|CLCN2,gastroenterology,heartburn,omeprazole,
NC(=O)c1cnccn1,Pyrazinamide,2-carbamylpyrazine; 2-pyrazinecarboxamide; Aldinamide; Pirazinamida; Pirazinamide; Pyrazinamid; Pyrazinamida; Pyrazinamide; Pyrazinamidum; Pyrazine carboxamide; pyrazine-2-carboxamide; Pyrazineamide; Pyrazinecarboxamide; Pyrazinoic acid amide; Pyrizinamide,Launched,fatty acid synthase inhibitor,FASN,infectious disease,tuberculosis,pyrazinamide,
CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1,Metixene,Methixen; Methixene; Metisene; Metixene; Métixène; Metixeno; Metixenum,Launched,acetylcholine receptor antagonist,CHRM5,neurology/psychiatry,Parkinson's Disease,metixene,
O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,Cetirizine,Cetirizin; Cetirizina; Cetirizine; Cetirizinum,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis,cetirizine,
CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,Terfenadine,(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol; Terfenadin; Terfenadina; Terfénadine; Terfenadine; Terfenadinum,Withdrawn,histamine receptor antagonist,HRH1|KCNH1|KCNH2,,,terfenadine,
COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,Diltiazem,"(+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester; (2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one; (2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate; Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester; d-cis-diltiazem; Diltiazem; Diltiazemum",Launched,calcium channel blocker,CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5,cardiology,hypertension|angina pectoris,diltiazem,
CNCCCC1c2ccccc2C=Cc2ccccc21,Protriptyline,"3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine; 3-(5H-dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine; 5-(3-methylaminopropyl)-5H-dibenzo[a,d]cycloheptene; 7-(3-methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene; Amimetilina; N-methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine; N-methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine; Protriptilina; Protriptylin; Protriptyline; Protriptylinum",Launched,tricyclic antidepressant,SLC6A2|SLC6A4,neurology/psychiatry,depression,protriptyline,
COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC,Alfuzosin,"(±)-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide; Alfuzosin; Alfuzosina; Alfuzosine; Alfuzosinum; N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide",Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,urology,benign prostatic hyperplasia (BPH),alfuzosin,
CN1C(=O)OC(C)(C)C1=O,Trimethadione,Trimetadiona; Trimethadion; Trimethadione; Triméthadione; Trimethadionum; Trimethinum; Troxidone,Launched,oxazolidine antiepileptic,CACNA1G|CACNA1H|CACNA1I,neurology/psychiatry,seizures,trimethadione,
O=C1CCCC(=O)C1C(=O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-],Nitisinone,"2-(alpha,alpha,alpha-Trifluoro-2-nitro-p-tuluoyl)-1,3-cyclohexanedione; Nitisinona; Nitisinone; Nitisinonum",Launched,hydroxyphenylpyruvate dioxygenase inhibitor,,metabolism,tyrosinemia,nitisinone,
Nc1cc(N2CCCCC2)nc(N)[n+]1[O-],Minoxidil,"2,4-Diamino-6-piperidinopyrimidine 3-oxide; 6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide; Minossidile; Minoxidil; Minoxidilum",Launched,KATP activator|Kir6 channel (KATP) activator|vasodilator,ABCC9|KCNJ1|KCNJ10|KCNJ11|KCNJ8|PTGS1,endocrinology,androgenetic alopecia,minoxidil,
Nc1nc(=S)c2[nH]cnc2[nH]1,Tioguanine,"2-Amino 6MP; 2-Amino-1,7-dihydro-6H-purine-6-thione; 2-amino-1,9-dihydropurine-6-thione; 2-Amino-6-mercaptopurine; 2-Amino-6-merkaptopurin; 2-Amino-6-purinethiol; 2-Aminopurin-6-thiol; 2-Aminopurine-6-thiol; 2-Aminopurine-6(1H)-thione; 6-Mercapto-2-aminopurine; 6-Mercaptoguanine; 6-TG; 6-Thioguanine; TG; ThG; Thioguanine; Thioguanine anhydrous; Thioguanine, anhydrous; Tioguanin; Tioguanina; Tioguanine; Tioguaninum",Launched,purine antagonist,,hematologic malignancy,acute myeloid leukemia (AML)|acute lymphoblastic leukemia (ALL)|chronic myeloid leukemia (CML),tioguanine,
CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,Methylergometrine,"9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide; D-lysergic acid 1-butanolamide; Ergotyl; Methylergobasin; Methylergometrin; Méthylergométrine; Methylergometrine; Methylergometrinum; Methylergonovine; Metilergometrina; Metilergometrinio",Launched,dopamine receptor antagonist|serotonin receptor antagonist,DRD1|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C,hematology|neurology/psychiatry,postpartum hemorrhage (PPH)|migraine headache,methylergometrine,
CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1,Buclizine,1-(p-tert-Butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine; Buclizina; Buclizine; Buclizinum,Launched,histamine receptor antagonist,HRH1,neurology/psychiatry,migraine headache,buclizine,
C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc([NH3+])n2)C(=O)N1S(=O)(=O)[O-],Aztreonam,"(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfo-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid; 2-({[(1Z)-1-(2-amino-1,3-thiazol-4-yl) -2- {[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino} -2- oxoethylidene]amino}oxy)-2-methylpropanoic acid; Aztreonam; Aztréonam; Aztreonamum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,urinary tract infections|respiratory tract infections|bacterial septicemia|skin infections|intra-abdominal infections|gynecologic infections,aztreonam,
O=c1[nH]c2cc(Cl)ccc2o1,Chlorzoxazone,2-hydroxy-5-chlorobenzoxazole; 5-chloro-2-benzoxazolinone; 5-chloro-2-benzoxazolol; 5-chloro-2-benzoxazolone; 5-chloro-2-hydroxybenzoxazole; 5-chloro-2(3H)-benzoxazolone; 5-chloro-3H-benzooxazol-2-one; 5-chlorobenzoxazolidone; 5-chlorobenzoxazolin-2-one; Chlorzoxane; Chlorzoxazon; Chlorzoxazona; Chlorzoxazone; Chlorzoxazonum; Clorzoxazona; Clorzoxazone,Launched,bacterial 30S ribosomal subunit inhibitor,KCNMA1|KCNN4,neurology/psychiatry,muscle relaxant,chlorzoxazone,
CCC1(c2ccc(N)cc2)CCC(=O)NC1=O,Aminoglutethimide,"2-(p-Aminophenyl)-2-ethylglutarimide; 3-Ethyl-3-(p-aminophenyl)-2,6-dioxopiperidine; Aminoglutethimid; Aminoglutéthimide; Aminoglutethimide; Aminoglutethimidum; Aminoglutetimida; Aminoglutetimide; DL-Aminoglutethimide; p-Aminoglutethimide; α-(p-Aminophenyl)-α-ethylglutarimide",Launched,glucocorticoid receptor antagonist,CYP11A1|CYP19A1,endocrinology|oncology,Cushing's syndrome|breast cancer,aminoglutethimide,
OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1,Mefloquine,"(DL-ERYTHRO-.ALPHA.-2-PIPERIDYL-2,8-BIS(TRIFLUOROMETHYL)-4-QUINOLINEMETHANOL; [(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol; 4-QUINOLINEMETHANOL, .ALPHA.-2-PIPERIDINYL-2,8-BIS(TRIFLUOROMETHYL)-, (R*,S*)-(±)-; alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol; Mefloquin; Mefloquina; Méfloquine; Mefloquine; Mefloquinum",Launched,adenosine receptor antagonist|hemoglobin antagonist,,infectious disease,malaria,mefloquine,
Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1,Sulfadiazine,2-sulfanilamidopyrimidine; 2-sulfanilylaminopyrimidine; 4-amino-N-2-pyrimidinylbenzenesulfonamide; N(1)-2-Pyrimidinylsulfanilamide; N(1)-2-Pyrimidylsulfanilamide; Sulfadiazin; Sulfadiazina; Sulfadiazine; Sulfadiazinum; Sulfapyrimidine; Sulphadiazine,Launched,bacterial antifolate,,infectious disease|ophthalmology,malaria|meningitis|urinary tract infections|conjunctivitis|trachoma|chancroid,sulfadiazine,
C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)[nH]c(=O)c2N1,Sapropterin,"(−)-(6R)-2-amino-6-((1R,2S)-1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-4(3H)-pteridinone; (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin; (6R)-L-erythro-tetrahydrobiopterin; 2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone; 5,6,7,8-Tetrahydrobiopterin; 6R-5,6,7,8-tetrahydrobiopterin; 6R-BH4; 6R-L-5,6,7,8-tetrahydrobiopterin; R-THBP; Sapropterin; Sapropterina; sapropterinum; Tetrahydrobiopterin",Launched,phenylalanine 4-hydroxylase stimulant,NOS3|PAH|TH|TPH1,metabolism,hyperphenylalaninemia (HPA),sapropterin,
CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,Vinorelbine,5'-Noranhydrovinblastine; Vinorelbin; Vinorelbina; Vinorelbine; Vinorelbinum,Launched,tubulin polymerization inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,oncology,non-small cell lung cancer (NSCLC),vinorelbine,
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,Clozapine,Clozapin; Clozapina; Clozapine; Clozapinum,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,neurology/psychiatry,schizophrenia,clozapine,
O.O=S(=O)(OC[C@H]1O[C@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O)O[Al](O)O.O[Al](O)O,Sucralfate,"Hexadeca-μ-hydroxytetracosahydroxy[μ8-[1,3,4,6-tetra-O-sulfo-β-Dfructofuranosyl-α-D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum; Sucralfat; Sucralfate; Sucralfato; Sucralfatum",Launched,antacid,,gastroenterology,duodenal ulcer disease,sucralfate,
CN(C)CCOC(C)(c1ccccc1)c1ccccn1,Doxylamine,"2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine; 2-Dimethylaminoethoxyphenylmethyl-2-picoline; Dossilamina; Doxilamina; Doxilminio; Doxylamine; Doxylaminum; N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine; Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether",Launched,histamine receptor antagonist,HRH1,neurology/psychiatry,sedative,doxylamine,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC,Levonorgestrel,"(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one; (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one; 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one; 13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one; 13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one; 17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one; 17-alpha-Ethynyl-13-ethyl-19-nortestosterone; 17-Ethynyl-18-methyl-19-nortestosterone; 17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol; 17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one; 17alpha-Ethynyl-18-homo-19-nortestosterone; 18-Methyl-17-alpha-ethynyl-19-nortestosterone; 18-Methylnorethisterone; d(-)-Norgestrel; Lèvonorgestrel; Levonorgestrel; Levonorgestrelum",Launched,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,endocrinology,contraceptive,levonorgestrel,
NC[C@H](O)c1ccc(O)c(O)c1,Norepinephrine,"(−)-arterenol; (−)-noradrenaline; (−)-norepinephrine; (R)-(−)-norepinephrine; (R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol; (R)-noradrenaline; (R)-norepinephrine; 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; Arterenol; L-noradrenaline; L-Norepinephrine; Nor-adrenaline; Noradrenaline; Norepinefrina; Norépinéphrine; Norepinephrine; Norepinephrinum",Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|SLC18A1|SLC18A2,cardiology|allergy|neurology/psychiatry,hypertension|urticaria|headache|seasonal affective disorder,norepinephrine,
Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1,Cidofovir,"({[(S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid; (S)-(3-(4-amino-2-Oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-1-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine; (S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine; (S)-HPMPC; [(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid; [[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid; 1-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine; 1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine; CDV; Cidofovir; Cidofovir anhydrous; Cidofovirum",Launched,DNA polymerase inhibitor,,infectious disease,acquired immunodeficiency syndrome (AIDS)|cytomegalovirus retinitis,cidofovir,
CN1CCN2c3ncccc3Cc3ccccc3C2C1,Mirtazapine,"1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine; 6-Azamianserin; Mepirzapine; Mirtazapin; Mirtazapina; Mirtazapine; Mirtazapinum",Launched,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR2A|HTR2C,neurology/psychiatry,depression,mirtazapine,
CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,Thiethylperazine,2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine; Norzine; Thiethylperazin; Thiéthylpérazine; Thiethylperazine; Thiethylperazinum; Tietilperazina,Launched,dopamine receptor antagonist,DRD1|DRD2|DRD4,gastroenterology,nausea,thiethylperazine,
CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1,Timolol,"(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol; Timolol; Timolol anhydrous; Timololo; Timololum",Launched,adrenergic receptor antagonist,ADRB1|ADRB2,ophthalmology,ocular hypertension|glaucoma,timolol,
CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O,Treprostinil,Tréprostinil; Treprostinil; Treprostinilo; Treprostinilum,Launched,prostanoid receptor agonist,P2RY12|PPARD|PTGIR,pulmonary,pulmonary arterial hypertension (PAH),treprostinil,
OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1,Trihexyphenidyl,Trihexifenidilo; Trihexyphenidyl; Trihexyphénidyle; Trihexyphenidylum,Launched,acetylcholine receptor antagonist,CHRM1,neurology/psychiatry,parkinsonism,trihexyphenidyl,
O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2,Palonosetron,"(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one; 2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one; Palonosétron; Palonosetron; Palonosetrón; Palonosetronum",Launched,serotonin receptor antagonist,HTR3A,gastroenterology,nausea|vomiting,palonosetron,
CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C,Dydrogesterone,"(9β,10α)-pregna-4,6-diene-3,20-dione; 10α-Isopregnenone; 6-Dehydro-retro-progesterone; 9β,10α-pregna-4,6-diene-3,20-dione; delta(6)-Retroprogesterone; delta(sup 6)-Retroprogesterone; Didrogesterona; Didrogesterone; Dydrogesterona; Dydrogesterone; Dydrogestérone; Dydrogesteronum; Gestatron; Hydrogesterone; Hydrogestrone; Isopregnenone; Retro-6-dehydroprogesterone",Launched,progesterone receptor agonist,PGR,obstetrics/gynecology,infertility,dydrogesterone,
Cc1cccc(C)c1OCC(C)N,Mexiletine,"(±)-1-(2,6-dimethylphenoxy)propan-2-amine; (2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane; 1-(2,6-dimethylphenoxy)-2-propanamine; 1-(2',6'-dimethylphenoxy)-2-aminopropane; 1-methyl-2-(2,6-xylyloxy)ethanamine; Mexiletina; Mexilétine; Mexiletine; Mexiletinum",Launched,sodium channel blocker,PLAU|SCN4A|SCN5A,cardiology,ventricular arrhythmias|ventricular tachycardia (VT),mexiletine,
C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,Dexrazoxane,"(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione; (+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane; 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione; Dexrazoxan; Dexrazoxane; Dexrazoxano; Dexrazoxanum; Dextrorazoxane",Launched,chelating agent|topoisomerase inhibitor,TOP2A|TOP2B,cardiology,cardiomyopathy,dexrazoxane,
CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,Amlodipine,"(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate; 3-Ethyl 5-methylester, (±)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate; Amlodipine; Amlodipine free base; Amlodipino; Amlodipinum",Launched,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1,cardiology,hypertension|chronic stable angina|vasospastic angina|coronary artery disease (CAD),amlodipine,
Nc1c2c(nc3ccccc13)CCCC2,Tacrine,"1,2,3,4-tetrahydro-9-acridinamine; 1,2,3,4-tetrahydro-9-aminoacridine; 1,2,3,4-tetrahydroacridin-9-amine; 5-amino-6,7,8,9-tetrahydroacridine; 9-amino-1,2,3,4-tetrahydroacridine; Tacrin; Tacrine; Tacrinum; Tetrahydroaminacrine; Tetrahydroaminoacridine; THA",Launched,acetylcholinesterase inhibitor,ACHE|BCHE,neurology/psychiatry,Alzheimer's disease,tacrine,
CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1,Oxyphencyclimine,Oxifencicliminum; Oxyphencyclimine; Oxyphencycliminum,Launched,cholinergic receptor antagonist,,gastroenterology,peptic ulcer disease (PUD),oxyphencyclimine,
Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,Triamterene,"6-phenylpteridine-2,4,7-triamine; Teridin; Triamteren; Triamterena; Triamtérène; Triamterene; Triamtereno; Triamterenum",Launched,sodium channel blocker,SCNN1A|SCNN1B|SCNN1D|SCNN1G,endocrinology|cardiology,hypokalemia|hypertension|edema,triamterene,
CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O,Valrubicin,"(8S, 10S)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 8²-valerate; 2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate; Valrubicin; Valrubicina; Valrubicine; Valrubicinum",Launched,DNA inhibitor|topoisomerase inhibitor,TOP2A,oncology,bladder cancer,valrubicin,
OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1,Procyclidine,1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride; 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol; Prociclidina; Procyclidin; Procyclidine; Procyclidinum; Tricyclamol,Launched,acetylcholine receptor antagonist,,neurology/psychiatry,parkinsonism|Parkinson's Disease|akathisia|dystonia,procyclidine,
CNC[C@H](O)c1cccc(O)c1,Phenylephrine,(−)-m-hydroxy-α-(methylaminomethyl)benzyl alcohol; Fenilefrina; l-(3-Hydroxyphenyl)-N-methylethanolamine; Phenylephrine; Phenylephrinum; R(-)-Phenylephrine,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,otolaryngology|gastroenterology|cardiology,nasal congestion|hemorrhoids|hypotension,phenylephrine,
CCOC(=O)n1ccn(C)c1=S,Carbimazole,Athyromazole; Carbethoxymethimazole; Carbimazol; Carbimazole; Carbimazolo; Carbimazolum; Carbinazole; Ethyl 3-methyl-2-thioimidazoline-1-carboxylate,Launched,antithyroid agent,TPO,endocrinology,hyperthyroidism,carbimazole,
C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,Digoxin,12β-hydroxydigitoxin; Digossina; Digoxin; Digoxina; Digoxine; Digoxinum,Launched,ATPase inhibitor,ATP1A1,cardiology,congestive heart failure|atrial fibrillation (AF),digoxin,
CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,Sulpiride,(±)-sulpiride; 5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide; N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide; N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide; Sulpirid; Sulpirida; Sulpiride; Sulpiridum; Sulpyrid,Launched,dopamine receptor antagonist,,neurology/psychiatry,schizophrenia,sulpiride,
CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21,Profenamine,"10-(2-diethylaminopropyl)phenothiazine; 10-[2-(diethylamino)-1-propyl]phenothiazine; 10-[2-(diethylamino)-2-methylethyl]phenothiazine; 10-[2-(diethylamino)propyl]phenothiazine; 2-diethylamino-1-propyl-N-dibenzoparathiazine; Ethopropazine; N,N-diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine; N,N-diethyl-α-methyl-10H-phenothiazine-10-ethanamine; Profenamina; Profenamine; Profénamine; Profenaminum",Launched,butyrylcholinesterase inhibitor|cholinergic receptor antagonist,CHRM1,neurology/psychiatry,Parkinson's Disease,profenamine,
COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,Nimodipine,"2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-β-methoxyethyl ester 5-isopropyl ester; isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate; isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; Nimodipine; Nimodipino; Nimodipinum",Launched,calcium channel blocker,CFTR|NR3C2,hematology,hemorrhage,nimodipine,
CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,Progesterone,"(S)-4-Pregnene-3,20-dione; (S)-Pregn-4-en-3,20-dione; (S)-Progesterone; 17alpha-Progesterone; 17α-progesterone; 4-Pregnene-3,20-dione; Agolutin; Akrolutin; Corpus Luteum Hormone; delta(4)-Pregnene-3,20-dione; Gelbkörperhormon; Luteohormone; Lutogynon; Pregn-4-ene-3,20-dione; Progesteron; Progesterona; Progestérone; Progesterone; Progesteronum",Launched,progesterone receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5,obstetrics/gynecology|endocrinology,infertility|amenorrhea,progesterone,
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,Sorafenib,4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; Sorafenib; Sorafénib; Sorafenibum,Launched,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,oncology,renal cell carcinoma (RCC)|thyroid cancer|hepatocellular carcinoma (HCC),sorafenib,
COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O,Griseofulvin,"(+)-griseofulvin; Amudane; Griseofulvin; Griseofulvin, microcrystalline; Griseofulvin, ultramicrosize; Griseofulvina; Griséofulvine; Griseofulvinum",Launched,tubulin polymerization inhibitor,KRT12,infectious disease,ringworm|tinea pedis,griseofulvin,
COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],Nisoldipine,"isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nisoldipin; Nisoldipina; Nisoldipine; Nisoldipino; Nisoldipinum",Launched,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S,cardiology,hypertension,nisoldipine,
CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,Ceruletide,Caerulein; Cerulein; Ceruletida; Ceruletide; Ceruletidum,Preclinical,CCK receptor agonist,CCKAR,,,ceruletide,
CN(C)CC[C@@H](c1ccc(Br)cc1)c1ccccn1,Dexbrompheniramine,"(+)-brompheniraminum; (R)-3-(4-Bromophenyl)-3-(2-pyridyl)propyldimethylamine; (S)-(+)-brompheniramine; (S)-brompheniramine; 3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine; d-brompheniramine; Desbrofeniramina; Dexbromfeniramina; Dexbrompheniramin; Dexbromphéniramine; Dexbrompheniramine; Dexbrompheniraminum",Launched,histamine receptor antagonist,HRH1,allergy|otolaryngology,allergic rhinitis|common cold,brompheniramine,
CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,Loxapine,"2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine; Loxapina; Loxapine; Loxapinum; Oxilapine",Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,schizophrenia,loxapine,
CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC,Remoxipride,Remoxiprida; Remoxipride; Remoxipridum,Withdrawn,dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|SIGMAR1,,,remoxipride,
C/C(=C\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O,Mupirocin,"9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3- [(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl] oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid; Mupirocin; Mupirocina; Mupirocine; Mupirocinum; Pseudomonic acid; Pseudomonic acid A",Launched,isoleucyl-tRNA synthetase inhibitor,,infectious disease,impetigo,mupirocin,
CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,Rosiglitazone,"(±)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione; (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion; Rosiglitazon; Rosiglitazona; Rosiglitazone; Rosiglitazonum",Withdrawn,insulin sensitizer|PPAR receptor agonist,FFAR1|PPARG|TRPC5|TRPM3,,,rosiglitazone,
CCCN[C@H]1CCc2nc(N)sc2C1,Pramipexole,"(-)-Pramipexole; (S)-N  6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; Pramipexol; Pramipexole; Pramipexolum",Launched,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,neurology/psychiatry,Parkinson's Disease,pramipexole,
CC(=O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,Acetohexamide,1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea; 1-[(4-acetylbenzene)sulfonyl]-3-cyclohexylurea 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide; Acetohexamid; Acetohexamida; Acétohexamide; Acetohexamide; Acetohexamidum; N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea,Launched,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,endocrinology,diabetes mellitus,acetohexamide,
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O,Ampicillin,"ABPC; Aminobenzylpenicillin; Ampicilina; Ampicillin; Ampicillin (anhydrous); Ampicillin acid; Ampicillin anhydrous; Ampicillin, anhydrous; Ampicilline; Ampicillinum; Anhydrous ampicillin; AP; D-(−)-6-(α-aminophenylacetamido)penicillanic acid; D-(−)-ampicillin",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,respiratory tract infections|meningitis|bacterial septicemia|endocarditis|urinary tract infections|gastrointestinal infections,ampicillin,
CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,Miglustat,"1,5-(butylimino)-1,5-dideoxy, D-glucitol; AT2221; BuDNJ; Butyldeoxynojirimycin; Miglustat; Miglustatum; N-(n-Butyl)deoxynojirimycin; n-Butyl deoxynojirimycin; N-butyl-1-deoxynojirimycin; N-butyl-deoxynojirimycin; N-Butylmoranoline; NB-DNJ",Launched,glycosyl transferase inhibitor,UGCG,hematology,Gaucher disease,miglustat,
CN(C)CCCN1c2ccccc2Sc2ccccc21,Promazine,"10-(3-(Dimethylamino)propyl)phenothiazine; N-(3-Dimethylaminopropyl)phenothiazine; N-Dimethylamino-1-methylethyl thiodiphenylamine; N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine; Promazin; Promazina; Promazine; Promazinum",Launched,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|HRH1|HTR2A|HTR2C,neurology/psychiatry,schizophrenia,promazine,
CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21,Spironolactone,Espironolactona; Spironolactone; Spironolactonum; Spironolattone,Launched,mineralocorticoid receptor antagonist,AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG,endocrinology|cardiology|gastroenterology|rheumatology,hyperaldosteronism|congestive heart failure|hepatic cirrhosis|nephrotic syndrome|hypertension|hypokalemia,spironolactone,
COc1ccccc1OCC(O)COC(N)=O,Methocarbamol,(RS)-2-hydroxy-3-(2-methoxyphenoxy)propyl carbamate; Methocarbamol; Méthocarbamol; Methocarbamolum; Metocarbamol; Metocarbamolo,Launched,muscle relaxant,CA1,neurology/psychiatry,muscle relaxant,methocarbamol,
CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)[C@H](CO)c1ccccc1)C2,Hyoscyamine,(−)-atropine; (−)-hyoscyamine; (S)-(−)-hyoscyamine; (S)-atropine; [3(S)-endo]-α-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester; Daturin; Daturine; Duboisine; Hyoscyamin; Hyoscyamine; Hyoscyaminum; L-Hyoscyamine; L-Tropine tropate; Tropine-L-tropate,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,gastroenterology|urology|neurology/psychiatry|allergy,peptic ulcer disease (PUD)|acute abdominal visceral spasm|ulcerative colitis|interstitial cystitis (IC)|enterocolitis|irritable bowel syndrome|tremors|allergic rhinitis,hyoscyamine,
CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O,Famciclovir,"2-(2-(2-amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate; 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine; acetic acid 2-acetoxymethyl-4-(2-amino-purin-9-yl)-butyl ester; Famciclovir; Famciclovirum; FCV",Launched,DNA polymerase inhibitor,,dental|infectious disease,cold sore|genitial herpes|shingles,famciclovir,
Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1,Triprolidine,(E)-2-[3-(1-pyrrolidinyl)-1-p-toluenepropenyl]pyridine; trans-1-(2-pyridyl)-3-pyrrolidino-1-p-tolylprop-1-ene; trans-1-(4-methylphenyl)-1-(2-pyridyl)-3-pyrrolidinoprop-1-ene; Tripolidina; Triprolidin; Triprolidina; Triprolidine; Triprolidinum,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis,triprolidine,
CN(N=O)C(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO,Streptozocin,"1-METHYL-1-NITROSO-3-((2R,3R,4S,5R)-3,4,5,6-TETRAHYDROXY-1-OXOHEXAN-2-YL)UREA; 1-METHYL-1-NITROSO-3-((3R,4R,5S,6R)-2,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3-YL)UREA; 2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose; 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose; D-GLUCOPYRANOSE, 2-DEOXY-2-(((METHYLNITROSOAMINO)CARBONYL)AMINO)-; Estreptozocina; N-D-Glucosyl-(2)-N'-nitrosomethylharnstoff; N-D-Glucosyl-(2)-N'-nitrosomethylurea; Streptozocin; Streptozocine; Streptozocinium; Streptozocinum; Streptozotocin",Launched,DNA alkylating agent,,oncology,pancreatic cancer,streptozotocin,
Cc1cc(O)c(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)cn1,Cefpiramide,Cefpiramide; Cefpiramido; Cefpiramidum,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,cefpiramide,
Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl,Lindane,"(1r,2c,3t,4c,5c,6t)-1,2,3,4,5,6-hexachlorocyclohexane; (1α,2α,3β,4α,5α,6β)-1,2,3,4,5,6-hexachlorocyclohexane; 1,2,3,4,5,6-hexachlorocyclohexane; Benzene hexachloride; gamma-1,2,3,4,5,6-hexachlorocyclohexane; gamma-benzene hexachloride; gamma-BHC; gamma-HCH; gamma-Hexachlorocyclohexane; gamma-Lindane; Gammallin; Gammaxene; Lindan; Lindane; Lindano; Lindanum; γ-hexachlorocyclohexane; γ-Hexachlorzyklohexan; γ-lindane",Launched,,GABRB1|GLRA1|GLRA2|GLRA3|GLRB,infectious disease,scabies,lindane,
O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F,Trifluridine,5-(Trifluoromethyl)deoxyuridine; 5-Trifluoromethyl-2-deoxyuridine; F₃T; TFT; Trifluoromethyldeoxyuridine; Trifluorothymidine; Trifluorothymine deoxyriboside; Trifluridin; Trifluridina; Trifluridine; Trifluridinum,Launched,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,TYMS,infectious disease,virus herpes simplex (HSV),trifluridine,
CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,Prochlorperazine,2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine; 2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine; 3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine; 3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine; Capazine; Chlormeprazine; Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine; Chloropernazine; N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine; Prochlorperazin; Prochlorperazine; Prochlorpérazine; Prochlorperazinum; Prochlorpermazine; Prochlorpromazine; Procloperazine; Proclorperazina,Launched,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4,gastroenterology,nausea|vomiting,prochlorperazine,
CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,Cyproheptadine,"1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine; 1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine; 4-(5-dibenzo(a,d)cyclohepten-5-ylidine)-1-methylpiperidine; 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine; 4-Dibenzo[a,d]cyclohepten-5-ylidene-1-methyl-piperidine; 5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene; Ciproheptadina; Cyproheptadin; Cyproheptadine; Cyproheptadinum",Launched,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7,allergy|otolaryngology|ophthalmology|dermatology,allergic rhinitis|vasomotor rhinitis|conjunctivitis|urticaria|dermatographism,cyproheptadine,
NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,Bendroflumethiazide,"±-3-benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide; Bendrofluazide; Bendroflumethiazid; Bendrofluméthiazide; Bendroflumethiazide; Bendroflumethiazidum; Bendroflumetiazida; Benzhydroflumethiazide",Launched,sodium/potassium/chloride transporter inhibitor,SLC12A1|SLC12A3,cardiology,hypertension,bendroflumethiazide,
Oc1ncnc2[nH]ncc12,Allopurinol,"1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one; 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidine-4-one; 1H-Pyrazolo(3,4-d)pyrimidin-4-ol; 4-HPP; 4-Hydroxy-1H-pyrazolo(3,4-d)pyrimidine; 4-Hydroxy-3,4-pyrazolopyrimidine; 4-Hydroxypyrazolo(3,4-d)pyrimidine; 4-Hydroxypyrazolopyrimidine; 4-Hydroxypyrazolyl(3,4-d)pyrimidine; 4'-Hydroxypyrazolol(3,4-d)pyrimidine; 4H-Pyrazolo(3,4-d)pyrimidin-4-one; Allopurinol; Allopurinolum; Alopurinol",Launched,xanthine oxidase inhibitor,XDH,rheumatology|urology,gout|kidney stones,allopurinol,
CC(C)(O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1)C(=O)O,Ceftazidime,CAZ; Ceftazidim; Ceftazidima; Ceftazidime; Ceftazidime anhydrous; Ceftazidimum,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,respiratory tract infections|skin infections|bacterial septicemia|bone and joint infections|gynecologic infections|intra-abdominal infections|meningitis,ceftazidime,
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Trimethoprim,"2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine; 5-[(3,4,5-trimethoxyphenyl)methyl]-2,4-pyrimidinediamine; Trimethoprim; Triméthoprime; Trimethoprimum; Trimetoprima",Launched,dihydrofolate reductase inhibitor,DHFR|TYMS,infectious disease|gastroenterology,urinary tract infections|ear infections|diarrhea,trimethoprim,
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,Gemcitabine,"2'-Deoxy-2',2'-difluorocytidine; 2',2'-Difluorodeoxycytidine; 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; Gemcitabin; Gemcitabina; Gemcitabine; Gemcitabinum",Launched,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,oncology,ovarian cancer|breast cancer|non-small cell lung cancer (NSCLC)|pancreatic cancer,gemcitabine,
C=C1[C@@H](n2cnc3c(=O)nc(N)[nH]c32)C[C@H](O)[C@H]1CO,Entecavir,Anhydrous entecavir; Entecavir; Entecavir (anhydrous); Entecavir anhydrous; Entecavirum,Launched,DNA replication inhibitor|nucleoside reverse transcriptase inhibitor,,infectious disease,hepatitis B,entecavir,
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,Betamethasone,"16β-Methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione; 9-Fluoro-16β-methylprednisolone; 9α-Fluoro-16β-methylprednisolone; beta-Methasone alcohol; Betadexamethasone; Betametasona; Betamethasone; Bétaméthasone; Betamethasonum",Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,betamethasone,
COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,Teniposide,"4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside); Epidophyllotoxin; Teniposid; Téniposide; Teniposide; Teniposido; Teniposidum",Launched,topoisomerase inhibitor,TOP2A|TOP2B,hematologic malignancy,acute lymphoblastic leukemia (ALL),teniposide,
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1,Epirubicin,"(1S,3S)-3-GLYCOLOYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-ARABINO-HEXOPYRANOSIDE; 4'-EPI-ADRIAMYCIN; 4'-Epiadriamycin; 5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-ARABINO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-, (8S-CIS)-; Epiadriamycin; Epirubicin; epirubicin-conjugated polymer micelles; Epirubicina; Epirubicine; Epirubicinum; Pidorubicina; Pidorubicine; Pidorubicinum",Launched,topoisomerase inhibitor,CHD1|TOP2A,oncology,breast cancer,epirubicin,
O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl,Chloramphenicol,"Chloramphenicol; Chloramphénicol; Chloramphenicolum; Chlornitromycin; Cloramfenicol; Cloranfenicol; D-(−)-2,2-dichloro-N-(β-hydroxy-α-(hydroxymethyl)-p-nitrophenylethyl)acetamide; D-(−)-threo-1-p-nitrophenyl-2-dichloroacetylamino-1,3-propanediol; Laevomycetinum; Levomicetina; Levomycetin",Launched,bacterial 50S ribosomal subunit inhibitor,CD55,infectious disease|endocrinology,meningitis|fever|cholera,chloramphenicol,
N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CC[C@H]12)c1ccccc1,Loracarbef,"Anhydrous loracarbef; Loracarbef; Loracarbef anhydrous; Loracarbef, anhydrous; Loracarbefum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease|otolaryngology|pulmonary,ear infections|laryngitis|bronchitis|pneumonia|urinary tract infections|skin infections,loracarbef,
Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1,Lansoprazole,Lansoprazol; Lansoprazole; Lansoprazolum,Launched,ATPase inhibitor,ATP4A|ATP4B,gastroenterology,heartburn,lansoprazole,
CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1,Dipivefrin,"(±)-4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate; 1-(3',4'-dipivaloyloxyphenyl)-2-methylamino-1-ethanol; 4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate; Dipivalyl epinephrine; Dipivefrin; Dipivefrina; Dipivefrine; Dipivéfrine; Dipivefrinum",Launched,adrenergic receptor agonist,,ophthalmology,glaucoma|intraocular pressure,dipivefrine,
O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,Droperidol,"1-(1-(3-(p-fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone; 1-(1-(4-(p-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone; 1-{1-[4-(4-Fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one; 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[d]imidazol-2-one; Droperidol; Dropéridol; Droperidolo; Droperidolum",Launched,dopamine receptor antagonist,ADRA1A|DRD2|DRD3|DRD4|HTR2A,gastroenterology,nausea|vomiting,droperidol,
N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,Levothyroxine,"3,3',5,5'-Tetraiodo-L-thyronine; 3,5,3',5'-Tetraiodo-L-thyronine; 4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine; L-T4; L-Thyroxine; Levothyroxin; LT4; O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine; O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine; T4; Thyroxine",Launched,thyroid hormone stimulant,THRA|THRB,endocrinology,myxedema coma,levothyroxine,
CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,Loratadine,Loratadina; Loratadine; Loratadinum,Launched,histamine receptor antagonist,HRH1,allergy|neurology/psychiatry,allergic rhinitis|itching,loratadine,
CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3cccs3)[C@H]2SC1,Cefalotin,3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid; 7-(2-Thienylacetamido)cephalosporanic acid; 7-(2'-thienylacetamido)cephalosporanic acid; 7-(Thiophene-2-acetamido)cephalosporin; Cefalothin; Cefalotin; Cefalotina; Céfalotine; Cefalotinum; Cephalothin; Cephalotin; CET,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections|surgical prophylaxis,cephalothin,
COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,Prazosin,"1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine; 2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline; Prazosin; Prazosina; Prazosine; Prazosinum",Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7,cardiology,hypertension,prazosin,
CN(C)CCCN1c2ccccc2CCc2ccccc21,Imipramine,"10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine; 5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine; Imipramin; Imipramina; Imipramine; Imipraminum; Imizine; N-(gamma-Dimethylaminopropyl)iminodibenzyl; N-(γ-dimethylaminopropyl)iminodibenzyl",Launched,norepinephrine reputake inhibitor|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry|urology,depression|nocturnal enuresis,imipramine,
COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C,Acitretin,"(all-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid; Acitretin; Acitretina; Acitretine; Acitretinum; all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid; Etretin",Launched,retinoid receptor agonist,RARA|RARB|RARG|RBP1|RXRA|RXRB|RXRG|STAT3,dermatology,psoriasis,acitretin,
COc1ccc2cc(CCC(C)=O)ccc2c1,Nabumetone,4-(6-Methoxy-2-naphthalenyl)-2-butanone; 4-(6-Methoxy-2-naphthyl)-2-butanone; Nabumeton; Nabumetona; Nabumétone; Nabumetone; Nabumetonum,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,rheumatoid arthritis|osteoarthritis,nabumetone,
O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O,Ketorolac,Kétorolac; Ketorolac; Ketorolaco; Ketorolacum; rac-Ketorolac,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief,ketorolac,
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21,Enoxacin,"1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid; Enoxacin; Enoxacina; Énoxacine; Enoxacino; Enoxacinum",Launched,topoisomerase inhibitor,TOP2A,infectious disease,urinary tract infections|gonorrhea,enoxacin,
C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12,Quinine,"(-)-Quinine; (−)-quinine; (8S,9R)-quinine; (R)-(−)-quinine; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; 6'-Methoxycinchonidine; Chinin; Chinine; Chininum; Quinina; Quinine",Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4,infectious disease,malaria,quinine,
CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O,Tenoxicam,Ténoxicam; Tenoxicam; Tenoxicamum,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology|orthopedics,rheumatoid arthritis|osteoarthritis|ankylosing spondylitis|tendinitis|bursitis|periarthritis,tenoxicam,
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,Montelukast,(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid; 1-[[[(1 R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid; Montélukast; Montelukast; Montelukastum,Launched,leukotriene receptor antagonist,ALOX5|CYSLTR1,pulmonary|allergy,asthma|allergic rhinitis|exercise-induced bronchoconstriction (EIB),montelukast,
CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,Fluoxetine,"(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine; (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine; Fluoxetin; Fluoxetina; Fluoxétine; Fluoxetine; Fluoxetinum",Launched,selective serotonin reuptake inhibitor (SSRI),ANO1|HTR2B|SLC6A4,neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|bulimia nervosa|panic disorders|bipolar disorder,fluoxetine,
CC(CNC1CCCCC1)OC(=O)c1ccccc1,Hexylcaine,Hexilcaina; Hexylcaine; Hexylcainum,Launched,sodium channel blocker,SCN5A,neurology/psychiatry,local anesthetic,hexylcaine,
CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,Duloxetine,(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine; (S)-duloxetine; Duloxetina; Duloxetine,Launched,norepinephrine reuptake inhibitor|serotonin–norepinephrine reuptake inhibitor (SNRI),HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,depression|generalized anxiety disorder (GAD)|muscle pain|peripheral neuropathy,duloxetine,
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,Chlorpromazine,"3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanamine; 3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine; Chlorpromazine; Chlorpromazinum; Clorpromazina; CPZ; N-(3-dimethylaminopropyl)-3-chlorophenothiazine",Launched,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5,neurology/psychiatry|gastroenterology|hematology|infectious disease,schizophrenia|nausea|vomiting|acute intermittent porphyria (AIP)|tetanus,chlorpromazine,
CC(N)C12CC3CC(CC(C3)C1)C2,Rimantadine,alpha-Methyl-1-adamantanemethylamine; alpha-Methyladamantanemethylamine; Rimantadina; Rimantadine; Rimantadinum,Launched,antiviral|RNA synthesis inhibitor,,infectious disease,influenza A virus infection,rimantadine,
NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,Amikacin,"1-N-(L(−)-γ-amino-α-hydroxybutyryl)kanamycin A; Amikacin; Amikacina; Amikacine; Amikacinum; D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-N(SUP 1)-(4-AMINO-2-HYDROXY-1-OXOBUTYL)-2-DEOXY-, (S)-; encochleated amikacin; O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6))-N(SUP 3)-(4-AMINO-L-2-HYDROXYBUTYRYL)-2-DEOXY-L-STREPTAMINE",Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections,amikacin,
Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,Lenalidomide,"1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline; 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione; Lenalidomida; Lenalidomide",Launched,anticancer agent,TNF,hematologic malignancy,multiple myeloma|mantle cell lymphoma (MCL)|myelodysplastic diseases (MDS),lenalidomide,
O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,Raloxifene,(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone; Raloxifène; Raloxifene; Raloxifeno; Raloxifenum,Launched,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1|ESR2,orthopedics|oncology,osteoporosis|breast cancer,raloxifene,
Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,Celecoxib,Célécoxib; Celecoxib; Celecoxibum; p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide,Launched,cyclooxygenase inhibitor,CA12|PDPK1|PTGS2,rheumatology|endocrinology,osteoarthritis|rheumatoid arthritis|ankylosing spondylitis|primary dysmenorrhea (PD),celecoxib,
Brc1c(NC2=NCCN2)ccc2nccnc12,Brimonidine,5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline; Brimonidina; Brimonidine; Brimonidinum; Bromoxidine,Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,ophthalmology,intraocular pressure|glaucoma|ocular hypertension,brimonidine,
Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,Dicloxacillin,"(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Dicloxacilina; Dicloxacillin; Dicloxacillina; Dicloxacilline; Dicloxacillinum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections,dicloxacillin,
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21,Pefloxacin,Pefloxacin; Pefloxacine; Pefloxacino; Pefloxacinum; PFLX,Launched,bacterial DNA gyrase inhibitor,TOP2A,infectious disease|urology,gastrointestinal infections|urethritis|gonorrhea|urinary tract infections,pefloxacin,
CN(C)c1nc(N(C)C)nc(N(C)C)n1,Altretamine,"2,4,6-tris(dimethylamino)-1,3,5-triazine; 2,4,6-tris(dimethylamino)-s-triazine; Altretamin; Altretamina; Altrétamine; Altretamine; Altretaminum; Hexamethylmelamine; HMM",Launched,DNA synthesis inhibitor,,oncology,ovarian cancer,altretamine,
CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1,Sotalol,4'-(1-hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide; Sotalol; Sotalolo; Sotalolum; β-cardone,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|KCNH2,cardiology,atrial fibrillation (AF)|ventricular arrhythmias,sotalol,
O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,Buspirone,"8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione; Buspiron; Buspirona; Buspirone; Buspironum",Launched,serotonin receptor agonist,DRD2|HTR1A,neurology/psychiatry,generalized anxiety disorder (GAD),buspirone,
OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,Miglitol,Miglitol; Miglitolum,Launched,glucosidase inhibitor,GAA|GANAB|GANC|MGAM,endocrinology,diabetes mellitus,miglitol,
CCC(=O)O[C@@H](O[P@@](=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)O)C(C)C,Fosinopril,Fosenopril; Fosinopril,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|congestive heart failure,fosinopril,
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1,Cefotaxime,"(6R,7R,Z)-3-(acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefotaxim; Cefotaxima; Céfotaxime; Cefotaxime; Cefotaximum; Cephotaxime",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,respiratory tract infections|bone and joint infections|pelvic inflammatory disease|intra-abdominal infections|skin infections|meningitis|urinary tract infections|bacterial septicemia|gynecologic infections,cefotaxime,
CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1,Entacapone,"(E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide; Entacapona; Entacapone; Entacaponum; N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide",Launched,catechol O methyltransferase inhibitor,COMT,neurology/psychiatry,Parkinson's Disease,entacapone,
Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,Zidovudine,Azidothymidine; AZT; ZDV; Zidovudina; Zidovudine; Zidovudinum,Launched,nucleoside reverse transcriptase inhibitor,TERT,infectious disease,human immunodeficiency virus (HIV-1)|acquired immunodeficiency syndrome (AIDS),zidovudine,
NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1,Darifenacin,"(S)-1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-α,α-diphenyl-3-pyrrolidineacetamide; Darifenacin; Darifenacina; Darifénacine; Darifenacinum",Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,urology,urinary incontinence,darifenacin,
O=C1c2ccccc2C(=O)C1c1ccccc1,Phenindione,"2-phenyl-1,3-diketohydrindene; 2-Phenyl-1,3-indandione; 2-phenyl-1,3(2H)-Indenedione; Fenindiona; Fenindione; Phenindion; Phénindione; Phenindione; Phenindionum; PID",Launched,vitamin K antagonist,VKORC1,hematology,deep vein thrombosis (DVT),phenindione,
CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,Flutamide,"4'-nitro-3'-trifluoromethylisobutyranilide; Flutamid; Flutamida; Flutamide; Flutamidum; FTA; NFBA; Niftolid; Niftolide; α,α,α-trifluoro-2-methyl-4'-nitro-m-propionotoluidide",Launched,androgen receptor antagonist,AHR|AR,oncology,prostate cancer,flutamide,
Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1,Tolmetin,1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid; 1-Methyl-5-p-toluoylpyrrole-2-acetic acid; 5-(p-Toluoyl)-1-methylpyrrole-2-acetic acid; Tolmetin; Tolmetina; Tolmétine; Tolmetino; Tolmetinum,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,rheumatoid arthritis|osteoarthritis,tolmetin,
CN/C(=N/C#N)NCCSCc1nc[nH]c1C,Cimetidine,1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 2-cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; Cimetidin; Cimetidina; Cimétidine; Cimetidine; Cimetidinum; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine,Launched,histamine receptor antagonist,HRH2|SLC29A4|SLC47A1|SLC47A2,gastroenterology|hematologic malignancy|endocrinology,duodenal ulcer disease|peptic ulcer disease (PUD)|gastroesophageal reflux disease (GERD)|aggressive systemic mastocytosis (ASM)|Zollinger-Ellison syndrome|endocrine adenoma,cimetidine,
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Haloperidol,1-(3-p-fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine; 4-(4-(para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone; 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one; 4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone; 4'-fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone; Haloperidol; Haloperidolum; γ-(4-(p-chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone,Launched,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1,neurology/psychiatry,schizophrenia|Tourette's disorder,haloperidol,
CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,Ritonavir,Ritonavir; Ritonavirum,Launched,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7,infectious disease,human immunodeficiency virus (HIV-1),ritonavir,
C=CCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13,Levallorphan,Levallofano; Levallorphan; Lévallorphane; Levallorphanum; Levalorfano,Launched,opioid receptor antagonist,CHRNA2|OPRM1,pulmonary,respiratory depression,levallorphan,
CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1,Nitazoxanide,Nitaxozanid; Nitaxozanide; Nitazoxanida; Nitazoxanide; Nitazoxanidum,Launched,pyruvate ferredoxin oxidoreductase inhibitor,,gastroenterology,diarrhea,nitazoxanide,
CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,Triflupromazine,10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine; 2-(Trifluoromethyl)promazine; 2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine; Fluopromazine; Triflupromazin; Triflupromazina; Triflupromazine; Triflupromazinum,Launched,dopamine receptor antagonist,CHRM1|CHRM2|DRD1|DRD2|HTR2B,neurology/psychiatry|gastroenterology,psychosis|nausea|vomiting,triflupromazine,
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,Vancomycin,Vancomicina; Vancomycin; Vancomycine; Vancomycinum,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,endocarditis,vancomycin,
COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,Dextromethorphan,(+)-dextromethorphan; D-methorphan; delta-Methorphan; Dex; Dextromethorfan; Dextromethorphan; Dextrométhorphane; Dextromethorphanum; Dextrometorfano; DM,Launched,glutamate receptor antagonist|sigma receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4,pulmonary,cough suppressant,dextromethorphan,
N[Pt](N)(Cl)Cl,Cisplatin,"(SP-4-2)-DIAMMINEDICHLOROPLATINUM; CDDP; Cis-DDP; CIS-DIAMMINEDICHLOROPLATINUM; CIS-DIAMMINEDICHLOROPLATINUM II; cis-diamminedichloroplatinum(II); Cisplatin; cisplatino; INT-230-6 COMPONENT CISPLATIN; INT230-6 COMPONENT CISPLATIN; PLATINUM, DIAMMINEDICHLORO-, (SP-4-2)-",Launched,DNA alkylating agent|DNA synthesis inhibitor,XIAP,oncology,testicular carcinoma|ovarian cancer|bladder cancer,cisplatin,
CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1,Albendazole,(5-(propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester; 5-(propylthio)-2-carbomethoxyaminobenzimidazole; Albendazol; Albendazole; Albendazolum; Eskazole; O-methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate; Proftril,Launched,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,infectious disease,cystic hydatid disease|parenchymal neurocysticercosis,albendazole,
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21,Trandolapril,Trandolapril; Trandolaprilum,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|myocardial infarction,trandolapril,
CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O,Caspofungin,"(4R,5S)-5-((2-Aminoethyl)amino)-N(sup 2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide; Caspofungin; Caspofungina",Launched,"""bacterial cell wall synthesis inhibitor|fungal 1,3-beta-D-glucan synthase inhibitor""",,infectious disease,candidemia|esophageal candidiasis|aspergillosis|peritonitis|fungal infection,caspofungin,
CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2,Carteolol,Cartéolol; Carteolol; Carteololum,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,ophthalmology,intraocular pressure|glaucoma|ocular hypertension,carteolol,
Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,Metolazone,"2-Methyl-3-o-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone; 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide; 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinesulfonamide; Metolazon; Metolazona; Métolazone; Metolazone; Metolazonum",Launched,carbonic anhydrase inhibitor,SLC12A3,cardiology,edema|hypertension,metolazone,
Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1,Tolnaftate,"2-Naphthyl N-methyl-N-(3-tolyl)thionocarbamate; m,N-Dimethylthiocarbanilic acid O-2-naphthyl ester; Methyl (3-methylphenyl)carbamothioic acid O-2-naphthalenyl ester; N-methyl-N-(3-methylphenyl)-1-(naphthalen-2-yloxy)methanethioamide; O-2-Naphthyl m,N-dimethylthiocarbanilate; Tolnaftate; Tolnaftato; Tolnaftatum; Tolnaphthate",Launched,fungal squalene epoxidase inhibitor,,infectious disease,tinea pedis|tinea corporis,tolnaftate,
O=C1O[Pt]2(N[C@@H]3CCCC[C@H]3N2)OC1=O,Oxaliplatin,"(SP-4-2-(1R-TRANS))-(1,2-CYCLOHEXANEDIAMINE-N,N')(ETHANEDIOATO(2-)-O,O')PLATINUM; Diaminocyclohexane Oxalatoplatinum; L-OHP; Oxalatoplatin; Oxalatoplatinum; Oxaliplatin; oxaliplatine; oxaliplatino; oxaliplatinum; PLATINUM, ((1R,2R)-1,2-CYCLOHEXANEDIAMINE-.KAPPA.N,.KAPPA.N')(ETHANEDIOATO(2-)-.KAPPA.O1,.KAPPA.O2)-, (SP-4-2)-",Launched,DNA inhibitor,,oncology,colorectal cancer,oxaliplatin,
CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1,Cinchocaine,2-butoxy-N-(2-(diethylamino)ethyl)cinchoninamide; 2-butoxy-N-(α-diethylaminoethyl)cinchoninamide; 2-butoxy-N-(β-diethylaminoethyl)cinchoninamide; 2-butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide; 2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide; 2-butoxyquinoline-4-carboxylic acid diethylaminoethylamide; 2-N-butoxy-N-(2-diethylaminoethyl)cinchoninamide; Cinchocaine; Cinchocainum; Cincocainio; Dibucaine; N-(2-(diethylamino)ethyl)-2-butoxycinchoninamide; α-butyloxycinchonic acid-γ-diethylethylenediamine; α-butyloxycinchoninic acid diethylethylenediamide,Launched,sodium channel blocker,CALM1|SCN10A|SCN5A,neurology/psychiatry,local anesthetic,cinchocaine,
COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1,Lercanidipine,Lercanidipine; Lercanidipino,Launched,calcium channel blocker,CACNA2D1,cardiology,hypertension,lercanidipine,
O=C(O)P(=O)(O)O,Foscarnet,Carboxyphosphonic acid; Foscarmet; Phosphonoformate; Phosphonoformic acid; Phosphonomethanoic acid,Launched,DNA polymerase inhibitor,,infectious disease,cytomegalovirus retinitis|acquired immunodeficiency syndrome (AIDS)|virus herpes simplex (HSV),foscarnet,
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,Erlotinib,"[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine; Erlotinib",Launched,EGFR inhibitor,EGFR|NR1I2,oncology,non-small cell lung cancer (NSCLC)|pancreatic cancer,erlotinib,
O=P1(N(CCCl)CCCl)NCCCO1,Cyclophosphamide,"(+-)-Cyclophosphamide; (±)-2-(BIS(2-CHLOROETHYL)AMINO)TETRAHYDRO-2H-1,3,2-OXAZAPHOSPHORINE 2-OXIDE MONOHYDRATE; (RS)-Cyclophosphamide; 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide; Anhydrous cyclophosphamide; Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester; Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamide anhydrous; Cyclophosphamidum; Cytophosphane; N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide",Launched,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP3A4|CYP3A5|CYP3A7,hematologic malignancy|oncology,Hodgkin's lymphoma|small lymphocytic lymphoma (SLL)|breast cancer|neuroblastoma|Burkitt's lymphoma|multiple myeloma|chronic lymphocytic leukemia (CLL)|acute myeloid leukemia (AML)|acute lymphoblastic leukemia (ALL)|chronic myeloid leukemia (CML)|true histiocytic lymphoma (THL)|retinoblastoma|ovarian cancer,cyclophosphamide,
CCC1(c2ccccc2)NC(=O)N(C)C1=O,Mephenytoin,mefenitoína; Mephenytoin,Launched,hydantoin antiepileptic,SCN5A,neurology/psychiatry,seizures,mephenytoin,
CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,Rofecoxib,3-phenyl-4-[4-(methylsulfonyl)phenyl]-2(5H)-furanone; 4-[4-(methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone; Rofecoxib; Rofécoxib; Rofecoxibum,Withdrawn,cyclooxygenase inhibitor,ELN|PTGS2,,,rofecoxib,
C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\O)c3csc(N)n3)[C@H]2SC1,Cefdinir,"(6R,7R,Z)-7-(2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido)-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-hydroxyimino]-acetylamino}-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefdinir; Cefdinirum; CFDN",Launched,bacterial cell wall synthesis inhibitor,MPO,infectious disease|otolaryngology|pulmonary,pneumonia|tonsillitis|pharyngitis|bronchitis|skin infections|otitis|sinusitis,cefdinir,
N=C(N)N,Guanidine,Aminomethanamidine; Gu; Guanidin; Guanidine; Imidourea; Iminourea,Launched,HSP inhibitor,ALDH2|DLG4|GAMT|RNASE1,neurology/psychiatry,Lambert-Eaton myasthenic syndrome (LEMS),guanidine,
O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Ciprofloxacin,"1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; 1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid; 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid; 1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid; 1-cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid; Ciprofloxacin; Ciprofloxacine; Ciprofloxacino; Ciprofloxacinum",Launched,bacterial DNA gyrase inhibitor,TOP2A,otolaryngology,otitis,ciprofloxacin,
CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1,Toremifene,Toremifene; Toremifeno; Toremifenum,Launched,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1,oncology,breast cancer,toremifene,
CNCCC=C1c2ccccc2CCc2ccccc21,Nortriptyline,"10,11-dihydro-N-methyl-5H-dibenzo[a,d]cycloheptene-Δ5,γ-propylamine; 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine; Demethylamitriptyline; Desmethylamitriptyline; Nortriptylina; Nortriptyline; Nortriptylinum",Launched,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4,neurology/psychiatry,depression,nortriptyline,
CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,Vincristine,22-Oxovincaleukoblastin; 22-Oxovincaleukoblastine; Leurocristine; Vincristin; Vincristina; Vincristine; Vincristinum,Launched,tubulin polymerization inhibitor,TUBA4A|TUBB,hematologic malignancy,acute lymphoblastic leukemia (ALL),vincristine,
CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O,Benazepril,Benazepril; Bénazépril; Benazeprilum,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension,benazepril,
Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,Amoxapine,"2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine; Amoxapin; Amoxapina; Amoxapine; Amoxapinum; Amoxepine; Desmethylloxapin",Launched,norepinephrine reputake inhibitor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,depression,amoxapine,
O=c1[nH]cc(F)c(=O)[nH]1,Fluorouracil,"5-Fluoracil; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluracil; 5-FU; Fluoro Uracil; Fluorouracil; Fluorouracilo; Fluorouracilum; Fluouracil",Launched,thymidylate synthase inhibitor,DPYD|TYMS,oncology,colorectal cancer|breast cancer|pancreatic cancer|gastric adenocarcinoma,5-fluorouracil,
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO,Desoximetasone,"(11β,16α)-9-fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione; 9alpha-fluoro-16alpha-methyl-delta(1)-corticosterone; Deoxymethasone; Desoximetason; Desoximetasona; Désoximétasone; Desoximetasone; Desoximetasonum; Desoxymethasone",Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,dermatology,corticosteroid-responsive dermatoses,desoximetasone,
COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,Zafirlukast,4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide; cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate; Zafirlukast,Launched,leukotriene receptor antagonist,CYSLTR1|CYSLTR2,pulmonary,asthma,zafirlukast,
CCCc1cc(=O)[nH]c(=S)[nH]1,Propylthiouracil,"2-Mercapto-6-propyl-4-pyrimidone; 2-Mercapto-6-propylpyrimid-4-one; 2-Thio-4-oxo-6-propyl-1,3-pyrimidine; 2-Thio-6-propyl-1,3-pyrimidin-4-one; 4-propyl-2-thiouracil; 6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione; 6-propyl-2-thiouracil; 6-propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one; 6-Propylthiouracil; 6-Thio-4-propyluracil; Propiltiouracilo; Propylthiouracil; Propylthiouracile; Propylthiouracilum",Launched,thyroid peroxidase inhibitor,DIO1|TPO,endocrinology,hyperthyroidism|Grave's disease|goiter,propylthiouracil,
OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)C[C@@H]1O,Pentostatin,Co-vidarabine; Pentostatin; Pentostatina; Pentostatine; Pentostatinum,Launched,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA,hematologic malignancy,hairy cell leukemia,pentostatin,
COc1c2occc2cc2ccc(=O)oc12,Methoxsalen,"6-hydroxy-7-methoxy-5-benzofuranacrylic acid δ-lactone; 8-methoxy-[furano-3'.2':6.7-coumarin]; 8-methoxy-2',3',6,7-furocoumarin; 8-methoxy-4',5':6,7-furocoumarin; 8-Methoxyfuranocoumarin; 8-methoxypsoralen; 8-MOP; 8-MP; 9-methoxy-7H-furo[3,2-g][1]benzopyran-7-one; Ammoidin; Methoxsalen; Méthoxsalène; Metoxaleno; O-methylxanthotoxol; Xanthotoxin; Xanthotoxine",Launched,DNA synthesis inhibitor,CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4,dermatology,psoriasis,methoxsalen,
CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O,Piroxicam,"4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid; Piroxicam; Piroxicam betadex; Piroxicamum; Pyroxycam",Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,osteoarthritis|rheumatoid arthritis,piroxicam,
Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,Lamotrigine,"3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; Lamotrigina; Lamotrigine; Lamotriginum",Launched,serotonin receptor antagonist|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,epilepsy|bipolar disorder,lamotrigine,
OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,Hydroxyzine,Hidroxizina; Hychotine; Hydroksyzyny; Hydroxine; Hydroxizine; Hydroxizinum; Hydroxycine; Hydroxyzin; Hydroxyzine; Hydroxyzinum; Idrossizina,Launched,antihistamine,HRH1,neurology/psychiatry|allergy|dermatology,anxiety|urticaria|itching|dermatosis,hydroxyzine,
CC(=O)N[C@@H]1[C@@H](N=C(N)N)C=C(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO,Zanamivir,"(2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid; 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid; 4-guanidino-Neu5Ac2en; 5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid; 5-acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid; GANA; Zanamivir",Launched,neuraminidase inhibitor,NEU2,infectious disease,influenza A virus infection,zanamivir,
COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,Bosentan,"4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide; Bosentan; bosentán; bosentan anhydrous; bosentanum; p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide",Launched,endothelin receptor antagonist,EDNRA|EDNRB,pulmonary,pulmonary arterial hypertension (PAH),bosentan,
CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,Tigecycline,"(4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Tigeciclina; Tigecycline; Tigecyclinum",Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,skin infections|pneumonia|intra-abdominal infections,tigecycline,
CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,Doxapram,"(±)-doxapram; 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone; Doxapram; Doxapramum",Launched,potassium channel blocker,,pulmonary|neurology/psychiatry,respiratory depression|central nervous system depression|acute hypercapnia (AHC),doxapram,
NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,Benzthiazide,"3-((benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide; 3-benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 3-benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide; 6-chloro-1,1-dioxo-3-(phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide; 6-chloro-7-sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; Benzothiazide; Benzotiazida; Benzthiazid; Benzthiazide; Benzthiazidum; Benztiazide",Launched,carbonic anhydrase inhibitor,CA2,cardiology,hypertension|edema,benzthiazide,
CN(Cc1cnc2nc(=N)[nH]c(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,Methotrexate,"4-amino-10-methylfolic acid; 4-amino-N(10)-methylpteroylglutamic acid; Amethopterin; Methotrexat; Méthotrexate; Methotrexate; Methotrexatum; Metotrexato; MTX; N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid",Launched,dihydrofolate reductase inhibitor,DHFR,oncology|hematologic malignancy|dermatology|rheumatology,gestational choriocarcinoma|hydatidiform mole|acute lymphoblastic leukemia (ALL)|psoriasis|rheumatoid arthritis,methotrexate,
NC(=O)N1c2ccccc2C=Cc2ccccc21,Carbamazepine,"5-Carbamoyl-5H-dibenz(b,f)azepine; 5-carbamoyl-5H-dibenz[b,f]azepine; 5-Carbamoyl-5H-dibenzo(b,f)azepine; 5-Carbamyl-5H-dibenzo(b,f)azepine; 5H-Dibenz(b,f)azepine-5-carboxamide; Carbamazepen; Carbamazepin; Carbamazepina; Carbamazépine; Carbamazepine; Carbamazepinum; CBZ; Molecusol-Carbamazepine",Launched,carboxamide antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures,carbamazepine,
COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC,Cisatracurium,"(1r,2r,1'r,2'r)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium]; Cisatracurium cation; Cisatracurium ion",Launched,acetylcholine receptor antagonist,CHRNA2,neurology/psychiatry|critical care,muscle relaxant|endotracheal intubation,cisatracurium,
CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1,Cephalexin,"(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid; 7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid; Anhydrous cefalexin; Anhydrous cephalexin; Cefalexin; Cefalexin anhydrous; Cefalexina; Céfalexine; Cefalexinum; Cephalexin anhydrous",Launched,bacterial cell wall synthesis inhibitor,,infectious disease|otolaryngology,respiratory tract infections|otitis|skin infections|bone and joint infections|genitourinary tract infections,cephalexin,
CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)O)[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)O)[C@H]3NS(=O)(=O)O)[C@H](O)[C@H]2OS(=O)(=O)O)[C@H](O)[C@H]1NS(=O)(=O)O,Fondaparinux,Natural heparin pentasaccharide,Launched,coagulation factor inhibitor,F10|SERPINC1,hematology,deep vein thrombosis (DVT),fondaparinux,
CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,Vinblastine,Vinblastin; Vinblastina; Vinblastine; Vinblastinum; Vincaleukoblastine,Launched,microtubule inhibitor|tubulin polymerization inhibitor,JUN|TUBA1A|TUBB|TUBD1|TUBE1|TUBG1,hematologic malignancy|infectious disease|oncology,Hodgkin's lymphoma|true histiocytic lymphoma (THL)|mycosis|small lymphocytic lymphoma (SLL)|testicular carcinoma|Kaposi sarcoma,vinblastine,
CC(C)NCC(O)COc1cccc2ccccc12,Propranolol,1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol; 1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol; beta-Propranolol; Propanalol; Propanolol; Propranolol; Propranololo; Propranololum; β-Propranolol,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,cardiology|neurology/psychiatry,hypertension|angina pectoris|migraine headache,propranolol,
CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2,Atropine,(±)-atropine; (±)-hyoscyamine; Atropin; Atropina; Atropine; Atropinum; dl-Hyoscyamine; dl-tropyltropate; Tropine tropate,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,ophthalmology,cycloplegia|mydriasis|amblyopia,atropine,
CC(C(=O)O)c1cccc(Oc2ccccc2)c1,Fenoprofen,(+/-)-fenoprofen; (+/-)-m-phenoxyhydratropic acid; (±)-2-(3-phenoxyphenyl)propionic acid; 2-(3-phenoxyphenyl)propionic acid; 2-(m-phenoxyphenyl)propionic acid; 3-phenoxyhydratropic acid; DL-2-(3-phenoxyphenyl)propionic acid; Fenoprofen; Fénoprofène; Fenoprofeno; Fenoprofenum; α-(m-phenoxyphenyl)propionic acid; α-methyl-3-phenoxybenzeneacetic acid,Launched,prostaglandin inhibitor,PTGS1|SLC5A8,rheumatology,rheumatoid arthritis|osteoarthritis,fenoprofen,
Clc1cccc(Cl)c1NC1=NCCN1,Clonidine,"2-((2,6-Dichlorophenyl)imino)imidazolidine; 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine; Chlofazoline; Clonidin; Clonidina; Clonidine; Clonidinum",Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,cardiology|neurology/psychiatry,hypertension|attention-deficit/hyperactivity disorder (ADHD),clonidine,
Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1,Sulfamethizole,Sulfaméthizol; Sulfamethizol; Sulfamethizole; Sulfamethizolum; Sulfamethylthiadiazole; Sulfametizol,Launched,bacterial antifolate,,infectious disease,urinary tract infections,sulfamethizole,
CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21,Valaciclovir,"L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester; Valaciclovir; Valaciclovirum; Valacyclovir",Launched,DNA polymerase inhibitor,,infectious disease,shingles|virus herpes simplex (HSV),valaciclovir,
CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O,Carbenicillin,"(2S,5R,6R)-6-{[carboxy(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Carbenicilina; Carbenicillin; Carbenicilline; Carbenicillinum; Carboxybenzylpenicillin; CBPC; N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenylmalonamic acid; α-carboxybenzylpencillin; α-phenyl(carboxymethylpenicillin)",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,carbenicillin,
Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,Valdecoxib,Valdecoxib,Withdrawn,cyclooxygenase inhibitor,CA12|PTGS2,,,valdecoxib,
OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,Lactulose,4-O-beta-D-Galactopyranosyl-D-fructofuranose; 4-O-beta-D-Galactopyranosyl-D-fructose; Lactulosa; Lactulose; Lactulosum,Launched,laxative,,gastroenterology,portal-systemic encephalopathy (PSE),lactulose,
C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,Voriconazole,"(R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol; (αR,βS)-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol; VCZ; Voriconazol; Voriconazole; Voriconazolum",Launched,cytochrome P450 inhibitor,CYP2C19|CYP2C9|CYP3A4|CYP3A5|PTGS1,infectious disease,esophageal candidiasis|aspergillosis|skin infections,voriconazole,
C[N+](C)(C)C[C@H](O)CC(=O)[O-],Levocarnitine,"(-)-Carnitine; (-)-L-Carnitine; (R)-Carnitine; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; Carnitina; Carnitine; L-Carnitine; Levocarnitin; Levocarnitina; Lévocarnitine; Levocarnitine; Levocarnitinum; Vitamin BT",Launched,,CRAT|CROT,endocrinology,carnitine deficiency,levocarnitine,
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O,Enalapril,(S)-1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline; (S)-1-{(S)-2-[1-((S)-Ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid; 1-(N-((S)-1-carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester; ánalapril; Enalapril; Enalaprila; Enalaprilum,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|congestive heart failure|left ventricular systolic dysfunction (LVSD),enalapril,
CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1,Nizatidine,"N-(4-(6-Methylamino-7-nitro-2-thia-5-aza-6-hepten-1-yl)-2-thiazolylmethyl)-N,N-dimethylamine; Nizatidina; Nizatidine; Nizatidinum",Launched,histamine receptor antagonist,HRH2,gastroenterology,duodenal ulcer disease|erosive esophagitis (EE)|ulcerative esophagitis (UE)|gastroesophageal reflux disease (GERD),nizatidine,
O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,Diclofenac,"[2-(2,6-dichloroanilino)phenyl]acetic acid; 2-((2,6-dichlorophenyl)amino)benzeneacetic acid; Diclofenac; Diclofenac acid; Diclofenaco; Diclofenacum",Launched,cyclooxygenase inhibitor,AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A,rheumatology|neurology/psychiatry,rheumatoid arthritis|osteoarthritis|migraine headache,diclofenac,
CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,Lisuride,"Lisurid; Lisurida; Lisuride; Lisuridum; N'-((8alpha)-9,10-Didehydro-6-methylergolin-8-yl)-N,N-diethylurea",Launched,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6,neurology/psychiatry,Parkinson's Disease,lisuride,
COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC,Doxazosin,"1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin; 1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin; Doxazosin; Doxazosina; Doxazosine; Doxazosinum",Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,urology|cardiology,benign prostatic hyperplasia (BPH)|hypertension,doxazosin,
C1CNCCN1,Piperazine,Diethylenediamine; Piperazidine; Piperazin; Piperazina; Piperazine,Launched,benzodiazepine receptor agonist,GABRB3,infectious disease,gastrointestinal roundworms,piperazine,
CCC1(C)CC(=O)NC1=O,Ethosuximide,"(±)-2-ethyl-2-methylsuccinimide; 2-ethyl-2-methylsuccinimide; 2-methyl-2-ethylsuccinimide; 3-ethyl-3-methyl-2,5-pyrrolidinedione; 3-ethyl-3-methylsuccinimide; 3-methyl-3-ethylpyrrolidine-2,5-dione; 3-methyl-3-ethylsuccinimide; Aethosuximide; Atysmal; Ethosuximid; Ethosuximide; éthosuximide; Ethosuximidum; Etosuximida; Thilopemal; α-ethyl-α-methylsuccinimide; α-methyl-α-ethylsuccinimide; γ-ethyl-γ-methyl-succinimide; γ-methyl-γ-ethyl-succinimide",Launched,succinimide antiepileptic,CACNA1G|CACNA1H|CACNA1I,neurology/psychiatry,epilepsy,ethosuximide,
N=C(N)NC(=O)c1nc(Cl)c(N)nc1N,Amiloride,"3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide; Amilorid; Amilorida; Amiloride; Amiloridum; Amipramidin; Amipramidine; Amyloride; N-amidino-3,5-diamino-6-chloropyrazinecarboxamide",Launched,sodium channel blocker,AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2,cardiology,hypertension|congestive heart failure,amiloride,
CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12,Oxytetracycline,5-Hydroxytetracycline; Embryostat; Hydroxytetracyclinum; Mepatar; Ossitetraciclina; Oxitetraciclina; Oxyterracin; Oxyterracine; Oxytetracyclin; Oxytétracycline; Oxytetracycline; Oxytetracycline (anhydrous); Oxytetracycline amphoteric; Oxytetracyclinum,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease|urology,chlamydia|urinary tract infections|skin infections|ear infections|gonorrhea|urethritis|Lyme disease,oxytetracycline,
CC(O)CN1CCN(CC(=O)[O-])CCN(CC(=O)[O-])CCN(CC(=O)[O-])CC1.[Gd+3],Gadoteridol,"gadolinium 2,2',2''-[10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetate; gadolinium-HP-DO3A; Gadoteridol; Gadoteridolum; GD-HP-DO 3A; Gd-HPDO3A",Launched,radiopaque medium,,radiology,MRI contrast agent,gadoteridol,
CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,Labetalol,3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol; 5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide; Labétalol; Labetalol; Labetalolum; Labetolol,Launched,adrenergic receptor antagonist,ADRA1D|ADRB1|ADRB2,cardiology,hypertension,labetalol,
CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,Thiopental,"(±)-thiopental; 2-Thio-5-ethyl-5-sec-pentylbarbituric acid; 5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione; Penthiobarbital; Pentothiobarbital; Thiopental; Thiopentobarbital; Thiopentobarbitone; Thiopentobarbituric acid; Thiopentone; Tiopentale",Launched,GABA receptor antagonist,FAAH,neurology/psychiatry,anesthetic,thiopental,
Oc1ccc(OCc2ccccc2)cc1,Monobenzone,4-(Benzyloxy)phenol; 4-(Benzyloxyl)phenol; 4-(Phenylmethoxy)phenol; 4-Benzyloxy-phenol; 4-Benzyloxyphenol; Benzyl p-hydroxyphenyl ether; Hydrochinon monobenzylether; Hydroquinone benzyl ether; Hydroquinone monobenzyl ether; Monobenzona; Monobenzone; Monobenzonum; Monobenzyl hydroquinone; p-(Benzyloxy)phenol; p-Hydroxyphenyl benzyl ether,Launched,melanin inhibitor,TYR,dermatology,skin depigmentation,monobenzone,
CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,Linezolid,Linezolid; Linezolide; Linezolidum; N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide,Launched,bacterial 50S ribosomal subunit inhibitor,MAOA|MAOB,infectious disease,pneumonia|skin infections,linezolid,
CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,Ivermectin,Ivermectin; Ivermectina; Ivermectine; Ivermectinum,Launched,benzodiazepine receptor agonist,CHRNA7|P2RX7,infectious disease,gastrointestinal roundworms|lungworms|cattle grubs|mites|lice|horn flies,ivermectin,
COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCN(CCCOc2ccc(F)cc2)C[C@@H]1OC,Cisapride,Cisaprid; Cisaprida; Cisapride; Cisapridum,Withdrawn,serotonin receptor agonist,HTR2A|HTR3A|HTR4|KCNH2,,,cisapride,
CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)=O)cc1,Sulindac,(Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid; Sulindac; Sulindaco; Sulindacum,Launched,cyclooxygenase inhibitor,AKR1B1,rheumatology,osteoarthritis|rheumatoid arthritis|ankylosing spondylitis,sulindac,
NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,Cyclothiazide,"6-chloro-3-(2-norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide; 6-chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-chloro-3,4-dihydro-3-(2-norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide; 6-chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; Ciclotiazida; Ciclotiazide; Cyclothiazide; Cyclothiazidum",Launched,glutamate receptor modulator,CA2|GRIA1|GRIA2|GRIA3|GRIA4|SLC12A3,cardiology,hypertension,cyclothiazide,
CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,Nafcillin,"(2-ethoxy-1-naphthalenyl)penicillin; (2-ethoxy-1-naphthyl)penicillin; (2S,5R,6R)-6-[(2-ethoxy-1-naphthoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6-(2-ethoxy-1-naphthamido)penicillanic acid; Nafcilina; Nafcillin; Nafcilline; Nafcillinum; Naphcillin",Launched,bacterial cell wall synthesis inhibitor,CYP1A2|CYP3A4|SLC22A6,infectious disease,gram-positive bacterial infections,nafcillin,
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,Chloroquine,"Chloraquine; Chlorochin; Chloroquina; Chloroquine; Chloroquinium; Chloroquinum; Cloroquina; N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine",Launched,antimalarial agent,MRGPRX1,infectious disease,malaria|amebiasis,chloroquine,
CCc1cc(C(N)=S)ccn1,Ethionamide,2-ethyl-4-thiopyridylamide; 2-ethylthioisonicotinamide; ETH; Ethinamide; Ethionamide; Ethionamidum; Ethioniamide; Ethylisothiamide; Ethyonomide; Etionamid; Etionamida; Etionamide; Etioniamid; ETP,Launched,mycolic synthesis inhibitor,,infectious disease,tuberculosis,ethionamide,
C[C@H](N)[C@H](O)c1cccc(O)c1,Metaraminol,(-)-Erythro-metaraminol; 1-(m-Hydroxyphenyl)-2-amino-1-propanol; 1-Metaraminol; 2-Amino-1-(m-hydroxyphenyl)-1-propanol; 3-Hydroxyphenylisopropanolamine; alpha-(1-Aminoethyl)-3-hydroxybenzenemethanol; alpha-(m-Hydroxyphenyl)-beta-aminopropanol; Hydroxynorephedrine; L-Metaraminol; m-Hydroxy norephedrine; m-Hydroxyphenylpropanolamine; m-Hydroxypropadrine; Metaraminol; Métaraminol; Metaraminolum,Launched,adrenergic receptor agonist,ADRA1A,cardiology,hypotension,metaraminol,
CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,Bisoprolol,(+-)-1-((alpha-(2-Isopropoxyethoxy)-p-tolyl)oxy)-3-(isopropylamino)-2-propanol; (RS)-1-(4-(2-Isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol; Bisoprolol; Bisoprololum,Launched,adrenergic receptor antagonist,ADRB1,cardiology,hypertension,bisoprolol,
CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,Amodiaquine,Amodiaquina; Amodiaquine; Amodiaquinum,Launched,histamine receptor agonist,HNMT,infectious disease,malaria,amodiaquine,
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O,Rifabutin,"1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin XIV; 4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S; 4-N-isobutylspiropiperidylrifamycin S; Ansamicin; Ansamycin; Rifabutin; Rifabutina; Rifabutine; Rifabutinum",Launched,protein synthesis inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),rifabutin,
CCC1(C)OC(=O)N(C)C1=O,Paramethadione,Parametadiona; Parametadione; Paramethadione; Paramethadionum,Launched,anticonvulsant,CACNA1G,neurology/psychiatry,seizures,paramethadione,
CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@H](O)[C@H]3C[C@@H]12,Demeclocycline,"[4S-(4α,4aα,5aα,6β,12aα)]-7-chloro-4-(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide; 6-demethyl-7-chlorotetracycline; 7-chloro-6-demethyltetracycline; Demeclociclina; Demeclocycline; Demeclocyclinum; Demethylchlortetracyclin; Demethylchlortetracycline; DMCT; DMCTC",Launched,bacterial 30S ribosomal subunit inhibitor,,endocrinology|infectious disease|ophthalmology|urology,fever|respiratory tract infections|psittacosis|trachoma|conjunctivitis|urethritis|chancroid|cholera|syphilis|listeria|anthrax|actinomycosis|tularemia|brucellosis,demeclocycline,
Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,Imatinib,Imatinib; Imatinibum; α-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide,Launched,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET,hematologic malignancy|oncology,chronic myeloid leukemia (CML)|acute lymphoblastic leukemia (ALL)|myelodysplastic diseases (MDS)|aggressive systemic mastocytosis (ASM)|hypereosinophilic syndrome (HES)|chronic eosinophilic leukemia (CEL)|dermatofibrosarcoma protuberans (DFSP)|gastrointestinal stromal tumors (GIST),imatinib,
C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,Triamcinolone,"11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione; 9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; 9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; 9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione; 9α-fluoro-16α-hydroxyprednisolone; Fluoxyprednisolone; Tiamcinolonum; Triamcinolona; Triamcinolone; Triamcinolonum",Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,triamcinolone,
COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1,Nicardipine,Nicardipine; Nicardipino; Nicardipinum,Launched,calcium channel blocker,ADORA3,cardiology,chronic stable angina|hypertension,nicardipine,
OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,Fluphenazine,1-(2-hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine; 10-(3-(2-hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine; 10-(3'-(4''-(β-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine; 2-(4-(3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol; 2-(trifluoromethyl)-10-(3-(1-(β-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine; 4-(3-(-trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol; 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol; 4-(3-(2-trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol; Flufenazina; Fluorfenazine; Fluorophenazine; Fluorphenazine; Fluphenazin; Fluphenazine; Fluphénazine; Fluphenazinum; Triflumethazine,Launched,dopamine receptor antagonist,CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7,neurology/psychiatry,schizophrenia,fluphenazine,
O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,Efavirenz,"(S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one; Éfavirenz; Efavirenz; Efavirenzum",Launched,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4,infectious disease,human immunodeficiency virus (HIV-1),efavirenz,
CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1,Bacitracin,Bacitracin; Bacitracin A; Bacitracina,Launched,bacterial cell wall synthesis inhibitor,IDE,infectious disease,first-aid antibiotic,bacitracin,
O=C(O)c1cccnc1,Niacin,3-carboxypyridine; 3-Pyridinecarboxylic acid; 3-Pyridylcarboxylic acid; Acide nicotinique; ácido nicotínico; Acidum Nicotinicum; anti-pellagra vitamin; m-pyridinecarboxylic acid; Niacin; Niacina; Nicotinic acid; Nikotinsäure; pyridine-β-carboxylic acid; β-pyridinecarboxylic acid,Launched,NAD precursor|vitamin B,DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT,endocrinology,hypertriglyceridemia,niacin,
NCCCC(O)(P(=O)(O)O)P(=O)(O)O,Alendronic acid,"(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid); (4-amino-1-hydroxybutylidene)bisphosphonic acid; 4-amino-1-hydroxybutane-1,1-diphosphonic acid; ABDP; Acide Alendronique; Acido Alendronico; Acidum Alendronicum; Alendronate; Alendronic acid",Launched,bone resorption inhibitor,ATP6V1A|FDPS|PTPN4|PTPRE|PTPRS,orthopedics,osteoporosis,alendronate,
Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F,Clofarabine,"(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol; 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine; 2-chloro-9-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl)adenine; CAFdA; Cl-F-Ara-A; Clofarabin; Clofarabina; Clofarabine; Clofarabinum",Launched,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,hematologic malignancy,acute lymphoblastic leukemia (ALL),clofarabine,
CCCCCCCCCCCCCCCCCCCCCCO,Docosanol,1-Docosanol; Behenic alcohol; Behenyl alcohol; Docosan-1-ol; Docosanol; Docosyl alcohol; N-Docosanol,Launched,lipase clearing factor inhibitor,TLR7,dental,cold sore,docosanol,
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,Dexmedetomidine,"(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole; (+)-4-((S)-α,2,3-trimethylbenzyl)imidazole; Dexmedetomidin; Dexmedetomidina; Dexmédétomidine; Dexmedetomidine; Dexmedetomidinum",Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,neurology/psychiatry,sedative,dexmedetomidine,
CC(=O)NS(=O)(=O)c1ccc(N)cc1,Sulfacetamide,Acetosulfamine; N-((p-Aminophenyl)sulfonyl)acetamide; N-(p-Aminobenzenesulfonyl)acetamide; N-[(p-Aminophenyl)sulfonyl]acetamide; N-Acetyl-4-aminobenzenesulfonamide; N-Acetylsulfanilamide; N-Sulfanilylacetamide; N-Sulphanilylacetamide; N'-acetylsulfanilamide; N(1)-Acetyl-4-aminophenylsulfonamide; N(1)-Acetylsulfanilamide; p-Aminobenzenesulfonacetamide; p-Aminobenzenesulfonoacetamide; Sulfacetamid; Sulfacetamida; Sulfacetamide; Sulfacétamide; Sulfacetamidum; Sulfanilazetamid; Sulphacetamide; Sulphacetamidum,Launched,PABA antagonist,,ophthalmology,conjunctivitis,sulfacetamide,
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,Prednisone,"1,2-Dehydrocortisone; 1,4-Pregnadiene-17α,21-diol-3,11,20-trione; 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione; Dehydrocortisone; Prednisona; Prednisone; Prednisonum",Launched,glucocorticoid receptor agonist,HSD11B1|NR3C1,endocrinology|rheumatology|infectious disease|dermatology|ophthalmology|hematology|gastroenterology|neurology/psychiatry,congenital adrenal hyperplasia|hypercalcemia|rheumatoid arthritis|psoriatic arthritis|ankylosing spondylitis|bursitis|osteoarthritis|epicondylitis|dermatomyositis|psoriasis|mycosis|conjunctivitis|anemia|ulcerative colitis|enteritis|multiple sclerosis|meningitis,prednisone,
CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1,Clofibrate,"2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester; 2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester; alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester; alpha-p-Chlorophenoxyisobutyryl ethyl ester; Clofibrate; Clofibrato; Clofibratum; EPIB; Ethyl 2-(p-chlorophenoxy)isobutyrate; Ethyl chlorophenoxyisobutyrate; Ethyl clofibrate; Liprin",Launched,PPAR receptor agonist,LPL|PPARA,endocrinology|cardiology,hyperlipidemia|cholesterol,clofibrate,
COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,Astemizole,1-(p-Fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole; 1-(p-Fluorobenzyl)-2-((1-(p-methoxyphenethyl)-4-piperidyl)amino)benzimidazole; Astemizol; Astemizole; Astémizole; Astemizolum,Withdrawn,histamine receptor antagonist,HRH1|KCNH1|KCNH2,,,astemizole,
Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1,Butoconazole,"1-[4-(4-Chloro-phenyl)-2-(2,6-dichloro-phenylsulfanyl)-butyl]-1H-imidazole; Butoconazol; Butoconazole; Butoconazolum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,vulvovaginal candidiasis,butoconazole,
Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,Adenosine,"(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; 9-beta-D-Ribofuranosidoadenine; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; 9-β-D-ribofuranosyl-9H-purin-6-amine; Ade-Rib; Adenin riboside; Adenine Deoxyribonucleoside; Adenogesic; Adenosin; Adenosina; Adenosine; Adénosine; Adenosinum; Ado; beta-D-Adenosine",Launched,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,cardiology,Wolff-Parkinson-White Syndrome (WPW),adenosine,
CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,Simvastatin,"2,2-dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one; Simvastatin; Simvastatina; Simvastatine; Simvastatinum",Launched,HMGCR inhibitor,HMGCR|ITGB2,endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia,simvastatin,
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,Pemetrexed,Pemetrexed,Launched,dihydrofolate reductase inhibitor|thymidylate synthase inhibitor,ATIC|DHFR|GART|TYMS,oncology,non-small cell lung cancer (NSCLC)|mesothelioma,pemetrexed,
COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1,Mebendazole,(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester; MBDZ; Mebendazol; Mébendazole; Mebendazole; Mebendazolum,Launched,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,infectious disease,pinworm|whipworm|hookworm|ascariasis,mebendazole,
CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1,Dyclonine,1-(4-Butoxyphenyl)-3-(1-piperidinyl)-1-propanone; 2-(1-piperidyl)ethyl p-butoxyphenyl ketone; 3-piperidino-4'-butoxypropiophenone; 4-butoxy-β-piperidinopropiophenone; 4-n-butoxy-β-(1-piperidyl)propiophenone; 4'-butoxy-3-piperidinopropiophenone; Diclonina; Dyclocaine; Dyclonin; Dyclonine; Dycloninum,Launched,sodium channel blocker,SCN10A|SCN5A,neurology/psychiatry,local anesthetic,dyclonine,
C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2,Nystatin,Nistatina; NYS; Nystatin; Nystatine; Nystatinum,Launched,fungal ergosterol inhibitor,,infectious disease,esophageal candidiasis|skin infections|yeast infection,nystatin,
Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1,Mitotane,"1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]-benzene; Mitotan; Mitotane; Mitotano; Mitotanum; o,p'-DDD",Launched,antineoplastic agent,CYP11A1|CYP11B1|ESR1,oncology,adrenal cortical carcinoma,mitotane,
Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O,Stavudine,"1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine; 2',3'-Didehydro-3'-deoxythimidine; 3'-Deoxy-2'-thymidinene; Estavudina; Sanilvudine; Stavudin; Stavudine; Stavudinum; STV",Launched,DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),stavudine,
Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2,Leucovorin,"(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate; 10-Formyl-7,8-dihydrofolic acid; 5-Formyl-5,6,7,8-tetrahydrofolic acid; 5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid; 5-Formyltetrahydrofolate; 5-formyltetrahydrofolic acid; Acide folinique; Acido folinico; Folinate; Folinic acid; L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid; Leucovorinum; N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid; N5-Formyl-5,6,7,8-tetrahydrofolic acid; N5-Formyltetrahydrofolic acid",Launched,folate receptor ligand,,oncology,osteosarcoma,leucovorin,
Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O,Dyphylline,"(±)-7-(2,3-dihydroxypropyl)theophylline; (±)-diprophylline; (±)-dyphylline; (1,2-dihydroxy-3-propyl)thiophyllin; 1,3-dimethyl-7-(2,3-dihydroxypropyl)xanthine; 7-(2,3-dihydroxypropyl)-1,3-dimethylxanthine; 7-(2,3-dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione; 7-(2,3-dihydroxypropyl)theophylline; 7-(β,γ-dihydroxypropyl)theophylline; Dihydroxypropyl theopylin; Diprofilina; Diprophylline; Diprophyllinum; Dyphylline",Launched,adenosine receptor antagonist|phosphodiesterase inhibitor,PDE4A,pulmonary,asthma|bronchitis|emphysema,dyphylline,
CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1,Latanoprost,"5-HEPTENOIC ACID, 7-(3,5-DIHYDROXY-2-(3-HYDROXY-5-PHENYLPENTYL)CYCLOPENTYL)-1-METHYLETHYL ESTER, (1R-(1.ALPHA.(Z),2.BETA.(R*),3.ALPHA.,5.ALPHA.))-; isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate; Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate; Latanoprost; Latanoprostum; propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate",Launched,prostanoid receptor agonist,PTGFR,ophthalmology,ocular hypertension|glaucoma,latanoprost,
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O,Estrone,"3-Hydroxy-1,3,5(10)-estratrien-17-one; Estrona; Estrone; Estronum; Follicular hormone; Folliculin; Oestrone",Launched,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2,endocrinology,menopause,estrone,
O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,Trazodone,"2-(3-[4-(3-chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one; Trazodona; Trazodone; Trazodonum",Launched,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4,neurology/psychiatry,depression,trazodone,
CNC1(C)C2CCC(C2)C1(C)C,Mecamylamine,Mecamylamine,Launched,acetylcholine receptor antagonist,CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB4,cardiology,hypertension,mecamylamine,
CC(=O)NCCCS(=O)(=O)O,Acamprosate,3-Acetamido-1-propanesulfonic acid; Acamprosate; Acamprosato; Acamprosatum; N-acetyl homotaurine; N-Acetylhomotaurine,Launched,glutamate receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM5,neurology/psychiatry,abstinence from alcohol,acamprosate,
Cc1cc(C)cc(OCC2CNC(=O)O2)c1,Metaxalone,Metassalone; Metaxalon; Metaxalona; Metaxalone; Metaxalonum,Launched,muscle relaxant,,neurology/psychiatry,muscle pain,metaxalone,
COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,Verapamil,Iproveratril; Verapamil; Vérapamil; Verapamilo; Verapamilum,Launched,calcium channel blocker,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4,cardiology,hypertension,verapamil,
COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC,Trimethobenzamide,"N-[[4-(2-dimethylaminoethoxy)phenyl]methyl]-3,4,5-trimethoxybenzamide; Trimethobenzamide; Trimethobenzamidum; Trimetobenzamida",Launched,histamine receptor antagonist,DRD2,gastroenterology,vomiting|nausea|gastroenteritis,trimethobenzamide,
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,Flumethasone,"6alpha,9-Difluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione; Flumetasona; Flumétasone; Flumetasone; Flumetasonum; Flumethasone",Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,otolaryngology|infectious disease|dermatology,otitis|ear infections|corticosteroid-responsive dermatoses,flumethasone,
COc1nccnc1NS(=O)(=O)c1ccc(N)cc1,Sulfametopyrazine,Solfametopirazina; Sulfalene; Sulfaleno; Sulfalenum; Sulfamethopyrazine,Launched,PABA antagonist,,infectious disease,malaria|urinary tract infections|respiratory tract infections,sulfametopyrazine,
CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,Nilutamide,"5,5-Dimethyl-3-(α,α,α-trifluoro-4-nitro-m-tolyl)hydantoin; Nilutamida; Nilutamide; Nilutamidum",Launched,androgen receptor antagonist,AR,oncology,prostate cancer,nilutamide,
CNC[C@H](O)c1ccc(O)c(O)c1,Epinephrine,"(−)-(R)-epinephrine; (−)-3,4-dihydroxy-α-((methylamino)methyl)benzyl alcohol; (−)-adrenaline; (R)-(-)-Adnephrine; (R)-(-)-Adrenaline; (R)-(-)-Epinephrine; (R)-(-)-Epirenamine; (R)-(−)-adrenaline; 1,2-BENZENEDIOL, 4-(1-HYDROXY-2-(METHYLAMINO)ETHYL)-, (R)-; 4-((1R)-1-HYDROXY-2-(METHYLAMINO)ETHYL)-1,2-BENZENEDIOL; 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol; Adrenaline; Adrénaline; BENZYL ALCOHOL, 3,4-DIHYDROXY-.ALPHA.-((METHYLAMINO)METHYL)-, (-)-; Epinefrin; Epinefrina; Epinephrin; Epinephrine; Epinephrinum; L-Adrenaline; Levoepinephrine; RACEPINEFRINE, (R)-",Launched,adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF,cardiology|allergy|pulmonary,cardiac arrest|anaphylactic shock|asthma,epinephrine,
CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,Sumatriptan,(3-[2-(dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide; 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide; 3-(2-(dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide; 3-[2-(dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide; Sumatriptán; Sumatriptan; Sumatriptanum,Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7,neurology/psychiatry,migraine headache,sumatriptan,
CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1,Pirenzepine,"11-((4-Methyl-1-piperazinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one; Pirenzepin; Pirenzepina; Pirenzepine; Pirenzépine; Pirenzepinum",Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,gastroenterology,peptic ulcer disease (PUD),pirenzepine,
C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OCC(=O)O)c3csc(N)n3)[C@H]2SC1,Cefixime,(−)-cefixim; Cefixim; Cefixima; Céfixime; Cefixime; Cefixime anhydrous; Cefiximum,Launched,bacterial cell wall synthesis inhibitor,,infectious disease|otolaryngology|pulmonary,urinary tract infections|otitis|pharyngitis|tonsillitis|gonorrhea|bronchitis,cefixime,
CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,Chlorpropamide,1-(p-chlorobenzenesulfonyl)-3-propylurea; 1-(p-chlorophenylsulfonyl)-3-propylurea; 1-propyl-3-(p-chlorobenzenesulfonyl)urea; 4-chloro-N-((propylamino)carbonyl)benzenesulfonamide; 4-chloro-N-[(propylamino)carbonyl]benzenesulfonamide; Chlorpropamid; Chlorpropamide; Chlorpropamidum; Clorpropamida; N-(4-chlorophenylsulfonyl)-N'-propylurea; N-(p-chlorobenzenesulfonyl)-N'-propylurea; n-propyl-N'-(p-chlorobenzenesulfonyl)urea; n-propyl-N'-p-chlorophenylsulfonylcarbamide,Launched,ATP channel blocker,ABCC8|KCNJ10,endocrinology,diabetes mellitus,chlorpropamide,
C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,Aprepitant,Aprepitant; Aprépitant; Aprepitantum,Launched,tachykinin antagonist,TACR1,gastroenterology,nausea|vomiting,aprepitant,
COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,Galantamine,(-)-Galanthamine; Galantamina; Galantamine; Galanthamine,Launched,acetylcholinesterase inhibitor,ACHE|BCHE|CHRNA1|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB1|CHRNB2|CHRNB3|CHRNB4|CHRND|CHRNE|CHRNG,neurology/psychiatry,senile dementia,galantamine,
CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,Tamoxifen,"(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine; 1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; Tamoxifen; Tamoxifène; Tamoxifene; Tamoxifeno; Tamoxifenum; trans-Tamoxifen",Launched,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ,oncology,breast cancer,tamoxifen,
CC(C)OP(=O)(F)OC(C)C,Isoflurophate,"DFP; Diisopropoxyphosphoryl fluoride; Diisopropyl fluorophosphate; Diisopropyl fluorophosphonate; Diisopropyl phosphofluoridate; Diisopropyl phosphorofluoridate; Diisopropylfluorophosphate; Diisopropylfluorophosphoric acid ester; Diisopropylphosphofluoridate; Diisopropylphosphorofluoridate; Fluorodiisopropyl phosphate; Fluorostigmine; Isofluorphate; Isoflurophate; Isoflurophosphate; Isopropyl fluophosphate; Isopropyl phosphorofluoridate; O,O'-diisopropyl phosphoryl fluoride",Launched,cholinesterase inhibitor,ACHE|BCHE,ophthalmology,glaucoma,isoflurophate,
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,Losartan,(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol; 2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole; Losartan,Launched,angiotensin receptor antagonist,AGTR1,cardiology|nephrology,hypertension|diabetic nephropathy|hypertension,losartan,
CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,Thioridazine,10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine; 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine; 3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine; Thioridazin; Thioridazine; Thioridazinum; Tioridazina,Withdrawn,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7,,,thioridazine,
CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,Moricizine,[10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester; Ethmozin; ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate; ethyl 10-(β-N-morpholinylpropionyl)phenothiazine-2-carbamate; Etmozin; Moracizin; Moracizina; Moracizine; Moracizinum; Moricizine,Withdrawn,sodium channel blocker,SCN5A,cardiology,ventricular arrhythmias,moracizine,
CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,Warfarin,4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin; Coumafene; Warfarin; Warfarina; Zoocoumarin,Launched,vitamin K antagonist,VKORC1,hematology|cardiology,deep vein thrombosis (DVT)|pulmonary embolism (PE)|atrial fibrillation (AF)|myocardial infarction,warfarin,
NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,Tobramycin,"3'-Deoxykanamycin B; Nebramycin 6; O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine; Tobramicina; Tobramycin; Tobramycine; Tobramycinum",Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,bacterial septicemia|respiratory tract infections|meningitis|skin infections|urinary tract infections,tobramycin,
N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12,Trovafloxacin,Trovafloxacin; trovafloxacino,Withdrawn,bacterial DNA gyrase inhibitor,TOP2A,,,trovafloxacin,
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O,Moexipril,Moexipril; Moexiprilum,Launched,angiotensin converting enzyme inhibitor,ACE|ACE2,cardiology,hypertension,moexipril,
Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,Phentolamine,"2-(N-(m-hydroxyphenyl)-p-toluidinomethyl)imidazoline; 3-((4,5-DIHYDRO-1H-IMIDAZOL-2-YLMETHYL)(4-METHYLPHENYL)AMINO)PHENOL; Fentolamina; Phentolamin; Phentolamine; Phentolaminum",Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,endocrinology|cardiology,pheochromocytoma|hypertension,phentolamine,
O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccccc21,Fluorescein,"3,6-fluorandiol; 3',6'-dihydroxyfluoran; 9-(o-carboxyphenyl)-6-hydroxy-3-isoxanthenone; 9-(o-carboxyphenyl)-6-hydroxy-3H-xanthen-3-one; C.I. Solvent Yellow 94; D and C Yellow No. 7; D&C Yellow No. 7; Fluorescein; Fluoresceína; Fluoresceina; Fluoresceine; Fluoreszein; Japan Yellow 201; Resorcinolphthalein; Solvent Yellow 94; Yellow fluorescein",Launched,,SLC22A6,ophthalmology,ophthalmology diagnostic,fluorescein,
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,Daunorubicin,"(+)-Daunomycin; (8S-cis)-8-acetyl-10-((3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione; Acetyladriamycin; Daunomycin; Daunorubicin; Daunorubicin liposomal; Daunorubicina; Daunorubicine; Daunorubicinum; Leukaemomycin C; Rubidomycin",Launched,RNA synthesis inhibitor|topoisomerase inhibitor,TOP2A|TOP2B,hematologic malignancy,acute myeloid leukemia (AML)|acute lymphoblastic leukemia (ALL),daunorubicin,
NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,Furosemide,2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid; 4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid; 4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid; 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid; Frusemide; Furosemid; Furosemida; Furosemide; Furosemidu; Furosemidum,Launched,diuretic,CA2|GPR35|SLC12A1|SLC12A2,cardiology|rheumatology,edema|hypertension|congestive heart failure|nephrotic syndrome,furosemide,
CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21,Ergotamine,"(5'α)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione; 12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione; 12'-hydroxy-2'-methyl-5'α-(phenylmethyl)ergotaman-3',6',18-trione; Ergotamin; Ergotamina; Ergotamine; Ergotaminum",Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|DRD1|DRD2|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|SLC6A2,neurology/psychiatry,migraine headache,ergotamine,
Clc1ccc2nsnc2c1NC1=NCCN1,Tizanidine,"5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole; Tizanidin; Tizanidina; Tizanidine; Tizanidinum",Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|NISCH,neurology/psychiatry,spasms,tizanidine,
O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,Nitrofurantoin,"1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione; 1-((5-nitrofurfurylidene)amino)hydantoin; 5-Nitrofurantoin; N-(5-Nitrofurfurylidene)-1-aminohydantoin; Nitrofurantoin; Nitrofurantoin anhydrous; Nitrofurantoin macrocrystal; Nitrofurantoin macrocrystalline; Nitrofurantoin, macrocrystalline; Nitrofurantoin, macrocrystals; nitrofurantoina; nitrofurantoine; nitrofurantoinum; Nitrofurantoinum anhydrous",Launched,DNA inhibitor,,infectious disease,urinary tract infections|pyelonephritis,nitrofurantoin,
CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13,Nicergoline,"(8β)-10-methoxy-1,6-dimethylergoline-8-methanol 5-bromo-3-pyridinecarboxylate (ester); 10-methoxy-1,6-dimethylergoline-8β-methanol 5-bromonicotinate; Nicergolin; Nicergolina; Nicergoline; Nicergolinum",Launched,adrenergic receptor antagonist,ADRA1A,rheumatology|neurology/psychiatry|cardiology|hematology,Raynaud's disease|migraine headache|atherosclerosis|thrombosis,nicergoline,
COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13,Eplerenone,Eplerenona; Eplerenone; Epoxymexrenone,Launched,cytochrome P450 inhibitor,NR3C2,cardiology,congestive heart failure|hypertension,eplerenone,
CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,Amprenavir,"(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate; Amprenavir; Amprénavir; Amprenavirum",Launched,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),amprenavir,
CC(=O)/N=c1/sc(S(N)(=O)=O)nn1C,Methazolamide,Metazolamida; Methazolamid; Méthazolamide; Methazolamide; Methazolamidum; Methenamide; Neptazaneat,Launched,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,ophthalmology,glaucoma|intraocular pressure,methazolamide,
O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5,Naltrexone,"17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one; 17-(Cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one; N-Cyclopropylmethyl-14-hydroxydihydromorphinone; N-Cyclopropylmethylnoroxymorphone; Naltrexon; Naltrexona; Naltrexone; Naltrexonum",Launched,opioid receptor antagonist,OPRD1|OPRK1|OPRM1|SIGMAR1,neurology/psychiatry,abstinence from alcohol,naltrexone,
CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,Delavirdine,(N-[2-[4-[3-(1-methylethylamino)pyridin-2-yl]piperazin-1-yl]carbonyl-1H-indol-5-yl] methanesulfonamide); 1-(3-((1-methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1H-indol-2-yl)carbonyl)piperazine; 2-(4-(5-methanesulfonamido-1H-indol-2-ylcarbonyl)-1-piperazinyl)-N-(1-methylethyl)-3-pyridinamine; Delavirdin; Delavirdina; Delavirdine; Delavirdinum; N-(2-(1-(3-(isopropylamino)pyridin-2-yl)piperazine-4-carbonyl)-1H-indol-5-yl)methanesulfonamide; N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,Launched,non-nucleoside reverse transcriptase inhibitor,CYP3A4,infectious disease,human immunodeficiency virus (HIV-1),delavirdine,
CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,Tamsulosin,(−)-tamsulosin; (R)-(−)-tamsulosin; (R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide; Tamsulosin; Tamsulosina; Tamsulosine; Tamsulosinum,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,urology,benign prostatic hyperplasia (BPH),tamsulosin,
Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,Lamivudine,"(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; (-)-2'-Deoxy-3'-thiacytidine; 2',3'-Dideoxy-3'-thiacytidine; 3'-Thia-2',3'-dideoxycytidine; 3TC; beta-L-2',3'-Dideoxy-3'-thiacytidine; beta-L-3'-Thia-2',3'-dideoxycytidine; Lamivudin; Lamivudina; Lamivudine; Lamivudinum",Launched,nucleoside reverse transcriptase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)|acquired immunodeficiency syndrome (AIDS)|hepatitis B,lamivudine,
CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,Ibandronate,ácido ibandrónico; Ibandronic acid,Launched,bone resorption inhibitor,FDPS,orthopedics,osteoporosis,ibandronate,
CCN(CC)C(=O)N1CCN(C)CC1,Diethylcarbamazine,Diethylcarbamazin; Diéthylcarbamazine; Diethylcarbamazine; Diethylcarbamazinum; Dietilcarbamazina,Launched,lipoxygenase inhibitor,ALOX5|PTGS1,infectious disease,filariasis,diethylcarbamazine,
Cc1onc(-c2ccccc2)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,Oxacillin,"(2S,5R,6R)-3,3-dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (5-methyl-3-phenyl-4-isoxazolyl)penicillin; 5-methyl-3-phenyl-4-isoxazolyl-penicillin; 6β-(5-methyl-3-phenylisoxazol-4-yl)penicillanic acid; Ossacillina; Oxacilina; Oxacillin; Oxacilline; Oxacillinum; Oxazocillin; Oxazocilline",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,staphylococcal infections,oxacillin,
Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,Paroxetine,"(−)-(3S,4R)-4-(p-fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine; (3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine; Paroxetina; Paroxetine; Paroxetinum",Launched,selective serotonin reuptake inhibitor (SSRI),CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4,neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|generalized anxiety disorder (GAD)|panic disorders|posttraumatic stress disorder|social anxiety disorder,paroxetine,
CCCc1c2oc(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)n(CC)c12,Nedocromil,"9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsäure; 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid; Nedocromil; Nédocromil; Nedocromilo; Nedocromilum",Launched,histamine receptor antagonist,CYSLTR1|CYSLTR2|FPR1|HSP90AA1|PTGDR,neurology/psychiatry|ophthalmology,itching|conjunctivitis,nedocromil,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C,Norethisterone,"(17alpha)-17-ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one; 17-hydroxy-19-nor-17-α-pregn-4-en-20-yn-3-one; 17-hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one; 17-α-ethynyl-17-hydroxy-4-estren-3-one; 17-α-ethynyl-19-norandrost-4-en-17-β-ol-3-one; 17-α-ethynyl-19-nortestosterone; 17-α-ethynyl-4-estren-17-ol-3-one; 17-β-hydroxy-19-norpregn-4-en-20-yn-3-one; 17α-ethinyl-19-nortestosterone; 17α-ethinylestra-4-en-17β-ol-3-one; 17α-ethynyl-17-hydroxy-4-estren-3-one; 17α-ethynyl-17β-hydroxy-19-norandrost-4-en-3-one; 17α-ethynyl-19-nor-4-androsten-17β-ol-3-one; 17α-ethynyl-19-norandrost-4-en-17β-ol-3-one; 17α-ethynyl-19-nortestosterone; 17α-ethynyl-4-estren-17-ol-3-one; 17β-hydroxy-19-norpregn-4-en-20-yn-3-one; 19-nor-17-α-ethynyl-17-β-hydroxy-4-androsten-3-one; 19-nor-17-α-ethynylandrosten-17-β-ol-3-one; 19-nor-17-α-ethynyltestosterone; 19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one; 19-nor-17α-ethynyl-17β-hydroxy-4-androsten-3-one; 19-nor-17α-ethynylandrosten-17β-ol-3-one; 19-nor-17α-ethynyltestosterone; 19-nor-ethindrone; 19-norethisterone; 4-estren-17α-ethynyl-17β-ol-3-one; Norethindrone; Norethisteron; Norethisterone; Noréthistérone; Norethisteronum; Noretisterona",Launched,progesterone receptor agonist,PGR,obstetrics/gynecology,endometriosis,norethindrone,
CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1,Azatadine,"11-(1-Methyl-4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; 6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine; Azatadin; Azatadina; Azatadine; Azatadinum",Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis,azatadine,
CCN(CC)CCOC(=O)c1ccc(N)cc1,Procaine,2-Diethylaminoethyl p-aminobenzoate; 4-aminobenzoic acid 2-diethylaminoethyl ester; Novocaine; p-Aminobenzoic acid 2-diethylaminoethyl ester; Procaina; Procaine; Procainum; Vitamin H3; β-(diethylamino)ethyl 4-aminobenzoate; β-(diethylamino)ethyl p-aminobenzoate,Launched,HMGCR inhibitor,CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3,neurology/psychiatry,anesthetic,procaine,
NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O,Lisinopril,(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline; [N2-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline; Lisinopril; Lisinopril anhydrous; Lisinoprilum,Launched,angiotensin converting enzyme inhibitor,ACE|ACE2,cardiology|endocrinology,hypertension|congestive heart failure|diabetes mellitus,lisinopril,
COc1ccc(OC)c(C(O)C(C)N)c1,Methoxamine,Méthoxamédrine; Methoxamin; Methoxamine; Méthoxamine; Methoxaminum; Metossamina; Metoxamina; Pseudomethoxamine,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,cardiology,hypotension,methoxamine,
CC(C)Cn1cnc2c(N)nc3ccccc3c21,Imiquimod,"1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine; 4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline; Imiquimod; Imiquimodum",Launched,interferon inducer|toll-like receptor agonist,TLR7|TLR8,dermatology|infectious disease|oncology,actinic keratosis (AK)|genital warts|basal cell carcinoma (BCC),imiquimod,
CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,Trimipramine,"10,11-dihydro-N,N,β-trimethyl-5H-dibenz[b,f]azepine-5-propanamine; 5-(γ-dimethylamino-β-methylpropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine; 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-5H-dibenz[b,f]azepine; beta-Methylimipramine; Trimeprimina; Trimeprimine; Trimeproprimine; Trimipramina; Trimipramine; Trimipraminum; β-methylimipramine",Launched,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,depression,trimipramine,
C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1,Rocuronium,Rocuronio; Rocuronium,Launched,acetylcholine receptor antagonist,CHRM2|CHRNA2|HTR3A,neurology/psychiatry,anesthetic,rocuronium,
c1ccc2[nH]c(-c3cscn3)nc2c1,Thiabendazole,"2-(1,3-thiazole-4-yl)-1H-benzimidazole; 2-(4-thiazolyl)-1H-benzimidazole; 2-(thiazol-4-yl)benzimidazole; 4-(2-benzimidazolyl)thiazole; TBDZ; Thiabendazole; Tiabendazol; Tiabendazole; Tiabendazolum",Launched,angiogenesis inhibitor,,infectious disease,gastrointestinal roundworms|hookworm,tiabendazole,
CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1,Nateglinide,Nateglinida; Natéglinide; Nateglinide; Nateglinidum,Launched,insulin secretagogue,ABCC8|KCNJ10|KCNJ11|PPARG,endocrinology,diabetes mellitus,nateglinide,
C[n+]1ccccc1/C=N/O,Pralidoxime,2-PAM; Pralidoxim; Pralidoxima; Pralidoxime; Pralidoximum,Launched,acetylcholinesterase inhibitor,ACHE|BCHE,critical care,organophosphate poisoning,pralidoxime,
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,Risperidone,Risperidona; Rispéridone; Risperidone; Risperidonum,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7,neurology/psychiatry,schizophrenia|bipolar disorder|irritability,risperidone,
CN(CC=Cc1ccccc1)Cc1cccc2ccccc12,Naftifine,Naftifin; Naftifina; Naftifine; Naftifinum,Launched,fungal squalene epoxidase inhibitor,,infectious disease,tinea pedis|tinea cruris|tinea corporis,naftifine,
COc1ccc2[nH]c([S@@](=O)Cc3ncc(C)c(OC)c3C)nc2c1,Esomeprazole,(−)-omeprazole; (S)-(−)-omeprazole; (S)-omeprazole; Esomeprazol; Ésoméprazole; Esomeprazole; Esomeprazolum; Omeprazole S-form; Perprazole,Launched,ATPase inhibitor,ATP4A,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),esomeprazole,
Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1,Meclizine,Meclizine; Meclozina; Meclozine,Launched,constitutive androstane receptor (CAR) agonist,NR1I3,gastroenterology|neurology/psychiatry,nausea|vomiting|motion sickness,meclizine,
N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Pentamidine,"1,5-bis(4-amidinophenoxy)pentane; 4,4'-(1,5-pentanediylbis(oxy))bis-benzenecarboximidamide; 4,4'-(pentamethylenedioxy)dibenzamidine; 4,4'-Diamidinodiphenoxypentane; p,p'-(pentamethylenedioxy)dibenzamidine; Pentamidin; Pentamidina; Pentamidine; Pentamidinum",Launched,anti-pneumocystis agent,TRDMT1,infectious disease,pneumonia,pentamidine,
CC1(C)S[C@@H]2[C@H](N3C(=O)[C@@H](c4ccccc4)NC3(C)C)C(=O)N2[C@H]1C(=O)O,Hetacillin,"(2S,5R,6R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6β-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid; Hetacilina; Hetacillin; Hétacilline; Hetacillinum",Launched,bacterial cell wall synthesis inhibitor,,obstetrics/gynecology,mastitis,hetacillin,
Nc1nc2ccc(OC(F)(F)F)cc2s1,Riluzole,Riluzol; Riluzole; Riluzolum,Launched,glutamate inhibitor,KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11,neurology/psychiatry,amyotrophic lateral sclerosis (ALS),riluzole,
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,Hydrocortisone,"(11β)-11,17,21-trihydroxypregn-4-ene-3,20-dione; 11beta-hydrocortisone; 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione; 11β-hydrocortisone; 17-Hydroxycorticosterone; 4-pregnen-11β,17α,21-triol-3,20-dione; Cortisol; Hidrocortisona; Hydrocortisone; Hydrocortisonum; Kendall's compound F; Reichstein's substance M",Launched,glucocorticoid receptor agonist,ANXA1|NOS2|NR3C1|NR3C2,dermatology|neurology/psychiatry,eczema|psoriasis|seborrheic dermatitis|itching,hydrocortisone,
CC(c1cc2ccccc2s1)N(O)C(N)=O,Zileuton,(±)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea; Leutrol; N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea; N-[1-(benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea; Zileuton; Zileutón; Zileutonum,Launched,leukotriene synthesis inhibitor|lipoxygenase inhibitor,ALOX5,pulmonary,asthma,zileuton,
CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21,Scopolamine,"(-)-hyoscine; (-)-scopolamine; (1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate; 6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate; 6,7-Epoxytropine tropate; alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester; Hyoscine; scopine (-)-tropate; scopine (−)-tropate; Scopolamine; Scopolamine hydrobromide",Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI,neurology/psychiatry|gastroenterology,motion sickness|vomiting|nausea,scopolamine,
CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1,Carbinoxamine,(±)-carbinoxamine; {2-[(4-Chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine; 2-(p-chloro-α-(2-(dimethylamino)ethoxy)benzyl)pyridine; Carbinoxamin; Carbinoxamina; Carbinoxamine; Carbinoxamine base; Carbinoxaminum; Paracarbinoxamine,Launched,histamine receptor antagonist,HRH1,allergy|ophthalmology|otolaryngology|dermatology,allergic rhinitis|conjunctivitis|vasomotor rhinitis|dermatographism,carbinoxamine,
CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3,Etodolac,"(±)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid; (1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid; 1,3,4,9-tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid; 1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid; 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid; Étodolac; Etodolac; Etodolaco; Etodolacum; Etodolic acid; Etodolsäure",Launched,cyclooxygenase inhibitor,PTGS2,rheumatology,osteoarthritis|rheumatoid arthritis,etodolac,
CCCNC(C)C(=O)Nc1ccccc1C,Prilocaine,2-(Propylamino)-o-propionotoluidide; 2-Methyl-alpha-propylaminopropionanilide; alpha-n-Propylamino-2-methylpropionanilide; N-(2-Methylphenyl)-2-(propylamino)propanamide; o-Methyl-2-propylaminopropionanilide; o-Methyl-alpha-propylaminopropionanilide; Prilocain; Prilocaina; Prilocaine; Prilocaïne; Prilocaine base; Prilocainum; Propitocaine,Launched,local anesthetic,SCN5A,neurology/psychiatry,anesthetic,prilocaine,
NC1=NCC2c3ccccc3Cc3ccccc3N12,Epinastine,"(±)-epinastine; 3-amino-9,13b-dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepine; Epinastin; Epinastina; Epinastine; épinastine; Epinastinum",Launched,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis,epinastine,
NC1CC1c1ccccc1,Tranylcypromine,"(±)-trans-2-phenylcyclopropylamine; (1R*,2S*)-2-phenylcyclopropan-1-amine; dl-tranylcypromine; Racemic Tranylcypromine; Tranilcipromina; trans-2-phenylcyclopropylamine; trans-DL-2-Phenylcyclopropylamine; Transamine; Tranylcypromin; Tranylcypromine; Tranylcyprominum",Launched,monoamine oxidase inhibitor,KDM1A|MAOA|MAOB,neurology/psychiatry,depression,tranylcypromine,
FC(F)OC(Cl)C(F)(F)F,Isoflurane,"1-chloro-2,2,2-trifluoroethyl difluoromethyl ether; Isoflurane; Isoflurano; Isofluranum",Launched,inhaled anaesthetic,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9,neurology/psychiatry,general anaesthetic,isoflurane,
CCN1C(=O)NC(c2ccccc2)C1=O,Ethotoin,"(±)-3-ethyl-5-phenylhydantoin; 1-ethyl-2,5-dioxo-4-phenylimidazolidine; 3-ethyl-5-phenyl-2,4-imidazolidinedione; 3-Ethyl-5-phenyl-imidazolidine-2,4-dione; 3-ethyl-5-phenylhydantoin; 3-ethyl-5-phenylimidazolidin-2,4-dione; Ethotoin; Ethotoïne; Ethotoinum; Etotoina",Launched,hydantoin antiepileptic,SCN5A,neurology/psychiatry,seizures,ethotoin,
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,Tretinoin,"(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ECL); Acide retinoique; all trans Retinoic acid; all trans-Retinoic acid; all-(E)-Retinoic acid; all-trans-beta-Retinoic acid; all-trans-Retinoic acid; all-trans-Tretinoin; all-trans-Vitamin A acid; all-trans-Vitamin A1 acid; ATRA; beta-Retinoic acid; Retinoic acid; Retionic acid; trans-Retinoic acid; Tretin M; Tretinoin; Tretinoina; Trétinoïne; Tretinoinum; Vitamin A acid",Launched,retinoid receptor agonist|retinoid receptor ligand,ALDH1A1|ALDH1A2|GPRC5A|NR0B1|NR2C2|PPARD|RARA|RARB|RARG|RARRES1|RORB|RORC|RXRB|RXRG,hematologic malignancy,acute promyelocytic leukemia (APL),tretinoin,
Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl,Hexachlorophene,"2,2'-dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane; 2,2'-dihydroxy-3,5,6,3',5',6'-hexachlorodiphenylmethane; 2,2'-methanediylbis(3,4,6-trichlorophenol); 2,2'-methylenebis(3,4,6-trichlorophenol); 2,2',3,3',5,5'-hexachloro-6,6'-dihydroxydiphenylmethane; bis(2-hydroxy-3,5,6-trichlorophenyl)methane; bis(3,5,6-trichloro-2-hydroxyphenyl)methane; hexachlorophène; Hexachlorophene; Hexachlorophenum; Hexaclorofeno",Launched,potassium channel activator,GLUD1|SDHD,infectious disease,gram-positive bacterial infections,hexachlorophene,
O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12,Dolasetron,Dolasétron; Dolasetron; Dolasetronum,Launched,serotonin receptor antagonist,HTR3A,gastroenterology,nausea|vomiting,dolasetron,
COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,Clopidogrel,(+)-Clopidogrel; Clopidogrel; Clopidogrelum,Launched,purinergic receptor antagonist,P2RY12,cardiology|neurology/psychiatry,myocardial infarction|stroke|peripheral artery disease (PAD)|acute coronary syndrome (ACS),clopidogrel,
CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,Tetracycline,"(4S,4aS,5aS,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide; Abramycin; Anhydrotetracycline; Deschlorobiomycin; Tetracyclin; Tétracycline; Tetracycline; Tetracyclinum; Tetrazyklin; Tsiklomitsin",Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease|dermatology,respiratory tract infections|pneumonia|skin infections|urinary tract infections|acne vulgaris (AV)|plague|psittacosis,tetracycline,
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,Meropenem,"(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; Meropenem; Meropenem anhydrous; Meropenemum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections|intra-abdominal infections|meningitis,meropenem,
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,Irinotecan,"(+)-Irinotecan; (S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 4-(2-(5-(3-(2,4-dihydroxy-5-isopropylphenyl)-5-hydroxy-4H-1,2,4-triazol-4-yl)-1H-indol-1-yl)ethyl)piperidine-1-carboxylate; Irinotecan; Irinotecan lactone; Irinotecan liposome injection; Irinotecanum",Launched,topoisomerase inhibitor,TOP1|TOP1MT,oncology,colorectal cancer,irinotecan,
Cn1cc[nH]c1=S,Methimazole,1-Methylimidazole-2(3H)-thione; Methimazole; Thiamazol; Thiamazole; Thiamazolum; Tiamazol,Launched,antithyroid agent,TPO,endocrinology,hyperthyroidism,methimazole,
C[C@](N)(Cc1ccc(O)cc1)C(=O)O,Metyrosine,(-)-alpha-Methyl-L-tyrosine; (–)-α-methyl-L-tyrosine; (S)-alpha-Methyltyrosine; Methyltyrosine; Metirosin; Metirosina; Métirosine; Metirosine; Metirosinum; Metyrosine; α-methyl-L-p-tyrosine; α-methyl-p-tyrosine; α-methyl-para-tyrosine; α-MPT,Launched,tyrosine hydroxylase inhibitor,TH,cardiology,hypertension,metirosine,
O=C(O)[C@H]1/C(=C/CO)O[C@@H]2CC(=O)N21,Clavulanic acid,"(Z)-(2R,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; Acide clavulanique; ácido clavulánico; Acidum clavulanicum; Clavulanate; Clavulanic acid; Clavulansäure",Launched,beta lactamase inhibitor,,otolaryngology,otitis,clavulanate,
CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21,Olopatadine,Olopatadin; Olopatadina; Olopatadine; Olopatadinum,Launched,histamine receptor antagonist,HRH1|S100A1|S100A12|S100A13|S100A2|S100B,ophthalmology,conjunctivitis,olopatadine,
CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,Alprostadil,"(11α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid; (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; 11α,15α-dihydroxy-9-oxo-13-trans-prostenoic acid; Alprostadil; Alprostadilum; PGE-1; PGE1; Prostaglandin E1",Launched,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR,cardiology,congenital heart defects,alprostadil,
C[N@+]12CC[C@H](CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2,Clidinium,"3-(2-Hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo[2.2.2]octane; 3-hydroxy-1-methylquinuclidinium benzilate ester; Bromure de Clidinium; Bromuro de clidinio; Clidinii Bromidum; Clidinium bromid; N-methyl quinuclidinyl benzilate",Launched,acetylcholine receptor antagonist,CHRM1|CHRM3,gastroenterology,peptic ulcer disease (PUD)|irritable bowel syndrome|enterocolitis,clidinium,
CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,Malathion,"[(dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester; Carbophos; diethyl (dimethoxyphosphinothioylthio)succinate; Karbofos; Malathion; Maldison; Mercaptothion; O,O-dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl); O,O-dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate; O,O-dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate; O,O-dimethyl S-1,2-di(ethoxycarbamyl)ethyl; O,O-dimethyldithiophosphate diethylmercaptosuccinate",Launched,cholinesterase inhibitor,ACHE,infectious disease,lice,malathion,
COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,Etoposide,"(−)-etoposide; 4-demethylepipodophyllotoxin β-D-ethylideneglucoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one; Etoposide; Etoposido; Etoposidum; trans-Etoposide",Launched,topoisomerase inhibitor,TOP2A|TOP2B,oncology,non-small cell lung cancer (NSCLC),etoposide,
NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,Hydroflumethiazide,Dihydroflumethazide; Hidroflumetiazid; Hidroflumetiazida; Hydrofluméthiazide; Hydroflumethiazide; Hydroflumethiazidum; Idroflumetiazide; Metforylthiadiazin,Launched,sodium/potassium/chloride transporter inhibitor,ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3,cardiology|gastroenterology|rheumatology|nephrology,edema|congestive heart failure|hepatic cirrhosis|nephrotic syndrome|chronic renal failure|acute glomerulonephritis (AGN)|hypertension,hydroflumethiazide,
CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O,Tirofiban,(2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid; N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine; Tirofiban; Tirofibán; Tirofibanum,Launched,platelet aggregation inhibitor|structural glycoprotein antagonist,ITGA2B|ITGB3,cardiology,myocardial infarction|refactory angina,tirofiban,
NC(=O)N1c2ccccc2CC(=O)c2ccccc21,Oxcarbazepine,"10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide; OCBZ; Oxcarbamazepine; Oxcarbazepina; Oxcarbazepine; Oxcarbazepinum",Launched,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures,oxcarbazepine,
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=NOCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O,Roxithromycin,(9E)-erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime); Roxithromycin; Roxithromycine; Roxithromycinum; Roxitromicina,Launched,bacterial 50S ribosomal subunit inhibitor,MLNR,infectious disease,respiratory tract infections|urinary tract infections|skin infections,roxithromycin,
NNCCc1ccccc1,Phenelzine,Fenelzina; Phenelzin; Phénelzine; Phenelzine; Phenelzinum,Launched,monoamine oxidase inhibitor,ABAT|AOC3|GAD2|GPT|GPT2|MAOA|MAOB|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,depression,phenelzine,
CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C,Propantheline,Propantheline,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,gastroenterology,peptic ulcer disease (PUD),propantheline,
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,Estradiol,"(17β)-estra-1,3,5(10)-triene-3,17-diol; 17beta oestradiol; 17β-estra-1,3,5(10)-triene-3,17-diol; 17β-estradiol; 17β-oestradiol; beta-Estradiol; cis-Estradiol; Estradiol; Estradiol-17beta; Estradiolum",Launched,estrogen receptor agonist,ESR1|ESR2|GPER1|KCNMA1|NR1I2,endocrinology,contraceptive,estradiol,
Nc1nc(=O)c2ncn(COCCO)c2[nH]1,Acyclovir,Aciclovir; Aciclovirum; Acycloguanosine; Acyclovir,Launched,DNA polymerase inhibitor,PNP,infectious disease,genitial herpes|shingles|chicken pox,acyclovir,
COc1ccc2cc([C@H](C)C(=O)O)ccc2c1,Naproxen,(+)-(S)-6-Methoxy-α-methyl-2-naphthaleneacetic acid; (+)-(S)-Naproxen; (+)-2-(6-Methoxy-2-naphthyl)propionic acid; (+)-2-(Methoxy-2-naphthyl)-propionic acid; (+)-2-(Methoxy-2-naphthyl)-propionsäure; (+)-Naproxen; (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid; (S)-(+)-Naproxen; (S)-2-(6-Methoxy-2-naphthyl)propanoic acid; (S)-2-(6-Methoxy-2-naphthyl)propionic acid; (S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid; (S)-Naproxen; Naprolag; Naproxen; Naproxène; Naproxeno; Naproxenum,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry|rheumatology|dental|otolaryngology|endocrinology,pain relief|rheumatoid arthritis|headache|toothache|backache|muscle pain|common cold|fever,naproxen,
CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC,Perindopril,"(2S,3aS,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid; Perindopril; Perindoprilum",Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|myocardial infarction|coronary artery disease (CAD),perindopril,
CN(C)CCN(Cc1ccccc1)c1ccccn1,Tripelennamine,Tripelennamin; Tripelennamina; Tripélennamine; Tripelennamine; Tripelennaminum,Launched,histamine receptor antagonist,HRH1,pulmonary|allergy,asthma|allergic rhinitis|urticaria,tripelennamine,
Clc1cc(Cl)c(OCC#CI)cc1Cl,Haloprogin,Haloprogin; Haloprogina; Haloprogine; Haloproginum,Launched,other antifungal,,infectious disease,tinea pedis,haloprogin,
CCC1(c2ccccc2)C(=O)NCNC1=O,Primidone,"2-deoxyphenobarbital; 5-Phenyl-5-ethyl-Hexahydropyrimidine-4,6-dione; Primidon; Primidona; Primidone; Primidonum",Launched,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures,primidone,
O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,Sulfasalazine,2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid; 2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid; 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene; 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid; 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid; 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid; Azopyrin; Salazosulfapiridina; Salazosulfapyridine; Salazosulfapyridinum; Salicylazosulfapyridine; Sulfasalazin; Sulfasalazina; Sulfasalazine; Sulfasalazinum,Launched,cyclooxygenase inhibitor,ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1,gastroenterology,ulcerative colitis,sulfasalazine,
c1ccc(CC2=NCCN2)cc1,Tolazoline,"2-Benzyl-2-imidazoline; 2-Benzyl-4,5-imidazoline; 2-Benzylimidazoline; 4,5-Dihydro-2-(phenylmethyl)-1H-imidazole; Benzazoline; Tolazolin; Tolazolina; Tolazoline; Tolazolinum",Launched,adrenergic receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|HRH1|HRH2,neurology/psychiatry,reverse sedative,tolazoline,
CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1,Tazarotene,Tazarotene; Tazarotène; Tazaroteno; Tazarotenum,Launched,retinoid receptor agonist,RARA|RARB|RARG|RXRB,dermatology,cosmetic|sunscreen lotion,tazarotene,
Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,Fenoldopam,Fenoldopam; Fénoldopam; Fenoldopamum,Launched,dopamine receptor agonist,DRD1|DRD4,cardiology,hypertension,fenoldopam,
CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,Dicyclomine,2-(diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate; Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester; Dicicloverina; Dicyclomine; Dicycloverin; Dicycloverine; Dicycloverinum,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,gastroenterology,irritable bowel syndrome,dicycloverine,
Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,Minaprine,4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine; 4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin; Minaprina; Minaprine; Minaprinum; N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine,Withdrawn,serotonin reuptake inhibitor,ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4,,,minaprine,
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,Pentoxifylline,Oxpentifylline; Pentoxifilina; Pentoxifyllin; Pentoxifylline; Pentoxifyllinum,Launched,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF,cardiology,claudication,pentoxifylline,
CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N,Proparacaine,Proximetacaina; Proxymetacaine; Proxymetacainum,Launched,sodium channel blocker,SCN10A|SCN5A,neurology/psychiatry,anesthetic,proxymetacaine,
CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,Indapamide,Indapamid; Indapamida; Indapamide; Indapamidum; Metindamide,Launched,thiazide diuretic,CA2|HTR3A|KCNQ1,cardiology,hypertension|congestive heart failure,indapamide,
CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1,Tropicamide,Tropicamid; Tropicamida; Tropicamide; Tropicamidum,Launched,acetylcholine receptor antagonist,CHRM3|CHRM4,ophthalmology,mydriasis diagnostic|cycloplegia diagnostic,tropicamide,
OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2,Biperiden,1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol; alpha-5-norbornen-2-yl-alpha-phenyl-1-piperidinepropanol; alpha-bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol; Biperiden; Biperidene; Biperideno; Biperidenum,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,neurology/psychiatry,Parkinson's Disease,biperiden,
NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,Ribavirin,"1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; RBV; Ribavirin; Ribavirina; Ribavirine; Ribavirinum; Tribavirin",Launched,antiviral,ADK|ENPP1|IMPDH1|IMPDH2|NT5C2,infectious disease,hepatitis C,ribavirin,
CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,Phenylbutazone,"3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine; 4-butyl-1,2-diphenyl-pyrazolidine-3,5-dione; 4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione; Fenilbutazona; Phenbutazone; Phenylbutazon; Phenylbutazone; Phénylbutazone; Phenylbutazonum",Withdrawn,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGIS|PTGS1|PTGS2,,,phenylbutazone,
Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,Meloxicam,Méloxicam; Meloxicam; Meloxicamum,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,osteoarthritis|rheumatoid arthritis,meloxicam,
CC(C)NCC(O)c1cc(O)cc(O)c1,Orciprenaline,Metaproterenol; Orciprenalina; Orciprenaline; Orciprenalinum,Launched,adrenergic receptor agonist,ADRB2,pulmonary,bronchospasm|asthma|bronchitis|emphysema,metaproterenol,
CCn1cc(C(=O)O)c(=O)c2ccc(-c3ccncc3)cc21,Rosoxacin,"1-ethyl-1,4-dihydro-4-oxo-7-(4-pyridyl)-3-quinolinecarboxylic acid; Acrosoxacin; Rosoxacin; Rosoxacina; Rosoxacine; Rosoxacino; Rosoxacinum",Launched,topoisomerase inhibitor,,infectious disease,urinary tract infections,rosoxacin,
CC(C)c1cccc(C(C)C)c1O,Propofol,"2,6-bis(1-methylethyl)phenol; 2,6-Diisopropylphenol; Propofol; Propofolum",Launched,benzodiazepine receptor agonist,FAAH|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|SCN2A|SCN4A,neurology/psychiatry,anesthetic,propofol,
CC(=O)Nc1nnc(S(N)(=O)=O)s1,Acetazolamide,"2-acetylamino-1,3,4-thiadiazole-5-sulfonamide; 5-acetamido-1,3,4-thiadiazole-2-sulfonamide; 5-acetylamino-1,3,4-thiadiazole-2-sulfonamide; Acetazolamid; Acetazolamida; Acétazolamide; Acetazolamide; Acetazolamidum; N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide; N-[5-(aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide",Launched,carbonic anhydrase inhibitor,AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7,ophthalmology,glaucoma,acetazolamide,
CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3c(c2)OCO3)C1=O,Tadalafil,"(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione; (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione; Tadalafil; Tadalafilo",Launched,phosphodiesterase inhibitor,PDE11A|PDE5A,urology,erectile dysfunction,tadalafil,
CC(C(=O)O)c1ccc2c(c1)[nH]c1ccc(Cl)cc12,Carprofen,(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid; (±)-6-chloro-α-methylcarbazole-2-acetic acid; 2-(6-Chloro-9H-carbazol-2-yl)-propionic acid; 6-chloro-α-methyl-9H-carbazole-2-acetic acid; Carprofen; Carprofène; Carprofeno; Carprofenum,Launched,cyclooxygenase inhibitor,PTGS2,rheumatology,osteoarthritis,carprofen,
CCN(CC)C(=S)SSC(=S)N(CC)CC,Disulfiram,"1,1'-dithiobis(N,N-diethylthioformamide); bis(diethylthiocarbamoyl) disulfide; Disulfiram; N,N,N',N'-tetraethylthiuram disulfide; Tetraethylthioperoxydicarbonic diamide; Tetraethylthiuram disulfide; Tetraethylthiuram disulphide",Launched,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist,ALDH2|DBH,neurology/psychiatry,abstinence from alcohol,disulfiram,
CCCn1c(=O)[nH]c(=O)c2[nH]cnc21,Enprofylline,"3-n-propylxanthine; 3-Propyl-3,7-dihydro-purine-2,6-dione; 3-propylxanthine; 3,7-dihydro-3-propyl-1H-purine-2,6-dione; Enprofilina; Enprofylline; Enprofyllinum",Phase 3,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B,,,enprofylline,
CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O,Levomenthol,"(-)-Menthol; (−)-(1R,3R,4S)-menthol; (−)-menthol; (1alpha,2beta,5alpha)-5-methyl-2(1-methylethyl)cyclohexanol; (1R-(1-α,2-β,5-α))-5-methyl-2-(1-methylethyl)cyclohexanol; (1R,3R,4S)-(−)-menthol; L-menthol; Lévomenthol; Levomenthol; Levomentholum; Levomentol; Mentol",Launched,,OPRK1|TRPA1|TRPM8|TRPV3,neurology/psychiatry,pain relief,levomenthol,
C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O,Natamycin,Natamicina; Natamycin; Natamycine; Natamycinum; Pimaracin; Pimaricin,Launched,fungal ergosterol inhibitor,,ophthalmology|infectious disease,conjunctivitis|fungal keratosis|blepharitis,natamycin,
CCn1nc(C(=O)O)c(=O)c2cc3c(cc21)OCO3,Cinoxacin,"1-ethyl-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acid; 5-Ethyl-8-oxo-5,8-dihydro-1,3-dioxa-5,6-diaza-cyclopenta[b]naphthalene-7-carboxylic acid; Cinoxacin; Cinoxacine; Cinoxacino; Cinoxacinum",Launched,topoisomerase inhibitor,,infectious disease,urinary tract infections,cinoxacin,
C[C@@H]1O[C@@H]1P(=O)(O)O,Fosfomycin,"(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid; (1R,2S)-epoxypropylphosphonic acid; (2R-cis)-(3-Methyloxiranyl)phosphonic acid; 1R-cis-(1,2-epoxypropyl)phosphonic acid; cis-(1R,2S)-epoxypropylphosphonic acid; FCM; Fosfocina; Fosfomicina; Fosfomycin; Fosfomycine; Fosfomycinum; L-cis-1,2-epoxypropylphosphonic acid; Phosphomycin; Phosphonemycin; Phosphonomycin",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,urinary tract infections,fosfomycin,
CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,Trifluoperazine,10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine; Trifluoperazina; Trifluopérazine; Trifluoperazine; Trifluoperazinum; trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine; Trifluoroperazine; Trifluperazine,Launched,dopamine receptor antagonist,ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1,neurology/psychiatry,schizophrenia,trifluoperazine,
CN1C(=O)CC(c2ccccc2)C1=O,Phensuximide,Fensuccimide; Fensuximida; Phensuximide; Phensuximidum,Launched,succinimide antiepileptic,,neurology/psychiatry,seizures,phensuximide,
N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1,Cefaclor,3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid; CCL; Céfaclor; Cefaclor; Cefaclor anhydrous; Cefaclorum; Céfeaclor; Cephaclor,Launched,bacterial cell wall synthesis inhibitor,,infectious disease|otolaryngology,pneumonia|skin infections|urinary tract infections|respiratory tract infections|tonsillitis|pharyngitis,cefaclor,
CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,Mifepristone,Mifepriston; Mifepristona; Mifepristone; Mifépristone; Mifepristonum,Launched,glucocorticoid receptor antagonist|progesterone receptor antagonist,AR|NR1I2|NR3C1|PGR,endocrinology,hyperglycemia|diabetes mellitus,mifepristone,
CN(C)CCC(c1ccc(Br)cc1)c1ccccn1,Brompheniramine,"[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine; 1-(p-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane; 2-(p-bromo-α-(2-dimethylaminoethyl)benzyl)pyridine; 3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine; 3-(p-bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine; BPN; Bromfeniramina; Brompheniramin; Brompheniramine; Bromphéniramine; Brompheniraminum",Launched,histamine receptor antagonist,HRH1,allergy|otolaryngology,allergic rhinitis|common cold,brompheniramine,
CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,Loperamide,Loperamid; Loperamida; Lopéramide; Loperamide; Loperamidum,Launched,opioid receptor agonist,CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC,gastroenterology,diarrhea,loperamide,
Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1,Tolazamide,"1-(Hexahydro-1-azepinyl)-3-p-tolylsulfonylurea; 1-(Hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea; 4-(p-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide; N-(p-Toluenesulfonyl)-N'-hexamethyleniminourea; Tolazamid; Tolazamida; Tolazamide; Tolazamidum",Launched,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,endocrinology,diabetes mellitus,tolazamide,
CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,Dobutamine,"(±)-4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol; 3,4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-β-phenylethylamine; 4-{2-[3-(4-Hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol; DL-dobutamine; Dobutamin; Dobutamina; Dobutamine; Dobutaminum; rac-dobutamine; racemic-dobutamine",Launched,adrenergic receptor agonist,ADRB1|ADRB2,cardiology,congestive heart failure,dobutamine,
COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,Donepezil,Domepezil; Donepezil; Donepezilo; Donepezilum,Launched,acetylcholinesterase inhibitor,ACHE,neurology/psychiatry,Alzheimer's disease,donepezil,
Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314,Nalbuphine,"N-cyclobutylmethyl-4,5α-epoxy-3,6α,14-morphinantriol; Nalbufina; Nalbuphin; Nalbuphine; Nalbuphinum",Launched,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,neurology/psychiatry,pain relief,nalbuphine,
CC(C)N=c1cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1,Clofazimine,Clofazimin; Clofazimina; Clofazimine; Clofaziminum; Riminophenazine,Launched,GK0582 inhibitor,,infectious disease,leprosy,clofazimine,
CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,Flurandrenolide,Fludroxicortida; Fludroxicortide; Fludroxycortid; Fludroxycortide; Fludroxycortidum; Flurandrenolide; Flurandrenolone,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,infectious disease|dermatology,skin infections|psoriasis,fludroxycortide,
NCCS,Cysteamine,2-amino-1-ethanethiol; 2-amino-ethanethiol; 2-aminoethanethiol; beta-aminoethanethiol; beta-Mercaptoethylamine; Cysteamine; MEA; Mercaptamina; Mercaptamine; Mercaptaminum; Thioethanolamine; β-aminoethylthiol; β-MEA,Launched,tissue transglutaminase inhibitor,NPY2R|SST,metabolism,cystinosis,cysteamine,
c1ccc([C@H]2CN3CCSC3=N2)cc1,Levamisole,Levamisol; Levamisole; Levamisolum,Withdrawn,acetylcholine receptor agonist,ALPL,,,levamisole,
OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,Perphenazine,2-(4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol; 2-chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine; 4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol; 4-[3-(2-chlorophenothiazin-10-yl)propyl]-1-piperazineethanol; Chlorpiprazine; Etaperazin; Etaperazine; Ethaperazine; Perfenazina; Perfenazine; Perphenazin; Perphenazine; Perphénazine; Perphenazinum; γ-(4-(β-hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine,Launched,dopamine receptor antagonist,CALM1|DRD1|DRD2|HRH1|HTR2A|HTR2C|HTR6|HTR7,neurology/psychiatry|gastroenterology,schizophrenia|nausea|vomiting,perphenazine,
CN(C)/N=N/c1[nH]cnc1C(N)=O,Dacarbazine,"4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide; 4-(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide; 4-(dimethyltriazeno)imidazole-5-carboxamide; 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide; 5-(3,3-dimethyltriazeno)imidazole-4-carboxamide; 5-(dimethyltriazeno)imidazole-4-carboxamide; Biocarbazine; Dacarbazin; Dacarbazina; Dacarbazine; Dacarbazinum; DIC; DTIC; ICDMT",Launched,DNA alkylating agent,PGD|POLA2,oncology|hematologic malignancy,melanoma|Hodgkin's lymphoma,dacarbazine,
Cn1nnc2c(C(N)=O)ncn2c1=O,Temozolomide,"(S)-perillyl alcohol temozolomide; 3-methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide; 3,4-dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide; 3,4-dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide; 8-carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one; Methazolastone; Temozolodida; Temozolomid; Temozolomida; Temozolomide; Témozolomide; Temozolomidum; TMZ",Launched,DNA alkylating agent,MGMT,oncology,glioblastoma|astrocytoma,temozolomide,
OCC(O)COc1ccc(Cl)cc1,Chlorphenesin,"3-(4-chlorophenoxy)-1,2-propanediol; 3-(p-chlorophenoxy)-1,2-propanediol; 3-(p-chlorophenoxy)propane-1,2-diol; Chlorphenesin; Chlorphénésine; Chlorphenesinum; Clorfenesina; glycerol α-p-chlorophenyl ether; p-chlorophenyl-α-glyceryl ether",Launched,muscle relaxant,,neurology/psychiatry,muscle relaxant|sedative,chlorphenesin,
CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12,Terbinafine,"(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine; (E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine; Terbinafina; Terbinafine; Terbinafinum",Launched,fungal squalene epoxidase inhibitor,SQLE,infectious disease,tinea pedis|tinea cruris|tinea corporis,terbinafine,
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,Prednisolone,"(11β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione; 1,4-pregnadiene-11β,17α,21-triol-3,20-dione; 1,4-pregnadiene-3,20-dione-11β,17α,21-triol; 3,20-dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene; delta-dehydrocortisol; delta-dehydrohydrocortisone; delta-hydrocortisone; delta(1)-Dehydrocortisol; delta(1)-Dehydrohydrocortisone; delta(1)-Hydrocortisone; Hydroretrocortine; Metacortandralone; PRDL; Prednisolona; Prednisolone; Prednisolonum",Launched,glucocorticoid receptor agonist,NR3C1|NR3C2|SERPINA6,ophthalmology|dermatology|infectious disease,conjunctivitis|rosacea|punctate keratitis|shingles|iritis|cyclitis,prednisolone,
O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,Diflunisal,"2-(hydroxy)-5-(2,4-difluorophenyl)benzoic acid; 2',4'-difluoro-4-hydroxy-3-biphenylcarboxylic acid; 5-(2,4-difluorophenyl)salicylic acid; Diflunisal; Diflunisalum",Launched,prostanoid receptor antagonist,PTGS1|PTGS2,rheumatology,rheumatoid arthritis|osteoarthritis,diflunisal,
CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,Vardenafil,Vardenafil; Vardénafil; Vardenafilo; Vardenafilum,Launched,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H,urology,erectile dysfunction,vardenafil,
CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1,Ranitidine,Ranitidina; Ranitidine; Ranitidinum,Launched,histamine receptor antagonist,HRH2,gastroenterology,heartburn,ranitidine,
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,Tacrolimus,"Anhydrous tacrolimus; Tacrolimus; Tacrolimus anhydrous; Tacrolimus, anhydrous",Launched,calcineurin inhibitor,FKBP1A,transplant,organ rejection,tacrolimus,
C[C@@H](NCCc1ccc(O)cc1)[C@@H](O)c1ccc(O)cc1,Ritodrine,p-Hydroxy-alpha-(1-((p-hydroxyphenethyl)amino)ethyl)benzyl alcohol; Ritodrina; Ritodrine; Ritodrinium,Withdrawn,adrenergic receptor agonist,,obstetrics/gynecology,premature labor,ritodrine,
CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1,Benzonatate,"2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-butylaminobenzoate; 2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-yl p-(butylamino)benzoate; 3,6,9,12,15,18,21,24,27-nonaoxaoctacosyl 4-butylaminobenzoate; 4-(butylamino)benzoic acid 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester; Benzonatat; Benzonatate; Benzonatato; Benzonatatum; Benzononatine; nonaethyleneglycol monomethyl ether p-n-butylaminobenzoate; p-butylaminobenzoic acid ω-O-methylnonaethyleneglycol ester",Launched,local anesthetic,SCN5A,pulmonary,cough suppressant,benzonatate,
CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,Dorzolamide,"(4S,6S)-4-ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide; (4S,trans)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide; 4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide; 4-ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide; 4S,6S-dorzolamide; Dorzolamid; Dorzolamida; Dorzolamide; Dorzolamidum",Launched,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,ophthalmology,intraocular pressure|glaucoma,dorzolamide,
CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1,Suprofen,(±)-2-(p-(2-thenoyl)phenyl)propionic acid; 2-(4-(2-Thenoyl)phenyl)propionsäure; 2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid; 4-(2-Thenoyl)hydratropsäure; p-2-thenoylhydratropic acid; Suprofen; Suprofene; Suprofeno; Suprofenum; Sutoprofen; α-methyl-4-(2-thienylcarbonyl)benzeneacetic acid,Withdrawn,cyclooxygenase inhibitor,PTGS1|PTGS2,,,suprofen,
CC(C)(C)NCC(O)c1cc(O)cc(O)c1,Terbutaline,Terbutalin; Terbutalina; Terbutaline; Terbutalinum,Launched,adrenergic receptor agonist,ADRB2,pulmonary,bronchospasm|bronchitis|emphysema,terbutaline,
Cc1nc2c([nH]1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2,Conivaptan,"4'-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide; Conivaptan",Launched,vasopressin receptor antagonist,AVPR1A|AVPR2,endocrinology,hyponatremia,conivaptan,
COc1ccccc1OCC(O)CO,Guaifenesin,Glyceryl guaiacolate; Guaifenesin; Guaifenesina; guaiphenesin,Launched,expectorant,,pulmonary,cough suppressant,guaifenesin,
OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,Flupentixol,Flupenthixol; Flupenthixole; Flupentixol; Flupentixolo; Flupentixolum,Launched,dopamine receptor antagonist,ADRA1A|CHRM1|DRD1|DRD2|DRD3|DRD5|HTR2A,neurology/psychiatry,schizophrenia|depression,flupentixol,
CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1,Eprosartan,(E)-2-butyl-1-(p-carboxybenzyl)-α-2-thenylimidazole-5-acrylic acid; (E)-3-[2-n-butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid; (E)-α{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid; Éprosartan; Eprosartan; Eprosartanum,Launched,angiotensin receptor antagonist,AGTR1,cardiology,hypertension,eprosartan,
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,Sirolimus,(-)-Rapamycin; Rapamycin; Sirolimús; Sirolimus; Sirolimusum,Launched,mTOR inhibitor,FKBP1A|MTOR,transplant|pulmonary,organ rejection|lymphangioleiomyomatosis,sirolimus,
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,Chlorhexidine,"1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide); Chlorhexidin; Chlorhexidine; Chlorhexidinum; Cloresidina; Clorhexidina; N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide",Launched,membrane integrity inhibitor,,dermatology|infectious disease|dental,cosmetic|skin infections|gingivitis,chlorhexidine,
N=c1nc(O)n([C@@H]2CS[C@H](CO)O2)cc1F,Emtricitabine,"(−)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (−)-2'-deoxy-5-fluoro-3'-thiacytidine; (−)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one; (−)-FTC; (−)-β-2',3'-dideoxy-5-fluoro-3'-thiacytidine; (2R-cis)-4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone; 4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one; 4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one; 5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; Emtricitabin; Emtricitabina; Emtricitabine; Emtricitabinum",Launched,nucleoside reverse transcriptase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),emtricitabine,
NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,Chlorothiazide,"6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide; 6-chloro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; Chlorothiazid; Chlorothiazide; Chlorothiazidum; Chlorthiazide; Clorotiazida",Launched,diuretic,CA1|CA2|CA4|SLC12A3,cardiology,hypertension,chlorothiazide,
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O,Quinapril,Quinapril; Quinaprilum,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|congestive heart failure|angioedema,quinapril,
CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1,Clomifene,"2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine; 2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)triethylamine; 2-(p-(β-chloro-α-phenylstyryl)phenoxy)triethylamine; Clomifene; Clomifeno; Clomifenum; Clomiphene",Launched,estrogen receptor antagonist,ESR1,obstetrics/gynecology,infertility,clomifene,
O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O,Risedronic acid,Acide risédroniqe; Acido risedronico; Acidum risedronicum; Risedronate; Risedronic acid; Risedronsäure,Launched,osteoclast inhibitor,FDPS,orthopedics|endocrinology,osteoporosis|Paget's disease,risedronate,
Cc1cccn2c(=O)c(-c3nn[nH]n3)cnc12,Pemirolast,Pemirolast; Pemirolastum,Launched,mediator release inhibitor,HRH1,pulmonary,asthma,pemirolast,
CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,Bumetanide,3-(aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid; 3-butylamino-4-phenoxy-5-sulfamoyl-benzoic acid; 3-butylamino-4-phenoxy-5-sulfamoylbenzoic acid; Bumetanida; Bumetanide; Bumetanidum,Launched,solute carrier family member inhibitor,CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5,cardiology,edema|congestive heart failure,bumetanide,
CN1[C@H]2CCC[C@@H]1C[C@H](NC(=O)c1nn(C)c3ccccc13)C2,Granisetron,Granisétron; Granisetron; Granisetrón; Granisetronum,Launched,serotonin receptor antagonist,HTR3A,gastroenterology,nausea|vomiting,granisetron,
C/C=C(C(=C/C)/c1ccc(O)cc1)\c1ccc(O)cc1,Dienestrol,"4,4'-Hydroxy-γ,δ-diphenyl-β,δ-hexadiene; alpha-dienestrol diacetate; Cycladiene; Dehydrostilbestrol; Dienestrol; Diènestrol; Dienestrolum; p,p'-(Diethylideneethylene)diphenol",Launched,estrogen receptor agonist,ESR1,endocrinology,menopause,dienestrol,
Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1,Sulfapyridine,"2-(p-Aminobenzenesulphonamido)pyridine; 2-Sulfanilamidopyridin; 2-Sulfanilamidopyridine; 2-Sulfanilylaminopyridine; 2-Sulfapyridine; 4-(2-Pyridinylsulfonyl)aniline; 4-[(2-Pyridylamino)sulfonyl]aniline; 4-Amino-N-pyridin-2-yl-benzenesulfonamide; 4-Amino-N,2-pyridinylbenzenesulfonamide; N-2-Pyridylsulfanilamide; N(1)-2-Pyridylsulfanilamide; N(1)-Pyridylsulfanilamide; Solfapiridina; Sulfapiridina; Sulfapyridin; Sulfapyridine; Sulfapyridinum; Sulphapyridine",Launched,PABA antagonist,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,sulfapyridine,
CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N,Oxybuprocaine,4-Amino-3-butoxy-2-(diethylamino)ethyl ester benzoic acid; 4-Amino-3-butoxy-benzoic acid 2-diethylamino-ethyl ester; 4-Amino-3-n-butoxy-benzoesäure-diäthylaminoäthylester; Benoxinate; BNX; Butoxyaminobenzoyldiethylaminoethanol; Oxibuprocaina; Oxybucaine; Oxybuprocaine; Oxybuprocainum; Oxyriprocaine,Launched,local anesthetic,SCN10A,neurology/psychiatry,local anesthetic,oxybuprocaine,
CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,Rimexolone,Rimexolon; Rimexolona; Rimexolone,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,ophthalmology,anterior uveitis,rimexolone,
O=c1nc[nH]c2c1ncn2[C@H]1CC[C@@H](CO)O1,Didanosine,"2,3-Dideoxyinosine; 9-((2R,5S)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one; 9-((2R,5S)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one; 9-((2S,5R)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol; 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one; ddI; ddIno; Didanosina; Didanosine; Didanosinum; Dideoxyinosine",Launched,nucleoside reverse transcriptase inhibitor,PNP,infectious disease,human immunodeficiency virus (HIV-1),didanosine,
Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,Ondansetron,Ondansetron,Launched,serotonin receptor antagonist,HTR3A|HTR3B,gastroenterology,nausea|vomiting,ondansetron,
CCNC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc1ccccc1,Bimatoprost,"(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide; Bimatoprost; Bimatoprostum",Launched,prostanoid receptor agonist,AKR1C3|PTGER1|PTGER3|PTGFR,ophthalmology,intraocular pressure|glaucoma|ocular hypertension,bimatoprost,
Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C,Tiagabine,Tiagabina; Tiagabine; Tiagabinum,Launched,GABA uptake inhibitor,SLC6A1,neurology/psychiatry,seizures,tiagabine,
C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,Quinidine,"(+)-quinidine; (8R,9S)-Quinidine; (R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol; (S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol; 6-methoxy-α-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol; beta-Quinine; Chinidin; Chinidinum; CIN-QUIN; Conchinin; Conquinine; Pitayine; Quinidina; α-(6-methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol; β-quinine",Launched,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,infectious disease|cardiology,malaria|atrial fibrillation (AF)|ventricular arrhythmias,quinidine,
NS(=O)(=O)Cc1noc2ccccc12,Zonisamide,"1,2-Benzisoxazole-3-methanesulfonamide; 3-(Sulfamoylmethyl)-1,2-benzisoxazole; Benzo[d]isoxazol-3-yl-methanesulfonamide; Zonisamida; Zonisamide; Zonisamidum",Launched,sodium channel blocker|T-type calcium channel blocker,CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures|epilepsy,zonisamide,
C[C@@H](/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C)C(C)(C)O,Paricalcitol,"19-Nor-1alpha,25-dihydroxyvitamin D2; Paricalcitol",Launched,vitamin D receptor agonist,VDR,nephrology|endocrinology,chronic kidney disease (CKD)|hyperthyroidism,paricalcitol,
CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C,Tinidazole,1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitroimidazole; Timidazole; Tinidazol; Tinidazole; Tinidazolum,Launched,antiprotozoal agent,,infectious disease|obstetrics/gynecology,giardiasis|amebiasis|bacterial vaginosis|trichomoniasis,tinidazole,
CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O,Repaglinide,Repaglinida; Repaglinide; Repaglinidum,Launched,insulin secretagogue,ABCC8|KCNJ11|PPARG,endocrinology,diabetes mellitus,repaglinide,
N=C(N)NC(=N)NCCc1ccccc1,Phenformin,Fenformin; Fenformina; Phenformin; Phenformine; Phenforminum; β-Phenethybiguanide,Withdrawn,AMPK activator,KCNJ8|PRKAA1,,,phenformin,
NC12CC3CC(CC(C3)C1)C2,Amantadine,1-adamantanamine; 1-adamantylamine; 1-aminoadamantane; Amantadina; Amantadine; Amantadinum; Amantidine; Aminoadamantane,Launched,glutamate receptor antagonist,DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A,infectious disease|neurology/psychiatry,influenza A virus infection|Parkinson's Disease,amantadine,
Cc1ncc([N+](=O)[O-])n1CCO,Metronidazole,1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole; 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole; 1-(β-ethylol)-2-methyl-5-nitro-3-azapyrrole; 1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole; 1-(β-oxyethyl)-2-methyl-5-nitroimidazole; 2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole; 2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole; 2-methyl-5-nitroimidazole-1-ethanol; Metronidazol; Métronidazole; Metronidazole; Metronidazolum,Launched,DNA inhibitor,CYP2C9|CYP3A4,dermatology,rosacea,metronidazole,
CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,Dinoprostone,"(15S)-prostaglandin E2; (5Z,11α,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid; Dinoproston; Dinoprostona; Dinoprostone; Dinoprostone Prostaglandin E2; Dinoprostonum; PGE2; Prostaglandin E2",Withdrawn,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R,,,dinoprostone,
CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,Almotriptan,1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine; Almotriptan,Launched,serotonin receptor agonist,HTR1B|HTR1D,neurology/psychiatry,migraine headache,almotriptan,
CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12,Spectinomycin,Actinospectacina; Espectinomicina; SCM; Spectinomicina; Spectinomycin; Spectinomycine; Spectinomycinum,Launched,bacterial 30S ribosomal subunit inhibitor,,pulmonary,airsacculitis|chronic respiratory disease,spectinomycin,
CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,Ketotifen,Ketotifen; Ketotifene; Ketotifeno; Ketotifenum,Launched,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor,HRH1,neurology/psychiatry,itching,ketotifen,
C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1,Levosimendan,Levosimendán; Levosimendan; Lévosimendan; Levosimendanum,Launched,calcium sensitizer,KCNJ11|KCNJ8|PDE3A|TNNC1,cardiology,congestive heart failure,levosimendan,
NCc1ccccc1CC(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3CC(=O)O)CS[C@H]12,Ceforanide,"(6R,7R)-7-[[2-[2-(aminomethyl)phenyl]acetyl]amino]-3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[O-(aminomethyl)phenylacetamido]-3-[[[1-(carboxymethyl)-1H-tetrazol-5-yl]thio]methyl]-3-cephem-4-carboxylic acid; 7β-[2-(aminomethyl)phenyl]acetamido-3-{[1-(carboxymethyl)-1H-tetrazol-5-yl]sulfanyl}methyl-3,4-didehydrocepham-4-carboxylic acid; Ceforanide; Ceforanido; Ceforanidum",Launched,penicillin binding protein inhibitor,,infectious disease,gram-negative bacterial infections,ceforanide,
CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cyclobenzaprine,"(3-Dibenzo[a,d]cyclohepten-5-ylidene-propyl)-dimethyl-amine; Ciclobenzaprina; Cyclobenzaprine; Cyclobenzaprinum; N,N-dimethyl-5H-dibenzo(a,d)cycloheptene-Δ5,γ-propylamine",Launched,adrenergic receptor agonist|serotonin receptor agonist,HTR2A,neurology/psychiatry,spasms,cyclobenzaprine,
CC(COc1ccccc1)N(CCCl)Cc1ccccc1,Phenoxybenzamine,Fenossibenzamina; Fenoxibenzamina; Phenoxybenzamine; Phenoxybenzaminum; POB,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,cardiology|endocrinology,hypertension|pheochromocytoma,phenoxybenzamine,
NC(N)=Nc1nc(CSCCC(N)=NS(N)(=O)=O)cs1,Famotidine,(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide; 3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide; 3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine; Famotidina; Famotidine; Famotidinum; N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide,Launched,histamine receptor antagonist,HRH2,gastroenterology,heartburn,famotidine,
Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,Azacitidine,4-amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one; 5-azacytidine; Azacitidina; Azacitidine; Azacitidinum; Azacytidine,Launched,DNA methyltransferase inhibitor,DNMT1|DNMT3A,hematologic malignancy|hematology,myelodysplastic diseases (MDS)|anemia|chronic myelomonocytic leukemia (CMMoL),azacitidine,
CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,Misoprostol,Misoprostol; Misoprostolum,Launched,prostanoid receptor agonist,PTGER2|PTGER3|PTGER4|PTGIR,gastroenterology,duodenal ulcer disease,misoprostol,
C=C1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12,Metacycline,6-Demethyl-6-deoxy-5-hydroxy-6-methylenetetracycline; 6-Deoxy-6-demethyl-6-methylene-5-oxytetracycline; 6-Methylene-5-hydroxytetracycline; 6-Methylene-5-oxytetracycline; 6-Methyleneoxytetracycline; Metaciclina; Metacycline; Methacycline; Methacyclinum; Methylenecycline; Tri-methacycline,Preclinical,protein synthesis inhibitor,,pulmonary,bronchitis,methacycline,
CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1,Tipranavir,Tipranavir,Launched,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),tipranavir,
CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,Mesoridazine,10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine; 10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine; 2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine; Mesoridazina; Mesoridazine; Mesoridazinum; Thioridazine 2-sulfoxide; Thioridazine thiomethyl sulfoxide; Thioridazine-2-sulfoxide,Launched,dopamine receptor antagonist,DRD2|HTR2A,neurology/psychiatry,schizophrenia,mesoridazine,
CNCCCC12CCC(c3ccccc31)c1ccccc12,Maprotiline,Maprotilina; Maprotiline; Maprotilinum; Maprotylina,Launched,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2,neurology/psychiatry,depression|dysthymic disorder,maprotiline,
Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,Oxymetazoline,"2-(4-tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline; 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol; 6-t-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol; 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol; Oximetazolinum; Oxymetazolina; Oxymetazoline; Oxymétazoline; Oxymetazolinum; Oxymethazoline; Oxymetozoline",Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C,otolaryngology,nasal congestion,oxymetazoline,
OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O,Salmeterol,Salmaterol; Salmeterol; Salmeterolum,Launched,adrenergic receptor agonist,ADRB2,pulmonary,asthma|chronic obstructive pulmonary disease (COPD)|bronchospasm,salmeterol,
CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21,Methantheline,Methantheline; Methantheline cation; Methantheline ion; Methanthelinium; Methanthelinum,Launched,acetylcholine receptor antagonist,CHRM1|HRH2,gastroenterology|neurology/psychiatry|urology,peptic ulcer disease (PUD)|irritable bowel syndrome|pancreatitis|dyskinesia|neurogenic bladder,methantheline,
Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1,Zalcitabine,"2',3'-Dideoxycytidine; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one; DDC; DDCYD; Dideoxycytidine; Zalcitabine",Launched,nucleoside reverse transcriptase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),zalcitabine,
CN(CCCCCCCCCCN(C)C(=O)Oc1cccc([N+](C)(C)C)c1)C(=O)Oc1cccc([N+](C)(C)C)c1,Demecarium,Demecarium; Demecarium cation; Demecarium ion,Launched,acetylcholinesterase inhibitor,ACHE|BCHE,ophthalmology,intraocular pressure|glaucoma,demecarium,
CC(=O)Oc1ccccc1C(=O)O,Acetylsalicylic acid,2-Acetoxybenzenecarboxylic acid; 2-Acetoxybenzoic acid; Acetylsalicylate; Acetylsalicylsäure; acide 2-(acétyloxy)benzoïque; Acide acétylsalicylique; ácido acetilsalicílico; Acidum acetylsalicylicum; ASA; Aspirin; Aspirina; Azetylsalizylsäure; o-acetoxybenzoic acid; O-acetylsalicylic acid; o-carboxyphenyl acetate; Polopiryna; Salicylic acid acetate,Launched,cyclooxygenase inhibitor,AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53,neurology/psychiatry|endocrinology|dental,headache|fever|toothache|muscle pain,aspirin,
CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O,Phenprocoumon,3-(1-Phenylpropyl)-4-hydroxycoumarin; 3-(1'-Phenyl-propyl)-4-oxycoumarin; 3-(alpha-Ethylbenzyl)-4-hydroxycoumarin; 3-(alpha-Phenylpropyl)-4-hydroxycoumarin; 4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one; 4-hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one; Fenprocumon; Fenprocumone; Phenprocoumarol; Phenprocoumarole; Phenprocoumon; Phenprocoumone; Phenprocoumonum; Phenprocumone,Launched,vitamin K antagonist,VKORC1,hematology,thrombosis|pulmonary embolism (PE),phenprocoumon,
C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O,Fulvestrant,"(7α,17β)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1(10),2,4-triene-3,17-diol; Fulvestrant",Launched,estrogen receptor antagonist,ESR1|ESR2|GPER1,oncology,breast cancer,fulvestrant,
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCN(S(C)(=O)=O)C3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O,Mezlocillin,"(2S,5R,6R)-3,3-dimethyl-6-{[(2R)-2-({[3-(methylsulfonyl)-2-oxoimidazolidin-1-yl]carbonyl}amino)-2-phenylacetyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6β-{(2R)-2-[3-(methanesulfonyl)-2-oxoimidazolidine-1-carboxamido]-2-phenylacetamido}penicillanic acid; Mezlocilina; Mezlocillin; Mezlocilline; Mezlocillinum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,mezlocillin,
NC(=O)OCC(COC(N)=O)c1ccccc1,Felbamate,"2-phenyl-1,3-propanediol dicarbamate; carbamic acid 2-phenyltrimethylene ester; Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester; Felbamate; Felbamato; Felbamatum",Launched,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,neurology/psychiatry,epilepsy,felbamate,
CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,Fexofenadine,"4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; Carboxyterfenadine; Fexofenadina; Fexofenadine; Terfenadine acid metabolite; Terfenadine carboxylate; Terfenadine-COOH",Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis|urticaria,fexofenadine,
NNC(=O)c1ccncc1,Isoniazid,4-pyridinecarbohydrazide; INH; Isoniazid; Isoniazida; Isonicotinic acid hydrazide; Isonicotinic hydrazide; Isonicotinohydrazide; Isonicotinoylhydrazide; Isonicotinsäurehydrazid; Isonicotinylhydrazine; Pyridine-4-carboxylic acid hydrazide,Launched,FABI inhibitor,CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4,infectious disease,tuberculosis,isoniazid,
CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1,Naratriptan,N-methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide; N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide; Naratriptán; Naratriptan; Naratriptanum,Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,neurology/psychiatry,migraine headache,naratriptan,
CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,Rizatriptan,"N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine; N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine; Risatriptan; Rizatriptán; Rizatriptan; Rizatriptanum",Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,neurology/psychiatry,migraine headache,rizatriptan,
CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O,Netilmicin,1-N-Ethylsisomicin; Netilmicin; Netilmycin,Launched,protein synthesis inhibitor,,infectious disease,gram-negative bacterial infections,netilmicin,
C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC,Norgestimate,"(+)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one oxime acetate (ester); (17α)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime; d-13β-Ethyl-17α-ethynyl-17β-acetoxygon-4-en-3-one oxime; Dexnorgestrel Acetime; Norgestimate; Norgestimato; Norgestimatum",Launched,progesterone receptor agonist,ESR1|PGR,endocrinology,contraceptive,norgestimate,
N[Pt]1(N)OC(=O)C2(CCC2)C(=O)O1,Carboplatin,"Carboplatin; Carboplatine; Carboplatino; CBDCA; cis-(1,1-cyclobutanedicarboxylato)diammineplatinum(II); cis-diammine(1,1-cyclobutanedicarboxylato)platinum; cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II)",Launched,DNA alkylating agent|DNA inhibitor,,oncology,ovarian cancer,carboplatin,
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,Methylprednisolone,"(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione; 1-dehydro-6α-methylhydrocortisone; 6α-methyl-11β,17α,21-triol-1,4-pregnadiene-3,20-dione; delta(1)-6alpha-Methylhydrocortisone; Methylprednisolon; Methylprednisolone; Methylprednisolonum; Metilprednisolona",Launched,glucocorticoid receptor agonist,NR3C1,endocrinology|rheumatology|dermatology|infectious disease|allergy|hematology|neurology/psychiatry|gastroenterology,hypercalcemia|thyroiditis|ankylosing spondylitis|bursitis|osteoarthritis|psoriatic arthritis|seborrheic dermatitis|mycosis|allergic rhinitis|psoriasis|anemia|multiple sclerosis|ulcerative colitis|enteritis,methylprednisolone,
CC(C)NCC(O)COc1cccc2[nH]ccc12,Pindolol,1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol; 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol; 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol; 4-(2-hydroxy-3-isopropylaminopropoxy)-indole; Pindolol; Pindololum,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR2A|HTR2B,cardiology,hypertension,pindolol,
Cc1cccc(C)c1NC(=O)C1CCCCN1C,Mepivacaine,"(+-)-1-Methyl-2',6'-pipecoloxylidide; 1-methyl-2',6'-pipecoloxylidide; DL-Mepivacaine; Mepivacaina; Mepivacaine; Mepivacainum; N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide; N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide",Launched,potassium channel blocker|sodium channel blocker,,neurology/psychiatry,local anesthetic,mepivacaine,
Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1,Bromfenac,[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid; 2-amino-3-(4-bromobenzoyl)benzeneacetic acid; Bromfenac; Bromfenaco; Bromfenacum,Withdrawn,cyclooxygenase inhibitor,PTGS1|PTGS2,,,bromfenac,
Nc1cc(Cl)c(NC2=NCCN2)c(Cl)c1,Apraclonidine,4-Aminoclonidine; Apraclonidina; Apraclonidine; Apraclonidinum,Launched,adrenergic receptor agonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C,ophthalmology,glaucoma|intraocular pressure,apraclonidine,
CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,Telmisartan,"4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid; 4'-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid; Telmisartan",Launched,angiotensin receptor antagonist,AGTR1|PPARG,cardiology,hypertension,telmisartan,
Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1,Desloratadine,"8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine; Descarboethoxyloratadine; Desloratadina; Desloratadine",Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis|urticaria,desloratadine,
C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,Methyldopa,(S)-(-)-alpha-Methyldopa; 3-Hydroxy-alpha-methyl-L-tyrosine; Alpha medopa; alpha-Methyl dopa; alpha-methyl-L-dopa; Alphamethyldopa; AMD; Anhydrous methyldopa; L-alpha-Methyldopa; L-Methyl Dopa; Methyl dopa; Methyldopa; Methyldopa anhydrous; metildopa; α-Methyl dopa; α-methyl-L-dopa,Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|DDC,cardiology,hypertension,methyldopa,
Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,Alosetron,"2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one; Alosetron",Withdrawn,serotonin receptor antagonist,HTR3A,,,alosetron,
Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O,Dactinomycin,"2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-i)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide; 3H-PHENOXAZINE-1,9-DICARBOXAMIDE, 2-AMINO-N,N'-BIS(HEXADECAHYDRO-6,13-DIISOPROPYL-2,5,9-TRIMETHYL-1,4,7,11,14-PENTAOXO-1H-PYRROLO(2,1-I)(1,4,7,10,13)OXATETRAAZACYCLOHEXADECIN-10-YL)-4,6-DIMETHYL-3-OXO-; ActD; Actinomycin C1; Actinomycin D; ACTINOMYCIN I1; Actinomycin IV; ACTINOMYCIN X1; ACTINOMYCIN-D; ANA-conjugated dactinomycin nanoemulsion; Dactinomicina; Dactinomycin; Dactinomycine; Dactinomycinum; DILACTONE ACTINOMYCIN D ACID; Meractinomycin; N,N'-((2-AMINO-4,6-DIMETHYL-3-OXO-3H-PHENOXAZINE-1,9-DIYL)-BIS(CARBONYLIMINO(2-HYDROXYPROPYLIDENE)CARBONYLIMINOISOBUTYLIDENECARBONYL-1,2-PYRROLIDINEDIYLCARBONYL(METHYLIMINO)METHYLENECARBONYL))BIS(N-METHYL-L-VALINE) DILACTONE; ONCOSTATIN K",Launched,RNA polymerase inhibitor,POLR2A,oncology,testicular carcinoma|Wilm's tumor|rhabdomyosarcoma|Ewing's sarcoma|gestational trophoblastic disease (GTD),dactinomycin,
CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1,Azelastine,4-(p-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone; Azelastina; Azelastine; Azélastine; Azelastinum,Launched,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis,azelastine,
O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1,Ezetimibe,Ezetimiba; ézétimibe; Ezetimibe; Ezetimibum,Launched,cholesterol inhibitor|Niemann-Pick C1-like 1 protein antagonist,ANPEP|NPC1L1|SOAT1,endocrinology|metabolism,hyperlipidemia|hypercholesterolemia|sitosterolemia,ezetimibe,
OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,Dipyridamole,Dipiridamol; Dipyridamine; Dipyridamole; Dipyridamolum; Dipyudamine; Dypyridamol,Launched,phosphodiesterase inhibitor,ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1,cardiology,coronary artery disease (CAD)|peripheral artery disease (PAD)|hypertension,dipyridamole,
CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,Telithromycin,Telithromycin; telitromicina,Launched,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,CYP1A2|CYP2D6|CYP3A4|CYP3A5|CYP3A7,infectious disease,pneumonia,telithromycin,
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21,Lomefloxacin,"(±)-1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1,4-Dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; LFLX; Lomefloxacin; Lomefloxacine; Lomefloxacino; Lomefloxacinum",Launched,bacterial DNA gyrase inhibitor,,infectious disease,respiratory tract infections|urinary tract infections,lomefloxacin,
CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1,Cyclopentolate,(±)-cyclopentolate; 1-hydroxy-α-phenylcyclopentaneacetic acid 2-(dimethylamino)ethyl ester; 2-(dimethylamino)ethyl 1-hydroxy-α-phenylcyclopentaneacetate; 2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate; 2-phenyl-2-(1-hydroxycyclopentyl)ethanoic acid β-(dimethylamino)ethyl ester; Ciclopentolato; Cyclopentolate; Cyclopentolatum; α-(1-hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester; β-(dimethylamino)ethyl (1-hydroxycyclopentyl)phenylacetate; β-dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate,Launched,acetylcholine receptor antagonist,,ophthalmology,mydriasis|cycloplegia,cyclopentolate,
CCC(=O)NCC[C@@H]1CCc2ccc3c(c21)CCO3,Ramelteon,Ramelteon,Launched,melatonin receptor agonist,MTNR1A|MTNR1B,neurology/psychiatry,insomnia,ramelteon,
CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,Physostigmine,Eserine; Physostigmine; Physostol,Launched,acetylcholinesterase inhibitor|cholinesterase inhibitor,ACHE|BCHE,cardiology|neurology/psychiatry|ophthalmology|gastroenterology,hypotension|Alzheimer's disease|glaucoma|gastroparesis,physostigmine,
CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1,Isotretinoin,"(7E,9E,11E,13Z)-retinoic acid; 13-cis-retinoic acid; 13-cis-Vitamin A acid; 13-RA; cis-RA; Isotretinoin; Isotretinoína; Isotrétinoine; Isotretinoino; Isotretinoinum; Neovitamin A acid",Launched,retinoid receptor agonist,RARA|RARB|RARG,dermatology,acne vulgaris (AV),isotretinoin,
COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1,Formoterol,2'-hydroxy-5'-(1-hydroxy-2-((p-methoxy-α-methylphenethyl)amino)ethyl)formanilide; 2'-hydroxy-5'-{1-hydroxy-2-[(p-methoxy-α-methylphenethyl)amino]ethyl}formanilide; Formoterol; Formoterolum; N-[2-hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide,Launched,adrenergic receptor agonist,ADRB2,pulmonary,asthma|chronic obstructive pulmonary disease (COPD)|bronchospasm,formoterol,
CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2nc(Cl)[nH]c2n(C)c1=O,Dimenhydrinate,"(O-benzhydryl(dimethylamino)ethanol) 8-chlorotheophyllinate; 8-chloro-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione - 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1); Benzhydryl-β-dimethylaminoethylether 8-chlorotheophylline; Dimenhidrinato; Dimenhydrinate; Dimenhydrinatum; diphenhydramine 8-chlorotheophyllinate; diphenhydramine 8-chlorotheophylline; Diphenhydramine theoclate; N,N-dimethyl-2-diphenylmethoxyethylamine 8-chlorotheophyllinate; O-benzhydryldimethylaminoethanol 8-chlorotheophyllinate; β-dimethylaminoethyl benzhydryl ether 1,3-dimethyl-8-chloroxanthine",Launched,histamine receptor antagonist,HRH1,neurology/psychiatry|gastroenterology,motion sickness|nausea|vomiting,dimenhydrinate,
C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1,Glycopyrronium,Glicopirronio; Glycopyrrolate; Glycopyrrolate cation; Glycopyrrolate ion; Glycopyrronium; Glycopyrronium cation; Glycopyrronium ion,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,gastroenterology,peptic ulcer disease (PUD),glycopyrrolate,
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,Cytarabine,1-beta-D-Arabinofuranosylcytosine; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; Citarabina; Cytarabine; Cytarabine liposome; Cytarabinum; Cytosine arabinoside; Cytosine-1-beta-D-arabinofuranoside; cytosine-β-D-arabinofuranoside,Launched,ribonucleotide reductase inhibitor,POLA1|POLB|POLD1|POLE,hematologic malignancy,acute lymphoblastic leukemia (ALL)|chronic lymphocytic leukemia (CLL)|acute myeloid leukemia (AML)|non-Hodgkin lymphoma (NHL),cytarabine,
NCCc1ccc(O)c(O)c1,Dopamine,"2-(3,4-dihydroxyphenyl)ethylamine; 3-Hydroxytyramine; 3,4-Dihydroxyphenethylamine; 4-(2-aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-aminoethyl)catechol; 4-(2-aminoethyl)pyrocatechol; Dopamina; Dopamine; Dopaminum; Oxytyramine",Launched,dopamine receptor agonist,DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4,cardiology|neurology/psychiatry,ventricular arrhythmias|depression|headache|tremors,dopamine,
CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Rivastigmine,(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate; m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate; Rivastigmina; Rivastigmine,Launched,acetylcholinesterase inhibitor,ACHE|BCHE,neurology/psychiatry,Alzheimer's disease|Parkinson's Disease|senile dementia,rivastigmine,
C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12,Exemestane,"6-methyleneandrosta-1,4-diene-3,17-dione; Exemestane; Exemestano; Exemestanum",Launched,aromatase inhibitor,CYP19A1,oncology,breast cancer,exemestane,
O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1,Oxaprozin,Oxaprozin; Oxaprozina; Oxaprozine; Oxaprozinum,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,osteoarthritis|rheumatoid arthritis,oxaprozin,
Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12,Azathioprine,6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine; 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine; Azamun; Azathioprine; Azathioprinum; Azatioprina,Launched,dehydrogenase inhibitor,HPRT1|IMPDH1|PPAT,transplant|rheumatology,renal homotransplantation|rheumatoid arthritis,azathioprine,
CC[P+](CC)(CC)[Au-]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O,Auranofin,"(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate; 2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold; Auranofin; Auranofina; Auranofine; Auranofinum; Triethylphosphine gold",Launched,NFkB pathway inhibitor,IKBKB|PRDX5|TRPA1,rheumatology,rheumatoid arthritis,auranofin,
NCC1(CC(=O)O)CCCCC1,Gabapentin,1-(Aminomethyl)cyclohexaneacetic acid; Gabapentin; Gabapentina; Gabapentine; Gabapentino; Gabapentinum,Launched,calcium channel blocker,ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,infectious disease|neurology/psychiatry,virus herpes simplex (HSV)|shingles|seizures|restless leg syndrome,gabapentin,
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,Doxorubicin,"(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside; (8S-cis)-10-((3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione; 14-hydroxydaunomycin; 14-hydroxydaunorubicine; Doxorubicin; Doxorubicin nanoparticles; Doxorubicina; Doxorubicine; Doxorubicinum; Hydroxydaunorubicin; MTC-DOX; MTC-DOX for Injection",Launched,topoisomerase inhibitor,TOP2A,hematologic malignancy|oncology,acute lymphoblastic leukemia (ALL)|acute myeloid leukemia (AML)|Wilm's tumor|breast cancer|ovarian cancer|Hodgkin's lymphoma|bladder cancer|multiple myeloma,doxorubicin,
CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1,Frovatriptan,Frovatriptan,Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D,neurology/psychiatry,migraine headache,frovatriptan,
NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,Hydrochlorothiazide,HCTZ; Hidroclorotiazida; Hydrochlorothiazide; Hydrochlorothiazidum,Launched,thiazide diuretic,CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A3,cardiology,hypertension|congestive heart failure,hydrochlorothiazide,
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,Albuterol,Albuterol; Salbutamol; Salbutamolum,Launched,adrenergic receptor agonist,ADRB2,pulmonary,asthma,albuterol,
Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1,Ganciclovir,"2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine; GA2; Ganciclovir; Ganciclovirum; Gancyclovir",Launched,DNA polymerase inhibitor,,infectious disease,cytomegalovirus (CMV),ganciclovir,
NC(=O)NO,Hydroxyurea,Carbamohydroxamic acid; Carbamohydroximic acid; Carbamoyl oxime; Carbamyl hydroxamate; Hidroxicarbamida; Hydrea; Hydroxycarbamid; Hydroxycarbamide; Hydroxycarbamidum; Hydroxyharnstoff; Hydroxyurea; N-Carbamoylhydroxylamine; N-Hydroxyurea; Oxyurea,Launched,ribonucleotide reductase inhibitor,RRM1|RRM2|RRM2B,hematologic malignancy|oncology,chronic myeloid leukemia (CML)|head and neck squamous cell carcinoma (HNSCC),hydroxyurea,
N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,Letrozole,Letrozol; Letrozole,Launched,aromatase inhibitor,CYP19A1,oncology,breast cancer,letrozole,
Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1,Tioconazole,Tioconazol; Tioconazole; Tioconazolum,Launched,sterol demethylase inhibitor,,infectious disease,yeast infection,tioconazole,
CS(=O)(=O)OCCCCOS(C)(=O)=O,Busulfan,"1,4-Bis(methanesulfonoxy)butane; 1,4-Butanediol dimethanesulfonate; 1,4-Dimesyloxybutane; 1,4-Dimethanesulfonoxybutane; Busulfan; Busulfano; Busulfanum; Busulphan; Tetramethylene bis(methanesulfonate)",Launched,DNA inhibitor,,hematologic malignancy,chronic myeloid leukemia (CML),busulfan,
CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,Ketoprofen,2-(3-Benzoylphenyl)propionic acid; 3-Benzoyl-alpha-methylbenzeneacetic acid; 3-Benzoyl-α-methylbenzeneacetic acid; 3-Benzoylhydratropic acid; Ketoprofen; Ketoprofeno; L'acide (benzoyl-3-phenyl)-2-propionique; m-Benzoylhydratropic acid,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2|SLC5A8,rheumatology,rheumatoid arthritis|osteoarthritis,ketoprofen,
CC[N+](C)(C)c1cccc(O)c1,Edrophonium,"(3-hydroxyphenyl)dimethylethylammonium; 3-hydroxy-N,N-dimethyl-N-ethylanilinium; Edrophonium cation; Edrophonium ion; Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium; N-ethyl-3-hydroxy-N,N-dimethylanilinium; N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium",Launched,acetylcholinesterase inhibitor,ACHE|BCHE,neurology/psychiatry,myasthenia gravis,edrophonium,
CC(C)(C(=O)c1cccnc1)c1cccnc1,Metyrapone,Metirapona; Metyrapone; Métyrapone; Metyraponum,Launched,cytochrome P450 inhibitor,CYP11B1,nephrology,adrenal diagnostic agent,metyrapone,
C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,Cinacalcet,(R)-α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine; Cinacalcet; CNC; N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine,Launched,calcium channel activator,CASR,endocrinology|nephrology|oncology,hyperparathyroidism|chronic kidney disease (CKD)|parathyroid carcinoma|hypercalcemia,cinacalcet,
O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1,Balsalazide,"(E)-5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid; (E)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid; 3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid; 5-[4-(2-carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid; Balsalazida; Balsalazide; Balsalazidum",Launched,cyclooxygenase inhibitor,ALOX5|PPARG|PTGS1|PTGS2,gastroenterology,ulcerative colitis,balsalazide,
Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,Sulfamethoxazole,3-(p-Aminophenylsulfonamido)-5-methylisoxazole; 3-Sulfanilamido-5-methylisoxazole; 4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide; SMX; Sulfamethoxazole; Sulfametoxazol; Sulphamethoxazole,Launched,PABA antagonist,,infectious disease|gastroenterology,pneumonia|enteritis|urinary tract infections,sulfamethoxazole,
COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,Glyburide,1-((p-(2-(5-chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea; 1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea; 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide; Glibenclamida; Glibenclamide; Glibenclamidum; Glyburide,Launched,ATP channel blocker|insulin secretagogue|sulfonylurea,ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1,endocrinology,diabetes mellitus|hyperglycemia,glyburide,
CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,Minocycline,"(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; 7-Dimethylamino-6-demethyl-6-deoxytetracycline; Minociclina; Minociclinum; Minocyclin; Minocycline; Minocyclinum; Minomycin",Launched,bacterial 30S ribosomal subunit inhibitor,,endocrinology|infectious disease|ophthalmology|urology,fever|respiratory tract infections|psittacosis|trachoma|conjunctivitis|urethritis|chancroid|tularemia|cholera|brucellosis,minocycline,
N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,Guanfacine,Guanfacina; Guanfacine; Guanfacinum,Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,cardiology,hypertension,guanfacine,
CC(C[N+](C)(C)C)OC(N)=O,Bethanechol,"(2-hydroxypropyl)trimethylammonium carbamate; 2-(carbamoyloxy)-N,N,N-trimethylpropan-1-aminium; 2-carbamoyloxypropyl-trimethylazanium; Amidopropyldimethylbetaine; Bethanechol; Carbamoyl-beta-methylcholine; carbamoyl-β-methylcholine; Carbamyl-beta-methylcholine; carbamyl-β-methylcholine",Launched,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,urology,urinary retention,bethanechol,
NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,Trichlormethiazide,Trichlormethiazide; triclormetiazida,Launched,chloride channel blocker,PTGS1|PTGS2|SLC12A1,cardiology,hypertension|edema,trichlormethiazide,
CC1=C(C/C=C(\C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=O)c2ccccc2C1=O,Phylloquinone,"2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione; 2-Methyl-3-[(2E)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone; 2-Methyl-3-phytyl-1,4-naphthochinon; 2-Methyl-3-phytyl-1,4-naphthoquinone; 3-Phytylmenadione; alpha-Phylloquinone; Fitomenadiona; Phyllochinon; Phyllochinonum; Phylloquinone; Phythyl-menadion; Phytomenadione; Phytomenadionum; Phytonadione; Phytonadionum; Phytylmenadione; trans-Phylloquinone; Vitamin K; Vitamin K1; α-phylloquinone",Launched,,BGLAP|GGCX,hematology,vitamin K deficiency|anticoagulation reversal,phytonadione,
CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,Felodipine,"(±)-ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate; 3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate; 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester; Felodipina; Felodipine; Felodipino; Felodipinum",Launched,calcium channel blocker,CFTR,cardiology,hypertension,felodipine,
CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1,Amlexanox,"2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid; Amlexanox; Amlexanoxo; Amlexanoxum; Amoxanox",Launched,histamine receptor modulator,FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13,dental|pulmonary|ophthalmology|allergy,aphthous ulcers|asthma|conjunctivitis|allergic rhinitis,amlexanox,
CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,Ketoconazole,Ketoconazol; Ketoconazole; Ketoconazolum; Ketozole,Launched,sterol demethylase inhibitor,KCNA10,dermatology,seborrheic dermatitis,ketoconazole,
COC(F)(F)C(Cl)Cl,Methoxyflurane,"Methoflurane; Methoxyfluoran; Methoxyfluran; Methoxyflurane; Methoxyfluranum; Methyl 1,1-difluoro-2,2-dichloroethyl ether; Metoxiflurano",Launched,membrane permeability inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|MT-ND1,neurology/psychiatry,general anaesthetic,methoxyflurane,
CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,Irbesartan,"2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one; Irbesartan",Launched,angiotensin receptor antagonist,AGTR1|JUN|SLC10A1,cardiology|nephrology,hypertension|diabetic nephropathy,irbesartan,
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,Topotecan,9-[(dimethylamino)methyl]-10-hydroxy-(4S)-camptothecin; Topotecan; Topotecane; Topotecanum,Launched,topoisomerase inhibitor,TOP1|TOP1MT,oncology,small cell lung cancer|cervical cancer,topotecan,
CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1,Probenecid,"4-((Dipropylamino)sulfonyl)benzoic acid; 4-(Di-n-propylsulfamoyl)benzoesäure; 4-(N,N-Dipropylsulfamoyl)benzoesäure; p-(Dipropylsulfamoyl)benzoic acid; Probenecid; Probenecid acid; Probenecida; Probenecide; Probenecidum",Launched,uricosuric blocker,PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1,nephrology|rheumatology,hyperuricemia|gout,probenecid,
S=c1nc[nH]c2nc[nH]c12,Mercaptopurine,"1,9-DIHYDRO-6H-PURINE-6-THIONE; 6 MP; 6-Mercaptopurine; 6-MP; 6-Thiohypoxanthine; 6-Thioxopurine; Mercaptopurina; Mercaptopurine; Mercaptopurine anhydrous; Mercaptopurinum; Mercapurin",Launched,immunosuppressant|protein synthesis inhibitor|purine antagonist,HPRT1|IMPDH1|IMPDH2|PPAT,hematologic malignancy,acute lymphoblastic leukemia (ALL),mercaptopurine,
CCN(CC)CCNC(=O)c1ccc(N)cc1,Procainamide,p-Amino-N-(2-diethylaminoethyl)benzamide; p-Aminobenzoic diethylaminoethylamide; Procainamida; Procaïnamide; Procainamide; Procainamidum,Launched,sodium channel blocker,DNMT1|SCN5A,cardiology,ventricular arrhythmias|ventricular tachycardia (VT),procainamide,
Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1,Tolterodine,(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol; (+)-Tolterodine; Tolterodina; Tolterodine; Tolterodinum,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,urology,urinary incontinence|urinary frequency,tolterodine,
C#CCN(C)[C@H](C)Cc1ccccc1,Selegiline,(−)-selegiline; L-Deprenalin; Selegilina; Selegiline; Selegilinum,Launched,monoamine oxidase inhibitor,MAOA|MAOB,neurology/psychiatry,Parkinson's Disease,selegiline,
CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,Fenofibrate,2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester; Fenofibrate; Fenofibrato; Fenofibratum; Finofibrate; FNF; Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionate; Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate; Procetofen,Launched,PPAR receptor agonist,MMP25|PPARA,endocrinology,hypercholesterolemia|hypertriglyceridemia,fenofibrate,
O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,Thalidomide,"(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide; (+-)-Thalidomide; (±)-N-(2,6-dioxo-3-piperidyl)phthalimide; (±)-thalidomide; 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline; 2,6-dioxo-3-phthalimidopiperidine; 3-Phthalimidoglutarimide; alpha-(N-Phthalimido)glutarimide; alpha-N-Phthalylglutaramide; N-(2,6-dioxo-3-piperidyl)phthalimide; N-Phthaloylglutamimide; N-Phthalyl-glutaminsaeure-imid; N-Phthalylglutamic acid imide; Talidomida; Thalidomide; Thalidomidum; α-(N-phthalimido)glutarimide; α-N-phthalylglutaramide; α-phthalimidoglutarimide",Launched,tumor necrosis factor production inhibitor,TNF,oncology,myeloma,thalidomide,
N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,Melphalan,"3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine; 3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine; 4-(Bis(2-chloroethyl)amino)-L-phenylalanine; L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine; L-PAM; L-Phenylalanine mustard; L-Sarcolysine; Melfalano; Melphalan; Melphalanum; p-Bis(beta-chloroethyl)aminophenylalanine; p-Di-(2-chloroethyl)amino-L-phenylalanine; p-L-Sarcolysin; p-N-Bis(2-chloroethyl)amino-L-phenylalanine; p-N,N-bis(2-chloroethyl)amino-L-phenylalanine; Phenylalanine mustard; Phenylalanine nitrogen mustard",Launched,DNA alkylating agent|DNA inhibitor,,hematologic malignancy,multiple myeloma,melphalan,
CC12CC3CC(C)(C1)CC(N)(C3)C2,Memantine,"1-Amino-3,5-dimethyladamantane; 1,3-Dimethyl-5-adamantanamine; 3,5-Dimethyl-1-adamantanamine; 3,5-Dimethyl-1-aminoadamantane; 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine; Memantina; Memantine; Memantinum",Launched,glutamate receptor antagonist,,neurology/psychiatry,Alzheimer's disease|senile dementia,memantine,
COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Gatifloxacin,"1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid; Gatifloxacin; Gatifloxacin anhydrous; Gatifloxacine; Gatifloxacino; Gatifloxacinum",Withdrawn,bacterial DNA gyrase inhibitor,,,,gatifloxacin,
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,Rifampin,"3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate; RFP; Rifampicin; Rifampicina; Rifampicine; Rifampicinum; Rifampin",Launched,RNA polymerase inhibitor,NR1I2|SLCO1A2|SLCO1B1|SLCO1B3,infectious disease,tuberculosis|meningitis,rifampin,
CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(=O)O)O1,Lubiprostone,Lubiprostone,Launched,chloride channel activator,CLCN2,gastroenterology,constipation|irritable bowel syndrome,lubiprostone,
CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,Fluocinonide,Fluocinonida; Fluocinonide; Fluocinonido; Fluocinonidum,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6|SMO,dermatology,seborrheic dermatitis|eczema,fluocinonide,
Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1,Abacavir,{(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol; Abacavir; ABC,Launched,nucleoside reverse transcriptase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),abacavir,
CC(C)Cc1ccc(C(C)C(=O)O)cc1,Ibuprofen,(±)-2-(p-isobutylphenyl)propionic acid; (±)-ibuprofen; (±)-p-isobutylhydratropic acid; (±)-α-methyl-4-(2-methylpropyl)benzeneacetic acid; (4-isobutylphenyl)-α-methylacetic acid; (RS)-ibuprofen; 2-(4-isobutylphenyl)propanoic acid; 4-isobutylhydratropic acid; Ibuprofen; Ibuprofene; Ibuprofeno; Ibuprofenum; Ibuprophen; α-(4-isobutylphenyl)propionic acid; α-(p-isobutylphenyl)propionic acid,Launched,cyclooxygenase inhibitor,,neurology/psychiatry|rheumatology|otolaryngology|obstetrics/gynecology|endocrinology|dental,headache|muscle pain|rheumatoid arthritis|backache|common cold|menstrual pain|fever|toothache,ibuprofen,
CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C,Novobiocin,Albamycin; N-{7-[(3-O-carbamoyl-6-deoxy-5-methyl-4-O-methyl-β-D-gulopyranosyl)oxy]-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl}-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide; Novobiocin; Novobiocina; Novobiocine; Novobiocinum,Launched,bacterial DNA gyrase inhibitor,,obstetrics/gynecology,mastitis,novobiocin,
CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,Benzylpenicillin,"(2S,5R,6R)-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6-(2-phenylacetamido)penicillanic acid; Bencilpenicilina; Bensylpenicillin; Benzyl benicillin; Benzylpenicillin; Benzylpénicilline; Benzylpenicillinic acid; Benzylpenicillinum; Free penicillin II; PCG; Penicillin G; PG",Launched,penicillin binding protein inhibitor,,infectious disease,celluitis|meningitis|endocarditis|syphilis|pneumonia|bacterial septicemia,benzylpenicillin,
CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,Nitrendipine,"1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester; Nitrendipine; Nitrendipino; Nitrendipinum",Launched,calcium channel blocker,CACNA1D|CACNA2D1|KCNN4,cardiology,hypertension,nitrendipine,
Cc1cccc(C)c1NC(=O)C(C)N,Tocainide,"2-Amino-2',6'-propionoxylidide; 2-amino-N-(2,6-dimethylphenyl)propanamide; 2-Amino-N-(2,6-dimethylphenyl)propionamid; Alanyl-2,6-xylidide; Tocainida; Tocainide; Tocainidum",Launched,sodium channel blocker,SCN5A,cardiology,cardiac arrythmia,tocainide,
O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1,Praziquantel,Praziquantel,Launched,anthelmintic agent,,infectious disease,gastrointestinal parasites|cystic hydatid disease|schistosomiasis,praziquantel,
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Norfloxacin,"1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsäure; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; NFLX; Norfloxacin; Norfloxacine; Norfloxacino; Norfloxacinum",Launched,bacterial DNA gyrase inhibitor,TOP2A,infectious disease|urology,urinary tract infections|gonorrhea|prostatitis,norfloxacin,
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,Amoxicillin,"(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid; Amox; Amoxicilina; Amoxicillin; Amoxicillin (anhydrous); Amoxicillin anhydrous; Amoxicilline; Amoxicillinum; Amoxycillin; AX; p-Hydroxyampicillin; α-amino-p-hydroxybenzylpenicillin",Launched,penicillin binding protein inhibitor,CYP2C19|SLC15A1|SLC15A2|SLC22A6,infectious disease|gastroenterology,skin infections|duodenal ulcer disease|gonorrhea|ear infections|throat infections|genitourinary tract infections|respiratory tract infections,amoxicillin,
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O,Azlocillin,"(2S,5R,6R)-3,3-dimethyl-7-oxo-6-{[(2R)-2-{[(2-oxoimidazolidin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Azlocilina; Azlocillin; Azlocilline; Azlocillinum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections|gram-negative bacterial infections,azlocillin,
CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,Oxybutynin,4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester; 4-Diethylamino-2-butinyl alpha-cyclohexylmandelat; 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate; Oxibutinina; Oxybutynin; Oxybutynine; Oxybutyninum,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,urology,urinary incontinence,oxybutynin,
CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,Acetophenazine,Acetophenazina; Acetophenazine; Acetophenazinum,Launched,dopamine receptor antagonist,DRD1|DRD2,neurology/psychiatry,psychosis,acetophenazine,
CC(C)NCC(O)c1ccc(O)c(O)c1,Isoprenaline,"(±)-isoprenaline; (±)-isoproterenol; 1-(3,4-dihydroxyphenyl)-2-(isopropylamino)ethanol; 1-(3,4-dihydroxyphenyl)-2-isopropylaminoethanol; 3,4-dihydroxy-α-[(isopropylamino)methyl]benzyl alcohol; Isoprenalina; Isoprénaline; Isoprenaline; Isoprenalinum; Isopropyl noradrenaline; Isoproterenol; N-isopropyl-β-dihydroxyphenyl-β-hydroxyethylamine; N-Isopropylnoradrenaline; N-Isopropylnorepinephrine; α-(isopropylaminomethyl)protocatechuyl alcohol",Launched,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,cardiology|pulmonary,bradycardia|heart block|asthma,isoprenaline,
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,Melatonin,5-methoxy-N-acetyltryptamine; Melatonin; Melatonina; Mélatonine; N-[2-(5-methoxyindol-3-yl)ethyl]acetamide; N-Acetyl-5-methoxytryptamine,Launched,melatonin receptor agonist|nitric oxide synthase inhibitor,ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB,neurology/psychiatry,sleep cycle support,melatonin,
Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1,Glipizide,1-cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea; Glipizida; Glipizide; Glipizidum; N-{4-[β-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-N'-cyclohexylurea,Launched,sulfonylurea,ABCC8|KCNJ10|KCNJ11|PPARG,endocrinology,diabetes mellitus|hyperglycemia,glipizide,
CC(CN1c2ccccc2Sc2ccccc21)N(C)C,Promethazine,"(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine; 10-(2-Dimethylaminopropyl)phenothiazine; 10-[2-(dimethylamino)propyl]phenothiazine; N-(2'-dimethylamino-2'-methyl)ethylphenothiazine; N,N,alpha-trimethyl-10H-phenothiazine-10-ethanamine; N,N,α-trimethyl-10H-phenothiazine-10-ethanamine; Proazamine; Prometazina; Promethazine; Promethazinum",Launched,histamine receptor antagonist,HRH1,neurology/psychiatry|allergy,sedative|allergic rhinitis,promethazine,
CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3\C[C@@H](O)CC[C@@H]3C)CCC[C@@]21C,Dihydrotachysterol,Anti-tetany substance 10; Dihidrotaquisterol; Dihydrotachysterol; Dihydrotachysterolum,Launched,vitamin analog,VDR,orthopedics|endocrinology,rickets|hypocalcemia|osteomalacia,dihydrotachysterol,
COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,Atazanavir,Atazanavir; Atazanavirum; ATZ,Launched,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),atazanavir,
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,Fludarabine,2-F-ARAA; 2-fluoro ARA-A; Fludarabina; Fludarabine; Fludarabinum,Launched,ribonucleotide reductase inhibitor,ADA|DCK|POLA1|RRM1|RRM2,hematologic malignancy,chronic lymphocytic leukemia (CLL),fludarabine,
C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,Perhexiline,Perhexilene; Perhexilina; Perhexiline; Perhexilinum,Launched,carnitine palmitoyltransferase inhibitor,CPT1A,cardiology,angina pectoris,perhexiline,
CN(C)CCOC(c1ccccc1)c1ccccc1,Diphenhydramine,"2-(benzhydryloxy)-N,N-dimethylethylamine; 2-diphenylmethoxy-N,N-demthylethanamine; Difenhidramina; Diphenhydramine; Diphenhydraminum; N-(2-(diphenylmethoxy)ethyl)-N,N-dimethylamine; O-benzhydryldimethylaminoethanol; α-(2-dimethylaminoethoxy)diphenylmethane; β-dimethylaminoethanol diphenylmethyl ether; β-dimethylaminoethyl benzhydryl ether",Launched,histamine receptor antagonist,HRH1,neurology/psychiatry,headache,diphenhydramine,
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,Atorvastatin,Atorvastatin; atorvastatina; atorvastatine; atorvastatinum,Launched,HMGCR inhibitor,AHR|DPP4|HMGCR,neurology/psychiatry|cardiology,stroke|heart attack,atorvastatin,
C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@]4(C)[C@H]5C[C@@H](O)[C@]6(C)[C@@H](C7=CC(=O)OC7)CC[C@]6(O)[C@@H]5CC[C@@H]4C3)O[C@@H]2C)C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](C)O1,Deslanoside,"(3β,5β,12β)-3-{[β-D-glucopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 3-[(O-β-D-glucopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-3β,5β,12β-card-20(22)-enolide; Deacetyllanatoside C; Desacetyllanatoside C; Deslanoside; Deslanosido; Deslanosidum; Glucodigoxin",Launched,Na/K-ATPase inhibitor,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2,cardiology,congestive heart failure|cardiac arrythmia,deslanoside,
CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12,Tegaserod,1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine; Tégasérod; Tegaserod; Tegaserodum,Withdrawn,serotonin receptor partial agonist,HTR2A|HTR2B|HTR2C|HTR4,,,tegaserod,
C=CC(N)CCC(=O)O,Vigabatrin,4-Amino-5-hexenoic acid; Gamma vinyl GABA; gamma-Vinyl GABA; gamma-Vinyl-gamma-aminobutyric acid; GVG; Vigabatrin; Vigabatrina; Vigabatrine; Vigabatrinum; Vinyl gamma-aminobutyric acid,Launched,GABA aminotransferase inhibitor,ABAT|SLC32A1,neurology/psychiatry,seizures|spasms,vigabatrin,
CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O,Streptomycin,"2,4-diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-alpha-L-glucopyranosyl)-3-C-formyl-beta-L-lyxopentanofuranoside; Estreptomicina; Streptomicina; Streptomycin; Streptomyzin",Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,tuberculosis,streptomycin,
CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,Orlistat,(-)-Tetrahydrolipstatin; Orlipastat; Orlipastatum; Orlistat; Tetrahydrolipstatin,Launched,lipase inhibitor,CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP,endocrinology,weight-loss aid,orlistat,
CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21,Emedastine,"1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole; 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole; 1-[2-(ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole; Emedastina; Emedastine; Emedastinum",Launched,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis,emedastine,
CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C,Pilocarpine,"2(3H)-FURANONE, 3-ETHYLDIHYDRO-4-((1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-, (3S-CIS)-; OCUCARPINE; Pilocarpina; Pilocarpine; PILOKARPIN; SPERSACARPINE; SYNCARPINE",Launched,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,ophthalmology|cardiology,glaucoma|hypertension,pilocarpine,
CCOC(=O)c1ccc(N)cc1,Benzocaine,4-aminobenzoic acid ethyl ester; Amben ethyl ester; Benzocaina; Benzocaine; Benzocainum; Ethyl aminobenzoate; Ethyl p-aminobenzoate; Ethyl p-aminophenylcarboxylate; p-(Ethoxycarbonyl)aniline; p-Carbethoxyaniline; p-Ethoxycarboxylic aniline,Launched,sodium channel blocker,SCN10A,infectious disease,first-aid antiseptic,benzocaine,
COc1cc(NC(C)CCCN)c2ncccc2c1,Primaquine,6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline; 8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline; 8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline; Primachin; Primachina; Primachinum; Primaquin; Primaquina; Primaquine; Primaquinum,Launched,antimalarial agent|DNA inhibitor,,infectious disease,malaria,primaquine,
CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O,Iloprost,"(5E)-[3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E)-(3S,4RS)-3-hydroxy-4-methyloct-1-en-6-ynyl]-hexahydropentalen-2(1H)-ylidene]pentanoic acid; (E)-(3aS, 4R, 5R, 6aS)-hexahydro-5-hydroxy-4-[(E)-(3S,4RS)­ 3-hydroxy-4-methyl-1-octen-6-ynyl]-Δ2(1H),Δ-pentalenevaleric acid; Iloprost; PENTANOIC ACID, 5-((3AS,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-((1E,3S)-3-HYDROXY-4-METHYL-1-OCTEN-6-YNYL)-2(1H)-PENTALENYLIDENE)-, (5E)-",Launched,platelet aggregation inhibitor|prostanoid receptor agonist,PTGDR|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|PTGIR|TBXA2R,pulmonary,pulmonary arterial hypertension (PAH),iloprost,
COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC,Deserpidine,"(3β,16β,17α,18β,20α)-17-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester; 11-demethoxyreserpine; 11-desmethoxyreserpine; Canescine; Deserpidina; Deserpidine; Deserpidinum; Raunormine; Recanescine",Launched,angiotensin converting enzyme inhibitor,ACE|SLC18A2,cardiology,hypertension,deserpidine,
C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,Pentolinium,Pentolineum; Pentolonium; Pentolonum,Launched,cholinergic receptor antagonist,CHRNA10|CHRNA3|CHRNA4|CHRNB4,cardiology,hypertension,pentolinium,
CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12,Butenafine,(4-tert-Butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine; (4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine; 4-tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine; Butenafina; Butenafine; Butenafinum; N-(p-tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine,Launched,fungal squalene epoxidase inhibitor,SQLE,infectious disease,tinea pedis|tinea cruris|tinea corporis,butenafine,
C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O,Ouabain,"3-(α-L-rhamnopyranosyloxy)-1β,5β,11α,14,19-pentahydroxy-5β-card-20(22)-enolide; G-Strophanthin; Ouabagenin L-Rhamnoside; Ouabagenin-L-rhamnosid; Ouabain anhydrous; Ouabaine; Oubain",Launched,ATPase inhibitor,ATP1A1,cardiology,hypertension|cardiac arrythmia,ouabain,
CS(C)=O,Dimethyl sulfoxide,Dimethyl sulfoxide; Dimethyl sulfur oxide; Dimethyl sulphoxide; Dimethyli sulfoxidum; Dimethylsulfoxid; Diméthylsulfoxyde; Dimetil sulfóxido; DMSO; Methylsulfinylmethane; S(O)Me2; Sulfinylbis(methane),Preclinical,control vehicle,,,,DMSO,
CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21,Fluvastatin,Fluvastatin; fluvastatina; fluvastatine; fluvastatinum,Launched,HMGCR inhibitor,HMGCR,endocrinology|cardiology,hypercholesterolemia|congenital heart defects,fluvastatin,
Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1,Leflunomide,"4-ISOXAZOLECARBOXAMIDE, 5-METHYL-N-(4-(TRIFLUOROMETHYL)PHENYL)-; 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide; 5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide; alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide; Leflunomida; Leflunomide; Léflunomide; Leflunomidum; N-(4-(TRIFLUOROMETHYL)PHENYL) 5 METHYLISOXAZOLE-4-CARBOXAMIDE; N-[4-(trifluoromethyl)phenyl] 5 methylisoxazole-4-carboxamide",Launched,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor,AHR|DHODH|PTK2B,rheumatology,rheumatoid arthritis,leflunomide,
CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,Rosuvastatin,"(3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; Rosuvastatin; Rosuvastatina",Launched,HMGCR inhibitor,HMGCR,endocrinology|cardiology,hyperlipidemia|dyslipidemia|hypertriglyceridemia|hypercholesterolemia|atherosclerosis,rosuvastatin,
Nc1nc(=O)[nH]cc1F,Flucytosine,5-FC; 5-Fluorocystosine; 5-Fluorocytosine; flucytosina; Flucytosine; Flucytosinum,Launched,other antifungal,DNMT1,infectious disease,bacterial septicemia|endocarditis|urinary tract infections|meningitis,flucytosine,
O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,Pimozide,Pimozida; Pimozide; Pimozidum,Launched,dopamine receptor antagonist,CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2,neurology/psychiatry,Tourette's disorder,pimozide,
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,Capecitabine,"(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester; Capecitabin; Capecitabina; Capecitabine; Capécitabine; Capecitabinum; Pentyl [1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate; pentyl 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate",Launched,DNA synthesis inhibitor|thymidylate synthase inhibitor,TYMS,oncology,breast cancer|colorectal cancer,capecitabine,
CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,Sertraline,"(+)-Sertraline; (1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine; (1S,4S)-sertraline; cis-(+)-sertraline; Sertralina; Sertraline; Sertralinum",Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A3|SLC6A4,neurology/psychiatry|obstetrics/gynecology,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,sertraline,
C[C@@H]1CN([C@H]2CC[C@](C#N)(c3ccc(F)cc3)CC2)CC[C@]1(C(=O)O)c1ccccc1,Levocabastine,Levocabastina; Levocabastine; Levocabastinum,Launched,histamine receptor antagonist,HRH1|NTSR2,ophthalmology,conjunctivitis,levocabastine,
C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(O)=C(C#N)C[C@]35C)[C@@H]1CC[C@@H]2O,Trilostane,Trilostane; Trilostano; Trilostanum,Launched,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,,endocrinology,Cushing's syndrome,trilostane,
Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,Miconazole,"1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole; 1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole; Miconazol; Miconazole; Miconazolum",Launched,bacterial cell wall synthesis inhibitor,TRPM2|TRPV5,infectious disease|neurology/psychiatry,yeast infection|itching,miconazole,
CCC(C)CCCCC(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC(C(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCNCS(=O)(=O)[O-])NC(=O)C(CCNCS(=O)(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCNCS(=O)(=O)[O-])NC1=O)C(C)O,Colistimethate,Colistin methanesulfonic acid; Colistin sulfomethate; Colistinmethanesulfonic acid,Launched,bacterial permeability inducer,,infectious disease,gram-negative bacterial infections,colistimethate,
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,Cefuroxime,"(6R,7R)-3-[(carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefuroxim; Cefuroxima; Cefuroxime; Cefuroximo; Cefuroximum; Cephuroxime",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,cefuroxime,
COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,Papaverine,Papaverina; Papaverine,Launched,phosphodiesterase inhibitor,PDE10A|PDE4B|PDE5A,cardiology|hematology|gastroenterology,myocardial infarction|angina pectoris|pulmonary embolism (PE)|colitis|vascular spasm,papaverine,
CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1,Chlorpheniramine,"1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane; 1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine; 2-[p-chloro-α-[2-(dimethylamino)ethyl]benzyl]pyridine; 3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine; Chlorophenylpyridamine; Chlorphenamin; Chlorphenamine; Chlorphenaminum; Chlorpheniramine; Chlorpheniramine polistirex; Chlorpheniraminum; Clorfenamina; Clorfeniramina; γ-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine; γ-(4-chlorophenyl)-γ-(2-pyridyl)propyldimethylamine",Launched,histamine receptor antagonist,,allergy,allergic rhinitis|urticaria,chlorphenamine,
COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],Nifedipine,"4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester; Nifedipine; Nifedipino; Nifedipinum",Launched,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNB2|CALM1|GLRA1|GLRA3|GLRB|KCNA1|KCNA5|NR1I2|TRPM3,cardiology,vasospastic angina|chronic stable angina,nifedipine,
O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21,Atovaquone,"2-(trans-4-(p-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone; Atovacuona; Atovaquone",Launched,mitochondrial electron transport inhibitor,,infectious disease,pneumonia,atovaquone,
CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,Amiodarone,"2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran; 2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone; 2-n-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran; Amiodarona; Amiodarone; Amiodaronum",Launched,potassium channel blocker,ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2,cardiology,ventricular arrhythmias,amiodarone,
CC1=NS(=O)(=O)c2cc(Cl)ccc2N1,Diazoxide,"7-chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; Diazossido; Diazoxide; Diazoxido; Diazoxidum",Launched,potassium channel activator,ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3,endocrinology,hypoglycemia,diazoxide,
Cc1ccc(S(=O)(=O)NC(=O)NN2C[C@H]3CCC[C@H]3C2)cc1,Gliclazide,1-(3-azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; 1-(hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Gliclazida; Gliclazide; Gliclazidum,Launched,ATP channel blocker|insulin secretagogue,,endocrinology,diabetes mellitus,gliclazide,
NC(=O)NC(=O)Cc1ccccc1,Phenacemide,Phenacemide,Launched,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,epilepsy|seizures,phenacemide,
CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl,Ambenonium,Ambenonium; Ambenonium base; Ambenonum,Launched,cholinesterase inhibitor,ACHE,neurology/psychiatry,myasthenia gravis,ambenonium,
CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1,Tolbutamide,1-Butyl-3-(p-methylphenylsulfonyl)urea; 1-Butyl-3-(p-tolylsulfonyl)urea; 1-Butyl-3-tosylurea; 1-p-Toluenesulfonyl-3-butylurea; 3-(p-Tolyl-4-sulfonyl)-1-butylurea; N-(4-Methylbenzenesulfonyl)-N'-butylurea; N-(4-Methylphenylsulfonyl)-N'-butylurea; N-(p-Methylbenzenesulfonyl)-N'-butylurea; N-(Sulfonyl-p-methylbenzene)-N'-N-butylurea; N-Butyl-N'-(4-methylphenylsulfonyl)urea; N-Butyl-N'-(p-tolylsulfonyl)urea; N-Butyl-N'-p-toluenesulfonylurea; N-n-Butyl-N'-tosylurea; Tolbutamida; Tolbutamide; Tolbutamidum; Tolylsulfonylbutylurea,Launched,ATP channel blocker,ABCC8|KCNJ1|KCNJ11|KCNJ8,endocrinology,diabetes mellitus,tolbutamide,
COc1ccc(C2C(=O)c3ccccc3C2=O)cc1,Anisindione,"2-(4-Methoxyphenyl)-1H-indene-1,3(2H)-dione; 2-(4-Methoxyphenyl)indan-1,3-dione; 2-(p-Methoxyphenyl)-1,3-indandione; 2-(p-Methoxyphenyl)indane-1,3-dione; 2-p-Anisyl-1,3-indandione; 2-para-Anisyl-1,3-indandione; Anisin indandione; Anisindiona; Anisindione; Anisindionum",Launched,vitamin K antagonist,GGCX,hematology,deep vein thrombosis (DVT),anisindione,
C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)Nc1cc(C(F)(F)F)ccc1C(F)(F)F,Dutasteride,"(5α,17β)-N-(2,5-bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; Dutasterida; Dutasteride; α,α,α,α',α',α'-hexafluoro-3-oxo-4-aza-5α-androst-1-ene-17β-carboxy-2',5'-xylidide",Launched,5 alpha reductase inhibitor,SRD5A1|SRD5A2|SRD5A3,urology,benign prostatic hyperplasia (BPH),dutasteride,
Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,Econazole,(+-)-Econazole; Econazol; Econazole,Launched,lanosterol demethylase inhibitor|sterol demethylase inhibitor,NPY1R|NPY2R|TRPM2|TRPV5,infectious disease,tinea pedis|tinea cruris|tinea corporis|tinea versicolor|cutaneous candidiasis,econazole,
CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Bicalutamide,Bicalutamida; Bicalutamide; Bicalutamidum,Launched,androgen receptor antagonist,AR,oncology,prostate cancer,bicalutamide,
COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C,Rabeprazole,Clofezone; Rabeprazole,Launched,ATPase inhibitor|gastrin inhibitor,ATP4A,gastroenterology,gastroesophageal reflux disease (GERD)|duodenal ulcer disease|Zollinger-Ellison syndrome,rabeprazole,
CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,Prednicarbate,Prednicarbate; Prednicarbato,Launched,phospholipase activator,PLA2G1B,dermatology|ophthalmology|neurology/psychiatry,eczema|contact dermatitis|itching,prednicarbate,
CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1,Proguanil,1-(p-Chlorophenyl)-5-isopropylbiguanide; Chlorguanide; Chloroguanide; Proguanil; Proguanile; Proguanilo; Proguanilum,Launched,dihydrofolate reductase inhibitor,DHFR,infectious disease,malaria,proguanil,
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,Pioglitazone,"(±)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione; 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione; Pioglitazona; Pioglitazone; Pioglitazonum",Launched,insulin sensitizer|PPAR receptor agonist,PPARG|TRPM3,endocrinology,diabetes mellitus,pioglitazone,
O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O,Tiludronic acid,Acide tiludronique; Acido tiludronico; Acidum tiludronicum; Tiludronate; Tiludronic acid,Launched,bone resorption inhibitor|osteoclast inhibitor,ATP6V1A|MMP2|PTPN1,orthopedics,navicular syndrome,tiludronate,
COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,Carvedilol,(+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol; Carvédilol; Carvedilol; Carvedilolum,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,cardiology,myocardial infarction|hypertension,carvedilol,
C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,Levofloxacin,"(-)-Ofloxacin; (3S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid; (S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (S)-Ofloxacin; L-Ofloxacin; Levofloxacin; Levofloxacin anhydrous; Levofloxacine; Levofloxacino; Levofloxacinum; Ofloxacin S-(-)-form",Launched,bacterial DNA gyrase inhibitor,,infectious disease|otolaryngology|gastroenterology|endocrinology,respiratory tract infections|sinusitis|skin infections|bone and joint infections|intra-abdominal infections|diarrhea|fever|urinary tract infections,ofloxacin,
O=C1C(CCS(=O)c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1,Sulfinpyrazone,"1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine; 1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione; 4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione; Sulfinpyrazone; Sulfoxyphenylpyrazolidine; Sulphinpyrazone",Launched,uricosuric blocker,ABCC1|FPR1|SLC22A12,rheumatology,gout,sulfinpyrazone,
CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CSc3ccncc3)[C@H]2SC1,Cefapirin,"(6R,7R)-3-(acetoxymethyl)-8-oxo-7-{[(pyridin-4-ylsulfanyl)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefapirin; Cefapirina; Cefapirine; Cefapirinum; Cefaprin; Cephapirin; Cephapirine; CEPR",Launched,bacterial cell wall synthesis inhibitor,,obstetrics/gynecology,mastitis,cephapirin,
CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1,Cefadroxil,CDX; Cefadroxil; Cefadroxil anhydrous; Cefadroxilo; Cefadroxilum; Cephadroxil; D-Cefadroxil,Launched,bacterial cell wall synthesis inhibitor,SLC15A1|SLC15A2|SLC22A6|SLC22A8,infectious disease|otolaryngology,urinary tract infections|skin infections|tonsillitis|pharyngitis,cefadroxil,
CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)c(OS(=O)(=O)O)c5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)no2)cc1,Micafungin,Micafungin; Micafungina,Launched,"""fungal 1,3-beta-D-glucan synthase inhibitor""",,infectious disease,candidemia|peritonitis|esophageal candidiasis,micafungin,
CN(C)CCC=C1c2ccccc2COc2ccccc21,Doxepin,Doxepin; Doxepina; Doxepinum,Launched,histamine receptor antagonist,HRH1|SLC6A2|SLC6A4,neurology/psychiatry,depression|anxiety,doxepin,
NCCCNCCSP(=O)(O)O,Amifostine,Amifostina; Amifostine; Amifostine anhydrous; Amifostinum; Aminopropylaminoethyl thiophosphate; Ethiofos,Launched,reducing agent,ALPPL2|ENPP1,nephrology,renal toxicity,amifostine,
NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1,Diclofenamide,"1,3-disulfamoyl-4,5-dichlorobenzene; 1,3-disulfamyl-4,5-dichlorobenzene; 3,4-dichloro-5-sulfamylbenzenesulfonamide; 4,5-dichloro-1,3-benzenedisulfonamide; 4,5-dichloro-1,3-disulfamoylbenzene; 4,5-dichloro-benzene-1,3-disulfonic acid diamide; 4,5-dichloro-m-benzenedisulfonamide; 4,5-dichlorobenzene-1,3-disulfonamide; Dichlofenamide; Dichlorophenamide; Dichlorphenamide; Diclofenamida; Diclofenamide; Diclofenamidum",Launched,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA4|CA7,ophthalmology|neurology/psychiatry,glaucoma|epilepsy,diclofenamide,
CN1CCC(OC(c2ccccc2)c2ccccc2)CC1,Diphenylpyraline,1-methyl-4-hydroxypiperidine benzhydryl ether; 1-methyl-4-piperidyl benzhydryl ether; 4-(benzhydryloxy)-1-methylpiperidine; 4-(benzhydryloxy)-N-methylpiperidine; Difenilpiralina; Diphenylpyralamine; Diphenylpyraline; Diphenylpyralinum,Launched,dopamine reuptake inhibitor,HRH1|SLC6A3,allergy,allergic rhinitis,diphenylpyraline,
Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,Cloxacillin,"(2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (3-(o-chlorophenyl)-5-methyl-4-isoxazolyl)penicillin; 6-(3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid; Cloxacilina; Cloxacillin; Cloxacilline; Cloxacillinum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections,cloxacillin,
Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,Flavoxate,2-(1-piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate; 2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate; 2-piperidinoethyl 3-methylflavone-8-carboxylate; Flavoxate; Flavoxato; Flavoxatum; β-piperidinoethyl 3-methylflavone-8-carboxylate,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2,urology,urinary incontinence|interstitial cystitis (IC)|urethritis|prostatitis,flavoxate,
CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1,Nefazodone,"1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one; Nefazodona; Nefazodone; Nefazodonum",Withdrawn,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4,,,nefazodone,
CC=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1,Cefprozil,Cefprozil; Cefprozil anhydrous; Cefprozilo; Cefprozilum,Launched,bacterial cell wall synthesis inhibitor,,otolaryngology|infectious disease|pulmonary,pharyngitis|tonsillitis|otitis|sinusitis|respiratory tract infections|skin infections|bronchitis,cefprozil,
CNCCCN1c2ccccc2CCc2ccccc21,Desipramine,5-(gamma-methylaminopropyl)iminodibenzyl; 5-(γ-methylaminopropyl)iminodibenzyl; Déméthylimipramine; Desipramin; Desipramina; Desipramine; Désipramine; Desipraminum; Desmethylimipramine; DMI; Monodemethylimipramine; N-(3-methylaminopropyl)iminobibenzyl; Norimipramine,Launched,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A4|SMPD1,neurology/psychiatry,depression,desipramine,
CC1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C(OC2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)CC(O)C(C(=O)O)C(O)CC(=O)CC(O)CC(O)CC(O)CC(=O)CCCC(=O)CC(=O)OC1C(C)CC(C)C(O)CC(=O)c1ccc(N)cc1,Candicidin,Candicidin; Candicidina; Candicidine; Candicidinum; Candizidin; Levorin; Levorina; Levorine; Levorinum,Launched,fungal ergosterol inhibitor,,infectious disease,vulvovaginal candidiasis,candicidin,
Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1,Sertaconazole,Sertaconazol; Sertaconazole; Sertaconazolum,Launched,sterol demethylase inhibitor,,infectious disease,tinea pedis,sertaconazole,
C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,Thiamylal,"5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid; 5-allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione; 5-allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione; dihydro-5-(1-methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione; Thiamylal",Launched,glutamate receptor antagonist,GABRA1,neurology/psychiatry,sedative,thiamylal,
CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,Gemifloxacin,Gemifloxacin,Launched,bacterial DNA gyrase inhibitor,,pulmonary|infectious disease,bronchitis|pneumonia,gemifloxacin,
CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,Bupropion,Amfebutamone; Bupropion,Launched,dopamine reuptake inhibitor,SLC6A2|SLC6A3,neurology/psychiatry,depression,bupropion,
COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC,Trimetrexate,Trimetrexate; Trimetrexato; Trimetrexatum,Phase 3,dihydrofolate reductase inhibitor,DHFR,,,trimetrexate,
CC[N+](C)(C)Cc1ccccc1Br,Bretylium,"(2-bromobenzyl)ethyldimethylaminium; 2-bromo-N-ethyl-N,N-dimethylbenzenemethanaminium; Bretylium; N-ethyl-N,N-dimethyl-2-bromobenzenemethanaminium",Launched,norepinephrine inhibitor,ATP1A1,cardiology,ventricular arrhythmias|ventricular fibrillation (VF)|ventricular tachycardia (VT),bretylium,
FC(F)(F)C(Cl)Br,Halothane,"1-bromo-1-chloro-2,2,2-trifluoroethane; 1,1,1-trifluoro-2-bromo-2-chloroethane; 1,1,1-trifluoro-2-chloro-2-bromoethane; 2-bromo-2-chloro-1,1,1-trifluoroethane; 2,2,2-trifluoro-1-chloro-1-bromoethane; Alotano; Bromochlorotrifluoroethane; Halotano; Halothane; Halothanum",Launched,glutamate receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|KCNK10|KCNK12|KCNK13|KCNK15|KCNK18|KCNK2|KCNK3|KCNK9,neurology/psychiatry,general anaesthetic,halothane,
CCN(CC)CCOC(=O)c1ccc(N)cc1Cl,Chloroprocaine,2-(Diethylamino)ethyl 4-amino-2-chlorobenzoate; 2-chloroprocaine; 4-amino-2-chlorobenzoic acid 2-(diethylamino)ethyl ester; Chloroprocain; Chloroprocaine; Chloroprocainum; Chlorprocaine; Cloroprocaina,Launched,sodium channel blocker,ATP1A1|CHRNA10|GRIN3A|HTR3A|SCN10A|SLC6A3,neurology/psychiatry,local anesthetic,chloroprocaine,
COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,Terazosin,"1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine; Terazosin; Terazosina; Terazosine; Térazosine; Terazosinum",Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,urology|cardiology,benign prostatic hyperplasia (BPH)|hypertension,terazosin,
CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,Ofloxacin,"8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid; Ofloxacin; Ofloxacine; Ofloxacino; Ofloxacinum; OFLX",Launched,bacterial DNA gyrase inhibitor,,infectious disease|otolaryngology|gastroenterology|endocrinology,respiratory tract infections|sinusitis|skin infections|bone and joint infections|intra-abdominal infections|diarrhea|fever|urinary tract infections,ofloxacin,
O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1,Cilostazol,"3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone; 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone; 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one; Cilostazol; Cilostazole; Cilostazolum",Launched,phosphodiesterase inhibitor,PDE3A|PDE3B,cardiology,claudication,cilostazol,
CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,Itraconazole,"(±)-1-SEC-BUTYL-4-(P-(4-(P-(((2R*,4S*)-2-(2,4-DICHLOROPHENYL)-2-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)-1-PIPERAZINYL)PHENYL)-.DELTA.(SUP 2)-1,2,4-TRIAZOLIN-5-ONE; 3H-1,2,4-TRIAZOL-3-ONE, 4-(4-(4-(4-((2-(2,4-DICHLOROPHENYL)-2-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)-1-PIPERAZINYL)PHENYL)-2,4-DIHYDRO-2-(1-METHYLPROPYL)-; Itraconazol; Itraconazole; ITRACONAZOLE COMPONENT OF SUBA-ITRACONAZOLE; Itraconazolum; Oriconazole",Launched,cytochrome P450 inhibitor,,infectious disease,onychomycosis|histoplasmosis|blastomycosis|aspergillosis,itraconazole,
CNNCc1ccc(C(=O)NC(C)C)cc1,Procarbazine,1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine; 2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine; 4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide; N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide; N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine; N-isopropyl-4-[(2-methylhydrazino)methyl]benzamide; N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide; N-Isopropyl-α-(2-methylhydrazino)-p-toluamide; p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide; Procarbazin; Procarbazina; Procarbazine; Procarbazinum,Launched,monoamine oxidase inhibitor,,hematologic malignancy,Hodgkin's lymphoma,procarbazine,
NC(N)=NCCN1CCCCCCC1,Guanethidine,"(2-(hexahydro-1(2h)-azocinyl)ethyl)guanidine; (2-(Octahydro-1-azocinyl)ethyl)guanidine; 2-(1-N,N-Heptamethyleneimino)ethylguanidine; 2-(1'-Azacyclooctyl)ethylguanidine; Azocine, 1-(2-guanidinoethyl)octahydro-; guanéthidine; Guanethidine; guanethidinum; guanetidina; Guanidine, (2-(hexahydro-1(2H)-azocinyl)ethyl)-; Heptamethylenimine, 1-(2-guanidinoethyl)-; N-(2-Perhydroazocin-1-ylethyl)guanidine",Launched,adrenergic inhibitor,SLC6A2,cardiology,hypertension,guanethidine,
O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,Moclobemide,4-Chlor-N-(2-morpholinoethyl)benzamid; Moclobemid; Moclobemida; Moclobemide; Moclobemidum; p-Chloro-N-(2-morpholinoethyl)benzamide,Launched,monoamine oxidase inhibitor,MAOA|MAOB,neurology/psychiatry,depression|anxiety,moclobemide,
NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,Kanamycin,"4,6-diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi-α-D-glucoside; 4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside; Kanamycin A",Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections,kanamycin,
Cc1ccccc1C(OCCN(C)C)c1ccccc1,Orphenadrine,"2-(phenyl-o-tolylmethoxy)ethyldimethylamine; 2-methyldiphenhydramine; beta-Dimethylaminoethyl 2-methylbenzhydryl ether; Dimethyl-[2-(phenyl-o-tolyl-methoxy)-ethyl]-amine; N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine; N,N-dimethyl-2-(phenyl(o-tolyl)methoxy)ethanamine; N,N-dimethyl-2-[(o-methyl-α-phenylbenzyl)oxy]ethylamine; o-methyldiphenhydramine; o-monomethyldiphenhydramine; Orfenadrina; Orphenadrine; Orphenadrinum; phenyl-o-tolylmethyl dimethyaminoethyl ether; β-dimethylaminoethyl 2-methylbenzhydryl ether",Launched,acetylcholine receptor antagonist,,neurology/psychiatry,muscle pain,orphenadrine,
CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,Escitalopram,(+)-Citalopram; (S)-Citalopram; Escitalopram; Escitalopramum; S-(+)-Citalopram; S(+)-Citalopram,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4,neurology/psychiatry,depression|generalized anxiety disorder (GAD),escitalopram,
CN1CCN(C(c2ccccc2)c2ccccc2)CC1,Cyclizine,(±)-1-diphenylmethyl-4-methylpiperazine; (N-Benzhydryl)(N'-methyl)diethylenediamine; 1-(Diphenylmethyl)-4-methylpiperazine; 1-Benzhydryl-4-methylpiperazin; Ciclizina; Cyclizine; Cyclizinum; N-Benzhydryl-N'-methylpiperazine; N-methyl-N'-benzhydrylpiperazine,Launched,histamine receptor modulator,HRH1|SULT1E1,gastroenterology|neurology/psychiatry,nausea|vomiting|vertigo|motion sickness,cyclizine,
CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O,Idarubicin,"(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside; 4-Demethoxydaunomycin; 4-Demethoxydaunorubicin; Idarubicin; Idarubicina; Idarubicine; Idarubicinum",Launched,topoisomerase inhibitor,TOP2A,hematologic malignancy,acute myeloid leukemia (AML),idarubicin,
CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1,Chlormezanone,"(±)-chlormezanone; 2-(p-chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide; 2-(p-chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-on-1,1-dioxide; Chlormethazanone; Chlormezanona; Chlormézanone; Chlormezanone; Chlormezanonum; Clormezanona",Withdrawn,GABA receptor modulator,GABRA1,,,chlormezanone,
COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,Podofilox,(−)-podophyllotoxin; Podofilox; Podophyllinic acid lactone; Podophyllotoxin; PPT,Launched,microtubule inhibitor|tubulin polymerization inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,infectious disease,genital warts,podophyllotoxin,
O=P1(NCCCl)OCCCN1CCCl,Ifosfamide,"3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide; Ifosfamida; Ifosfamide; Ifosfamidum; Iphosphamide; Isofosfamide; Isophosphamide; Isosfamide",Launched,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1,oncology|urology,testicular carcinoma|hemorrhagic cystitis,ifosfamide,
CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,Propafenone,1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone; 2-(2'-hydroxy-3'-propylaminopropoxy)-ω-phenylpropiophenone; Propafenona; Propafenone; Propafenonum,Launched,antiarrhythmic,ADRB1|ADRB2|KCNA5|KCNH2,cardiology,atrial fibrillation (AF)|ventricular tachycardia (VT)|ventricular arrhythmias,propafenone,
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,Naloxone,"(−)-naloxone; 1-N-Allyl-14-hydroxynordihydromorphinone; 17-allyl-3,14-dihydroxy-4,5α-epoxymorphinan-6-one; Nalossone; Naloxona; Naloxone; Naloxonum",Launched,opioid receptor antagonist,CREB1|ESR1|OPRD1|OPRK1|OPRM1|TLR4,pulmonary,respiratory depression,naloxone,
O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,Domperidone,"1-(3-(4-(5-chloro-2-oxo-2,3-dihydrobenzo[d]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[d]imidazol-2(3H)-one; 5-chloro-1-(1-(3-(2-oxo-1-benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone; 5-chloro-1-(1-(3-(2-oxo-2,3-dihydrobenzo[d]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one; 5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one; Domperidona; Domperidone; Domperidonum",Launched,dopamine receptor antagonist,DRD2|DRD3,infectious disease,fescue toxicosis,domperidone,
CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,Pergolide,Pergolida; Pergolide; Pergolidum,Withdrawn,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,,,pergolide,
Cc1cc(C2CCCCC2)n(O)c(=O)c1,Ciclopirox,6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone; Ciclopirox; Ciclopiroxum,Launched,membrane integrity inhibitor,ATP1A1,infectious disease,onychomycosis,ciclopirox,
CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1,Clindamycin,"7-CDL; 7(S)-Chloro-7-deoxylincomycin; Clindamicina; Clindamycin; Clindamycine; Clindamycinum; Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside",Launched,protein synthesis inhibitor,,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,clindamycin,
CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,Acebutolol,(±)-acebutolol; 3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone; Acebutolol; Acebutololum; Acetobutolol; N-(3-acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide; N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide,Launched,adrenergic receptor antagonist,ADRB1,cardiology,hypertension|ventricular arrhythmias,acebutolol,
CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,Brinzolamide,Brinzolamida; Brinzolamide,Launched,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA5A|CA7,ophthalmology,intraocular pressure|glaucoma|ocular hypertension,brinzolamide,
O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F,Flecainide,"(±)-flecainide; Flecaine; Flecainida; Flécaïnide; Flecainide; Flecainidum; N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide",Launched,sodium channel blocker,KCNA5|KCNA7|SCN5A,cardiology,ventricular tachycardia (VT)|atrial fibrillation (AF)|ventricular arrhythmias,flecainide,
C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,Estramustine,"17β-Estradiol 3-(bis(2-chloroethyl)carbamate); Estradiol 3-(N,N-bis(2-chloroethyl)carbamate); Estramustina; Estramustine; Estramustinum",Launched,DNA alkylating agent,ESR1|ESR2|MAP1A|MAP2,oncology,prostate cancer,estramustine,
C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,Captopril,(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid; Captopril; Captoprilum; Captopryl; CP; D-2-methyl-3-mercaptopropanoyl-L-proline; D-3-mercapto-2-methylpropanoyl-L-proline; L-Captopril,Launched,angiotensin converting enzyme inhibitor,ACE|LTA4H|MMP2|MMP9,cardiology|endocrinology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetes mellitus|diabetic nephropathy,captopril,
COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C,Tubocurarine,"(+)-tubocurarine; 7',12'-dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium; d-tubocurarine; Tubocurarin; Tubocurarine; Tubocurarinum",Launched,acetylcholine receptor antagonist,ACHE|CHRNA2|HTR3A|HTR3B|KCNN1|KCNN2|KCNN3|ZACN,neurology/psychiatry,anesthetic,tubocurarine,
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,Bromocriptine,2-Bromo-alpha-ergocryptine; 2-Bromo-alpha-ergokryptin; 2-Bromo-alpha-ergokryptine; 2-bromo-α-ergocryptine; 2-bromo-α-ergokryptin; 2-bromo-α-ergokryptine; Bromocriptina; Bromocriptine; Bromocriptinum; Bromocryptine; Bromoergocriptine; Bromoergocryptine,Launched,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,endocrinology|neurology/psychiatry,hyperprolactinemia|Parkinson's Disease|acromegaly,bromocriptine,
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,Rifapentine,3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)rifamycin; Cyclopentylrifampicin; Rifapentin; Rifapentine,Launched,RNA polymerase inhibitor,CYP2C8|CYP2C9|CYP3A4,infectious disease,tuberculosis,rifapentine,
CC[C@@H](C(N)=O)N1CCCC1=O,Levetiracetam,Levetiracetam; Levetiracetame; Levetiracetamum,Launched,calcium channel blocker,CACNA1B|SCN1A|SV2A,neurology/psychiatry,seizures,levetiracetam,
CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2,Nadolol,Nadolol,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,cardiology,angina pectoris|hypertension,nadolol,
O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,Mitoxantrone,"1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone; Mitoxantrona; Mitoxantrone; Mitoxantronum",Launched,topoisomerase inhibitor,TOP2A,neurology/psychiatry|oncology|hematologic malignancy,multiple sclerosis|prostate cancer|acute myeloid leukemia (AML),mitoxantrone,
CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2,Flumazenil,Flumazenil; Flumazenilo; Flumazenilum; Flumazepil,Launched,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,neurology/psychiatry,sedative,flumazenil,
O=NN(CCCl)C(=O)NC1CCCCC1,Lomustine,1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea; 1-(2-chloroethyl)-3-cyclohexylnitrosourea; Chloroethylcyclohexylnitrosourea; CINU; Cyclohexyl chloroethyl nitrosourea; Lomustina; Lomustine; Lomustinum; N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea,Launched,DNA synthesis inhibitor,,hematologic malignancy|oncology,Hodgkin's lymphoma|brain tumors,lomustine,
C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,Sparfloxacin,"cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; Sparfloxacin",Withdrawn,bacterial DNA gyrase inhibitor,TOP2A,,,sparfloxacin,
CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O,Levobunolol,"(-)-Bunolol; (S)-5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone; Levobunolol; Levobunololum",Launched,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,ophthalmology,glaucoma|ocular hypertension,levobunolol,
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Clarithromycin,6-O-methyl erythromycin; 6-O-methylerythromycin; 6-O-methylerythromycin A; CLA; Clarithromycin; Clarithromycina; Clarithromycine; Clarithromycinum; Claritromicina,Launched,bacterial 50S ribosomal subunit inhibitor,CYP3A4,otolaryngology|pulmonary|infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,clarithromycin,
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(=O)[nH]n3C)CS[C@H]12)c1csc(N)n1,Ceftriaxone,Ceftriaxona; Ceftriaxone; Ceftriaxonum; Rocephin,Launched,bacterial cell wall synthesis inhibitor,,infectious disease|otolaryngology,gonorrhea|pneumonia|otitis|skin infections|urinary tract infections|pelvic inflammatory disease|bacterial septicemia|bone and joint infections|intra-abdominal infections|meningitis|surgical prophylaxis,ceftriaxone,
Cc1cn[nH]c1,Fomepizole,4-methylpyrazol; 4-methylpyrazole; Fomepizol; Fomepizole; Fomepizolum,Launched,alcohol dehydrogenase inhibitor,ADH1A|ADH1B|ADH1C|AKR1A1|CAT,critical care,poison antidote,fomepizole,
CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C,Metipranolol,"(±)-metipranolol; Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester; Metipranolol; Metipranololum",Withdrawn,adrenergic receptor antagonist,,,,metipranolol,
CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,Finasteride,"(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; Finasterida; Finasteride; Finasteridum",Launched,5 alpha reductase inhibitor,AKR1D1|SRD5A1|SRD5A2,endocrinology,androgenetic alopecia,finasteride,
CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1,Anastrozole,"Anastrozol; Anastrozole; α,α,α',α'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile",Launched,aromatase inhibitor,CYP19A1,oncology,breast cancer,anastrozole,
CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12,Halofantrine,Halofantrina; Halofantrine; Halofantrinum,Launched,antimalarial agent,KCNN4,infectious disease,malaria,halofantrine,
O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,Dantrolene,1-((5-(p-nitrophenyl)furfurylidene)amino)hydantoin; Dantrolene; Dantroleno; Dantrolenum,Launched,calcium channel blocker,RYR1|RYR3,neurology/psychiatry|endocrinology,spasms|malignant hyperthermia (MH),dantrolene,
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,Rifaximin,Rifamycin L 105; Rifamycin L 105SV; Rifaxidin; Rifaximin; Rifaximina; Rifaximine; Rifaximinun,Launched,RNA synthesis inhibitor,,gastroenterology,diarrhea|irritable bowel syndrome|hepatic encephalopathy (HE),rifaximin,
CNC1(c2ccccc2Cl)CCCCC1=O,Ketamine,(+-)-Ketamine; (±)-ketamine; 2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone; 2-(methylamino)-2-(2-chlorophenyl)cyclohexanone; 2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone; DL-ketamine; Ketamina; Ketamine; Kétamine; Ketaminum; NMDA; Special K,Preclinical,glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,,,NMDA,
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,Budesonide,"(11β,16α)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione; Budesónida; Budesonide",Launched,glucocorticoid receptor agonist,NR3C1,gastroenterology,Crohn's disease,budesonide,
Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN,Aminophylline,Aminofilina; Aminophyllin; Aminophylline; Aminophyllinum; Theophyline ethylenediamine; Theophylline ethylenediamine,Launched,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,pulmonary,asthma|bronchitis|emphysema,aminophylline,
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,Quetiapine,"2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol; Quetiapina; Quetiapine; Quétiapine; Quetiapinum",Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2,neurology/psychiatry,schizophrenia|bipolar disorder,quetiapine,
COc1cc2c(cc1OC)[C@@H](Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3[C@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2,Mivacurium,Mivacurium,Launched,acetylcholine receptor antagonist,CHRNA2,critical care|neurology/psychiatry,endotracheal intubation|muscle relaxant,mivacurium,
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,Paclitaxel,"5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine; ABI-007 COMPONENT PACLITAXEL; BENZENEPROPANOIC ACID, .BETA.-(BENZOYLAMINO)-.ALPHA.-HYDROXY-, (2AR,4S,4AS,6R,9S,11S,12S,12AR,12BS)-6,12B-BIS(ACETYLOXY)-12-(BENZOYLOXY)-2A,3,4,4A,5,6,9,10,11,12,12A,12B-DODECAHYDRO-4,11-DIHYDROXY-4A,8,13,13-TETRAMETHYL-5-OXO-7,11-METHANO-1H-CYCLODECA(3,; liposomal encapsulated paclitaxel; NAB-PACLITAXEL COMPONENT PACLITAXEL; Nanoparticulate paclitaxel; Paclitaxel; paclitaxel protein-bound particles; Paclitaxel protein-bound particles for injection suspension; Taxol A",Launched,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,oncology,ovarian cancer|breast cancer|non-small cell lung cancer (NSCLC),paclitaxel,
OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1,Diphenidol,"alpha,alpha-Diphenyl-1-piperidinebutanol; Difénidol; Difenidol; Difenidolo; Difenidolum; Diphenidol; Diphenyl(3-(1-piperidyl)propyl)carbinol",Launched,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,neurology/psychiatry,vertigo,diphenidol,
CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,Saquinavir,Saquinavir,Launched,HIV protease inhibitor,CYP3A4,infectious disease,human immunodeficiency virus (HIV-1),saquinavir,
CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,Metoclopramide,"2-methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide; 2-methoxy-5-chloroprocainamide; 4-amino-5-chloro-2-methoxy-N-(β-diethylaminoethyl)benzamide; 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide; Metoclopramida; Metoclopramide; Metoclopramidum",Launched,dopamine receptor antagonist|serotonin receptor antagonist,CHRM1|DRD2|HTR3A|HTR3B|HTR4,gastroenterology,gastroparesis|nausea|vomiting,metoclopramide,
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,Dexamethasone,1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone; 1-Dehydro-16α-methyl-9α-fluorohydrocortisone; 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol; 16α-Methyl-9α-fluoro-1-dehydrocortisol; 9alpha-Fluoro-16alpha-methylprednisolone; 9α-Fluoro-16α-methylprednisolone; Dexametasona; Dexaméthasone; Dexamethasone; Dexamethasonum,Launched,glucocorticoid receptor agonist,ANXA1|NOS2|NR0B1|NR3C1|NR3C2,endocrinology|rheumatology|allergy|gastroenterology|hematology|neurology/psychiatry|dermatology,hypercalcemia|rheumatoid arthritis|psoriatic arthritis|osteoarthritis|allergic rhinitis|ulcerative colitis|anemia|multiple sclerosis|enteritis|lupus|dermatitis herpetiformis (DH)|nephrotic syndrome|psoriasis,dexamethasone,
N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,Levodopa,"(−)-3-(3,4-dihydroxyphenyl)-L-alanine; (−)-dopa; 3-Hydroxy-L-tyrosine; 3,4-Dihydroxy-L-phenylalanine; Dihydroxy-L-phenylalanine; L-3,4-dihydroxyphenylalanine; L-beta-(3,4-Dihydroxyphenyl)alanine; L-DOPA; Levodopa; Levodopum; β-(3,4-dihydroxyphenyl)-L-alanine; β-(3,4-dihydroxyphenyl)alanine",Launched,dopamine precursor,DRD1|DRD2|DRD3|DRD4|DRD5|GPR143,neurology/psychiatry,Parkinson's Disease,levodopa,
FCOC(C(F)(F)F)C(F)(F)F,Sevoflurane,"1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane; Sevofluran; Sevoflurane; Sevoflurano; Sevofluranum",Launched,membrane integrity inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9|MT-ND1,neurology/psychiatry,anesthetic,sevoflurane,
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,Aripiprazole,Aripiprazol; Aripiprazole; Aripiprazolum,Launched,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7,neurology/psychiatry,depression|schizophrenia|bipolar disorder,aripiprazole,
CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21,Chlorprothixene,Alpha-Chlorprothixene; Chlorprothixen; Chlorprothixene; Chlorprothixine; Chlorprotixen; Chlorprotixene; Chlorprotixine; Chlothixen,Launched,dopamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C,neurology/psychiatry,schizophrenia|bipolar disorder,chlorprothixene,
CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2O/C(=C\CCCC(=O)O)C[C@@H]21,Epoprostenol,"(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate; (5Z,9α,11α,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid; Epoprostenol; PGI2; PGX; Prostacyclin; Prostaglandin I2; Prostaglandin X; Vasocyclin",Launched,prostacyclin analog,P2RY12|PTGER1|PTGER4|PTGIR|PTGIS,cardiology,hypertension,epoprostenol,
Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1,Gemfibrozil,"2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansäure; 2,2-Dimethyl-5-(2,5-xylyloxy)valeriansäure; 2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid; Gemfibrozil; Gemfibrozilo; Gemfibrozilum",Launched,lipoprotein lipase activator,LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1,endocrinology|cardiology,hyperlipidemia|coronary heart disease,gemfibrozil,
CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,Clomipramine,"3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine; 3-(3-chloro-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine; 3-Chloroimipramine; Chlorimipramine; Clomipramina; Clomipramine; Clomipraminum; Monochlorimipramine",Launched,serotonin transporter (SERT) inhibitor,GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,obsessive compulsive disorder (OCD),clomipramine,
Oc1c(Cl)cc(Cl)c2cccnc12,Chloroxine,"5,7-dichlor-8-hydroxychinolin; 5,7-dichloro-8-hydroxyquinoline; 5,7-dichloro-8-oxyquinoline; 5,7-dichloro-8-quinolinol; 5,7-dichlorooxine; 5,7-dichloroxine; Chloroxine; Chlorquinol; CHQ",Launched,opioid receptor antagonist,OPRK1,gastroenterology|infectious disease|dermatology,diarrhea|inflammatory bowel disease|giardiasis|dandruff,chloroxine,
CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,Bepridil,"1-(2-(N-BENZYLANILINO)-1-(ISOBUTOXYMETHYL)ETHYL)-PYRROLIDINE; 1-PYRROLIDENEETHANAMINE, .BETA.-((2-METHYLPROPOXY)METHYL)-N-PHENYL-N-(PHENYLMETHYL)-; Bepadin; Bepridil",Launched,calcium channel blocker,KCNQ4,cardiology,angina pectoris,bepridil,
C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,Decamethonium,"Decamethonium; Decamethonium cation; Decamethonium ion; Decamethonum; Decamethylenebis(trimethylammonium); N,N,N,N',N',N'-hexamethyl-1,10-decanediaminium",Launched,acetylcholine receptor agonist,ACHE|CHRNA2,neurology/psychiatry,muscle relaxant,decamethonium,
CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,Alimemazine,Alimemazina; Alimemazine; Alimemazinum; Methylpromazine; Trimeprazine,Launched,histamine receptor agonist|histamine receptor antagonist,HRH1,neurology/psychiatry|allergy|pulmonary,sedative|urticaria|itching|cough suppressant,alimemazine,
Cc1cc(C(=O)NNCc2ccccc2)no1,Isocarboxazid,Isocarboxazid; Isocarboxazida; Isocarboxazide; Isocarboxazidum,Launched,monoamine oxidase inhibitor,MAOA|MAOB,neurology/psychiatry,depression,isocarboxazid,
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,Docetaxel,Docetaxel; Docetaxel anhydrous; N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; TXL,Launched,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,oncology,breast cancer|non-small cell lung cancer (NSCLC)|prostate cancer|gastric adenocarcinoma|head and neck squamous cell carcinoma (HNSCC),docetaxel,
CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I,Iodixanol,"5,5'-((2-hydroxytrimethylene)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide); Indixanol; Iodixanol; Iodixanolum",Launched,radiopaque medium,,radiology,contrast agent,iodixanol,
O=C(O)c1cc(/N=N/c2ccc(O)c(C(=O)O)c2)ccc1O,Olsalazine,Olsalazine,Launched,cyclooxygenase inhibitor,IFNG|TPMT,gastroenterology,ulcerative colitis,olsalazine,
COc1ccc2c(c1)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C(=O)C2(C)C,Gliquidone,Gliquidona; Gliquidone; Gliquidonum,Launched,sulfonylurea,ABCC8|KCNJ10|KCNJ8,endocrinology,diabetes mellitus,gliquidone,
C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,Ergometrine,"(6aR,9R)-7-Methyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid ((S)-2-hydroxy-1-methyl-ethyl)-amide; [8β(S)]-9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide; 9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8β(S)-carboxamide; 9,10-didehydro-N-(α-(hydroxymethyl)ethyl)-6-methylergoline-8-β-carboxamide; D-lysergic acid 1-hydroxymethylethylamide; D-lysergic acid-L-propanolamide; Ergobasine; Ergometrina; Ergométrine; Ergometrine; Ergometrinum; Ergonovine; Ergotocine; Margonovine; N-(2-Hydroxy-1-methylethyl)-D-(+)-lysergamide; N-(α-(hydroxymethyl)ethyl)-D-lysergamide",Launched,adrenergic receptor agonist|serotonin receptor agonist,ADRA1A|HTR1E,hematology,postpartum hemorrhage (PPH),ergonovine,
Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,Dasatinib,"Anh. dasatinib; Anhydrous dasatinib; BMS dasatinib; Dasatinib; Dasatinib (anh.); dasatinib (anhydrous); Dasatinib anhydrous; Dasatinibum; N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide",Launched,Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor|tyrosine kinase inhibitor,ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1,hematologic malignancy,chronic myeloid leukemia (CML)|acute lymphoblastic leukemia (ALL),dasatinib,
C=C[C@]1(C)C[C@@H](OC(=O)CS[C@H]2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,Retapamulin,Retapamulin; Retapamulina,Launched,protein synthesis inhibitor,,infectious disease,impetigo,retapamulin,
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,Lapatinib,Lapatinib; N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine,Launched,EGFR inhibitor,EGFR|ERBB2,oncology,breast cancer,lapatinib,
CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,Desonide,"11β,21-dihydroxy-16α,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione; 11β,21-dihydroxy-16α,17-isopropylidenedioxypregna-1,4-diene-3,20-dione; 11β,21-dihydroxy-16α,17α-isopropylidenedioxypregna-1,4-diene-3,20-dione; 16α-hydroxyprednisole-16,17-acetonide; 16α-hydroxyprednisolone-16α,17-acetonide; 16α,17α-isopropylidenedioxyprednisolone; Desfluorotriamcinolone acetonide; Desonida; Desonide; Desonidum",Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,gastroenterology,Crohn's disease,desonide,
N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Sitagliptin,Sitagliptin; Sitagliptina; Sitagliptine; Sitagliptinum,Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,sitagliptin,
Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,Decitabine,4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-s-triazin-2(1H)-one; 5-aza-2'-deoxycytidine; 5-azadeoxycytidine; DAC; Decitabina; Decitabine,Launched,DNA methyltransferase inhibitor,DNMT1|DNMT3A,hematologic malignancy|hematology,myelodysplastic diseases (MDS)|anemia|chronic myeloid leukemia (CML),decitabine,
CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O,Posaconazole,Posaconazole,Launched,sterol demethylase inhibitor,CYP3A4,infectious disease,oropharyngeal candidiasis,posaconazole,
CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,Darunavir,"(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester; {(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester; Darunavir; Darunavirum; N-((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide",Launched,HIV protease inhibitor,CYP3A4,infectious disease,human immunodeficiency virus (HIV-1),darunavir,
Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O,Telbivudine,1-(2-deoxy-β-L-ribofuranosyl)-5-methyluracil; 2'-Deoxy-L-thymidine; Beta-l-thymidine; Epavudine; L-deoxythymidine; L-DT; L-thymidine; LDT; Telbivudin; Telbivudina; Telbivudine; β-L-2'-deoxythymidine,Launched,DNA polymerase inhibitor,,infectious disease,hepatitis B,telbivudine,
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,Paliperidone,9-hydroxyrisperidone; Paliperidona; Paliperidone,Launched,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,neurology/psychiatry,schizophrenia,paliperidone,
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,Sunitinib,Sunitinib; Sunitinibum,Launched,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,CSF1R|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB|RET,oncology,gastrointestinal stromal tumors (GIST)|renal cell carcinoma (RCC)|neuroendocrine tumors of pancreatic origin (PNET),sunitinib,
c1cnc2cc3c(cc2n1)C1CNCC3C1,Varenicline,Vareniclina; Varenicline; Vareniclinum,Launched,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNA6|CHRNA7,neurology/psychiatry,smoking cessation,varenicline,
NNc1nncc2ccccc12,Hydralazine,(1Z)-1(2H)-Phthalazinone hydrazone; (2H)-Phthalazinone hydrazone; 1-Hydrazinophthalazine; 1-Phthalazinylhydrazine; 6-Hydralazine; Hidralazina; Hydralazin; Hydralazine; Hydralazinum; Hydrallazine; Hydrazinophthalazine; Hydrazone 1(2H)-phthalazinone; Hypophthalin; Idralazina; Phthalazin-1-ylhydrazine,Launched,vasodilator,,cardiology,hypertension,hydralazine,
COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,Nelarabine,2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine; Nelarabina; Nelarabine; Nelzarabine,Launched,DNA synthesis inhibitor|T cell inhibitor,POLA1,hematologic malignancy,acute lymphoblastic leukemia (ALL),nelarabine,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,Carbetocin,1-butanoic acid-2-(O-methyl-L-tyrosine)-1-carbaoxytocin; 1-butyric acid-2-(3-(p-methoxyphenyl)-L-alanine)oxytocin; Carbetocin; Carbetocina; Carbetocino; Carbetocinum; deamino-2-O-methyltyrosine-1-carbaoxytocin,Launched,oxytocin receptor agonist,OXTR,hematology,hemorrhage,carbetocin,
Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,Lumiracoxib,2-((2-chloro-6-fluorophenyl)amino)-5-methylbenzeneacetic acid; Lumiracoxib; Lumiracoxibum,Withdrawn,cyclooxygenase inhibitor,PTGS1|PTGS2,,,lumiracoxib,
CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1,Fenoterol,"1-(3,5-dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane; 1-(p-hydroxyphenyl)-2-((β-hydroxy-β-(3',5'-dihydroxyphenyl))ethyl)aminopropane; 3,5-dihydroxy-α-(((p-hydroxy-α-methylphenethyl)amino)methyl)benzyl alcohol; 5-{1-Hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol; Fenoterol; Fenoterolum; Phenoterol",Withdrawn,adrenergic receptor agonist,ADRB2,,,fenoterol,
N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,Glucosamine,2-amino-2-deoxy-D-glucose; Chitosamine; D-Glucosamine; Glucosamina; Glucosamine,Launched,glycosylated protein precursor,IL1B,neurology/psychiatry|rheumatology,muscle pain|rheumatoid arthritis|joint pain|backache,glucosamine,
CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1,Practolol,(±)-practolol; 1-(4-acetamidophenoxy)-3-isopropylamino-2-propanol; 4'-(2-hydroxy-3-(isopropylamino)propoxy)acetanilide; N-(4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)acetamide; Practolol; Practololo; Practololum; Praktololu,Withdrawn,adrenergic receptor antagonist,ADRB1,,,practolol,
COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC,Sulfadoxine,"4-Sulfanilamido-5,6-dimethoxypyrimidine; Sulfadoxina; Sulfadoxine; Sulfadoxinum; Sulforthomidine; Sulphadoxine; Sulphormethoxine",Launched,dihydropteroate synthase inhibitor,,infectious disease,malaria,sulfadoxine,
CN(C)[C@@H]1C(O)=C(C(=O)NCN2CCCC2)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,Rolitetracycline,N-(1-Pyrrolidinylmethyl)-tetracycline; N-(Pyrrolidinomethyl)tetracycline; Pyrrolidino-methyl-tetracycline; Rolitetraciclina; Rolitetracycline; Rolitetracyclinum,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,rolitetracycline,
CC(C)CN(C[C@@H](OP(=O)(O)O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,Fosamprenavir,FOS-APV; Fosamprenavir,Launched,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),fosamprenavir,
O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)(O)O,Fosphenytoin,(3-Phosphoryloxymethyl)phenytoin; Fosfenitoina; Fosphenytoin; Fosphenytoine; Fosphenytoinum,Launched,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures,phenytoin,
CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,Polythiazide,Polythiazide,Launched,sodium/chloride cotransporter inhibitor,SLC12A3,cardiology|gastroenterology|rheumatology|nephrology,edema|congestive heart failure|hepatic cirrhosis|nephrotic syndrome|acute glomerulonephritis (AGN)|chronic renal failure|hypertension,polythiazide,
CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,Quinethazone,Chinetazone; Quinetazona; Quinethazon; Quinethazone; Quinethazonum,Launched,thiazide diuretic,,cardiology,hypertension,quinethazone,
Cn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](O)c3ccccc3)[C@H]2SC1,Cefamandole,"(6R,7R)-7-(R)-Mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-carboxylic acid; (6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-((HYDROXYPHENYLACETYL)AMINO)-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-, (6R-(6.ALPHA.,7.BETA.(R*)))-; 7-D-MANDELAMIDO-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-3-CEPHEM-4-CARBOXYLIC ACID; Cefadole; Cefamandol; Céfamandole; Cefamandole; Cefamandolum; Cephadole; Cephamandole; COMPOUND 83405; L-Cefamandole",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections|urinary tract infections|respiratory tract infections,cefamandole,
Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,Cefazolin,"(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefamezin; Cefazolin; Cefazolina; Cefazoline; Cefazolinum; Cephamezine; Cephazolidin; Cephazolin; Cephazoline; CEZ",Launched,bacterial cell wall synthesis inhibitor,PON1,infectious disease,urinary tract infections|skin infections|bacterial septicemia|endocarditis|surgical prophylaxis|bone and joint infections,cefazolin,
O=C(O)C1=C(CSc2nnnn2CS(=O)(=O)O)CS[C@@H]2[C@H](NC(=O)[C@H](O)c3ccccc3)C(=O)N12,Cefonicid,"(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefonicid; Cefonicido; Cefonicidum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections,cefonicid,
CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O,Cefoperazone,"(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefoperazone; Cefoperazono; Cefoperazonum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,cefoperazone,
CO[C@@]1(NC(=O)C2SC(=C(C(N)=O)C(=O)O)S2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21,Cefotetan,"(6R,7S)-7-(4-(carbamoylcarboxymethylene)-1,3-dithiethane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5- yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid; Cefotetan; Cefotetanum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,urinary tract infections|respiratory tract infections|skin infections|gynecologic infections|chlamydia|intra-abdominal infections|bone and joint infections|surgical prophylaxis,cefotetan,
CO[C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@@H]21,Cefoxitin,"(6R,7S)-4-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(thiophen-2-enyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefoxitin; Cefoxitina; Cefoxitine; Cefoxitinum; Ceftoxitin; Cephoxitin; CFX; Rephoxitin",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,respiratory tract infections|urinary tract infections|intra-abdominal infections|gynecologic infections|bacterial septicemia|bone and joint infections|skin infections,cefoxitin,
CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CCC=CC3)[C@H]2SC1,Cefradine,"(6R,7R)-7-((R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-(D-2-Amino-2-(1,4-cyclohexadienyl)acetamide)desacetoxycephalosporanicacid; CED; Cefradina; Cefradine; Cefradinum; Cephradin; Cephradine",Launched,bacterial cell wall synthesis inhibitor,CYP3A4,infectious disease|otolaryngology,respiratory tract infections|otitis|skin infections|urinary tract infections|tonsillitis|pharyngitis|pneumonia,cefradine,
COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)[C@H]3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1[C@@H](C2)[N+](C)(C)CC3,Metocurine,"Dimethylchondrocurarine; O,O-Dimethylchondrocurarine",Launched,acetylcholine receptor antagonist,CHRM2|CHRNA2,neurology/psychiatry,muscle relaxant,metocurine,
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1[N+]1(C)CCCCC1,Pancuronium,Pancuronium,Launched,acetylcholine receptor antagonist,CHRM2|CHRM3|CHRNA1|CHRNA2,critical care|neurology/psychiatry,endotracheal intubation|muscle relaxant,pancuronium,
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H](N3CC[N+](C)(C)CC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CC[N+](C)(C)CC1,Pipecuronium,Pipecurium; Pipecuronium,Launched,neuromuscular blocker,CHRM2|CHRM3|CHRNA2,neurology/psychiatry,anesthetic,pipecuronium,
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1,Vecuronium,Vecuronio; Vecuronium cation,Launched,acetylcholine receptor antagonist,CHRNA2,neurology/psychiatry,muscle relaxant,vecuronium,
CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O,Cilazapril,Cilazapril; Cilazapril anhydrous; Cilazaprilum,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|congestive heart failure,cilazapril,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C,Mestranol,Mestranol,Launched,estrogen receptor agonist,ESR1,endocrinology,contraceptive,mestranol,
CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1,Penbutolol,(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol; Penbutolol; Penbutololum,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR1B,cardiology,hypertension,penbutolol,
CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I,Iohexol,"Iohexol; Iohexolum; N,N'-Bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6-triiodoisophthalamide",Launched,radiopaque medium,,radiology,contrast agent,iohexol,
CN[C@@H](C)[C@H](O)c1ccccc1,Ephedrine,"(-)-Ephedrine; (1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane; Efedrina; Ephedrine; L-Ephedrine; L-erythro-2-(Methylamino)-1-phenylpropan-1-ol; L(−)-ephedrine",Launched,adrenergic receptor agonist,ACHE|ADRA1A|ADRB2|SLC18A2|SLC6A2,cardiology|pulmonary|neurology/psychiatry|endocrinology,hypotension|asthma|narcolepsy|obesity,ephedrine,
CNC(C)(C)Cc1ccccc1,Mephentermine,Mefentermina; Mephentermine; Mephenterminum,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3,cardiology,hypotension,mephentermine,
CC[C@@H](NC(C)C)[C@@H](O)c1ccc(O)c2[nH]c(=O)ccc12,Procaterol,Procaterol; Procaterolo; Procaterolum,Launched,adrenergic receptor agonist,ADRB2,pulmonary,asthma,procaterol,
C#CCN[C@@H]1CCc2ccccc21,Rasagiline,(1R)-N-propargylindan-1-amine; (R)-indan-1-yl-prop-2-ynyl-amine; (R)-N-2-Propynyl-1-indanamine; RAS; Rasagilina; Rasagiline,Launched,monoamine oxidase inhibitor,BCL2|MAOB,neurology/psychiatry,Parkinson's Disease,rasagiline,
COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21,Yohimbine,"(+)-yohimbine; (16α,17α)-17-hydroxyyohimban-16-carboxylic acid methyl ester; 17α-hydroxyyohimban-16α-carboxylic acid methyl ester; Johimbin; Quebrachin; Yohimbic acid methyl ester; Yohimbin; Yohimbine; Yohimbinum",Launched,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8,cardiology,cardiac arrythmia|bradycardia,yohimbine,
CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O,Bezafibrate,2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid; Bezafibrate; Bezafibrato; Bezafibratum,Launched,PPAR receptor agonist,PPARA|PPARD|PPARG,cardiology,cholesterol,bezafibrate,
COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,Colchicine,Colchicin; Colchicina; Colchicine; Colchicinum,Launched,microtubule inhibitor,GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,rheumatology|endocrinology,gout|fever,colchicine,
C[C@]12CC[C@H]3[C@H]([C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1)[C@H]1C[C@H]1C1=CC(=O)CC[C@@]13C,Drospirenone,"1,2-Dihydrospirorenone; 6β,7β;15β,16β-Dimethylene-3-oxo-17α-pregn-4-ene-21,17-carbolactone; Dehydrospirorenone; Drospirenona; Drospirenone; Drospirénone; Drospirenonum; DRSP",Launched,mineralocorticoid receptor antagonist,AR|NR3C2|PGR,endocrinology,contraceptive,drospirenone,
C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,Digitoxin,Digitoksin; Digitoxin; Digitoxina; Digitoxine; Digitoxinum; Digitoxoside,Launched,ATPase inhibitor,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2,cardiology,congestive heart failure|cardiac arrythmia,digitoxin,
O=C(Oc1ccccc1C(=O)O)c1ccccc1O,Salsalate,2-Carboxyphenyl salicylate; Disalicylic acid; Disalicylsäure; O-Salicylcylsalicylsäure; o-Salicylsalicylic acid; Salicylic acid bimolecular ester; Salicyloxysalicylic acid; Salicyloylsalicylic acid; Salicylsalicylic acid; Salsalate; Salsalato; Salsalatum; Sasapyrin; Sasapyrine; Sasapyrinum,Launched,NFkB pathway inhibitor,PTGS1|PTGS2,rheumatology,osteoarthritis|rheumatoid arthritis,sasapyrine,
CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,Neostigmine,"(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate; 3-Trimethylammoniumphenyl N,N-dimethylcarbamate; Eustigmin; Eustigmine; m-Trimethylammoniumphenyldimethylcarbamate; Neostigmina",Launched,acetylcholinesterase inhibitor,ACHE,neurology/psychiatry,myasthenia gravis,neostigmine,
COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2,Methotrimeprazine,"(-)-(2R)-3-(2-methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine; (-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine; 2-Methoxytrimeprazine; Levomepromazina; Lévomépromazine; Levomepromazine; Levomepromazinum; Methotrimeprazine",Launched,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR2A|HTR2C,neurology/psychiatry|gastroenterology,psychosis|schizophrenia|bipolar disorder|nausea|insomnia,levomepromazine,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,Danazol,Danazol; Danazolum,Launched,estrogen receptor antagonist|progesterone receptor agonist,AR|CCL2|ESR1|GNRHR|GNRHR2|PGR,obstetrics/gynecology|cardiology,endometriosis|angioedema,danazol,
CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1,Clenbuterol,"(±)-clenbuterol; 1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol; 4-amino-3,5-dichloro-α-(((1,1-dimethylethyl)amino)methyl)benzenemethanol; 4-amino-α-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol; Clenbutérol; Clenbuterol; Clenbuterolum",Launched,adrenergic receptor agonist,ABCC8|ADRB2|KCNJ11,pulmonary,chronic obstructive pulmonary disease (COPD)|asthma,clenbuterol,
C[N+]1(C)[C@H]2C[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@@H]1[C@H]1O[C@@H]21,Tiotropium,,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,pulmonary,chronic obstructive pulmonary disease (COPD)|bronchitis|emphysema,tiotropium,
CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C,Ciclesonide,Ciclesonida; Ciclesonide,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,allergy,allergic rhinitis,ciclesonide,
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1,Cefepime,"(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Cefepima; Cefepime; Cefepimum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,pneumonia|urinary tract infections|skin infections|intra-abdominal infections,cefepime,
Nc1nc(/C(=C/CC(=O)O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=CCS[C@H]23)cs1,Ceftibuten,"(+)-(6R,7R)-7-((Z)-2-(2-amino-4-thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; Ceftibuten; Ceftibutene; Ceftibuteno; Ceftibutenum; cis-ceftibuten",Launched,bacterial cell wall synthesis inhibitor,,pulmonary|otolaryngology,bronchitis|otitis|pharyngitis|tonsillitis,ceftibuten,
COCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OC)c3csc(N)n3)[C@H]2SC1,Cefpodoxime,Cefpodoxima; Cefpodoxime; Cefpodoximum,Launched,bacterial cell wall synthesis inhibitor,,otolaryngology|infectious disease|pulmonary,pharyngitis|pneumonia|bronchitis|gonorrhea|skin infections|urinary tract infections|sinusitis|tonsillitis,cefpodoxime,
CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O,Acenocoumarol,3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin; 3-(alpha-(p-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin; 3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin; 3-(alpha-Acetonyl-p-nitrobenzyl)-4-hydroxycoumarin; 3-(alpha-p-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin; 4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one; 4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one; Acenocoumarin; Acénocoumarol; Acenocoumarol; Acenocoumarolum; Acenocumarol; Acenocumarolo; Acenokumarin; Nicoumalone; Nicumalon; Nitrophenylacetylethyl-4-hydroxycoumarine; Nitrovarfarian; Nitrowarfarin,Launched,vitamin K antagonist,VKORC1,hematology,deep vein thrombosis (DVT),acenocoumarol,
NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,Paromomycin,"(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside; Aminosidin; Aminosidine; Catenulin; Crestomycin; Estomycin; Hydroxymycin; Monomycin A; Neomycin E; Paromomicina; Paromomycin; Paromomycin I; Paromomycine; Paromomycinum; Paucimycin; Paucimycinum; Zygomycin A1",Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,amebiasis,paromomycin,
Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C,Aminophenazone,"(Dimethylamino)phenazone; 1-Phenyl-2,3-dimethyl-4-(dimethylamino)-5-pyrazolone; 1-Phenyl-2,3-dimethyl-4-dimethylaminopyrazol-5-one; 1,5-Dimethyl-4-dimethylamino-2-phenyl-3-pyrazolone; 2,3-Dimethyl-4-dimethylamino-1-phenyl-5-pyrazolone; 3-Keto-1,5-dimethyl-4-dimethylamino-2-phenyl-2,3-dihydropyrazole; 4-(Dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one; 4-(Dimethylamino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one; 4-(Dimethylamino)antipyrine; 4-Dimethylamino-1-phenyl-2,3-dimethylpyrazolone; 4-Dimethylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one; 4-Dimethylamino-2,3-dimethyl-1-phenyl-5-pyrazolone; 4-Dimethylaminoantipyrine; 4-Dimethylaminophenazone; Aminofenazona; Aminofenazone; Aminophenazon; Aminophenazone; Aminophenazonum; Aminopyrine; Dimethylaminoantipyrine; Dimethylaminoazophene; Dimethylaminophenazon; Dimethylaminophenazone; Dimethylaminophenyldimethylpyrazolone; Dipyrine",Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief,phenazone,
CC[C@H]1[C@@H]2C[C@H]3[C@@H]4N(C)c5ccccc5[C@]45C[C@@H](C2[C@H]5O)N3[C@@H]1O,Ajmaline,"(+)-Ajmaline; (5aR,6S,8S,10S,11S,11aS,12aR,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol; Ajmalin; Ajmaline",Launched,sodium channel blocker,,cardiology,Wolff-Parkinson-White Syndrome (WPW),ajmaline,
Nc1cc(-c2ccncc2)c[nH]c1=O,Amrinone,Amrinona; Amrinone; Amrinonum; Inamrinone,Launched,phosphodiesterase inhibitor,PDE3A|PDE3B|PDE4B|TNF,cardiology,congestive heart failure,amrinone,
COc1ccc(C(=O)c2ccccc2)c(O)c1,Oxybenzone,2-Benzoyl-5-methoxyphenol; 2-Hydroxy-4-methoxybenzophenone; 4-Methoxy-2-hydroxybenzophenone; Benzophenone-3; Oxibenzona; Oxybenzone; Oxybenzonum,Launched,lipase inhibitor,LIPE,dermatology,sunscreen lotion,oxybenzone,
C=CCNc1nc(NCC=C)nc(N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)n1,Almitrine,"2,4-Bis(allylamino)-6-(4-(bis(p-fluorophenyl)methyl)-1-piperazinyl)-s-triazine; Almitrina; Almitrine; Almitrinum",Launched,neurotransmitter agonist,ATP1A1,pulmonary,chronic obstructive pulmonary disease (COPD),almitrine,
Cc1cc(=O)n(-c2ccccc2)n1C,Antipyrine,"1,2-Dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one; 2,3-Dimethyl-1-phenyl-5-pyrazolone; Analgesine; Antipyrine; Fenazon; Fenazona; Phenazon; Phenazone",Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief,phenazone,
C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O,Alfacalcidol,"(5Z,7E)-9,10-seco-5,7,10(19)-cholestatrien-1α,3β-diol; 1-hydroxycholecalciferol; 1alpha-hydroxycholecalciferol; 1α-hydroxy-vitamin D3; 1α-hydroxycholecalciferol; 1α-hydroxyvitamin D3; 9,10-secocholesta-5,7,10(19)-triene-1α,3β-diol; Alfacalcidol; Alfacalcidolum",Launched,vitamin D receptor agonist,CYP27B1|VDR,endocrinology,vitamin D deficiency,alfacalcidol,
Nc1ccc(/N=N/c2ccccc2)c(N)n1,Phenazopyridine,"2,6-Diamino-3-(phenylazo)pyridine; 2,6-Diamino-3-phenylazopyridine; 3-(Phenylazo)-2,6-pyridinediamine; Fenazopiridina; Phenazopyridine; Phénazopyridine; Phenazopyridinum",Launched,local anesthetic,SCN1A,infectious disease,urinary tract infections,phenazopyridine,
C=CCOc1ccccc1OCC(O)CNC(C)C,Oxprenolol,Oxprenolol; Oxprenololum,Launched,adrenergic receptor antagonist,ADRB1,cardiology,angina pectoris|hypertension|cardiac arrythmia,oxprenolol,
Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1,Sulfamerazine,(p-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin; 2-(4-Aminobenzenesulfonamido)-4-methylpyrimidine; 2-(p-Aminobenzolsulfonamido)-4-methylpyrimidine; 2-(Sulfanilamido)-4-methylpyrimidine; 2-Sulfa-4-methylpyrimidine; 4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide; N-(4-Methyl-2-pyrimidyl)sulfanilamide; N(1)-(4-Methyl-2-pyrimidinyl)sulfanilamide; Sulfamerazina; Sulfamerazine; Sulfamerazinum; Sulfamethyldiazine; Sulphamerazine,Launched,bacterial antifolate,,infectious disease,coccidiosis|cholera,sulfamerazine,
Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1,Sulfamethazine,"(p-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin; 2-(4-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine; 2-(p-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine; 2-Sulfanilamido-4,6-dimethylpyrimidine; 4-Amino-N-(2,6-dimethyl-4-pyrimidinyl)benzenesulfonamide; 4-Amino-N-(4,6-dimethyl-pyrimidin-2-yl)-benzenesulfonamide; 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide; 4,6-Dimethyl-2-sulfanilamidopyrimidine; 6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin; N-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide; N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide; N(1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide; SMZ; Sulfadimethyldiazine; Sulfadimethylpyrimidine; Sulfadimidina; Sulfadimidine; Sulfadimidinum; Sulfametazina; Sulfametazyny; Sulfamethazine; Sulfamezathine; Sulphadimethylpyrimidine; Sulphamethazine",Launched,PABA antagonist,,gastroenterology,enteritis,sulfamethazine,
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,Ursodeoxycholic acid,"(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid; (3α,5β,7β)-3,7-dihydroxycholan-24-oic acid; 3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid; Acide ursodesoxycholique; Acido ursodeossicolico; Acido ursodeoxicolico; Acidum ursodeoxycholicum; UDCA; Ursodeoxycholate; Ursodeoxycholic acid; Ursodiol",Launched,nuclear factor erythroid derived|like (NRF2) activator,AKR1C2|NR1H4,gastroenterology,gallstones,ursodiol,
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,Everolimus,40-O-(2-hydroxyethyl)-rapamycin; 42-O-(2-Hydroxyethyl)rapamycin; évérolimus; Everolimus,Launched,mTOR inhibitor,MTOR,oncology|neurology/psychiatry|genetics|urology,breast cancer|neuroendocrine tumors of pancreatic origin (PNET)|renal cell carcinoma (RCC)|subependymal giant cell astrocytoma (SEGA)|tuberous sclerosis complex (TSC)|renal angiomyolipoma,everolimus,
CC1(C)C[C@@H]1C(=O)N/C(=C\CCCCSC[C@H](N)C(=O)O)C(=O)O,Cilastatin,"(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid; (Z)-(S)-6-carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine; (Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid; Cilastatin; Cilastatina; Cilastatine; Cilastatinum",Launched,dehydropeptidase inhibitor,DPEP1,,,cilastatin,
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCC/N=C/N)C[C@H]12,Imipenem,"(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid; (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid; (5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure; Imipenem; Imipenem anhydrous; Imipenemum; N-formimidoyl thienamycin; N-formimidoylthienamycin",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,pneumonia|urinary tract infections|intra-abdominal infections|gynecologic infections|bacterial septicemia|bone and joint infections|skin infections|endocarditis,imipenem,
CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1,Probucol,"4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol); Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole; Biphenabid; Bisbid; Bisphenabid; Probucol; Probucolum",Launched,atherogenesis inhibitor,ABCA1|ABCB11|CES1,cardiology,coronary artery disease (CAD),probucol,
Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,Lopinavir,Lopinavir,Launched,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),lopinavir,
CCOC(=O)OC(C)OC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C,Bacampicillin,"1-[(ethoxycarbonyl)oxy]ethyl (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; 1'-ethoxycarbonyloxyethyl-(6-D-α-aminophenylacetamido)penicillanate; Bacampicilina; Bacampicillin; Bacampicilline; Bacampicillinum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections|gram-negative bacterial infections,bacampicillin,
COc1cccc(OC)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,Meticillin,"(2,6-Dimethoxyphenyl)penicillin; (2S,5R,6R)-6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6-(2,6-Dimethoxybenzamido)penicillanic acid; 6β-(2,6-dimethoxybenzamido)penicillanic acid; Methicillin; Methicillinum; Methycillin; Meticilina; Meticillin; Meticillina; Meticilline; Meticillinum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,methicillin,
CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C,Pivampicillin,Ampicillin pivaloyloxymethyl ester; Pivaloylampicillin; Pivaloyloxymethyl ampicillinate; Pivampicilina; Pivampicillin; Pivampicilline; Pivampicillinum,Launched,bacterial cell wall synthesis inhibitor,,pulmonary|infectious disease,bronchitis|pneumonia|gynecologic infections,pivampicillin,
CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](N=CN3CCCCCC3)[C@H]2SC1(C)C,Pivmecillinam,"Amdinocillin pivoxil; amdinocillin, pivaloyloxymethyl ester; Pivmecilinamo; Pivmecillinam; Pivmecillinamum",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,urinary tract infections|gram-negative bacterial infections,pivmecillinam,
C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O,Tazobactam,Tazobactam; Tazobactamum,Launched,beta lactamase inhibitor,,infectious disease,pneumonia,tazobactam,
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(=O)O)c3ccsc3)C(=O)N2[C@H]1C(=O)O,Ticarcillin,"(2S,5R,6R)-6-{[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Ticarcilina; Ticarcillin; Ticarcilline; Ticarcillinum; α-carboxy-3-thienylmethylpenicillin",Launched,lactamase inhibitor,,infectious disease,gram-negative bacterial infections,ticarcillin,
O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1,Deferasirox,Deferasirox; Deferasiroxum,Launched,chelating agent,CYP3A4,hematology,transfusional hemosiderosis|thalassemia|iron overload,deferasirox,
CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)nc(N)[nH]c21,Valganciclovir,Valganciclovir,Launched,DNA synthesis inhibitor,,infectious disease,cytomegalovirus (CMV),valganciclovir,
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,Hydroxychloroquine,(±)-hydroxychloroquine; 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol; 2-(N-(4-(7-chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol; 7-chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline; 7-chloro-4-(4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino)quinoline; 7-chloro-4-[4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino]quinoline; 7-chloro-4-[5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline; Hidroxicloroquina; Hydroxychloroquine; Hydroxychloroquinum; Oxichlorochine; Oxichloroquine,Launched,antimalarial agent,TLR7|TLR9,infectious disease,malaria,hydroxychloroquine,
CCN(CCCc1ccccc1)CCCc1ccccc1,Alverine,"Alverina; Alverine; Alverinum; Bis(gamma-phenylpropyl)ethylamine; Di(phenylpropyl)ethylamine; N-Ethyl-3-phenyl-N-(3-phenylpropyl)-1-propanamine; N-Ethyl-3,3'-diphenyldipropylamine; N-Ethyl-N-(3-phenylpropyl)benzenepropanamine; N,N-Bis(3-phenylpropyl)ethylamine; Phenopropamine; Phenpropamine",Launched,muscle relaxant,HTR1A,gastroenterology,irritable bowel syndrome|diverticular disease,alverine,
CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,Molindone,(+/-)-molindone; Molindona; Molindone; Molindonum,Launched,dopamine receptor antagonist,DRD2|HRH1|HTR2A,neurology/psychiatry,schizophrenia,molindone,
CN1CCC2=C(C1)C(c1ccccc1)c1ccccc12,Phenindamine,Fenindamina; Phenindamine; Phenindaminum; Thephorin,Launched,histamine receptor antagonist,HRH1,allergy|otolaryngology,allergic rhinitis|common cold,phenindamine,
CN(C)CCC(c1ccccc1)c1ccccn1,Pheniramine,Feniramina; Pheniramine; Pheniraminum,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis|urticaria,pheniramine,
CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,Pipotiazine,Piportil; Pipothiazine; Pipotiazina; Pipotiazine; Pipotiazinum,Launched,dopamine receptor antagonist,DRD1|DRD2|HTR1A|HTR2A,neurology/psychiatry,schizophrenia,pipotiazine,
CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,Thiothixene,cis-thiothixene; Thiothixene; Tiotixene; Tiotixeno; Tiotixenum,Launched,dopamine receptor antagonist,DRD1|DRD2|HRH1|HTR2A,neurology/psychiatry,schizophrenia,thiothixene,
OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1,Zuclopenthixol,(Z)-4-(3-(2-Chlorothioxanthen-9-ylidene)propyl)-1-piperazineethanol; Zuclopenthixol; Zuclopenthixolum; Zuclopentixol,Launched,dopamine receptor antagonist,ADRA1A|ADRA2A|DRD1|DRD2|DRD5|HRH1|HTR2A,neurology/psychiatry,schizophrenia|bipolar disorder,zuclopenthixol,
C#CCN(C)Cc1ccccc1,Pargyline,Pargilina; Pargyline; Pargylinum,Launched,monoamine oxidase inhibitor,MAOA|MAOB,cardiology,hypertension,pargyline,
CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1,Lincomycin,Cillimycin; LCM; Lincomicina; Lincomycin; Lincomycine; Lincomycinum,Launched,bacterial 30S ribosomal subunit inhibitor,,gastroenterology,enteritis,lincomycin,
Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,Etoricoxib,"5-chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine; 5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl; 5-chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine; Etoricoxib; étoricoxib; Etoricoxibum",Launched,cyclooxygenase inhibitor,PTGS2,rheumatology,rheumatoid arthritis|psoriatic arthritis|osteoarthritis|gout|ankylosing spondylitis,etoricoxib,
OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,Sorbitol,(−)-sorbitol; D-(−)-sorbitol; D-glucitol; D-Sorbit; D-Sorbitol; G-ol; L-Gulitol; Sorbitol,Launched,mucolytic agent,,gastroenterology,constipation,sorbitol,
O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,Roflumilast,Roflumilast; Roflumilastum,Launched,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,pulmonary,chronic obstructive pulmonary disease (COPD)|bronchitis,roflumilast,
C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,Rutin,"3-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one; 3-Rhamnoglucosylquercetin; 3-Rutinosyl quercetin; Phytomelin; Quercetin 3-rutinoside; Quercetin-3-rutinoside; Rutin; Rutoside; Rutosido; Rutosidum; Sophorin; Vitamin P",Launched,antioxidant|capillary stabilizing agent|nitric oxide scavenger,AKR1C3,rheumatology|otolaryngology|gastroenterology|neurology/psychiatry|allergy,joint pain|nasal congestion|constipation|irritability|allergic rhinitis,rutin,
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CCC2=O,Prasterone,3-beta-hydroxy-5-androsten-17-one; 3beta-hydroxyandrost-5-en-17-one; 3β-hydroxyandrost-5-en-17-one; Dehydroandrosterone; Dehydroepiandrosterone; Dehydroisoandrosterone; DHEA; Prasterone,Launched,protein synthesis stimulant,ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1,endocrinology,menopause,dehydroepiandrosterone,
CCCCCCCCCCCCCCCC[N+](C)(C)C,Cetrimonium,"Cetrimonium cation; Cetrimonium ion; Cetyl-Trimethyl-Ammonium; Cetyltrimethylammonium; Cetyltrimethylammonium cation; Cetyltrimethylammonium ion; Hexadecyltrimethylammonium; Hexadecyltrimethylammonium cation; Hexadecyltrimethylammonium ion; N,N,N-Trimethyl-1-hexadecanaminium; Trimethylhexadecylammonium",Launched,,,dermatology,cosmetic,cetrimonium,
CCN(CC)CCS(=O)(=O)[C@@H]1CCN2C(=O)c3coc(n3)CC(=O)C[C@H](O)/C=C(C)/C=C/CNC(=O)/C=C/[C@@H](C)[C@@H](C(C)C)OC(=O)[C@@H]12,Dalfopristin,Dalfopristin; Dalfopristina; Dalfopristine; Dalfopristinum,Preclinical,antibacterial,,,,dalfopristin,
NCCS(=O)(=O)O,Taurine,Aminoethylsulfonic acid; Taurine; Taurineold,Launched,antioxidant,,neurology/psychiatry,anxiety|irritability|sleeplessness,taurine,
C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@@H](O)C2CC2)C[C@@H](O)C[C@@H]1O,Calcipotriol,Calcipotriene; Calcipotriol,Launched,vitamin D receptor agonist,VDR,dermatology,psoriasis,calcipotriol,
Cc1ccc(C(C)C)c(O)c1,Thymol,2-isopropyl-5-methylphenol; 5-Methyl-2-(1-Methylethyl)Phenol; IPMP,Launched,GABA receptor positive allosteric modulator,TRPA1,infectious disease,ringworm|antiseptic,thymol,
O=C(CCCCCCC(=O)Nc1ccccc1)NO,Vorinostat,Octanedioic acid hydroxyamide phenylamide; SAHA; SHH; Suberanilohydroxamic acid; Suberoylanilide hydroxamic acid; Vorinostat; Vorinostatum,Launched,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC5|HDAC6|HDAC8|HDAC9,hematologic malignancy,cutaneous T-cell lymphoma (CTCL),vorinostat,
NC(=O)c1cccnc1,Nicotinamide,3-pyridinecarboxamide; Niacinamide; Nicotinamida; Nicotinamide; Nicotinamidum; Nicotinic acid amide; Nicotinic amide; β-pyridinecarboxamide,Launched,protein synthesis stimulant,BST1|LDHA|PARP1|SIRT5,dermatology,acne vulgaris (AV),nicotinamide,
OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,Sucrose,1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside; Beet sugar; Cane sugar; Sacarosa; Saccharose; Sacharose; Sucraloxum; Sucrose; Table sugar; White sugar,Launched,,ACTA1|ATOX1|C22orf28|LYZ,,,sucrose,
CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,Pregnenolone,Pregnenolone,Launched,glutamate receptor modulator,SULT2B1,rheumatology,rheumatoid arthritis,pregnenolone,
CSCC[C@@H](N)C(=O)O,D-Methionine,,Launched,voltage-gated calcium channel ligand,BHMT|BHMT2|METAP2|MTR|MTRR,pulmonary|allergy|neurology/psychiatry,asthma|allergic rhinitis|depression|Parkinson's Disease|schizophrenia,L-methionine,
NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1,Piretanide,Piretanida; Piretanide,Launched,glucocorticoid receptor agonist,SLC12A1|SLC12A2,cardiology,hypertension|edema,piretanide,
N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O,Oxitriptan,5-hydroxy-L-tryptophan; 5-hydroxytryptophan L-form; L-5 Hydroxytrytophan; L-5-HTP; L-5-hydroxytryptophan; Oxitriptan; Oxitriptano; Oxitriptanum,Launched,neurotransmitter,SLC36A1|SLC36A2,neurology/psychiatry,insomnia,5-hydroxytryptophan,
CC(=O)OCC[N+](C)(C)C,Acetylcholine,Acetylcholine; ACh; Choline acetate; O-Acetylcholine,Launched,acetylcholine receptor agonist,ACHE|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,neurology/psychiatry|gastroenterology|pulmonary,drowsiness|fatigue|headache|indigestion|chest congestion,acetylcholine,
Oc1ccccc1,Phenol,Acide carbolique; Acide phénique; Benzenol; Carbolic acid; Carbolsäure; Fenol; Hydroxybenzene; Karbolsäure; Monohydroxybenzene; Oxybenzene; Phenic Acid; Phenol; Phenyl alcohol; Phenyl hydroxide; Phenylic acid; Phenylic alcohol; PHOH,Preclinical,,CA1|CA12|CA14|CA2|CA4|CA9,otolaryngology,pharyngitis,phenol,
O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1/C=C/Br,Brivudine,(E)-5-(2-Bromovinyl)-deoxyuridine; Brivudina; Brivudine; Brivudinum; BVdU,Launched,DNA directed DNA polymerase inhibitor,,infectious disease,shingles,brivudine,
CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O,Oxyphenbutazone,Oxifenbutazona; Oxiphenbutazone; Oxyphenbutazone; Oxyphenbutazonum,Withdrawn,cyclooxygenase inhibitor,,,,oxyphenbutazone,
CC1=C2[N+]3=C(C=C4[N+]5=C(C(C)=C6N7[C@@H]8[C@H](CC(N)=O)[C@@]6(C)CCC(=O)NC[C@@H](C)OP(=O)([O-])O[C@@H]6[C@@H](CO)O[C@@H]([C@@H]6O)n6c[n+](c9cc(C)c(C)cc96)[Co-3]753(C)[N+]3=C1[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@]83C)[C@@H](CCC(N)=O)C4(C)C)[C@@H](CCC(N)=O)[C@]2(C)CC(N)=O,Mecobalamin,Co-methylcobalamin; MeCbl; Mecobalamin; Mecobalamina; Mecobalaminum; Methyl vitamin B12; Methyl(III)cobalamin; Methylcobalamin,Phase 3,vitamin B,,,,methylcobalamin,
NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,Ribostamycin,Ribostamicina; Ribostamycin; Ribostamycin A; Ribostamycine; Ribostamycinum; Vistamycin,Launched,bacterial 30S ribosomal subunit inhibitor,P4HB,infectious disease,human immunodeficiency virus (HIV-1),ribostamycin,
NC(CO)(CO)CO,Tromethamine,"1,1,1-tris(hydroxymethyl)methanamine; 2-Amino-2-(hydroxymethyl)-1,3-propanediol; aminotris(hydroxymethyl)methane; THAM; Tris; Tris(hydroxymethyl)aminomethane; Trometamol; Tromethamine",Launched,,AMD1|CANT1|DCN|NEIL1|VEGFA,,,trometamol,
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,Doconexent,"(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid; 22:6-4, 7,10,13,16,19; 22:6(n-3); 4,7,10,13,16,19-docosahexaenoic acid; all-cis-4,7,10,13,16,19-docosahexaenoic acid; all-cis-DHA; cervonic acid; DHA; Doconexent; docosa-4,7,10,13,16,19-hexaenoic acid; Docosahexaenoic acid; Docosahexanoic Acid",Launched,PPAR receptor agonist,FFAR1|PTGS1|PTGS2,,,doconexent,
NC(N)=O,Urea,Carbamide; Carbonyldiamide; Harnstoff; Karbamid; Urea; Urée,Launched,hydroxy radical formation stimulant,ARG1|CA2|CTNNB1,dermatology,psoriasis|xerosis cutis|ichthyosis vulgaris|eczema|keratosis|dermatitis,urea,
N[C@H](CO)C(=O)O,D-Serine,,Launched,glutamate receptor agonist,GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3,,,D-serine,
CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,Ergosterol,"(22E,24S)-24-methylcholesta-5,7,22-trien-3β-ol; Provitamin D2",Preclinical,vitamin D precursor,,,,ergosterol,
COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2,Berberine,,Launched,LDL receptor activator,LDLR,,,berberine,
Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21,Dequalinium,"1,1'-(1,10-Decanediyl)bis(4-amino-2-methylquinolinium) dichloride; 1,1'-Decamethylenebis(4-aminoquinaldinium chloride); Decamethylenebis(4-aminoquinaldinium chloride)",Launched,PKC inhibitor,KCNN1|KCNN3,infectious disease,first-aid antiseptic,dequalinium,
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,Cholesterol,"(3β,14β,17α)-cholest-5-en-3-ol; Cholest-5-en-3beta-ol; Cholesterin; Cholesterol",Preclinical,,RORA,,,cholesterol,
O=C1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,Gluconolactone,"1,5-D-gluconolactone; 1,5-Gluconolactone; D-gluconic acid delta-lactone; D-glucono-1,5-lactone; D-threo-Aldono-1,5-lactone; delta-gluconolactone; GDL; Gluconic acid lactone; Glucono delta-lactone; Glucono-delta-lactone; Gluconolactone",Launched,,LCT,,,gluconolactone,
CO[C@@]1(NC(=O)C(C(=O)O)c2ccc(O)cc2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CO[C@@H]21,Latamoxef,Festamoxin; Lamoxactam; Latamoxef; Latamoxefum; Moxalactam,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections|gram-negative bacterial infections|skin infections|bone and joint infections|pneumonia|urinary tract infections|meningitis,moxalactam,
Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1,Trioxsalen,"2',4,8-Trimethylpsoralen; 4,5',8-Trimethylpsoralen; 4,8,5'-Trimethylpsoralen; 6-hydroxy-β,2,7-trimethyl-5-benzofuranacrylic acid, δ-lactone; Trimethylpsoralen; Trioxisaleno; Trioxsalen; Trioxysalen; Trioxysalene; Trioxysalenum; Trisoralen",Launched,DNA synthesis inhibitor,,dermatology,vitiligo|eczema,trioxsalen,
S=P(N1CC1)(N1CC1)N1CC1,Thiotepa,Thiotepa,Launched,cytochrome P450 inhibitor,CYP2B6|CYP3A4,oncology,breast cancer|ovarian cancer|bladder cancer,thiotepa,
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O,Estriol,"(16α,17β)-estra-1,3,5(10)-triene-3,16,17-triol; 1,3,5(10)-Estratriene-3,16-alpha,17beta-triol; 16-alpha-Hydroxyestradiol; 16alpha-hydroxyestradiol; 16α-hydroxyestradiol; 16α,17β-estriol; 3,16alpha,17beta-Trihydroxy-delta(1,3,5)-estratriene; Estriol; Oestriol; Östriol; Trihydroxyestrin",Launched,estrogen receptor agonist,ESR1|ESR2,endocrinology|obstetrics/gynecology|infectious disease,menopause|vaginal atrophy|urinary tract infections,estriol,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC5CCCC5)ccc4[C@H]3CC[C@@]21C,Quinestrol,17-alpha-Ethinylestradiol 3-cyclopentyl ether; 17alpha-Ethynylestradiol 3-cyclopentyl ether; Estradiol-17-beta 3-cyclopentyl ether; Quinestrol; Quinestrolo; Quinestrolum,Launched,estrogen receptor agonist,ESR1|ESR2,endocrinology,menopause,quinestrol,
COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O,Hesperidin,(S)-(−)-hesperidin; Cirantin; Ciratin; Hesperetin 7-O-rutinoside; Hesperidin; Hesperidina; Hesperidoside,Launched,flavanone glycoside,AURKB|CACNA1B,,,hesperidin,
O=C(CCCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I,Iodipamide,"3,3'-(adipoyldiimino)bis(2,4,6-triiodobenzoic acid); Adipiodona; Adipiodone; Adipiodonum; Iodipamide",Launched,radiopaque medium,ALB,radiology,contrast agent,iodipamide,
CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1,Nimesulide,Nimesulida; Nimesulide; Nimesulidum,Launched,cyclooxygenase inhibitor,LTF|PLA2G2E|PTGS1|PTGS2,rheumatology|obstetrics/gynecology,osteoarthritis|menstrual pain,nimesulide,
c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1,Bifonazole,"(+-)-1-(p,alpha-Diphenylbenzyl)imidazole; 1-((4-Biphenylyl)phenylmethyl)-1H-imidazole; 1-(alpha-(4-Biphenylyl)benzyl)imidazole; 1-(p,alpha-Diphenylbenzyl)imidazole; 1-[biphenyl-4-yl(phenyl)methyl]imidazole; Bifonazol; Bifonazole; Bifonazolum",Launched,sterol demethylase inhibitor,,infectious disease,tinea pedis|tinea cruris,bifonazole,
Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O,Bithionol,"2-Hydroxy-3,5-dichlorophenyl sulfide; 2-Hydroxy-3,5-dichlorophenyl sulphide; 2,2'-Dihydroxy-3,3',5,5'-tetrachlorodiphenyl sulfide; 2,2'-Dihydroxy-3,3',5,5'-tetrachlorodiphenylsulfide; 2,2'-sulfanediylbis(4,6-dichlorophenol); 2,2'-Thiobis(4,6-dichlorophenol); Bis(3,5-dichloro-2-hydroxyphenyl) sulfide; Bithionol; Bithionol sulfide; Bithionolate; Bithionolum; Bitionol",Withdrawn,autotaxin inhibitor,ESR1|ESR2|MCL1,,,bithionol,
Oc1c(I)cc(Cl)c2cccnc12,Clioquinol,5-Chlor-7-jod-8-hydroxy-chinolin; 5-Chloro-7-iodo-8-hydroxyquinoline; 5-Chloro-7-iodo-8-quinolinol; 5-chloro-7-iodoquinolin-8-ol; 5-Chloro-8-hydroxy-7-iodoquinoline; 7-Iodo-5-chloro-8-hydroxyquinoline; 7-Iodo-5-chloroxine; Chloroiodoquin; Clioquinol; Clioquinolum; Iodochlorhydroxyquin; Iodochlorhydroxyquinoline; Iodochlorohydroxyquin; Iodochloroxyquinoline,Withdrawn,chelating agent,OPRK1,,,clioquinol,
O=C1c2cccc(O)c2C(=O)c2c(O)cccc21,Dantron,"1,8-dihydroxy-9,10-anthracenedione; 1,8-dihydroxy-9,10-anthraquinone; 1,8-dihydroxyanthra-9,10-quinone; 1,8-Dihydroxyanthrachinon; 1,8-Dihydroxyanthraquinone; Chrysazin; Danthron; Dantron; Dantrona; Dantrone; Dantronum",Withdrawn,laxative,,,,dantron,
Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C,Metamizole,Dipyrone; Metamizol,Withdrawn,cyclooxygenase inhibitor|opioid receptor agonist,PTGS1,,,metamizole,
O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,Nialamide,"1-(2-(Benzylcarbamoyl)ethyl)-2-isonicotinoylhydrazine; 2-(2-(Benzylcarbamoyl)ethyl)hydrazide isonicotinic acid; 2-(2-(Benzylcarbamyl)ethyl)hydrazide isonicotinic acid; BEIH; Isonicotinic acid 2-((2-benzylcarbamoyl)ethyl)hydrazide; Isonicotinic acid, 2-(2-(benzylcarbamoyl)ethyl)hydrazide; N-(2-(Benzylcarbamyl)ethylamino)isonicotinamide; N-benzyl-beta-(isonicotinoylhydrazine)propionamide; N-benzyl-beta-(isonicotinylhydrazino)propionamide; N-Isonicotinoyl-N'(beta-N-benzylcarboxamidoethyl)hydrazine; Nialamida; Nialamide; Nialamidum",Withdrawn,monoamine oxidase inhibitor,COMT|MAOA|MAOB,,,nialamide,
CN1Cc2c(N)cccc2C(c2ccccc2)C1,Nomifensine,"(+-)-nomifensin; (+-)-nomifensine; 2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine; 8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline; D,L-nomifensine; Nomifensin; Nomifensina; Nomifensine; Nomifensinum",Withdrawn,dopamine reuptake inhibitor|noradrenaline uptake inhibitor,DRD2|SLC6A2|SLC6A3,,,nomifensine,
O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21,Phenolphthalein,"3,3-Bis(4-hydroxyphenyl)phthalide; Fenolftalein; Fenolftaleina; Phenolphtaleine; Phenolphthalein; Phenolphthaleinum; Phthalimetten; Phthalin; Yellow phenolphthalein",Withdrawn,indicator dye,UGT1A9,,,phenolphthalein,
CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1,Prenylamine,"1-Phenyl-2-(1',1'-diphenylpropyl-3'-amino)propane; DL-prenylamine; N-(1-Methyl-2-phenylethyl)-gamma-phenylbenzenepropanamine; N-(3,3-Diphenylpropyl)-alpha-methylphenaethylamin; N-(3,3-Diphenylpropyl)-alpha-methylphenethylamine; Prenilamina; Prenylamine; Prenylaminum",Withdrawn,calcium channel blocker,,,,prenylamine,
CCOC(N)=O,Urethane,Aethylcarbamat; Aethylurethan; Carbamic acid ethyl ester; Carbamidsaeure-aethylester; Ethyl carbamate; Ethylester kyseliny karbaminove; Uretan etylowy; Uretano; Urethan; Urethane; Urethanum,Preclinical,local anesthetic,,,,urethane,
CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1,Zimelidine,(Z)-3-(4'-Bromophenyl)-3-(3''-pyridyl)dimethylallylamine; (Z)-zimelidine; cis-zimelidine; Zimeldina; Zimeldine; Zimeldinum,Withdrawn,selective serotonin reuptake inhibitor (SSRI),MAOA|MAOB|SLC6A4,,,zimelidine,
Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,Maraviroc,Maraviroc; Maravirocum,Launched,CC chemokine receptor antagonist,CCR5,infectious disease,human immunodeficiency virus (HIV-1),maraviroc,
CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl,Clofedanol,Chlophedianol; Clofedanol; Clofedanolum; Clofedianolo,Launched,histamine receptor antagonist,HRH1,pulmonary,cough suppressant,clofedanol,
CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1,Cyclandelate,"3,3,5-Trimethylcyclohexyl mandelate; 3,5,5-Trimethylcyclohexyl amygdalate; Ciclandelato; Cyclandelate; Cyclandelatum",Launched,calcium channel blocker,,cardiology|rheumatology,claudication|arteriosclerosis|Raynaud's disease,cyclandelate,
N=C(N)N1CCc2ccccc2C1,Debrisoquine,Debrisochinum; Debrisoquin; Debrisoquina; Debrisoquine; Débrisoquine; Debrisoquinum,Launched,adrenergic neuron blocker,SLC6A2,cardiology,hypertension,debrisoquin,
Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1,Flunarizine,1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine; Flunarizina; Flunarizine; Flunarizinum,Launched,calcium channel blocker,CACNA1G|CACNA1H|CACNA1I|CALM1|HRH1,neurology/psychiatry|cardiology,migraine headache|vertigo|peripheral artery disease (PAD),flunarizine,
O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,Fluspirilene,Fluspirilene; Fluspirileno; Fluspirilenum,Launched,dopamine receptor antagonist,CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A,neurology/psychiatry,schizophrenia,fluspirilene,
C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1,Mepenzolate,Mepenzolate; Mepenzolic acid,Launched,acetylcholine receptor antagonist,,gastroenterology,peptic ulcer disease (PUD),mepenzolate,
COc1cc2c(cc1OC)C1CC(=O)C(CC(C)C)CN1CC2,Tetrabenazine,"1,2,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one; 2-oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine; 2-oxo-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine; Tetrabenazina; Tetrabenazine; Tetrabenazinum",Launched,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,infectious disease|neurology/psychiatry,cholera|Huntington's disease,tetrabenazine,
C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1,Ixabepilone,Aza-epothilone B; Azaepothilone B; Ixabepilone,Launched,microtubule stabilizing agent,TUBB,oncology,breast cancer,ixabepilone,
CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1,Celiprolol,"Celiprolol; Celiprololum; RS)-N'-{3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N,N-diethylurea",Launched,adrenergic receptor antagonist,ADRA2A|ADRB1|ADRB2,genetics,Ehlers-Danlos syndrome (EDS),celiprolol,
Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,Febuxostat,"2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid; Febuxostat; Fébuxostat; Febuxostatum",Launched,xanthine oxidase inhibitor,XDH,nephrology,hyperuricemia,febuxostat,
CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,Dronedarone,Dronedarona; Dronedarone; N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide; N-(2-butyl-3-(p-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|KCNA5|KCNH2|KCNK2|SCN1A,cardiology,atrial fibrillation (AF),dronedarone,
OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,Nebivolol,Narbivolol; Nebivolol; Nebivololum,Launched,adrenergic receptor antagonist,ADRB1,cardiology,hypertension,nebivolol,
C/C=C1\[C@H]2C=C(C)C[C@]1(N)c1ccc(=O)[nH]c1C2,Huperzine A,(-)-Huperzine A; (−)-huperazine A; (−)-selagine; Huperzine-A; L-huperzine A; Selagine,Phase 2,acetylcholinesterase inhibitor,ACHE,,,huperzine-A,
COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4,Omacetaxine mepesuccinate,"(−)-homoharringtonine; (2'R,3S,4S,5R)-(−)-homoharringtonine; 1-[(1S,3aR,14bS)-2-Methoxy-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[a][1,3]dioxolo[4,5-H]pyrrolo[2,1-b][3]benzazepin-1-yl] 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate; CEPHALOTAXINE 4-METHYL (2R)-2-HYDROXY-2-(4-HYDROXY-4-METHYLPENTYL)BUTANEDIOATE (ESTER); CEPHALOTAXINE, 4-METHYL (2R)-2-HYDROXY-2-(4-HYDROXY-4-METHYLPENTYL)BUTANEDIOATE (ESTER); HHT; Homoharringtonin; Homoharringtonine; mepesuccinato de omacetaxina; Omacetaxine mepesuccinate",Launched,protein synthesis inhibitor,RPL3,hematologic malignancy,chronic myeloid leukemia (CML),homoharringtonine,
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,Nilotinib,Nilotinib; Nilotinibum,Launched,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|KIT,hematologic malignancy,chronic myeloid leukemia (CML),nilotinib,
N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,Vildagliptin,Vildagliptin; Vildagliptina,Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,vildagliptin,
CSc1ccc(C(=O)c2[nH]c(=O)[nH]c2C)cc1,Enoximone,Enoximona; Enoximone; Enoximonum,Launched,phosphodiesterase inhibitor,PDE3A,cardiology,congestive heart failure,enoximone,
O=C(O)CCCN1CCC(OC(c2ccc(Cl)cc2)c2ccccn2)CC1,Bepotastine,bepotastina; Bepotastine,Launched,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis,bepotastine,
CCN(CC)C(=O)C1(c2ccccc2)CC1CN,Milnacipran,(+-)-Milnacipran; Midalcipran; Milnacipran; Milnacipranum,Launched,serotonin–norepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,rheumatology,fibromyalgia,milnacipran,
O=c1[nH]c2ccccc2n1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1,Flibanserin,Flibanserin,Launched,serotonin receptor agonist,DRD4|HTR1A|HTR2A,neurology/psychiatry,hypoactive sexual desire disorder,flibanserin,
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O[C@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(NCc3ccc(-c4ccc(Cl)cc4)cc3)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,Oritavancin,Chlorobiphenyl-chloroeremomycin; Oritavancin,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections,oritavancin,
Nc1nc(/C(=N/O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(/C=C4\CCN([C@@H]5CCNC5)C4=O)CS[C@H]23)ns1,Ceftobiprole,Ceftobiprol; Ceftobiprole,Phase 3,antiinfective drug,,,,ceftobiprole,
CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1,Permethrin,"(3-Phenoxyphenyl)methyl (±)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate; 3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester; Permethrin",Launched,,,infectious disease,lice,permethrin,
CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C,Afamelanotide,Afamelanotide; Melanotan 1; Melanotan I; Melanotan-1; MT-I,Launched,melanocyte-stimulating hormone mimetic,,,,afamelanotide,
OCCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1,Ospemifene,"2-(4-(4-Chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol; 2-(p-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol; Deamino-hydroxytoremifene; Ospemifene; Ospemifeno",Launched,selective estrogen receptor modulator (SERM),ESR1|ESR2,obstetrics/gynecology|endocrinology,vaginal atrophy|dyspareunia|menopause,ospemifene,
COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,Iloperidone,"1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone; 4'-(3-(4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone; Iloperidona; Ilopéridone; Iloperidone; Iloperidonum",Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR2A|HTR6|HTR7,neurology/psychiatry,schizophrenia,iloperidone,
CC(Oc1c(Cl)cccc1Cl)C1=NCCN1,Lofexidine,"2-(alpha-(2,6-Dichlorophenoxy)ethyl)2-imidazoline; Lofexidina; Lofexidine; Lofexidinum",Launched,adrenergic receptor agonist,,neurology/psychiatry,opioid withdrawal,lofexidine,
Cc1ccc(=O)n(-c2ccccc2)c1,Pirfenidone,Pirfenidona; Pirfenidone,Launched,TGF beta receptor inhibitor,FURIN|TNF,pulmonary,idiopathic pulmonary fibrosis (IPF),pirfenidone,
O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO,Belinostat,"(2E)-N-HYDROXY-3-(3-(PHENYLSULFAMOYL)PHENYL)PROP-2-ENAMIDE; 2-PROPENAMIDE, N-HYDROXY-3-(3-((PHENYLAMINO)SULFONYL)PHENYL)-; 2-PROPENAMIDE, N-HYDROXY-3-(3-((PHENYLAMINO)SULFONYL)PHENYL)-, (2E)-; Belinostat; N-HYDROXY-3-(3-((PHENYLAMINO)SULFONYL)PHENYL)-2-PROPENAMIDE; N-Hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide",Launched,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,hematologic malignancy,peripheral T-cell lymphoma (PTCL),belinostat,
O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1,Ataluren,"3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid; Ataluren",Launched,CFTR channel agonist|dystrophin stimulant,DMD,genetics|pulmonary,duchenne muscular dystrophy (DMD)|cystic fibrosis,ataluren,
CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,Indacaterol,Indacaterol,Launched,adrenergic receptor agonist,ADRB1|ADRB2,pulmonary,chronic obstructive pulmonary disease (COPD),indacaterol,
O=C(O)CSCC(=O)NC1CCSC1=O,Erdosteine,Erdosteine,Launched,mucolytic agent,,pulmonary|infectious disease,bronchitis|cough suppressant|chronic obstructive pulmonary disease (COPD)|respiratory tract infections,erdosteine,
CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C,Ganaxolone,Ganaxolone,Phase 3,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,,,ganaxolone,
COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H](O)[C@@H]3Cc5cc(C)c(OC)c(O)c5[C@H]([C@H]21)N3C)OCO4,Trabectedin,Ecteinascidin 743; Trabectedin; Trabectedina,Phase 3,antitumor agent,,,,trabectedin,
O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(OC(F)(F)F)cc1)C2,Pretomanid,Pretomanid,Launched,nitric oxide donor,FASN,,,pretomanid,
CSc1ccc(C(=O)/C=C/c2cc(C)c(OC(C)(C)C(=O)O)c(C)c2)cc1,Elafibranor,"Elafibranor; PROPANOIC ACID, 2-(2,6-DIMETHYL-4-((1E)-3-(4-(METHYLTHIO)PHENYL)-3-OXO-1-PROPEN-1-YL)PHENOXY)-; PROPANOIC ACID, 2-(2,6-DIMETHYL-4-(3-(4-(METHYLTHIO)PHENYL)-3-OXO-1-PROPEN-1-YL)PHENOXY)-2-METHYL-",Phase 3,PPAR receptor agonist,PPARA|PPARD|PPARG,,,elafibranor,
N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1,Crisaborole,Crisaborole,Launched,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,dermatology,dermatitis,crisaborole,
O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1,Cobimetinib,Cobimetinib,Launched,MEK inhibitor,MAP2K1,oncology,melanoma,cobimetinib,
CN1C(=O)CC(C)(c2ccccc2)C1=O,Methsuximide,"(RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion; 1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine; 1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione; 1,3-Dimethyl-3-phenylsuccinimide; alpha-Methyl-alpha-phenyl N-methyl succinimide; alpha-Methylphensuximide; Mesuximida; Mesuximide; Mesuximidum; Methsuximid; Methsuximide; Metosuccimmide; N-methyl-alpha-methyl-alpha-phenylsuccinimide; N,2-Dimethyl-2-phenylsuccinimide",Launched,T-type calcium channel blocker,CACNA1G|CACNA1H|CACNA1I,neurology/psychiatry,seizures,methsuximide,
CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1,Rotigotine,"(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol; Rotigotina; Rotigotine",Launched,dopamine receptor agonist,ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A,neurology/psychiatry,Parkinson's Disease|restless leg syndrome,rotigotine,
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,Vandetanib,N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine; Vandetanib,Launched,EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA,oncology,medullary thyroid cancer (MTC),vandetanib,
CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1,Pimavanserin,Pimavanserin,Launched,serotonin receptor inverse agonist,DRD2|HTR2A,neurology/psychiatry,Parkinson's Disease,pimavanserin,
Cc1c(OCC(F)(F)F)ccnc1C[S@@](=O)c1nc2ccccc2[nH]1,Dexlansoprazole,"(+)-2-((R)-((3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-2-YL)METHYL)SULFINYL)-1H-BENZIMIDAZOLE; (R)-LANSOPRAZOLE; 1H-BENZIMIDAZOLE, 2-((R)-((3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDINYL)METHYL)SULFINYL)-; 2-((R)-((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole; Dexlansoprazole; LANSOPRAZOLE R-FORM; LANSOPRAZOLE, (R)-",Launched,ATPase inhibitor,ATP4A,gastroenterology,gastroesophageal reflux disease (GERD)|erosive esophagitis (EE),dexlansoprazole,
NCCc1c[nH]cn1,Histamine,1H-Imidazole-4-ethanamine; 2-(4-imidazolyl)ethylamine; 4-imidazoleethylamine; 5-imidazoleethylamine; beta-aminoethylglyoxaline; beta-aminoethylimidazole,Launched,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,allergy,allergic rhinitis,histamine,
CC1(C)CCC(C)(C)c2cc(Cn3cccn3)c(/C=C/c3ccc(C(=O)O)cc3)cc21,Palovarotene,Palovarotene,Phase 3,retinoid receptor agonist,RARG,,,palovarotene,
CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,Telaprevir,"(1S,3aR,6aS)-(2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydrocyclopenta(c)pyrrole-1-carboxamide; Telaprevir",Launched,HCV inhibitor,CTSA|PGR,infectious disease,hepatitis C,telaprevir,
CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,Apremilast,"Aprémilast; Apremilast; Apremilastum; N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide",Launched,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,dermatology|rheumatology,psoriasis|psoriatic arthritis,apremilast,
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1,Abiraterone,"(3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol; 17-(3-Pyridyl)androsta-5,16-dien-3beta-ol; Abiraterona; Abiraterone",Launched,androgen biosynthesis inhibitor,CYP11B1|CYP17A1,oncology,prostate cancer,abiraterone,
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,Cariprazine,"Cariprazine; trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N’,N’-dimethylurea hydrochloride",Launched,dopamine receptor antagonist,DRD2|DRD3,neurology/psychiatry,schizophrenia,cariprazine,
C[C@@]1(C(=O)N[C@@H](CCC(=O)O)C(=O)O)CCCN1C(=O)CN,Trofinetide,glycyl-L-2-methylprolyl-L-glutamic acid; Trofinetide,Phase 2,cytokine production inhibitor,IFNG|IL6|TNF,,,trofinetide,
CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12,Lumateperone,Lumateperone,Launched,dopamine receptor modulator|serotonin receptor antagonist,DRD2|HTR2A,,,lumateperone,
CC(C)c1c(O)cc(/C=C/c2ccccc2)cc1O,Tapinarof,"3,5-Dihydroxy-4-isopropyl-trans-stilbene; Benvitimod; Tapinarof",Phase 3,aryl hydrocarbon receptor agonist,,,,tapinarof,
NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl,Cenobamate,Cenobamate; Cénobamate; Cenobamato; Cenobamatum,Launched,GABA receptor modulator|voltage-gated sodium channel blocker,,,,cenobamate,
O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,Sertindole,1-[2-[4-[5-chloro-1-(4-fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one; Sertindol; Sertindole; Sertindolum,Withdrawn,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2,,,sertindole,
CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O,Spiramycin,Demycarosylturimycin H; Foromacidin A; Foromacidine A; Spiramycin 1; Spiramycin A; Spiramycin I,Launched,bacterial 50S ribosomal subunit inhibitor,,infectious disease,toxoplasmosis|soft tissue infection,spiramycin,
Nc1ccc(S(=O)(=O)Nc2nccs2)cc1,Sulfathiazole,2-(p-Aminobenzenesulfonamido)thiazole; 2-(p-Aminobenzenesulphonamido)thiazole; 2-(Sulfanilylamino)thiazole; 2-Sulfanilamidothiazol; 2-Sulfanilamidothiazole; 2-Sulfonamidothiazole; 4-Amino-N-2-thiazolylbenzenesulfonamide; N(1)-2-Thiazolylsulfanilamide; N1-2-Thiazolylsulfanilamide; Sulfanilamidothiazole; Sulfathiazol; Sulfathiazole; Sulfathiazolum; Sulfatiazol; Sulphathiazole,Launched,dihydropteroate synthase inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,sulfathiazole,
CN1CCN2c3ccccc3Cc3ccccc3C2C1,Mianserin,"1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine; Mianserin; Mianserina; Mianserine; Miansérine; Mianserinum; Mianseryna",Launched,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HRH1|HRH2|HTR2A|HTR2B|HTR2C|HTR6|HTR7,neurology/psychiatry,depression,mianserin,
CCCCCCCCCC(=O)N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(OC4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](CO)[C@@H](O)[C@@H]1O,Teicoplanin,Teichomycin A2; Teicoplanin; teicoplanina; téicoplanine; teicoplaninum,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections,teicoplanin,
COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1,Sulfadimethoxine,"2,4-dimethoxy-6-sulfanilamido-1,3-diazine; 2,6-dimethoxy-4-(p-aminobenzenesulfonamido)pyrimidine; 2,6-dimethoxy-4-sulfanilamidopyrimidine; 4-amino-N-(2,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide; 6-sulfanilamido-2,4-dimethoxypyrimidine; N(1)-(2,6-Dimethoxy-4-pyrimidinyl)sulfanilamide; Sulfadimethoxine; Sulfadimethoxinum; Sulfadimethoxydiazine; Sulfadimetoxina; Sulphadimethoxine",Launched,dihydropteroate synthetase inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,sulphadimethoxine,
CC(=O)N[C@@H](CS)C(=O)O,Acetylcysteine,(2R)-2-acetylamino-3-sulfanylpropanoic acid; (R)-2-acetylamino-3-mercaptopropanoic acid; (R)-mercapturic acid; Acetilcisteina; Acetylcysteine; Acetylcysteinum; L-acetylcysteine; L-α-acetamido-β-mercaptopropionic acid; Mercapturic acid; N-acetyl-L-(+)-cysteine; N-acetyl-L-cysteine; N-acetylcysteine; NAC,Launched,mucolytic agent,ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11,gastroenterology,acetaminophen overdose|hepatic injury,acetylcysteine,
CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1,Nylidrin,Bufenina; Buphenin; Buphenine; Bupheninum,Launched,adrenergic receptor agonist,ADRB2,rheumatology,Raynaud's disease,buphenine,
CN1CCC(=C2c3ccccc3CCc3sccc32)CC1,Pizotifen,Pizotifen; pizotifeno; Pizotyline,Launched,serotonin receptor antagonist,HTR1A|HTR2A|HTR2C,neurology/psychiatry,migraine headache,pizotifen,
Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,Rimonabant,Rimonabant,Withdrawn,cannabinoid receptor antagonist,CNR1|GPR55,,,rimonabant,
COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C,Noscapine,(−)-narcotine; (−)-α-narcotine; alpha-Narcotine; Noscapina; Noscapine; Noscapinum,Launched,bradykinin receptor antagonist|tubulin polymerization inhibitor,SIGMAR1,pulmonary,cough suppressant,noscapine,
C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O,Romidepsin,Romidepsin; Romidepsina; Romidepsine; Romidepsinum,Launched,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,hematologic malignancy,cutaneous T-cell lymphoma (CTCL),romidepsin,
NCCNc1ccc(NCCN)c2c1C(=O)c1ccncc1C2=O,Pixantrone,"6,9-bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione; Pixantrona; Pixantrone",Launched,topoisomerase inhibitor,TOP2A,hematologic malignancy,non-Hodgkin lymphoma (NHL),pixantrone,
NC(=O)c1cn(Cc2c(F)cccc2F)nn1,Rufinamide,Rufinamida; Rufinamide; Xilep,Launched,voltage-gated sodium channel blocker,GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures,rufinamide,
Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1,Lasofoxifene,"(-)-cis-5,6,7,8-Tetrahydro-6-phenyl-5-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-naphthol; Lasofoxifene",Launched,selective estrogen receptor modulator (SERM),ESR1|ESR2,orthopedics|oncology,osteoporosis|breast cancer,lasofoxifene,
Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,Alogliptin,Alogliptin; Alogliptina; Alogliptine; Alogliptinum,Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,alogliptin,
O=C(O)CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]4[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]5[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]6[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]7[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]8[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]9[C@@H](CSCCC(=O)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,Sugammadex,Sugammadex,Launched,neuromuscular blockade reversal agent,,,,sugammadex,
C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F,Silodosin,Silodosin; Silodosina,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,urology,benign prostatic hyperplasia (BPH),silodosin,
CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2,Prasugrel,Prasugrel,Launched,purinergic receptor antagonist,P2RY12,cardiology,myocardial infarction|acute coronary syndrome (ACS),prasugrel,
CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\Nc1cccc(-c2cccc(C(=O)O)c2)c1O,Eltrombopag,Eltrombopag; Eltrombopagum,Launched,thrombopoietin receptor agonist,MPL,hematology|infectious disease,anemia|hepatitis C|thrombocytopenia,eltrombopag,
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)[C@H](C)[C@H]12,Doripenem,Doripenem,Launched,bacterial cell wall synthesis inhibitor,DPEP1,infectious disease,intra-abdominal infections|urinary tract infections|pyelonephritis,doripenem,
Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[C@@H](O)c3cc(Cl)ccc32)c(C)c1,Tolvaptan,,Launched,vasopressin receptor antagonist,AVPR1A|AVPR2,endocrinology|cardiology|gastroenterology,hyponatremia|congestive heart failure|hepatic cirrhosis,tolvaptan,
CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1,Regadenoson,Regadenoson; Regadenoson anhydrous,Launched,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,radiology,myocardial perfusion imaging (MPI),regadenoson,
CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1,Asenapine,Asenapina; Asenapine,Launched,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A,neurology/psychiatry,schizophrenia|bipolar disorder,asenapine,
COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC,Vernakalant,"(3R)-1-((1R,2R)-2-(2-(3,4-dimethoxyphenyl)ethoxy)cyclohexyl)pyrrolidin-3-ol; Vernakalant",Launched,potassium channel blocker,KCNA5,cardiology,atrial fibrillation (AF),vernakalant,
O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,Rivaroxaban,Rivaroxaban,Launched,coagulation factor inhibitor,F10,neurology/psychiatry|hematology|cardiology,stroke|systemic embolism|atrial fibrillation (AF)|deep vein thrombosis (DVT)|pulmonary embolism (PE),rivaroxaban,
C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5,Nalmefene,"17-(Cyclopropylmethyl)-4,5α-epoxy-6-methylenemorphinan-3,14-diol; MORPHINAN-3,14-DIOL, 17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-6-METHYLENE-, (5.ALPHA.)-; Nalmefene; Nalmefeno",Launched,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,pulmonary,respiratory depression,nalmefene,
CC(C)Nc1nc2cc(Cl)c(Cl)cc2n1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O,Maribavir,Maribavir,Phase 3,cytomegalovirus inhibitor|protein kinase inhibitor,PYGM,,,maribavir,
COc1ccc(CNc2nc(N3CCC[C@H]3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,Avanafil,(S)-4-(3-Chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-N-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide; Avanafil; Avanafilo,Launched,phosphodiesterase inhibitor,PDE5A,urology,erectile dysfunction,avanafil,
NCCCC(N)(C(=O)O)C(F)F,Eflornithine,"(RS)-2,5-diamino-2-(difluoromethyl)pentanoic acid; 2-(difluoromethyl)ornithine; alpha-difluoromethylornithine; DFMO; Eflornithine; α-difluoromethylornithine",Launched,ornithine decarboxylase inhibitor,ARG2|ODC1,dermatology,facial hair reduction,eflornithine,
CCCCCCOC(=O)CCC(=O)CN,Hexaminolevulinate,"4-Hexyloxycarbonyl-2-oxobutylammoniumchloride; Hexaminolevulinato; Hexyl 5-amino-4-oxopentanoate hydrochloride; Hexyl(5-amino-4-oxopentanoat)-hydrochlorid; Pentanoic acid, 5-amino-4-oxo-, hexyl ester, hydrochloride",Launched,,,radiology,diagnostic agent,hexaminolevulinate,
N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1,Droxidopa,DOPS; Droxidopa; L-Dihydroxyphenylserine; L-DOPS; L-threo-dihydroxyphenylserine,Launched,norepinephrine precursor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH,cardiology|neurology/psychiatry,hypertension|Parkinson's Disease,droxidopa,
CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,Udenafil,Udenafil,Launched,phosphodiesterase inhibitor,,urology,erectile dysfunction,udenafil,
Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2,Sitaxentan,Sitaxentan; Sitaxsentan,Withdrawn,endothelin receptor antagonist,EDNRA|EDNRB,,,sitaxentan,
C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c1cccc(O)c1,Alvimopan,Alvimopan; Alvimopan anhydrous; Anhydrous alvimopan,Launched,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,gastroenterology,postoperative ileus,alvimopan,
O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1,Levocetirizine,2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid; Levocetirizina; Levocetirizine,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis|urticaria,levocetirizine,
CO[C@H]1C[C@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,Temsirolimus,Temsirolimus,Launched,mTOR inhibitor,MTOR,oncology,renal cell carcinoma (RCC),temsirolimus,
CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,Amisulpride,4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide; 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide; Aminosultopride; Amisulprida; Amisulpride; Amisulpridum,Launched,dopamine receptor antagonist,DRD2,neurology/psychiatry,psychosis|bipolar disorder|schizophrenia,amisulpride,
COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1C,Simeprevir,Simeprevir,Launched,HCV inhibitor,CYP1A2|CYP3A4,infectious disease,hepatitis C,simeprevir,
CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,Dapagliflozin,"(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; Dapagliflozin; Dapagliflozina",Launched,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,endocrinology,diabetes mellitus,dapagliflozin,
N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,Saxagliptin,"(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile; Saxagliptin; Saxagliptin anhydrous; Saxagliptina",Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,saxagliptin,
CCNCCc1ccc(CN(CC)c2cc(OC)ccc2[C@@H]2CCc3cc(O)ccc3C2)cc1,Elacestrant,"(2R)-2-(2-(ethyl-((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxy-phenyl)tetralin-6-ol; (6R)-6-(2-(ethyl((4-(2- (ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)- 5,6,7,8-tetrahydronaphthalen-2-ol; 2-naphthalenol, 6-(2-(ethyl((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydro-, (6R)-; Elacestrant",Phase 3,estrogen receptor degrader,,,,elacestrant,
Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12,Bazedoxifene,Bazedoxifene; Bazedoxifeno,Launched,selective estrogen receptor modulator (SERM),ESR1|ESR2,orthopedics|endocrinology,osteoporosis|menopause,bazedoxifene,
COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O,Ambrisentan,"(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid; Ambrisentan",Launched,endothelin receptor antagonist,EDNRA|EDNRB,pulmonary,pulmonary arterial hypertension (PAH),ambrisentan,
C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@H](C)C(C)C)C[C@@H](O)C[C@@H]1O,Doxercalciferol,"(1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol; 1-Hydroxyergocalciferol; 1-Hydroxyvitamin D2; 1α-Hydroxyergocalciferol; 1α-hydroxyvitamin D2; Doxercalciferol; Doxercalciferolum; Doxercalciférolum",Launched,vitamin D receptor agonist,VDR,nephrology|endocrinology,chronic kidney disease (CKD)|hyperparathyroidism,doxercalciferol,
Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,Etravirine,Etravirina; Etravirine,Launched,non-nucleoside reverse transcriptase inhibitor,CYP2C19|CYP2C9|CYP3A4,infectious disease,human immunodeficiency virus (HIV-1),etravirine,
CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)[C@@H](O)[C@H]1O,Cangrelor,"[dichloro-[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]phosphonic acid; Cangrelor",Launched,purinergic receptor antagonist,,cardiology,myocardial infarction,cangrelor,
NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1,Lonafarnib,Lonafarnib; Lonafarnibum,Phase 3,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS,,,lonafarnib,
COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1,Prucalopride,Prucaloprida; Prucalopride,Launched,serotonin receptor agonist,HTR4,gastroenterology,constipation,prucalopride,
Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,Pazopanib,Pazopanib; Pazopanibum,Launched,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3,oncology,renal cell carcinoma (RCC)|soft tissue sarcoma (STS),pazopanib,
COc1ccc2cccc(CCNC(C)=O)c2c1,Agomelatine,Agomelatina; Agomelatine,Launched,melatonin receptor agonist|serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B,neurology/psychiatry,depression,agomelatine,
CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Midostaurin,4'-N-benzoylstaurosporine; Midostaurin,Launched,FLT3 inhibitor|KIT inhibitor|PKC inhibitor,FLT3|PRKCG,hematologic malignancy,acute myeloid leukemia (AML),midostaurin,
Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1,Panobinostat,"(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide; 2-PROPENAMIDE, N-HYDROXY-3-(4-(((2-(2-METHYL-1H-INDOL-3-YL)ETHYL)AMINO)METHYL)PHENYL)-, (2E)-; hydroxypropyl-B-cyclodextrin-panobinostat complex; Panobinostat; Panobinostatum",Launched,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8|HDAC9,hematologic malignancy,multiple myeloma,panobinostat,
COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1,Apixaban,Apixaban; apixabán; apixabanum,Launched,coagulation factor inhibitor,F10,neurology/psychiatry|hematology|cardiology,stroke|systemic embolism|pulmonary embolism (PE)|atrial fibrillation (AF)|deep vein thrombosis (DVT),apixaban,
COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc(NC(C)CCCN)c2n1,Tafenoquine,Tafenoquine,Launched,antimalarial agent,,infectious disease,malaria,tafenoquine,
CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(=O)O)C[C@H]1NC(=N)N,Peramivir,Peramivir; Peramivir anhydrous,Launched,neuraminidase inhibitor,,infectious disease,influenza A virus infection,peramivir,
COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,Bosutinib,"4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile; Bosutinib",Launched,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK,hematologic malignancy,chronic myeloid leukemia (CML),bosutinib,
CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,Axitinib,Axitinib; Axitinibum; N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide,Launched,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|FLT1|FLT4|KDR|PLK4,oncology,renal cell carcinoma (RCC),axitinib,
Nc1ccncc1,Dalfampridine,4-Aminopyridine; 4-AP; 4-Pyridinamine; 4-Pyridylamine; Dalfampridine; Fampridina; Fampridine; Fampridinum; p-Aminopyridine; γ-Aminopyridine,Launched,potassium channel blocker,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2,neurology/psychiatry,multiple sclerosis,dalfampridine,
C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,Safinamide,Safinamida; Safinamide,Launched,dopamine reuptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor,MAOB,neurology/psychiatry,Parkinson's Disease,safinamide,
NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O,Pasireotide,cyclo((4R)-4-(2-aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-); Pasireotida; Pasireotide; Pasiréotide; Pasireotidum,Launched,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5,endocrinology,Cushing's syndrome|acromegaly,pasireotide,
N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1,Vilazodone,Vilazodona; Vilazodone; Vilazodonum,Launched,serotonin reuptake inhibitor,DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4,neurology/psychiatry,depression,vilazodone,
COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,Mepyramine,"Mepiramina; Mepyramine; N-(p-methoxybenzyl)-N',N'-dimethyl-N-(α-pyridyl)ethylenediamine; N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl-1,2-ethanediamine; N',N'-dimethyl-N-(p-methoxybenzyl)-N-(2-pyridyl)ethylenediamine; Pyranisamine; Pyrilamine",Launched,histamine receptor antagonist,HRH1,otolaryngology|obstetrics/gynecology,common cold|menstrual pain,mepyramine,
Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,Xylometazoline,Xylometazoline; Xylometazolinum; Xylomethazoline,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,otolaryngology|allergy,nasal congestion|allergic rhinitis,xylometazoline,
CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3,Artemether,"(1R,4S,5R,8S,9R,10S,12R,13R)-10-methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane; 10-methoxy-1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane; Artemetero; Artemether; Artemetherum; Artemisininelactol methyl ether; Dihydroartemisinin methyl ether; Dihydroqinghaosu methyl ether; methyl-dihydroartemisinine; β-artemether; β-dihydroartemisinin methyl ether",Launched,antimalarial agent,ATP1A1,infectious disease,malaria,artemether,
CNCCc1ccccn1,Betahistine,[2-(2-pyridyl)ethyl]methylamine; 2-(β-methylaminoethyl)pyridine; 2-[2-(methylamino)ethyl]pyridine; Betahistina; Bétahistine; Betahistine; Betahistinum; N-methyl-2-(2-pyridinyl)ethanamine; N-methyl-2-pyridineethanamine,Launched,histamine receptor agonist|histamine receptor antagonist,HRH1|HRH3,neurology/psychiatry,Meniere's disease,betahistine,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(NC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,Degarelix,Degarelix,Launched,gonadotropin releasing factor hormone receptor antagonist,GNRHR,oncology,prostate cancer,degarelix,
CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,Desvenlafaxine,Desvenlafaxina; Desvenlafaxine; O-desmethylvenlafaxine; ODV,Launched,serotonin–norepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,depression,desvenlafaxine,
CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1,Fesoterodine,FESO; Fesoterodina; Fesoterodine,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,urology,urinary incontinence,fesoterodine,
O=C([O-])C[N+]12CC[N+]3(CC(=O)[O-])CC[N+]4([C@@H](CO)[C@@H](O)CO)CC[N+](CC(=O)[O-])(CC1)[Gd-]234,Gadobutrol,"Gadobutrol; gadolinium(III) 2,2',2''-(10-((2R,3S )-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate",Launched,radiopaque medium,,radiology,MRI contrast agent,gadobutrol,
NC(N)=NCc1cccc(I)c1,Iobenguane,((3-iodophenyl)methyl)guanidine; 3-iodobenzylguanidine; m-iodobenzylguanidine; Metaiodobenzylguanidine; mIBG,Launched,antineoplastic agent,,oncology|cardiology|endocrinology,neuroblastoma|congestive heart failure|pheochromocytoma,iobenguane,
C[C@H](N)[C@H](O)c1ccc(O)c(O)c1,Levonordefrin,(-)-cobefrin; alpha-Methylnoradrenaline; Corbadrina; Corbadrine; Corbadrinum; L-alpha-methylnoradrenaline; L-Nordefrin; Levonordefrin; Neo-cobefrin,Launched,vasodilator,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|SLC6A2,hematology,hemorrhage,levonordefrin,
CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1,Lumefantrine,"(±)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-α-((dibutylamino)methyl)fluorene-4-methanol; 2-Dibutylamino-1-[2,7-dichloro-9-(4-chloro-benzylidene)-9H-fluoren-4-yl]-ethanol; 2-Dibutylamino-1-{2,7-dichloro-9-[1-(4-chloro-phenyl)-meth-(Z)-ylidene]-9H-fluoren-4-yl}-ethanol; Benflumetol; dl-Benflumelol; Lumefantrine",Launched,antimalarial agent,ATP1A1,infectious disease,malaria,lumefantrine,
CC(=O)OC(C)C[N+](C)(C)C,Methacholine,Acetyl-beta-methylcholine; Acetylmethylcholine; beta-Methylacetylcholine; MCh; Methacholine; Methacholinum,Launched,acetylcholine receptor agonist,CHRM2|CHRM4,pulmonary,bronchial hyperresponsiveness diagnostic,methacholine,
c1ccc2c(CC3=NCCN3)cccc2c1,Naphazoline,Nafazolin; Nafazolina; Naphazoline,Launched,adrenergic receptor agonist,ADRA1A|ADRA2A,ophthalmology,eye irritation,naphazoline,
COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,Nilvadipine,Nilvadipine; Nilvadipino; Nilvadipinum,Launched,calcium channel blocker,CACNA1C|CACNA1D,cardiology,hypertension|cerebral artery occlusion,nilvadipine,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=NO)CC[C@@H]4[C@H]3CC[C@@]21CC,Norelgestromin,17-Deacetylnorgestimate; 17-Deacylnorgestimate; 18-Methylnorethindrone oxime; D-Norgestrel 3-oxime; Deacetylnorgestimate; Levonorgestrel 3-oxime; Levonorgestrel oxime; Norelgestromin; Norelgestromina; Norplant 3-oxime,Launched,,PGR,endocrinology,contraceptive,norelgestromin,
CNC(C)CC1CCCCC1,Propylhexedrine,Propylhexedrine,Launched,adrenergic receptor agonist,,otolaryngology|endocrinology|allergy,nasal congestion|fever|allergic rhinitis,propylhexedrine,
CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O,Lornoxicam,Chlortenoxicam; Lornoxicam; Lornoxicamum,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology|neurology/psychiatry,osteoarthritis|sciata,lornoxicam,
Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1,Sulfaphenazole,1-phenyl-5-sulfanilamidopyrazole; 3-(p-aminobenzenesulfonamido)-2-phenylpyrazole; 5-sulfanilamido-1-phenylpyrazole; N'-(1-phenylpyrazol-5-yl)sulfanilamide; N(1)-(1-phenylpyrazol-5-yl)sulfanilamide; Sulfafenazol; Sulfafenazolo; Sulfaphénazol; Sulfaphenazole; Sulfaphenazolum; Sulphaphenazole,Launched,dihydropteroate synthetase inhibitor,DHPS,infectious disease,urinary tract infections,sulfaphenazole,
O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,Aceclofenac,"2-[(2,6-dichlorophenyl)amino]benzeneacetic acid carboxymethyl ester; 2-[(2,6-dichlorophenyl)amino]phenylacetoxyacetic acid; 2-[(2',6'-dichlorophenyl)amino]phenylacetoxyacetic acid; Aceclofenac; Acéclofénac; Aceclofenac betadex; Aceclofenaco; Aceclofenacum; glycolic acid [o-(2,6-dichloroanilino)phenyl]acetate ester",Launched,prostanoid receptor antagonist,PTGS2,rheumatology,rheumatoid arthritis|ankylosing spondylitis|osteoarthritis|periarthritis|lumbago|ischiadynia,aceclofenac,
Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1,Ambroxol,"Ambroxol; Ambroxolum; Bisolvon metabolite vIII; Bromhexine metabolite vIII; Bromhexine-metabolite vIII; Cyclohexanol, 4-((2-amino-3,5-dibromobenzyl)amino)- (E)-; N-(2-Amino-3,4-dibromociclohexil)-trans-4-aminociclohexanol; N-(2-Amino-3,4-dibromocyclohexyl)-trans-4-aminocyclohexanol; trans-4-((2-Amino-3,5-dibromobencil)amino)ciclohexanol; trans-4-((2-Amino-3,5-dibromobenzyl)amine)cyclohexanol; trans-4-((2-Amino-3,5-dibromobenzyl)amino)cyclohexanol",Launched,sodium channel blocker,CYP3A4,pulmonary,bronchitis,ambroxol,
CCOc1ccc(/C=C2\NCCc3cc(OCC)c(OCC)cc32)cc1OCC,Drotaverine,Drotaverin; Drotaverina; Drotaverine; Drotaverinum,Launched,phosphodiesterase inhibitor,,obstetrics/gynecology,labor induction,drotaverine,
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)C(C)(C)CCC1,Beta carotene,all-trans-β-carotene; Beta carotene; beta-carotene; Betacarotene; β-Karotin,Launched,,,,,beta-carotene,
C[N+](C)(C)CC(=O)[O-],Betaine,"2-(Trimethylammonio)Acetate; 2-N,N,N-trimethylammonio acetate; 2-trimethylammonioacetate; Abromine; Acidol; Betaína anhidra; Betaine; Betaine, anhydrous; Glycine betaine; Glycinebetaine; Glykokollbetain; N,N,N-trimethylammonioacetate; N,N,N-Trimethylglycine; TMG; Trimethylaminoacetate; Trimethylammonioacetate; Trimethylglycine; Trimethylglycocoll",Launched,nitric oxide donor,,metabolism,homocystinuria,betaine,
CC(N/C(=N/c1ccncc1)NC#N)C(C)(C)C,Pinacidil,Pinacidil; Pinacidil anhydrous; Pinacidilum,Launched,ATP channel activator|potassium channel activator,ABCC8|ABCC9,cardiology,hypertension,pinacidil,
c1ccc2c(c1)CCCC2C1=NCCN1,Tetryzoline,"(RS)-2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole; 2-(1,2,3,4-Tetrahydro-1-naphthyl)-2-imidazoline; 2-Tetralin-1-yl-4,5-dihydro-1H-imidazole; 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-1H-imidazole; Tetrahydrozoline; Tetrizolina; Tetryzolin; Tetryzolina; Tetryzoline; Tétryzoline; Tetryzolinum",Launched,adrenergic receptor agonist,,ophthalmology,eye irritation,tetrahydrozoline,
CN1CCC(=C2c3ccccc3CCn3c(C=O)cnc32)CC1,Alcaftadine,Alcaftadina; Alcaftadine; Alcaftadinum,Launched,histamine receptor antagonist,HRH1,allergy,allergic conjunctivitis,alcaftadine,
CC(O)C(=O)[O-].[NH4+],Ammonium lactate,Ammonium (+-)-lactate; Ammonium lactate; Lactic acid ammonium salt,Launched,,HCAR1,dermatology,xerosis cutis|ichthyosis vulgaris,ammonium-lactate,
Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21,Bendamustine,Bendamustina; Bendamustine; Ribomustine,Launched,DNA inhibitor,,hematologic malignancy,chronic lymphocytic leukemia (CLL)|non-Hodgkin lymphoma (NHL),bendamustine,
N[C@@H]1CCCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,Besifloxacin,Besifloxacin,Launched,bacterial DNA gyrase inhibitor,,ophthalmology,conjunctivitis,besifloxacin,
CO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C([C@@H](OC)C(=O)[C@]12C)C3(C)C,Cabazitaxel,"1-HYDROXY-7.BETA.,10.BETA.-DIMETHOXY-9-OXO-5.BETA.,20-EPOXYTAX-11-ENE-2.ALPHA.,4,13.ALPHA.-TRIYL 4-ACETATE 2-BENZOATE 13-((2R,3S)-3-(((TERT-BUTOXY)CARBONYL)AMINO)-2-HYDROXY-3-PHENYLPROPANOATE); Cabazitaxel; Cabazitaxelum",Launched,microtubule inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,oncology,prostate cancer,cabazitaxel,
COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O,Capsaicin,(E)-8-Methyl-N-vanillyl-6-nonenamide; Capsaicin; Capsaicina; Isodecenoic acid vanillylamide; trans-8-Methyl-N-vanillyl-6-nonenamide,Launched,TRPV agonist,CFTR|TRPV1,neurology/psychiatry|rheumatology,muscle pain|rheumatoid arthritis,capsaicin,
CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,Difluprednate,DFBA; Difluoroprednisolone butyrate acetate; Difluprednate,Launched,glucocorticoid receptor agonist,NR3C1,ophthalmology,endogenous uveitis,difluprednate,
OCC(S)CS,Dimercaprol,"1,2-dimercapto-3-propanol; 1,2-dithioglycerol; 2,3-dimercapto-1-propanol; 2,3-dimercaptol-1-propanol; 2,3-dimercaptopropanol; 2,3-dithiopropanol; 2,3-mercaptopropan-1-ol; 2,3-Mercaptopropanol; 3-hydroxy-1,2-propanedithiol; BAL; British anti-lewisite; British antilewisite; Dimercaprol; Dimercaprolum; Dimercaptopropanol; Dithioglycerine; Dithioglycerol; Sulfactin; α,β-dithioglycerol",Launched,chelating agent,,neurology/psychiatry,metal toxicity,dimercaprol,
CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1,Halcinonide,"(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-6b-(chloroacetyl)-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one; Halcinonid; Halcinonida; Halcinonide; Halcinonidum",Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,halcinonide,
N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1,Lodoxamide,"Lodoxamida; Lodoxamide; N,N'-(2-chloro-5-cyano-m-phenylene)dioxamate",Launched,histamine receptor antagonist,,ophthalmology,vernal keratoconjunctivitis (VKC),lodoxamide,
NCc1ccc(S(N)(=O)=O)cc1,Mafenide,4-(aminomethyl)benzenesulfonamide; 4-Homosufanilamide; Bensulfamide; Mafenide; Maphenidum,Launched,carbonic anhydrase inhibitor,CA12|CA14|CA2|CA4|CA6|CA9,infectious disease,first-aid antibiotic|skin infections,mafenide,
Cc1nc(COP(=O)(O)O)cc(CN(CCN(CC(=O)[O-])Cc2cc(COP(=O)(O)O)nc(C)c2O)CC(=O)[O-])c1O.[Mn+2],Mangafodipir,Mangafodipir,Launched,contrast agent,,radiology,contrast agent,mangafodipir,
C1N2CN3CN1CN(C2)C3,Methenamine,"1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane; Hexamethylenamine; Hexamethylene tetramine; Hexamethylenetetramine; Hexamethylentetramin; Hexamethylentetraminum; Hexamine; Hexaminum; HMT; HMTA; metenamina; méthénamine; Methenamine; methenaminum",Launched,bacterial DNA inhibitor,,infectious disease,urinary tract infections,methenamine,
C[N@+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,Methylnaltrexone,MNTX,Launched,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,gastroenterology,constipation,methylnaltrexone,
NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N,Nepafenac,2-amino-3-benzoylbenzeneacetamide; Nepafenac; Népafénac; Nepafenaco; Nepafenacum,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,ophthalmology,eye inflammation,nepafenac,
O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,Niclosamide,Niclosamide,Launched,DNA replication inhibitor|STAT inhibitor,STAT3,infectious disease,tapeworm,niclosamide,
CCCCCCCCCc1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1,Nonoxynol-9,"26-(Nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol; Nonaethylene glycol mono(nonylphenyl) ether; Nonaethylene glycol nonylphenyl ether; Nonoxynol 9; Nonylphenol octa(oxyethylene) ethanol; P-Nonylphenyl polyethylene glycol ether; PEG-9 nonyl phenyl ether; Polyoxyethylene (9) nonyl phenyl ether; Tergitol NP-9; Tergitol NP9",Launched,membrane integrity inhibitor,,endocrinology,contraceptive,nonoxynol-9,
CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,Piperacetazine,Piperacetazine,Launched,dopamine receptor antagonist,,neurology/psychiatry,schizophrenia,piperacetazine,
c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,Plerixafor,"1,1'-(1,4-phenylenebis(methylene))bis-1,4,8,11-tetraazacyclotetradecane; 1,4,8,11-tetraazacyclotetradecane, 1,1'-(1,4-phenylenebis(methylene))bis-; Plerixafor",Launched,CC chemokine receptor antagonist,ACKR3|CCR4|CXCR4,hematologic malignancy,non-Hodgkin lymphoma (NHL)|multiple myeloma,plerixafor,
CO[C@H](C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@H]2C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@@H](O)[C@@H](C)O2)[C@H](O)[C@@H](C)O1,Plicamycin,Aureolic acid; Mithramycin; Mithramycine; Mithramycinum; Plicamicina; Plicamycin; Plicamycine; Plicamycinum,Launched,alcohol dehydrogenase inhibitor,,oncology|endocrinology,testicular carcinoma|Paget's disease|hypercalcemia,plicamycin,
CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,Polidocanol,Aethoxy-sklerol; Laureth 9; Laureth-9; Macrogol 9 lauryl ether; Nonaethylene glycol monododecyl ether; Nonaethylene glycol monolauryl ether; PEG-9 lauryl ether; Polidocanol; Polydocanol; Polyethylene glycol 450 lauryl ether; Polyoxyl 9 lauryl ether,Launched,local anesthetic,,dermatology,varicose veins,polidocanol,
C#CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,Pralatrexate,"(2S)-2-((4-((1RS)-1-((2,4-Diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic acid; (2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}amino)pentanedioic acid; 10-Propargyl-10-deazaaminopterin; N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid; PDX; Pralatrexate; Pralatrexato; Pralatrexatum",Launched,dihydrofolate reductase inhibitor,DHFR,hematologic malignancy,peripheral T-cell lymphoma (PTCL),pralatrexate,
Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,Raltegravir,Raltegravir,Launched,HIV integrase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),raltegravir,
O=C(O)CCCc1ccccc1,Phenylbutyric acid,4-Phenyl-n-butyric acid; 4-phenylbutyrate; 4-phenylbutyric acid; Benzenebutyric acid; PBA; Phenylbutyrate; γ-Phenyl-n-butyric acid; γ-phenylbutyric acid; ω-Phenylbutanoic acid; ω-phenylbutyric acid,Launched,HDAC inhibitor,HDAC1,metabolism,urea cycle disorders,phenylbutyrate,
Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,Sulconazole,Sulconazole,Launched,sterol demethylase inhibitor,,infectious disease,tinea pedis|tinea cruris|tinea corporis,sulconazole,
COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1,Sulfameter,Sulfa-5-methoxypyrimidine; Sulfameter; Sulfamethoxydiazine; Sulfametoxidiazina; Sulfametoxydiazine; Sulfametoxydiazinum,Launched,dihydrofolate reductase inhibitor,DHFR,infectious disease,urinary tract infections,sulfameter,
CC(S)C(=O)NCC(=O)O,Tiopronin,Tiopronin; Tiopronine; Tiopronino; Tioproninum,Launched,chelating agent|reducing agent,,urology,kidney stones,tiopronin,
NCCNCCNCCN,Triethylenetetramine,TETA; Trien; Trientine,Launched,chelating agent,CA14,metabolism,Wilson's disease,trientine,
CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,Triptorelin,"(6-D-Tryptophan)luteinizing hormone-releasing hormone; (D-Trp6)-GnRH; Luteinizing hormone-releasing factor (pig), 6-D-tryptophan; pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2	; Triptorelin; Triptorelina; Triptoreline; Triptorelinum",Launched,gonadotropin releasing factor hormone receptor agonist,GNRHR,oncology|endocrinology|obstetrics/gynecology,prostate cancer|breast cancer|precocious puberty|endometriosis|myoma|gender dysphoria,triptorelin,
N=C1N[C@@H](O)C[C@H]([C@@H]2NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)C[C@@H](N)CCCN)CNC2=O)N1,Viomycin,Vinacetin A; Viomicina; Viomycin; Viomycine; Viomycinum,Launched,protein synthesis inhibitor,,infectious disease,tuberculosis,viomycin,
NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1,Sulthiame,Sulthiame; Sultiame; Sultiamo; Sultiamum,Phase 3,carbonic anhydrase inhibitor,CA2,,,sultiame,
CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1,Parecoxib,N-((p-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propionamide; Parécoxib; Parecoxib; Parecoxibum,Launched,cyclooxygenase inhibitor,LTF,neurology/psychiatry,pain relief,parecoxib,
Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl,Triclosan,"2,4,4'-Trichloro-2'-hydroxydiphenyl ether; 5-Chloro-2-(2,4-dichloro-phenoxy)-phenol; Triclosán; Triclosan; Triclosanum",Launched,antibacterial agent,DNMT1,infectious disease,first-aid antiseptic,triclosan,
NC(=O)c1ccccc1O,Salicylamide,2-Carbamoylphenol; 2-Carboxamidophenol; 2-Hydroxybenzamide; o-hydroxybenzamide; OHB; Salicilamida; Salicylamide; Salicylamidum; Salicylic Acid amide,Launched,analgesic agent,,neurology/psychiatry|endocrinology,pain relief|fever,salicylamide,
c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1,Antazoline,"2-(N-Benzylanilinomethyl)-2-imidazoline; 2-(N-Phenyl-N-benzylaminomethyl)imidazoline; 4,5-Dihydro-N-phenyl-N-phenylmethyl-1H-imidazole-2-methanamine; Antazolina; Antazoline; Antazolinum",Launched,antihistamine,HRH1,ophthalmology|otolaryngology,conjunctivitis|nasal congestion,antazoline,
CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1,Dimetindene,Dimethindene; Dimetindene; Dimetindeno,Launched,cholinergic receptor antagonist|histamine receptor antagonist,HRH1,allergy,allergic rhinitis,dimetindene,
O=C(O)C(Cl)Cl,Dichloroacetic acid,DCA; Dichloracetic acid; Dichloroacetate,Phase 3,pyruvate dehydrogenase kinase inhibitor,,,,dichloroacetate,
CC(=O)Oc1cc(C(F)(F)F)ccc1C(=O)O,Triflusal,Triflusal; Triflusalum,Launched,cyclooxygenase inhibitor|platelet aggregation inhibitor|thromboxane synthase inhibitor,NFKB1|NOS2|PDE10A|PTGS1,neurology/psychiatry|cardiology,stroke|myocardial infarction|atrial fibrillation (AF),triflusal,
O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1,Lurasidone,Lurasidona; Lurasidone; Lurasidonum,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7,neurology/psychiatry,schizophrenia,lurasidone,
CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1,Ticagrelor,"(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol; Ticagrelor",Launched,purinergic receptor antagonist,P2RY12,cardiology,acute coronary syndrome (ACS)|myocardial infarction,ticagrelor,
CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/C(F)(F)COc1ccccc1,Tafluprost,Tafluprost,Launched,prostaglandin inhibitor,PTGFR,ophthalmology,glaucoma|ocular hypertension,tafluprost,
CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O,Ivacaftor,"Ivacaftor; Ivacaftorum; N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide",Launched,CFTR channel potentiator,CFTR,pulmonary,cystic fibrosis,ivacaftor,
CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,Azilsartan medoxomil,Azilsartan; Azilsartan medoxomil; Azilsartan médoxomil; Azilsartán medoxomilo; Azilsartanum medoxomilum,Launched,angiotensin receptor antagonist,AGTR1|AGTR2,cardiology,hypertension,azilsartan,
Cc1c(O)c(=O)ccn1C,Deferiprone,"1,2-Dimethyl-3-hydroxypyrid-4-one; 3-Hydroxy-1,2-dimethyl-4(1H)-pyridone; Deferiprona; Deferiprone; Défériprone; Deferipronum",Launched,chelating agent,UGT1A6,hematology,transfusional hemosiderosis|thalassemia|iron overload,deferiprone,
O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1,Lomitapide,Lomitapida; Lomitapide; Lomitapidum,Launched,microsomal trigylceride transfer protein inhibitor,MTTP,endocrinology,hypercholesterolemia,lomitapide,
CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1,Vismodegib,"2-chloro-N-(4-chloro-3-pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide; Benzamide, 2-chloro-N-(4-chloro-3-(2-pyridinyl)phenyl)-4-(methylsulfonyl)-; Vismodégib; Vismodegib; Vismodegibum",Launched,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO,oncology,basal cell carcinoma (BCC),vismodegib,
C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,Tauroursodeoxycholic acid,Tauroursodeoxycholate; Tauroursodesoxycholic acid; Taurursodiol; TUDCA; Ursodeoxycholyltaurine; Ursodoxicoltaurine,Phase 3,cholesterol inhibitor,,,,ursodeoxycholyltaurine,
O=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1,Pitavastatin,Pitavastatia; Pitavastatin; Pitavastatina; Pitavastatine; Pitavastatinum,Launched,HMGCR inhibitor,HMGCR,endocrinology,hyperlipidemia,pitavastatin,
Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,Rilpivirine,"4-{[4-({4-[(E)-2-cyanovinyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile; Rilpivirina; Rilpivirine",Launched,non-nucleoside reverse transcriptase inhibitor,NR1I2|SCN10A,infectious disease,human immunodeficiency virus (HIV-1),rilpivirine,
C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,Crizotinib,(R)-crizotinib; Crizotinib; Crizotinibum,Launched,ALK tyrosine kinase receptor inhibitor,ALK|MET,oncology,non-small cell lung cancer (NSCLC),crizotinib,
CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,Ulipristal,Ulipristal,Launched,progesterone receptor antagonist,PGR,endocrinology,contraceptive,ulipristal,
CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,Fingolimod,Fingolimod; Fingolimodum,Launched,immunosuppressant|sphingosine 1-phosphate receptor agonist,S1PR1|S1PR5,neurology/psychiatry,multiple sclerosis,fingolimod,
C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@H]3[C@H](C[C@H]4O[C@@H](CC[C@@H]1O2)C[C@@H](C)C4=C)O[C@H](C[C@H](O)CN)[C@@H]3OC,Eribulin,Eribulin; Eribulina,Launched,microtubule inhibitor,,oncology,breast cancer,eribulin,
CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C,Boceprevir,Boceprevir,Launched,HCV inhibitor,CMA1|CTSA|CTSF|CTSK|CTSL|CTSS,infectious disease,hepatitis C,boceprevir,
CCc1c(Cl)c(O)c(Cl)c(O)c1C(=O)O[C@H]1[C@H](O)[C@H](OC)[C@H](OC/C2=C\C=C\C[C@H](O)/C(C)=C/[C@H](CC)[C@@H](O[C@@H]3OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]3O)/C(C)=C/C(C)=C/C[C@@H]([C@@H](C)O)OC2=O)O[C@@H]1C,Fidaxomicin,Difimicin ; Fidaxomicin; Fidaxomicina; Lipiarmicin; Lipiarmycin; Lipiarrmycin; Tiacumicin B,Launched,RNA polymerase inhibitor,,gastroenterology,diarrhea,fidaxomicin,
COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,Cabozantinib,Cabozantinib,Launched,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET|RET,oncology,medullary thyroid cancer (MTC),cabozantinib,
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,Ruxolitinib,Ruxolitinib,Launched,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,hematologic malignancy|hematology,myelofibrosis|polycythemia vera,ruxolitinib,
C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1,Teriflunomide,"(Z)-2-cyano-alpha,alpha,alpha-trifluoro-3-hydroxy-p-crotonotoluidide; Teriflunomida; Teriflunomide; Tériflunomide; Teriflunomidum",Launched,dihydroorotate dehydrogenase inhibitor,DHODH,neurology/psychiatry,multiple sclerosis,teriflunomide,
CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,Vemurafenib,Vémurafénib; Vemurafenib; Vemurafenibum,Launched,RAF inhibitor,BRAF|RAF1,oncology,melanoma,vemurafenib,
CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Linagliptin,"(R)-8-(3-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione; Linagliptin; Linagliptina",Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,linagliptin,
CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,Carfilzomib,Carfilzomib,Launched,proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9,hematologic malignancy,multiple myeloma,carfilzomib,
C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSSC[C@H](N)C(=O)N[C@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)CSSC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC3=O)C(=O)N2,Linaclotide,"(9-L-TYROSINE)HEAT-STABLE ENTEROTOXIN (ESCHERICHIA COLI)-(6-19)-PEPTIDE; L-TYROSINE, L-CYSTEINYL-L-CYSTEINYL-L-.ALPHA.-GLUTAMYL-L-TYROSYL-L-CYSTEINYL-L-CYSTEINYL-L-ASPARAGINYL-L-PROLYL-L-ALANYL-L-CYSTEINYL-L-THREONYLGLYCYL-L-CYSTEINYL-, CYCLIC (1->6),(2->10),(5->13)-TRIS(DISULFIDE); Linaclotida; Linaclotide",Launched,guanylate cyclase activator,GUCY2C,gastroenterology,irritable bowel syndrome|constipation,linaclotide,
Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1,Mirabegron,Mirabegron,Launched,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,urology,urinary incontinence,mirabegron,
C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,Tofacitinib,Tasocitinib; Tofacitinib; Tofacitinibum,Launched,JAK inhibitor,JAK1|JAK2|JAK3,rheumatology,rheumatoid arthritis,tofacitinib,
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,Regorafenib,Regorafenib; Régorafénib; Regorafenibum,Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK,oncology,colorectal cancer|gastrointestinal stromal tumors (GIST),regorafenib,
O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1,Aclidinium,Aclidinio,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,pulmonary,bronchitis|emphysema|chronic obstructive pulmonary disease (COPD),aclidinium,
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,Enzalutamide,Enzalutamida; Enzalutamide,Launched,androgen receptor antagonist,AR,oncology,prostate cancer,enzalutamide,
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,Ponatinib,Ponatinib; Ponatinibum,Launched,Bcr-Abl kinase inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|BCR|FGFR1|FGFR2|FGFR3|FGFR4|FLT3|KDR|KIT|LCK|LYN|PDGFRA|RET|SRC|TEK,hematologic malignancy,chronic myeloid leukemia (CML)|acute lymphoblastic leukemia (ALL),ponatinib,
COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12,Bedaquiline,1-(6-Bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol; Bedaquilina; Bedaquiline; Bédaquiline; Bedaquilinum,Launched,ATPase inhibitor,,infectious disease,tuberculosis,bedaquiline,
C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@@]43C)[C@@H]1CCC2=O,Formestane,"4-hydroxy-4-androstene-3,17-dione; 4-Hydroxy-delta(4)-androstenedione; 4-hydroxy-Δ4-androstenedione; 4-hydroxyandrostenedione; 4-OH-A; 4-OHAD; Formestane; Formestano; Formestanum",Launched,aromatase inhibitor,CYP19A1,oncology,breast cancer,formestane,
Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1,Canagliflozin,Canagliflozin; Canagliflozin anhydrous; Canagliflozina,Launched,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,endocrinology,diabetes mellitus,canagliflozin,
Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,Pomalidomide,Pomalidomida; Pomalidomide,Launched,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,hematologic malignancy,multiple myeloma,pomalidomide,
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,Trametinib,Trametinib; Tramétinib; Trametinibum,Launched,MEK inhibitor,MAP2K1|MAP2K2,oncology,melanoma,trametinib,
CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,Dabrafenib,Dabrafenib,Launched,RAF inhibitor,BRAF|LIMK1|NEK11|RAF1|SIK1,oncology,melanoma,dabrafenib,
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,Afatinib,Afatinib; Afatinibum,Launched,EGFR inhibitor,EGFR|ERBB2|ERBB4,oncology,non-small cell lung cancer (NSCLC),afatinib,
C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N21,Dolutegravir,Dolutegravir,Launched,HIV integrase inhibitor,CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1,infectious disease,human immunodeficiency virus (HIV-1),dolutegravir,
COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N,Riociguat,"Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate; Riociguat; Riociguatum",Launched,guanylate cyclase stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,cardiology,hypertension,riociguat,
CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,Macitentan,Macitentán; Macitentan; Macitentanum,Launched,endothelin receptor antagonist,EDNRA|EDNRB,endocrinology,contraceptive,macitentan,
N#C/C(=C1/SC[C@@H](c2ccc(Cl)cc2Cl)S1)n1ccnc1,Luliconazole,Luliconazole,Launched,sterol demethylase inhibitor,,infectious disease,tinea pedis|tinea cruris|tinea corporis,luliconazole,
CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1,Sofosbuvir,"S)-Isopropyl 2-((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4- dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)- (phenoxy)phosphorylamino)propanoate; Sofosbuvir",Launched,HCV inhibitor,,infectious disease,hepatitis C|hepatitis C,sofosbuvir,
CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,Chlorcyclizine,Chlorcyclizin; Chlorcyclizine; Chlorcyclizinum; Clorciclicina; Clorciclizina; Clorciclizinio,Launched,histamine receptor antagonist,,allergy,allergic rhinitis,chlorcyclizine,
C[C@H](COc1ccccc1)N[C@H](C)[C@@H](O)c1ccc(O)cc1,Isoxsuprine,Isoxsuprine,Launched,adrenergic receptor agonist,ADRB2,rheumatology|cardiology,Raynaud's disease|arteriosclerosis|Buerger's disease,isoxsuprine,
Cc1cc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)no1,Isoxicam,Isoxicam; Isoxicamo; Isoxicamum,Withdrawn,cyclooxygenase inhibitor,PTGS1|PTGS2,,,isoxicam,
Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1,Isoconazole,Isoconazol; Isoconazole; Isoconazolum,Launched,fungal lanosterol demethylase inhibitor,CYP17A1,infectious disease,gram-positive bacterial infections,isoconazole,
C[C@H](O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I,Iopamidol,Iopamidol; Iopamidolum,Launched,radiopaque medium,,radiology,contrast agent,iopamidol,
O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1,Indoramin,Indoramin; Indoramina; Indoramine; Indoraminum,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C,urology|cardiology,benign prostatic hyperplasia (BPH)|hypertension,indoramin,
CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1,Hexetidine,Esetidina; Hexetidina; Hexétidine; Hexetidine; Hexetidinum,Launched,local anesthetic,,otolaryngology|infectious disease|dental|gastroenterology,pharyngitis|meningitis|laryngitis|gingivitis|ulcerative colitis,hexetidine,
C/C(=C(/CCO)SSCC1CCCO1)N(C=O)Cc1cnc(C)nc1N,Fursultiamine,Fursultiamina; Fursultiamine; Fursultiaminum; Thiamin tetrahydrofurfuryl disulfide; Thiamine tetrahydrofurfuryl disulfide; TTFD,Launched,vitamin B,,metabolism,thiamine deficiency,fursultiamine,
O=C(OCC(O)CO)c1ccccc1Nc1ccnc2c(C(F)(F)F)cccc12,Floctafenine,Floctafenina; Floctafenine; Floctafeninum,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief,floctafenine,
O=C(O)CCC(=O)c1ccc(-c2ccccc2)cc1,Fenbufen,"3-(4-Biphenylylcarbonyl)propionic acid; 3-(4-Phenylbenzoyl)propionic acid; 4-(4-Biphenylyl)-4-oxobutyric acid; Fenbufén; Fenbufen; Fenbufène; Fenbufenum; gamma-oxo(1,1'-biphenyl)-4-butanoic acid",Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief,fenbufen,
CCNCC(O)c1cccc(O)c1,Etilefrine,Etilefrina; Etilefrine; Etilefrinum,Launched,adrenergic receptor agonist,ADRA1A|ADRB1,neurology/psychiatry|otolaryngology|endocrinology|pulmonary,headache|nasal congestion|fever|cough suppressant|common cold,etilefrine,
COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O,Diosmin,"3',5,7-trihydroxy-4'-methoxyflavone 7-rhamnoglucoside; 3',5,7-trihydroxy-4'-methoxyflavone-7-rutinoside; diosmetin 7-neohesperidoside; Diosmetin 7-O-rutinoside; Diosmin; Diosmina; Diosmine; Diosminum",Launched,aryl hydrocarbon receptor agonist|capillary stabilizing agent,AHR,cardiology|hematology|dermatology,chronic venous insufficiency (CVI)|edema|deep vein thrombosis (DVT)|statis dermatitis|heavy leg syndrome,diosmin,
CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC,Articaine,Articaína; Articaine; Articainum,Launched,local anesthetic,,neurology/psychiatry,local anesthetic,articaine,
CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1,Bromhexine,"3,5-dibromo-N(alpha)-cyclohexyl-N(alpha)-methyltoluene-alpha-2-diamine; Bromexina; Bromhexina; Bromhexine; Bromhexinum; N-cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)amine",Launched,mucolytic agent,,pulmonary,chest congestion,bromhexine,
CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1,Bisacodyl,"Bisacodilo; Bisacodyl; Bisacodyle; Bisacodylum; Phenol, 4,4'-(2-pyridinylmethylene)bis-, diacetate (ester)",Launched,laxative,,gastroenterology,constipation,bisacodyl,
COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1nc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5[nH]c([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5c4)ccc2-3)c[nH]1)C(C)C,Ledipasvir,Ledipasvir; Lédipasvir; Ledipasvirum,Launched,HCV inhibitor,,infectious disease,hepatitis C,ledipasvir,
CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1,Vorapaxar,"[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-{(E)-2-[5-(3-Fluorophényl)-2-pyridinyl]vinyl}-1-méthyl-3-oxododécahydronaphto[2,3-c]furan-6-yl]carbamate d'éthyle; Carbamic acid, [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-fluorophenyl)-2- pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, ethyl ester; Carbamic acid, N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(E)-2-[5-(3-fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, ethyl ester; Ethyl N-[(3R,3aS,4S,4aR,7R,8aR,9aR)-4-[(E)-2-[5-(3-fluorophenyl)-2-pyridyl]vinyl]-3-methyl-1-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-3H-benzo[f]isobenzofuran-7-yl]carbamate; Vorapaxar",Launched,thrombin inhibitor,F2R,cardiology,myocardial infarction|peripheral artery disease (PAD),vorapaxar,
CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Miltefosine,HDPC; hexadecyl 2-(trimethylazaniumyl)ethyl phosphate; Hexadecylphosphocholine; Hexadecylphosphorylcholine; Miltefosin; Miltefosina; Miltéfosine; Miltefosine; Monohexadecylphosphocholine; Monohexadecylphosphorylcholine,Launched,membrane integrity inhibitor,PLA2G1B,infectious disease,leishmaniasis,miltefosine,
OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,Empagliflozin,"(1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol; 1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene; Empagliflozin; Empagliflozina; Empagliflozine; Empagliflozinum",Launched,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,endocrinology,diabetes mellitus,empagliflozin,
CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2,Eliglustat,"Eliglustat; éliglustat; Eliglustatum; N-[(1R,2R)-1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-(1-pyrrolidinyl)-2-propanyl]octanamide",Launched,glycosyl transferase inhibitor,UGCG,hematology,Gaucher disease,eliglustat,
C=C1CCN([C@H](C)[C@](O)(Cn2cncn2)c2ccc(F)cc2F)CC1,Efinaconazole,"(2R,3R)-2-(2,4-Difluorophenyl)-3-(4-methylene-1-piperidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol; efinaconazol; Efinaconazole",Launched,lanosterol demethylase inhibitor,CYP51A1,infectious disease,onychomycosis,efinaconazole,
OB1OCc2cc(F)ccc21,Tavaborole,"5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole; 5-Fluoro-2,1-benzoxaborol-1(3H)-ol; Tavaborole",Launched,leucyl-tRNA synthetase inhibitor,,infectious disease,onychomycosis,tavaborole,
N#Cc1c(N2C[C@@H]3NCCO[C@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Finafloxacin,"8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid; Finafloxacin; gastrochinolon; gastroquinolone",Launched,bacterial DNA gyrase inhibitor,,infectious disease|pulmonary,intra-abdominal infections|chronic obstructive pulmonary disease (COPD)|cystic fibrosis,finafloxacin,
Cc1ccccc1-c1cc(N2CCN(C)CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,Netupitant,"2-[3,5-Bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl]propanamide; Netupitant",Launched,tachykinin antagonist,TACR1,gastroenterology,nausea|vomiting,netupitant,
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](OCCOCCOCCOCCOCCOCCOCCOC)CC[C@@]3(O)[C@H]1C5,Naloxegol,"(5α,6α)-17-Allyl-6-[(20-hydroxy-3,6,9,12,15,18-hexaoxaicos-1-yl)oxy]-4,5-epoxymorphinan-3,14-diol; Naloxegol",Launched,opioid receptor antagonist,OPRM1,gastroenterology,constipation,naloxegol,
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,Ibrutinib,"1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one; Ibrutinib",Launched,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,hematologic malignancy,chronic lymphocytic leukemia (CLL)|mantle cell lymphoma (MCL)|Waldenstrom's macroglobulinemia (WM),ibrutinib,
CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,Idelalisib,5-Fluoro-3-phenyl-2-((S)-1-(9H-purin-6-ylamino)-propyl)-3H-quinazolin-4-one; 5-fluoro-3-phenyl-2-[(1S)-1-(3H-purin-6-ylamino)propyl]quinazolin-4(3H)-one; Idelalisib,Launched,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,hematologic malignancy,chronic lymphocytic leukemia (CLL),idelalisib,
Cc1cnc(C(=O)O)c[n+]1[O-],Acipimox,Acipimox,Launched,cholesterol inhibitor,HCAR2,endocrinology,hyperlipidemia,acipimox,
CCC(C)(C)c1ccc(CC(C)CN2C[C@H](C)O[C@H](C)C2)cc1,Amorolfine,Amorolfin; Amorolfina; Amorolfine,Launched,membrane integrity inhibitor,,infectious disease,onychomycosis,amorolfine,
CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,Atosiban,Atosiban,Launched,oxytocin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,neurology/psychiatry|cardiology|endocrinology,stroke|angina pectoris|myocardial infarction|hyperlipidemia,atosiban,
NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O,Avibactam,Avibactam,Launched,beta lactamase inhibitor,,infectious disease,intra-abdominal infections|urinary tract infections|pyelonephritis,avibactam,
Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1,Ceritinib,Ceritinib; Céritinib; Ceritinibum; N-{2-[(5-chloro-2-{[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}propane-2-sulfonamide,Launched,ALK tyrosine kinase receptor inhibitor,ALK|FLT3|IGF1R|INSR|TSSK1B,oncology,non-small cell lung cancer (NSCLC),ceritinib,
CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O,Ciprofibrate,Ciprofibrate; ciprofibrato,Launched,PPAR receptor agonist,PPARA,endocrinology,hyperlipidemia,ciprofibrate,
CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,Cobicistat,"1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2S)-2-({[(2-isopropyl-1,3-thiazol-4-yl)methyl](methyl)carbamoyl}amino)-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphenylhexan-2-yl]carbamate; Cobicistat",Launched,cytochrome P450 inhibitor,CYP3A4|CYP3A43|CYP3A5|CYP3A7,infectious disease,human immunodeficiency virus (HIV-1),cobicistat,
Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,Vortioxetine,Vortioxetina; Vortioxétine; Vortioxetine; vortioxetinum,Launched,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4,neurology/psychiatry,depression,vortioxetine,
COc1ccc(CN2CCNCC2)c(OC)c1OC,Trimetazidine,"1-[2,3,4-trimethoxybenzyl] piperazine dihydrochloride; Trimetazidina; Trimetazidine",Launched,3-ketoacyl CoA thiolase inhibitor,ACAA2,cardiology,angina pectoris,trimetazidine,
C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)C1=C(CC(=O)CC1)C[C@H]3C,Tibolone,17-hydroxy-7alpha-methyl-19-nor-17alpha-pregn-5(10)-en-20-yn-3-one; tibolona; Tibolone; tibolonum,Launched,androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist,ESR1,obstetrics/gynecology,endometriosis,tibolone,
CCC(=O)NC[C@@H]1C[C@H]1c1cccc2c1CCO2,Tasimelteon,"N-{[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide; Tasimelteón; Tasimeltéon; Tasimelteon; Tasimelteonum",Launched,melatonin receptor agonist,MTNR1A|MTNR1B,neurology/psychiatry,Non-24-Hour Sleep-Wake Disorder,tasimelteon,
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,Palbociclib,"6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one; Palbociclib",Launched,CDK inhibitor,CDK4|CDK6,oncology,breast cancer,palbociclib,
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,Olaparib,4-(3-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorobenzyl)phthalazin-1(2H)-one; Olaparib,Launched,PARP inhibitor,PARP1|PARP2,oncology,ovarian cancer,olaparib,
CN1CCc2nc(C(=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@@H]3NC(=O)C(=O)Nc3ccc(Cl)cn3)sc2C1,Edoxaban,Edoxaban,Launched,coagulation factor inhibitor,F10,neurology/psychiatry|hematology|cardiology,stroke|pulmonary embolism (PE)|systemic embolism|deep vein thrombosis (DVT)|atrial fibrillation (AF),edoxaban,
OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2,Umeclidinium,1-[2-(benzyloxy)ethyl]-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane; Umeclidinium,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,pulmonary,chronic obstructive pulmonary disease (COPD)|bronchitis|emphysema,umeclidinium,
COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,Lenvatinib,4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide; Lenvatinib,Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,oncology,thyroid cancer,lenvatinib,
COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,Nintedanib,"methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate; Nintedanib",Launched,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,pulmonary,idiopathic pulmonary fibrosis (IPF),nintedanib,
COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O,Idebenone,"2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-1,4-benzoquinone; 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-p-benzoquinone; 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione; 2,3-dimethoxy-5-methyl-6-(10'-hydroxydecyl)-1,4-benzoquinone; 6-(10-hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone; 6-(10-hydroxydecyl)-2,3-dimethoxy-5-methyl-p-benzoquinone; idebenona; idébénone; Idebenone",Launched,calcium channel modulator,,neurology/psychiatry|ophthalmology,Alzheimer's disease|Friedreich's ataxia|Leber hereditary optic neuropathy (LHON),idebenone,
OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O,Vilanterol,Vilanterol; Vilantérol; Vilanterolum,Launched,adrenergic receptor agonist,ADRB2,pulmonary,chronic obstructive pulmonary disease (COPD),vilanterol,
COc1cc2c(cc1OC)CC(=O)N(CCCN(C)C[C@H]1Cc3cc(OC)c(OC)cc31)CC2,Ivabradine,"3-[3-({[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino)propyl]-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one; Ivabradin; Ivabradina; Ivabradine; Ivabradinum",Launched,HCN channel blocker|potassium channel blocker|sodium channel blocker,HCN1|HCN3|HCN4,cardiology,angina pectoris,ivabradine,
CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12,Benzydamine,Bencidamina; Benzydamine; Benzydaminum,Launched,prostanoid receptor antagonist,,dental|otolaryngology,mouth inflammation|throat inflammation,benzydamine,
CCCCNc1ccc(C(=O)OCCN(C)C)cc1,Tetracaine,2-(dimethylamino)ethyl 4-(butylamino)benzoate; 2-(Dimethylamino)ethyl p-(butylamino)benzoate; Amethocaine; Amethocaine HCl; Diäthylaminoäthanol ester der p-butylaminobenzösäure; Dicaine; Medihaler-Tetracaine; Metraspray; p-(butylamino)benzoic acid β-(dimethylamino)ethyl ester ; p-Butylaminobenzoyl-2-dimethylaminoethanol; Tetracaína; Tétracaïne; Tetracaine; Tetracaine HCl,Launched,membrane integrity inhibitor,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,anesthetic,tetracaine,
C=CCc1ccc(O)c(OC)c1,Eugenol,Eugenol,Launched,androgen receptor antagonist,AR,dental,toothache,eugenol,
CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,Trimebutine,"2-Dimethylamino-2-phenylbutyl 3,4,5-trimethoxybenzoat; Trimébutine; Trimebutine; Trimebutino",Launched,opioid receptor agonist,OPRD1|OPRK1|OPRM1,gastroenterology,irritable bowel syndrome,trimebutine,
COc1cc(Br)c(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)cc1OC,Pinaverium,,Launched,T-type calcium channel blocker,CACNA1C,gastroenterology,irritable bowel syndrome,pinaverium,
CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12,Chlortetracycline,Chlortétracycline; Chlortetracycline; Chlortetracyclinum; Clortetraciclina,Launched,protein synthesis inhibitor,,ophthalmology,conjunctivitis,chlortetracycline,
CCCN1C[C@@H](NS(=O)(=O)N(CC)CC)C[C@@H]2Cc3c(O)cccc3C[C@H]21,Quinagolide,"(+-)-N,N-Diethyl-N'-((3R*,4aR*,10aS*)-1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1-propylbenzo(g)quinolin-3-yl)sulfamide; Quinagolida; Quinagolide; Quinagolidum",Launched,dopamine receptor agonist,DRD2,endocrinology,hyperprolactinemia,quinagolide,
C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O,Somatostatin,Somatostatin; Somatostatina; Somatostatine; Somatostatinum; Synthetic growth hormone release-inhibiting hormone; Synthetic somatostatin-14,Launched,somatostatin receptor agonist,OPRD1|OPRM1|SSTR1|SSTR2|SSTR3|SSTR4|SSTR5,hematology,hemorrhage,somatostatin,
COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,Elvitegravir,"6-(3-chloro-2-fluorobenzyl)-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; elvitégravir; Elvitegravir; EVG; GS 9137",Launched,HIV integrase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),elvitegravir,
COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C,Daclatasvir,BMS-790052; Daclatasvir,Launched,HCV inhibitor,,infectious disease,hepatitis C,daclatasvir,
Oc1c(I)cc(I)c2cccnc12,Diiodohydroxyquinoline,Diiodohydroxyquin; Diiodohydroxyquinoline; Iodoquinol; Ioquin,Launched,antiseptic,,infectious disease,amebiasis,iodoquinol,
CC(C)(C)C(O)/C=C/c1ccc2c(c1)OCO2,Stiripentol,"1-(1,3-Benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol; 4,4-Dimethyl-1-((3,4-methylenedioxy)phenyl)-1-penten-3-ol; Estiripentol; Stiripentol; Stiripentolum",Launched,GABA uptake inhibitor,GABRA3,neurology/psychiatry,epilepsy,stiripentol,
OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O,Aurothioglucose,Auromyose; Aurothioglucose; Gold thioglucose,Launched,PKC inhibitor,PRKCI,rheumatology,rheumatoid arthritis,aurothioglucose,
C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N,Dienogest,"17-alpha-Cyanomethyl-17-beta-hydroxy-estra-4,9(10)-dien-3-one; 17alpha-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile; Dienogest; Dienogestril; Dienogestum; Endometrion",Launched,progesterone receptor agonist,PGR,endocrinology|obstetrics/gynecology,contraceptive|endometriosis,dienogest,
O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,Brexpiprazole,Brexpiprazole; Lu-AF41156,Launched,dopamine receptor partial agonist,DRD2,neurology/psychiatry,depression|schizophrenia,brexpiprazole,
O=C(NCC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(N(CCO)C(=O)CO)c1I,Ioversol,"Ioversol; N,N'-Bis (2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl) -glycolamido] -2,4,6-triiodoisophthalamide; Optiray",Launched,radiopaque medium,,radiology,contrast agent,ioversol,
CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCCO)c(I)c(C(=O)NCC(O)CO)c1I,Ioxilan,"Ioxilan; Ioxilane; Ioxilanum; N-(2,3-dihydroxypropyl)-N’-(2- hydroxyethyl)-5-[N-(2,3-dihydroxypropyl) acetamido]-2,4,6-triiodoisophthal-amide",Launched,radiopaque medium,,radiology,angiography,ioxilan,
Cc1c(C(=O)Nc2ccc(N3C[C@H](C)O[C@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1,Sonidegib,"Erismodegib; N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridin-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide; Sonidegib",Launched,smoothened receptor antagonist,SMO,oncology,basal cell carcinoma (BCC),sonidegib,
COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I,Iopromide,"Iopromida; Iopromide; N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methylisophthalamide",Launched,radiopaque medium,,radiology,contrast agent,iopromide,
CN(C)CC/C=C1\c2ccccc2CSc2ccccc21,Dosulepin,"(3E)-3-dibenzo[b,e]thiepin-11(6H)-ylidene-N,N-dimethylpropan-1-amine; 11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenzo(b,e)thiepin; Dosulepin; Dosulepina; Dosulépine; Dosulepinum; Dothiepin; trans-dothiepin",Launched,norepinephrine reuptake inhibitor|serotonin–norepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4,neurology/psychiatry,depression,dosulepin,
COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C,Dasabuvir,"Sodium 3-(3-tert-butyl-4-methoxy-5-{6­ [(methylsulfonyl)amino]naphthalene-2-yl}phenyl)-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-ide hydrate (1:1:1); Dasabuvir; N-{6-[3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl}methanesulfonamide",Launched,HCV inhibitor,,infectious disease,hepatitis C,dasabuvir,
CCOc1ccccc1OCC1CNCCO1,Viloxazine,2-((2-Ethoxyphenoxy)methyl)morpholine; Viloxazina; Viloxazine; Viloxazinum,Launched,norepinephrine reuptake inhibitor,SLC6A2,neurology/psychiatry,depression,viloxazine,
CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C,Moxisylyte,(2-(4-ACETOXY-2-ISOPROPYL-5-METHYLPHENOXY)ETHYL)DIMETHYLAMINE; 6-ACETOXYTHYMOL 2-(DIMETHYLAMINO)ETHYL ETHER; Moxisylyte; Thymoxamine,Withdrawn,adrenergic receptor antagonist,,,,moxisylyte,
NC(=O)CN1CCCC1=O,Piracetam,Piracetam; Piracetamum,Launched,acetylcholine receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,neurology/psychiatry,senile dementia,piracetam,
CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1,Loxoprofen,Loxoprofen; Loxoprofene; Loxoprofeno; Loxoprofenum,Launched,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGS2,neurology/psychiatry,pain relief,loxoprofen,
O=C(NCCO[N+](=O)[O-])c1cccnc1,Nicorandil,2-Nicotinamidoethyl nitrate; N-(2-Hydroxyethyl)nicotinamide nitrate; N-(2-Hydroxyethyl)nicotinamide nitrate (ester); Nicorandil; Nicorandilum,Launched,nitric oxide donor|potassium channel activator,KCNJ11,cardiology,angina pectoris,nicorandil,
CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,Zotepine,Zotepina; Zotepine,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2B|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR6|HTR7|SLC6A2|SLC6A4,neurology/psychiatry,schizophrenia,zotepine,
CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C,Lacidipine,Lacidipine; Lacidipino,Launched,calcium channel blocker,CACNA1C,cardiology,hypertension,lacidipine,
CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl,Levamlodipine,Levamlodipine; Levoamlodipine; S-amlodipine,Launched,calcium channel blocker,,cardiology,hypertension,levamlodipine,
COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1,Manidipine,Manidipine; Manidipino,Launched,calcium channel blocker,CACNA1C|CACNA1D,cardiology,hypertension,manidipine,
COc1nc(C)nc(Cl)c1NC1=NCCN1,Moxonidine,"(2R,4R)-1-[(2S)-5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8- quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid; Moxonidina; Moxonidine; Moxonidinum",Launched,imidazoline receptor agonist,ADRA2A|ADRA2B|ADRA2C,cardiology,hypertension,moxonidine,
O=c1cc(O)c(Cl)c[nH]1,Gimeracil,"5-Chloro-2,4-dihydroxypyridine; 5-Chloro-4-hydroxy-2-pyridone; Gimeracil; gimestat; Teysuno; Ts-1 (TN)",Launched,dihydropyrimidine dehydrogenase inhibitor,DPYD,oncology,gastric adenocarcinoma,gimeracil,
COc1ccc(CN(C(=O)[C@@H](N)Cc2c(C)cc(C(N)=O)cc2C)[C@@H](C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,Eluxadoline,"5-({(4-carbamoyl-2,6-dimethyl-L-phenylalanyl)[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino}methyl)-2-methoxybenzoic acid; Eluxadoline",Launched,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,gastroenterology,irritable bowel syndrome,eluxadoline,
C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(=O)O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4,Artesunate,"Artesunate; Artesunato; Artesunatum; Artesunic acid; AS; butanedioic acid, 1-[(3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-yl] ester; dihydroqinghasu hemsuccinate; Succinyl dihydroartemisinin",Launched,DNA synthesis inhibitor,,infectious disease,malaria,artesunate,
Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1,Lumacaftor,"3-(6-{[1-(2,2-difluoro-2H-1,3-benzodioxol-5-yl)cyclopropane-1-carbonyl]amino}-3-methylpyridin-2-yl)benzoic acid; Lumacaftor",Launched,CFTR channel agonist,CFTR,pulmonary,cystic fibrosis,lumacaftor,
CCOC(=O)[N-]c1c[n+](N2CCOCC2)no1,Molsidomine,Molsidomina; Molsidomine; Molsidominum,Launched,guanylate cyclase stimulant,GUCY1A3,cardiology,coronary artery disease (CAD),molsidomine,
C[C@@H](OC[C@@]1(c2ccccc2)CC[C@]2(CCC(=O)N2)CN1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,Rolapitant,Rolapitant,Phase 3,neurokinin receptor antagonist,,,,rolapitant,
CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O,Sacubitril,Sacubitril; Sacubitrilo,Launched,neprilysin inhibitor,MME,cardiology,congestive heart failure,sacubitril,
COC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc([C@@H]2CC[C@@H](c3ccc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)OC)C(C)C)cc3)N2c2ccc(C(C)(C)C)cc2)cc1)C(C)C,Ombitasvir,"dimethyl ([(2S,5S)-1-(4-tert-butylphenyl)pyrrolidine-2,5-diyl]bis{(4,1-phenylene)carbamoyl(2S)pyrrolidine-2,1-diyl[(2S)-3-methyl-1-oxobutane-1,2-diyl]})biscarbamate; Ombitasvir",Launched,HCV inhibitor,,infectious disease,hepatitis C,ombitasvir,
Cc1cnc(C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@@]3(C(=O)NS(=O)(=O)C3CC3)NC(=O)[C@@H]3C[C@@H](Oc4nc5ccccc5c5ccccc45)CN3C2=O)cn1,Paritaprevir,"(2R,6S,12Z,13aR,14aR,16aS)-N-(cyclopropanesulfonyl)-6-[(5-methylpyrazine-2-carbonyl)amino]-5,16-dioxo-2-[(phenanthridin-6-yl)oxy]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide; Paritaprevir; Veruprevir",Launched,HCV inhibitor,,infectious disease,hepatitis C,paritaprevir,
CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O,Sulbactam,"(2S,5R)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid 4,4-dioxide; (2S,5R)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide; Penicillanic acid 1,1-dioxide; Penicillanic acid sulfone; Sulbactam; Sulbactamum",Launched,beta lactamase inhibitor,,infectious disease,skin infections|intra-abdominal infections|gynecologic infections,sulbactam,
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,Osimertinib,Mereletinib; N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide; Osimertinib; Osimertinibum,Launched,EGFR inhibitor,EGFR,oncology,non-small cell lung cancer (NSCLC),osimertinib,
CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC,Propoxycaine,Propoxycaine,Launched,local anesthetic,,neurology/psychiatry,anesthetic,propoxycaine,
N=C1CCCN1Cc1[nH]c(=O)[nH]c(=O)c1Cl,Tipiracil,"5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione; 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1H-pyrimidine-2,4-dione; Tipiracil; Tipiracilo",Launched,thymidine phosphorylase inhibitor,,oncology,colorectal cancer,tipiracil,
CCCCOc1ccc(OCCCN2CCOCC2)cc1,Pramocaine,Pramocaína; Pramocaine; Pramoxine,Launched,topical anesthetic,,dermatology,corticosteroid-responsive dermatoses,pramoxine,
O=C1CCO1,Propiolactone,"1,3-propiolactone; 3-propanolide; beta-Propiolactone; betapron; Propiolactona; Propiolactone; β-propiolactone",Launched,,,infectious disease,antiseptic,propiolactone,
CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1,Levobetaxolol,(S)-betaxolol; Levobetaxolol,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,ophthalmology,intraocular pressure|glaucoma,levobetaxolol,
CC(N)Cc1ccc(O)cc1,Hydroxyamphetamine,4-(2-aminopropyl)phenol; 4-hydroxyamphetamine; dl-4-hydroxyamphetamine; dl-p-hydroxyamphetamine; Hydroxyamphetamine; p-hydroxyamphetamine,Launched,trace amine associated receptor agonist,TAAR1,ophthalmology,mydriasis,hydroxyamphetamine,
Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1,Sulfabenzamide,N-Benzoylsulfanilamide; N-Sulfanilylbenzamide; Sulfabenzamida; Sulfabenzamide; Sulfabenzamidum; Sulfabenzoylamide; Sulfamylbenzamide,Launched,bacterial antifolate,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,sulfabenzamide,
CC(C)(CO)[C@@H](O)C(=O)NCCCO,Dexpanthenol,"(+)-Panthenol; (2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide; Bepanthen; Bepanthene; Bepantol; D-panthenol; D-panthenol 50; D-Pantothenol; D-Pantothenyl alcohol; D(+)-Panthenol; Dexpantenol; Dexpanthenol; Dexpanthenolum; Pantol; Pantothenyl alcohol; Provitamin B",Launched,,,gastroenterology,paralytic ileus,dexpanthenol,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C,Norethynodrel,Norethynodrel; Noretynodrel; Noretynodrelum,Launched,progestogen hormone,PGR,endocrinology,contraceptive,noretynodrel,
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO,Meprednisone,Meprednisone,Launched,,NR3C1,,,meprednisone,
C/C1=C2/N=C(/C=C3\N=C(/C(C)=C4\[N-]C([C@H](CC(N)=O)[C@@]4(C)CCC(=O)NC[C@@H](C)OP(=O)([O-])O[C@@H]4[C@@H](CO)O[C@H](n5cnc6cc(C)c(C)cc65)[C@@H]4O)[C@]4(C)N=C1[C@@H](CCC(N)=O)[C@]4(C)CC(N)=O)[C@@H](CCC(N)=O)C3(C)C)[C@@H](CCC(N)=O)[C@]2(C)CC(N)=O.[60Co+3].[C-]#N,Cyanocobalamin Co-60,Cyanocobalamin (60Co); Cyanocobalamin Co 60; Cyanocobalamine (60 Co); Cyanocobalaminum (60 Co); Vitamin B12 - 60Co,Launched,methylmalonyl CoA mutase stimulant|vitamin B,MUT,hematology|infectious disease|gastroenterology,anemia|fish tapeworm infestation|celiac disease,cyanocobalamin,
C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21CC,Norgestrel,17-ethynyl-17-hydroxy-18a-homoestr-4-en-3-one; LD norgestrel; Methylnorethindrone; Norgestrel; Norgestrelum,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1,endocrinology,contraceptive,norgestrel,
C[75Se]CC[C@H](N)C(=O)O,Selenomethionine Se-75,Selenomethionine (75 Se); Selenomethionine (75Se); Selenomethionine Se 75; Selenometionina (75 Se),Launched,,,,,selenomethionine,
O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12,Isosorbide,Isosorbide,Launched,nitric oxide stimulant,,cardiology,angina pectoris|coronary artery disease (CAD),isosorbide,
CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,Meglumine,1-deoxy-1-methylaminosorbitol; Iosulamide; Meglumina; Méglumine; Meglumine; Megluminum; N-methyl-D-glucamine,Launched,excipient,,,,meglumine,
O=C[C@H](O)[C@@H](O)[C@H](O)CO,Xylose,(+)-Xylose; aldehydo-D-xylose; D-Xylose; Wood sugar; Xylose,Launched,,,,,xylose,
NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1,Protirelin,5-oxo-L-prolyl-L-histidyl-L-prolinamide; L-pyroglutamyl-L-histidyl-L-prolineamide; Protirelin; Protirelina; Thyroliberin; Thyrotropic releasing hormone; Thyrotropic-releasing factor; Thyrotropin releasing hormone; Thyrotropin-releasing factor; TRH; TSH-releasing factor; TSH-releasing hormone,Launched,thyrotropin releasing hormone receptor agonist,TRHR,radiology,thyroid function diagnostic,protirelin,
C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O,Enalaprilat,Enalaprilat; Enalaprilat anhydrous,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension,enalaprilat,
Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1,Acrivastine,(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid; acrivastina; Acrivastine,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis,acrivastine,
COc1ccc(C(=O)CC(=O)c2ccc(C(C)(C)C)cc2)cc1,Avobenzone,Avobenzone; Butyl Methoxydibenzoylmethane; Parsol 1789,Launched,topical sunscreen agent,,dermatology,cosmetic|sunscreen lotion,avobenzone,
CCCCC(CC)COC(=O)/C=C/c1ccc(OC)cc1,Octinoxate,ethylhexyl methoxycinnamate; ethylhexyl p-methoxycinnamate; Octinoxate; octyl methoxycinnamate; parsol,Launched,,,dermatology,sunscreen lotion,octinoxate,
N[13C](N)=O,Urea C-13,"(13C)urea; 13C-urea; Carbon 13 urea; Carbon-13 urea; Urea (13C); Urea 13 C; Urea C 13; Urea-13C; Urea, C-13",Launched,hydroxy radical formation stimulant,ARG1|CA2|CTNNB1,dermatology,psoriasis|xerosis cutis|ichthyosis vulgaris|eczema|keratosis|dermatitis,urea,
N[14C](N)=O,Urea C-14,"14C-urea; Carbon 14 urea; Carbon-14 urea; Urea (14C); Urea 14 C; Urea C 14; Urea-14C; Urea, C-14",Launched,hydroxy radical formation stimulant,ARG1|CA2|CTNNB1,dermatology,psoriasis|xerosis cutis|ichthyosis vulgaris|eczema|keratosis|dermatitis,urea,
COc1ccc(O)cc1,Mequinol,4-Methoxyphenol; Mequinol,Launched,,TYR,dermatology,skin depigmentation,mequinol,
Oc1ccc(O)cc1,Hydroquinone,"1,4-benzenediol; 1,4-dihydroxybenzene; 4-Hydroxyphenol; benzene-1,4-diol; Hydroquinone; p-Benzenediol; p-Hydroquinone; p-hydroxyphenol; Quinol",Launched,melanin inhibitor,TYR,dermatology,dyschromia,hydroquinone,
CCCCC(CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1,Octocrylene,Octocrileno; Octocrilenum; Octocrylene,Launched,,,dermatology,sunscreen lotion,octocrylene,
CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(OC)cc1)c1ncccn1,Thonzonium,Tonzonium,Launched,ATPase inhibitor,,infectious disease,ear infections,thonzonium,
CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O,Ixazomib,"((1R)-1-((2,5-DICHLOROBENZAMIDO)ACETAMIDO)-3-METHYLBUTYL)BORONIC ACID; 2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diacetic acid; BORONIC ACID, B-((1R)-1-((2-((2,5-DICHLOROBENZOYL)AMINO)ACETYL)AMINO)-3-METHYLBUTYL)-; Ixazomib",Launched,proteasome inhibitor,,hematologic malignancy,multiple myeloma,ixazomib,
CCCCC(CC)COC(=O)c1ccccc1O,Octisalate,2-Ethylhexyl 2-hydroxybenzoate; 2-Ethylhexyl salicylate; Octisalate; Octyl salicylate,Launched,,,dermatology,sunscreen lotion,octisalate,
CC1CC(OC(=O)c2ccccc2O)CC(C)(C)C1,Homosalate,"3,3,5-Trimethylcyclohexyl 2-hydroxybenzoate; Homosalate; Homosalato; Homosalatum",Preclinical,HSP inducer,,,,homosalate,
CCCCCCCCCCCCCCCC[n+]1ccccc1,Cetylpyridinium,1-hexadecylpyridinium,Launched,,,dental,gingivitis|mouth inflammation,cetylpyridinium,
Oc1cccc(O)c1,Resorcinol,"1,3-Benzenediol; 1,3-Dihydroxybenzene; 1,3-Dihydroxybenzol; m-Hydroquinone; m-hydroxyphenol; Resorcinol; Resorzin",Launched,phosphodiesterase inhibitor,CA12|CA14|CA2|PTGS1,dermatology,acne vulgaris (AV)|eczema|psoriasis|seborrheic dermatitis,resorcinol,
CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O,Docusate,Dioctyl sulfosuccinate; Docusate hydrogen,Launched,laxative,,gastroenterology,constipation,docusate,
NC(=O)NC1NC(=O)NC1=O,Allantoin,"(2,5-Dioxo-4-imidazolidinyl)urea; 2,5-Dioxo-4-imidazolidinyl-urea; 4-ureido-2,5-imidazolidinedione; 5-Ureido-2,4-imidazolidindione; 5-Ureidohydantoin; Alantoína; Allantoin; Glyoxyldiureide; N-(2,5-Dioxo-4-imidazolidinyl)urea",Launched,cosmetic,,dermatology,skin protectant,allantoin,
CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O,N-acetyltyrosine,(+)-(2s)-2-(acetylamino)-3-(4-hydroxyphenyl)propanoic acid; (2s)-2-acetylamino-3-(4-hydroxyphenyl)propanoic acid; Acetyl tyrosine; L-N-acetyltyrosine; Melanowhite-A; N-acetyl-L-tyrosine; N-acetyl-tyrosine; N-acetyltyrosin,Launched,,,,,N-acetyl-tyrosine,
Cc1cc(O)cc(C)c1Cl,Chloroxylenol,"2-chloro-5-hydroxy-1,3-dimethylbenzene; 2-chloro-5-hydroxy-m-xylene; 2-Chloro-m-xylenol; 3,5-dimethyl-4-chlorophenol; 4-chloro-1-hydroxy-3,5-dimethylbenzene; 4-chloro-3,5-dimethylphenol; 4-chloro-m-xylenol; chloro-xylenol; Chloroxylenol; cloroxilenol; p-chloro-3,5-xylenol; p-chloro-m-xylenol; parachlorometaxylenol; PCMX",Launched,ATP synthase inhibitor,,infectious disease,skin infections,chloroxylenol,
CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1,Benzethonium,,Launched,sodium channel blocker,SCN10A,infectious disease,first-aid antiseptic,benzethonium,
C[Se]CC[C@H](N)C(=O)O,Selenomethionine,,Launched,,,,,selenomethionine,
Oc1cccc2cccnc12,Oxyquinoline,8-Hydroxyquinoline; hydroxybenzopyridine; Hydroxyquinoline; oxine; Oxyquinoline; Phenopyridine,Launched,chelating agent,METAP2,dermatology,cosmetic,oxyquinoline,
CCCCOC(=O)c1ccc(N)cc1,Butamben,Butamben; Butyl aminobenzoate,Withdrawn,sodium channel blocker,,,,butamben,
O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1,Triclocarban,"1-(3',4'-dichlorophenyl)-3-(4'-chlorophenyl)urea; 3,4,4'-trichloro carbanilide; 3,4,4'-trichlorocarbanilide; 3,4,4'-trichlorodiphenylurea; N-(4-chlorophenyl)-N'-(3,4-dichlorophenyl)urea; Triclocarban",Launched,other antibiotic,,infectious disease,first-aid antiseptic,triclocarban,
CN1CCCN=C1/C=C/c1cccs1,Pyrantel,Pirantel; Pyrantel; Pyrantelum,Launched,acetylcholine receptor agonist|nicotinic receptor agonist,,infectious disease,gastrointestinal roundworms,pyrantel,
O=C1c2c(O)cccc2Cc2cccc(O)c21,Anthralin,Anthralin; Dithranol; Ditranol,Launched,DNA synthesis inhibitor,,dermatology,psoriasis,dithranol,
CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2,Homatropine,Homatropina; Omatropina,Launched,acetylcholine receptor antagonist,CHRM1,ophthalmology,uveal tract inflammation|pupil dilation,homatropine,
CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1,Pentoxyverine,Carbetapentane; Pentoxyverine,Launched,acetylcholine receptor antagonist,CHRM2,otolaryngology|pulmonary,common cold|nasal congestion|bronchitis,carbetapentane,
CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO,Pantethine,Bis(pantothenamidoethyl) disulfide; D-Bis(N-pantothenyl-beta-aminoethyl) disulfide; D-pantethine; Pantethine; Pantetina; Pantomin,Launched,coenzyme A precursor,,,,pantethine,
CCCCC(CC)COc1ccc(-c2nc(-c3ccc(OC)cc3)nc(-c3ccc(OCC(CC)CCCC)cc3O)n2)c(O)c1,Bemotrizinol,Bemotrizinol; BEMT,Launched,,,dermatology,sunscreen lotion,bemotrizinol,
OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O,Arbutin,4-Hydroxyphenyl-beta-D-glucopyranoside; beta-Arbutin; hydroquinone O-β-D-glucopyranoside; Hydroquinone-O-beta-D-glucopyranoside; p-hydroxyphenyl β-D-glucopyranoside; p-hydroxyphenyl β-D-glucoside,Phase 2/Phase 3,melanin inhibitor,TYR,,,arbutin,
Cc1ccc(/C=C2/C(=O)C3(C)CCC2C3(C)C)cc1,Enzacamene,(+/-)-3-(p-methylbenzylidene)camphor; 3-(4-methylbenzylidene)camphor; 3-(p-Methylbenzylidene)-DL-camphor; 4-MBC; 4-methylbenzylidene camphor; enzacamène; Enzacamene; Enzacamene D-L form; enzacameno; enzacamenum; Methyl benzylidene camphor,Launched,endocrine disruptor,,dermatology,sunscreen lotion,3-(4-methylbenzylidene)camphor,
COc1ccc(C(=O)c2ccccc2O)c(O)c1,Dioxybenzone,"2,2'-Dihydroxy-4-methoxybenzophenone; Dioxybenzone",Preclinical,topical sunscreen agent,,,,dioxybenzone,
CC(C)=CCC/C(C)=C/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C=C(\C)CCC=C(C)C,Lycopene,,Launched,free radical scavenger,,,,lycopene,
COc1ccc(CN(CCN(C)C)c2ncccn2)cc1,Thonzylamine,neohetramine; Thonzylamine,Launched,antihistamine,,neurology/psychiatry,itching,thonzylamine,
CCCCCCc1ccc(O)cc1O,Hexylresorcinol,"4-hexyl-1,3-benzenediol; 4-hexylresorcinol; Hexylresorcinol",Launched,local anesthetic,TYR,infectious disease,skin infections|first-aid antiseptic,hexylresorcinol,
CC(C)(C)CC(C)(C)c1cc(Cc2cc(C(C)(C)CC(C)(C)C)cc(-n3nc4ccccc4n3)c2O)c(O)c(-n2nc3ccccc3n2)c1,Bisoctrizole,Bisoctrizole; MBBT,Phase 2,,,,,bisoctrizole,
OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,Polydatin,"3,4,5-Trihydroxystilbene-3-beta-monoglucoside; 3,4',5-trihydroxystilbene-3-β-d-glucoside; Piceid; Polydatin (E)-isomer; Resveratrol 3-O-beta-glucopyranoside; resveratrol-3-O-b-mono-D-glucoside; trans-piceid; trans-resveratrol 3-O-β-D-glucoside; trans-resveratrol 3-β-D-glucoside; trans-resveratrol 3-β-glucoside",Phase 2,ICAM1 expression inhibitor,ICAM1,,,polydatin,
CCN(CC)C(=O)c1cccc(C)c1,Diethyltoluamide,"3-methyl-N,N-diethylbenzamide; DEET; diethyl toluamide; Diethyltoluamide; diéthyltoluamide; diethyltoluamidum; dietiltoluamida; N,N-diethyl-m-toluamide",Launched,ionotropic receptor IR40a activator,,dermatology,sunscreen lotion,diethyltoluamide,
C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21,Methscopolamine,Methylscopolamine,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,gastroenterology,peptic ulcer disease (PUD),methscopolamine,
c1coc(CNc2ncnc3nc[nH]c23)c1,Kinetin,,Launched,cell division inducer,,dermatology,sunburn,kinetin,
COc1ccccc1O,Guaiacol,1-hydroxy-2-methoxybenzene; 2-methoxyl-4-vinylphenol; 2-methoxyphenol; Guaiacol; o-guaiacol; o-hydroxyanisole; o-Methoxyphenol; Pyrocatechol monomethyl ether; Pyroguaiac acid,Launched,local anesthetic,CA2,pulmonary,cough suppressant,guaiacol,
CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,Selexipag,Selexipag,Launched,IP1 prostacyclin receptor agonist|platelet aggregation inhibitor,PTGIR,pulmonary,pulmonary arterial hypertension (PAH),selexipag,
CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,Alectinib,"9-ethyl-6,6-dimethyl-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile; Alectinib",Launched,ALK tyrosine kinase receptor inhibitor,ALK|MET,oncology,non-small cell lung cancer (NSCLC),alectinib,
CC(C)(O)C(Cl)(Cl)Cl,Chlorobutanol,Chloretone; Chlorobutanol,Launched,,,neurology/psychiatry,anesthetic|sedative,chlorobutanol,
CO/N=C1\C[C@]2(C[C@@H]3C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C4\CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@H](/C(C)=C/C(C)C)[C@H]1C,Moxidectin,Moxidectin; Moxidectina; Moxidectinum,Launched,chloride channel antagonist,,infectious disease,gastrointestinal parasites,moxidectin,
CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1,Butacaine,Butacaina; Butacaine; Butacainum,Launched,local anesthetic,,neurology/psychiatry,local anesthetic,butacaine,
CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O,Dihydrostreptomycin,"DHMS; Dihidroestreptomicina; Dihydrostreptomycin; Dihydrostreptomycine; Dihydrostreptomycinum; DST; N,N'''-[(1R,2R,3S,4R,5R,6S)-4-({5-deoxy-2-O-[2-deoxy-2-(methylamino)-a-L-glucopyranosyl]-3-C-(hydroxymethyl)-a-L-lyxofuranosyl}oxy)-2,5,6-trihydroxycyclohexane-1,3-diyl]diguanidine; N,N'''-[(1R,2R,3S,4R,5R,6S)-4-({5-deoxy-2-O-[2-deoxy-2-(methylamino)-alpha-L-glucopyranosyl]-3-C-(hydroxymethyl)-alpha-L-lyxofuranosyl}oxy)-2,5,6-trihydroxycyclohexane-1,3-diyl]diguanidine; N,N'''-[(1R,2R,3S,4R,5R,6S)-4-({5-deoxy-2-O-[2-deoxy-2-(methylamino)-α-L-glucopyranosyl]-3-C-(hydroxymethyl)-α-L-lyxofuranosyl}oxy)-2,5,6-trihydroxycyclohexane-1,3-diyl]diguanidine",Withdrawn,bacterial 30S ribosomal subunit inhibitor,,,,dihydrostreptomycin,
O=C(O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12,Lesinurad,"{[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid; Lesinurad",Launched,uric acid diuretic,SLC22A12,rheumatology,gout,lesinurad,
COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc3c(c2)O[C@@H](c2ccccc2)n2c-3cc3cc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)ccc32)[nH]1)C(C)C,Elbasvir,Elbasvir,Launched,HCV inhibitor,,infectious disease,hepatitis C,elbasvir,
C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)O[C@@H]1C[C@H]1CCCCCc1nc3ccc(OC)cc3nc1O2)C(=O)NS(=O)(=O)C1CC1,Grazoprevir,Grazoprevir; Grazoprevir anhydrous,Launched,HCV inhibitor,,infectious disease,hepatitis C,grazoprevir,
CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1,Venetoclax,"4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzamide; 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide; 4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-(3-nitro-4-{[(oxan-4-yl)methyl]amino}benzene-1-sulfonyl)-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide",Launched,BCL inhibitor,BCL2,hematologic malignancy,chronic lymphocytic leukemia (CLL),venetoclax,
C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,Asunaprevir,Asunaprevir,Phase 3,HCV inhibitor,,,,asunaprevir,
CC[Hg]Sc1ccccc1C(=O)[O-].[Na+],Thimerosal,[(o-carboxyphenyl)thio]ethylmercury sodium salt; BTL-TML-COVID; BTL-TML-HSV; BTL-TML001; ethyl(2-mercaptobenzoato-S)mercury sodium salt; ethylmercurithiosalicylate sodium; ethylmercurithiosalicylic acid sodium salt; mercurothiolate; o-(ethylmercurithio)benzoic acid sodium salt; sodium ethylmercurithiosalicylate; sodium merthiolate; Thimerosal; Thiomersal; Thiomersalate; Thiomersalum; Tiomersal,Launched,other antibiotic,OXCT1,infectious disease,preservative,thiomersal,
CCOCCn1c(C2CCN(CCc3ccc(C(C)(C)C(=O)O)cc3)CC2)nc2ccccc21,Bilastine,Bilastina; Bilastine,Launched,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis,bilastine,
CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1,Domiphen,"(beta-phenoxyethyl)dimethyldodecylammonium; 1-dodecanaminium, n,n-dimethyl-n-(2-phenoxyethyl); Dodecyldimethyl(2-phenoxyethyl)ammonium; Domiphen cation; Domiphen ion; Phenododecinium",Preclinical,,,,,domiphen,
CS(=O)(=O)c1cccc(C[C@H](NC(=O)c2c(Cl)cc3c(c2Cl)CCN(C(=O)c2ccc4ccoc4c2)C3)C(=O)O)c1,Lifitegrast,Lifitegrast,Launched,lymphocyte function-associated antigen negative modulator,,ophthalmology,dry eye syndrome,lifitegrast,
COC[C@H]1C[C@@H](c2ncc(-c3ccc4c(c3)COc3cc5c(ccc6nc([C@@H]7CC[C@H](C)N7C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c65)cc3-4)[nH]2)N(C(=O)[C@H](NC(=O)OC)c2ccccc2)C1,Velpatasvir,Velpatasvir; Velpatasvirum,Launched,antiviral,,infectious disease,hepatitis C,velpatasvir,
Cc1cncc(CN2CCC(=C3c4ccc(Cl)cc4CCc4cccnc43)CC2)c1,Rupatadine,Rupatadina; Rupatadine,Launched,histamine receptor antagonist|platelet activating factor receptor antagonist,HRH1|PTAFR,allergy,allergic rhinitis|urticaria,rupatadine,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21CC,Gestrinone,Ethylnorgestrienone; Gestrinona; Gestrinone; Gestrinonum,Launched,progesterone receptor antagonist,AR|ESR1|PGR,obstetrics/gynecology,endometriosis,gestrinone,
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C(=O)C[C@@H]4CC(=O)CC[C@]4(C)[C@H]3CC(=O)[C@@]21C,Dehydrocholic acid,"3,7,12-Triketo-5beta-cholanoic acid; 3,7,12-triketocholanic acid; 3,7,12-trioxo-5beta-cholanic acid; 3,7,12-trioxo-5β-cholanic acid; 3,7,12-trioxocholanic acid; Decholin; Dehydrocholate; Dehydrocholic acid",Preclinical,,,,,dehydrocholate,
CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3,Laropiprant,Laropiprant,Launched,prostanoid receptor antagonist,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R,cardiology,cholesterol,laropiprant,
Oc1cccc(-c2c3nc(c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4nc(c(-c5cccc(O)c5)c5ccc2[nH]5)CC4)C=C3)c1,Temoporfin,"2,3-dihydro-5,10,15,20-tetra(m-hydroxyphenyl)porphyrin; m-THPC; meso-tetrahydroxyphenylchlorin; Temoporfin",Launched,radical formation stimulant,,oncology,head and neck squamous cell carcinoma (HNSCC),temoporfin,
Cc1c(Cl)c(C)[n+]([O-])c(Cl)c1-c1noc(-c2cc(O)c(O)c([N+](=O)[O-])c2)n1,Opicapone,Opicapona; Opicapone,Phase 3,catechol O methyltransferase inhibitor,COMT,,,opicapone,
C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@](O)(Cn1cncn1)c1cc(F)ccc1F,Isavuconazole,isavuconazol; Isavuconazole; isavuconazolum,Phase 3,cytochrome P450 inhibitor,CYP3A4,,,isavuconazole,
C[C@]1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,Delamanid,"(2R)-2-methyl-6-nitro-2-((4-(4-(4-(trifluoromethoxy)phenoxy)piperidin-1-yl)phenoxy)methyl)-2,3-dihydroimidazo(2,1-B)(1,3)oxazole; (R)-2-methyl-6-nitro-2-{4-[4-(4-trifluoromethoxyphenoxy)piperidin-1-yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-b]oxazole; Delamanid; Imidazo(2,1-B)oxazole, 2,3-dihydro-2-methyl-6-nitro-2-((4-(4-(4-(trifluoromethoxy)phenoxy)-1-piperidinyl)phenoxy)methyl)-, (2R)-",Launched,bacterial cell wall synthesis inhibitor,,infectious disease,tuberculosis,delamanid,
C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4,Artenimol,Artenimol; beta-Dihydroartemisinin; Dihydroartemisinin,Launched,antimalarial agent,,infectious disease,malaria,dihydroartemisinin,
Nc1ccncc1N,Amifampridine,"3,4 diaminopyridine; 3,4-DAP; 3,4-Diaminopyridine; 3,4-Pyridinediamine; 4,5-Diaminopyridine; Amifampridine; DAP",Launched,potassium channel blocker,,neurology/psychiatry,Lambert-Eaton myasthenic syndrome (LEMS),amifampridine,
CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32,Vinflunine,"20',20'-difluoro-3',4'-dihydrovinorelbine; 4'-deoxy-20',20'-difluoro-5'-norvincaleukoblastine; 4'-deoxy-20',20'-difluoro-8'-norvincaleukoblastine; Vinflunina; Vinflunine; Vinfluninum",Launched,microtubule inhibitor,,oncology,bladder cancer,vinflunine,
Clc1ccc(CCCOCCCN2CCCCC2)cc1,Pitolisant,Pitolisant,Launched,histamine receptor antagonist,HRH3,,,pitolisant,
Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1,Tucatinib,Tucatinib,Phase 3,EGFR inhibitor,ERBB2,,,tucatinib,
O=C(NC(Cc1cc(=O)[nH]c2ccccc12)C(=O)O)c1ccc(Cl)cc1,Rebamipide,Rebamipida; Rebamipide; Rébamipide; Rebamipidum,Launched,free radical scavenger,FPR1,gastroenterology,peptic ulcer disease (PUD)|gastritis,rebamipide,
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,Curcumin,Curcumin; Diferuloylmethane,Launched,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CHRM3|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH,,,curcumin,
CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O,Treosulfan,DIHYDROXYBUSULFAN; OVASTAT; Treosulfan,Launched,DNA synthesis inhibitor,,oncology,ovarian cancer,treosulfan,
CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12,Fruquintinib,Fruquintinib,Launched,VEGFR inhibitor,KDR,oncology,colorectal cancer,fruquintinib,
O=C(O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O,Daprodustat,"Daprodustat; Glycine, N-((1,3-dicyclohexylhexahydro-2,4,6-trioxo-5-pyrimidinyl)carbonyl)-",Phase 3,hypoxia inducible factor inhibitor,EGLN1,,,daprodustat,
Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,Selumetinib,Selumetinib; Sélumétinib; Selumetinibum,Phase 3,MEK inhibitor,MAP2K1,,,selumetinib,
C=C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,Voclosporin,Voclosporin,Phase 3,calcineurin inhibitor,,,,voclosporin,
C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1,Pacritinib,Pacritinib; Pacritinibum,Phase 3,FLT3 inhibitor|JAK inhibitor,FLT3|JAK1|JAK2|JAK3,,,pacritinib,
CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)c1c[nH]c3ccccc13)C2,Tropisetron,Tropisetron,Launched,serotonin receptor antagonist,GLRA1|GLRA2|GLRB|HTR3A|HTR4,gastroenterology,nausea|vomiting,tropisetron,
CC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](C)NC1=O,Setmelanotide,Setmelanotida; Setmelanotide; Setmélanotide; Setmelanotidum,Phase 3,melanocortin receptor agonist,,,,setmelanotide,
CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,Acalabrutinib,Acalabrutinib; Acalabrutinibum,Launched,Bruton's tyrosine kinase (BTK) inhibitor,BTK,hematologic malignancy,mantle cell lymphoma (MCL),acalabrutinib,
CC(C)(CO)c1cc2cc(NC(=O)C3(c4ccc5c(c4)OC(F)(F)O5)CC3)c(F)cc2n1C[C@@H](O)CO,Tezacaftor,Tezacaftor,Launched,CFTR channel agonist,,pulmonary,cystic fibrosis,tezacaftor,
COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1,Encorafenib,Encorafenib,Launched,RAF inhibitor,BRAF,oncology,melanoma,encorafenib,
CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1,Ribociclib,Ribociclib,Launched,CDK inhibitor,CDK4|CDK6,oncology,breast cancer,ribociclib,
CN1CCC(C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1,Lasmiditan,Lasmiditan,Launched,serotonin receptor agonist,,,,lasmiditan,
C1COC(NC(C2CC2)C2CC2)=N1,Rilmenidine,HYPERIUM; Rilmenidine,Launched,adrenergic receptor agonist|imidazoline receptor agonist,ADRA2A,cardiology,hypertension,rilmenidine,
CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccnc2)c1,Vonoprazan,1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine; Vonoprazan,Launched,potassium-competitive acid antagonist,ATP4A,gastroenterology,peptic ulcer disease (PUD),vonoprazan,
CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,Ebastine,Ebastina; Ebastine,Launched,histamine receptor antagonist,CYP3A4|HRH1,allergy,allergic rhinitis|urticaria,ebastine,
C/C(=C(\CCOP(=O)(O)O)SC(=O)c1ccccc1)N(C=O)Cc1cnc(C)nc1N,Benfotiamine,Benfotiamina; Benfotiamine; Benphothiamine; Benzoylthiamine monophosphate; S-benzoylthiamine monophosphate,Launched,antioxidant,AGER,rheumatology,lumbago,benfotiamine,
C[C@H]1CO[C@@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,Cabotegravir,Cabotegravir,Phase 3,HIV integrase inhibitor,,,,cabotegravir,
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,Rifamycin,Rifamicina; Rifamicine SV; Rifamycin; Rifamycin SV; Rifamycine; Rifamycinum; Rifomycin SV,Launched,DNA directed RNA polymerase inhibitor,SLCO1A2|SLCO1B1|SLCO1B3|SLCO2B1,infectious disease,tuberculosis|leprosy,rifamycin,
CCn1c(=O)c2c(nc(/C=C/c3ccc(OC)c(OC)c3)n2C)n(CC)c1=O,Istradefylline,Istradefylline,Launched,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,neurology/psychiatry,Parkinson's Disease|dyskinesia,istradefylline,
Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1,Talazoparib,Talazoparib,Launched,PARP inhibitor,PARP2,oncology,breast cancer,talazoparib,
CN1Cc2c(Cl)cc(Cl)cc2[C@H](c2cccc(S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)c2)C1,Tenapanor,Tenapanor,Launched,sodium/hydrogen exchanger inhibitor,,,,tenapanor,
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,Niraparib,Niraparib,Launched,PARP inhibitor,PARP1,oncology,primary peritoneal cancer (PPC),niraparib,
COc1cnc(-n2cnc(C)n2)c2c1c(C(=O)C(=O)N1CCN(C(=O)c3ccccc3)CC1)cn2COP(=O)(O)O,Fostemsavir,Fostemsavir,Phase 3,antiviral,,,,fostemsavir,
O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c(O)c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2,Bictegravir,Bictegravir,Launched,HIV integrase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),bictegravir,
COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,Tivozanib,Tivozanib,Launched,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,oncology,renal cell carcinoma (RCC),tivozanib,
CNC(=N)NCCC[C@H](N)C(=O)O,Tilarginine,L-Monomethylarginine; L-Ng-monomethyl Arginine; L-NMMA; N-Methylarginine; N-Monomethyl-L-arginine; N(G)-Methylarginine; N(G)-Monomethyl-L-arginine; N5-(Methylamidino)-L-ornithine; NG-Monomethyl-L-arginine; omega-N-Methylarginine; omega-N-Monomethylarginine; Targinine; Tilarginine,Phase 3,nitric oxide synthase inhibitor,NOS3,,,targinine,
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,Baricitinib,Baricitinib,Launched,JAK inhibitor,JAK1|JAK2,rheumatology,rheumatoid arthritis,baricitinib,
CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1,Nifurtimox,Nifurtimox; Nifurtimoxum,Launched,DNA inhibitor,,infectious disease,Chagas disease|African trypanosomiasis,nifurtimox,
CCOc1ccc(Cc2cc([C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1,Ertugliflozin,"(1S,2S,3S,4R,5S)-5-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol; 1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-β-L-idopyranose; Ertugliflozin; β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-",Launched,sodium/glucose cotransporter inhibitor,SLC5A2,endocrinology,diabetes mellitus,ertugliflozin,
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,Neratinib,Neratinib,Launched,EGFR inhibitor,EGFR|ERBB2|KDR,oncology,breast cancer,neratinib,
N#Cc1ccc([C@H]2CCc3cncn32)c(F)c1,Osilodrostat,Osilodrostat,Launched,cytochrome P450 inhibitor,,,,osilodrostat,
CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1,Relugolix,Relugolix,Phase 3,gonadotropin releasing factor hormone receptor antagonist,,,,relugolix,
CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1,Revefenacin,Revefenacin,Launched,cholinergic receptor antagonist,,,,revefenacin,
CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,Apalutamide,Apalutamide,Launched,androgen receptor antagonist,,oncology,prostate cancer,apalutamide,
COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2,Valbenazine,Valbenazine,Launched,vesicular monoamine transporter inhibitor,,neurology/psychiatry,dyskinesia,valbenazine,
CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C,Deflazacort,"11.BETA.,21-DIHYDROXY-2'-METHYL-5'.BETA.H-PREGNA-1,4-DIENO(17,16-D)OXAZOLE-3,20-DIONE 21-ACETATE; 5'H-PREGNA-1,4-DIENO(17,16-D)OXAZOLE-3,20-DIONE, 21-(ACETYLOXY)-11-HYDROXY-2'-METHYL-, (11.BETA.,16.BETA.)-; Deflazacort",Launched,glucocorticoid receptor agonist,NR3C1,rheumatology,joint inflammation,deflazacort,
Cc1ccc(-c2ccc(C)cn2)nc1,Abametapir,"5,5'-Dimethyl-2,2'-bipyridine; 5,5'-Dimethyl-2,2'-dipyridyl; Abametapir",Phase 3,metalloproteinase inhibitor,MMP9,,,abametapir,
O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1,Selinexor,Selinexor,Launched,exportin antagonist,XPO1,hematologic malignancy,multiple myeloma,selinexor,
Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(O)C4)c(Cl)c32)c(F)cc1F,Delafloxacin,Delafloxacin,Phase 3,antiinfective drug,,,,delafloxacin,
Cc1ncc(OC[C@@]2(c3cccc(F)c3)C[C@H]2C(=O)Nc2ccc(F)cn2)c(C)n1,Lemborexant,Lemborexant,Launched,orexin receptor antagonist,HCRTR1|HCRTR2,,,lemborexant,
C[C@H](Nc1ncnc2[nH]cnc12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1,Duvelisib,Duvelisib,Launched,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,,,duvelisib,
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1,Dacomitinib,Dacomitinib; Dacomitinib anhydrous; Dacomitinibum,Launched,EGFR inhibitor,EGFR|ERBB2|ERBB4,,,dacomitinib,
Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21,Binimetinib,Binimetinib,Launched,MEK inhibitor,MAP2K1|MAP2K2,oncology,melanoma,binimetinib,
CN1CC[C@@H](NC(=O)Nc2ccc(C#N)cc2)C[C@@H]1c1nc2ccccc2[nH]1,Glasdegib,Glasdegib,Launched,hedgehog pathway inhibitor,SMO,hematologic malignancy,acute myeloid leukemia (AML),glasdegib,
COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(C[C@H](NCCCC(=O)O)c3ccccc3)c2=O)c1F,Elagolix,Elagolix,Launched,gonadotropin releasing factor hormone receptor antagonist,GNRHR,,,elagolix,
CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,Entrectinib,"Entrectinib; N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide",Launched,ALK tyrosine kinase receptor inhibitor|proto-oncogene tyrosine protein kinase inhibitor,ALK|NTRK1|NTRK2|NTRK3|ROS1,oncology,non-small cell lung cancer (NSCLC),entrectinib,
O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1,Benznidazole,Benznidazol; Benznidazole; Benznidazolum,Launched,DNA synthesis inhibitor,,infectious disease,Chagas disease,benznidazole,
CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O,Diacerein,Diacerein; Diacereína,Launched,interleukin inhibitor,IL1B,rheumatology,osteoarthritis,diacerein,
O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1,Avatrombopag,Avatrombopag,Launched,thrombopoietin receptor agonist,MPL,hematology,thrombocytopenia,avatrombopag,
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,Abemaciclib,Abemaciclib,Launched,CDK inhibitor,CDK4|CDK6,oncology,breast cancer,abemaciclib,
COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,Fostamatinib,Fostamatinib,Launched,SYK inhibitor,SYK,hematology,chronic immune thrombocytopenia (ITP),fostamatinib,
Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,Alpelisib,Alpelisib,Launched,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,oncology,breast cancer,alpelisib,
CCC/N=C1\S/C(=C\c2ccc(OC[C@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C,Ponesimod,Ponesimod,Phase 3,sphingosine 1-phosphate receptor agonist,S1PR1,,,ponesimod,
O=C(NN1C(=O)[C@H]2[C@H]3C=C[C@H]([C@@H]4C[C@H]34)[C@H]2C1=O)c1ccc(C(F)(F)F)cc1,Tecovirimat,ST-246; Tecovirimat,Launched,orthopoxvirus egress inhibitor,,infectious disease,smallpox,tecovirimat,
COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1,Letermovir,Letermovir,Launched,CMV terminase inhibitor,,infectious disease,cytomegalovirus (CMV),letermovir,
O=C(O)C[C@@H]1CC[C@H](NC(=O)Cc2cccs2)B(O)O1,Vaborbactam,Vaborbactam,Launched,beta lactamase inhibitor,,,,vaborbactam,
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)OCOC(=O)[C@@H]1N2C(=O)C[C@H]2S(=O)(=O)C1(C)C,Sultamicillin,Sultamicilina; Sultamicillin; Sultamicillinum,Launched,antibacterial,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,sultamicillin,
C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21,Lorlatinib,Lorlatinib,Launched,ALK tyrosine kinase receptor inhibitor,ALK,oncology,non-small cell lung cancer (NSCLC),lorlatinib,
CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1,Gilteritinib,Gilteritinib,Launched,FLT3 inhibitor,FLT3,,,gilteritinib,
COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,Erdafitinib,Erdafitinib,Launched,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4,,,erdafitinib,
CCCCCCCCCCCCCCCCOCCCOP(=O)(O)CO[C@H](CO)Cn1ccc(N)nc1=O,Brincidofovir,Brincidofovir; Cidofovir hexadecyloxypropyl ester,Phase 3,antiviral,,,,brincidofovir,
C[N+](C)(C)CCOP(=O)([O-])OP(=O)(O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@H](O)[C@@H]1O,Citicoline,CDP-choline; CDP-colina; citicolina; Citicoline; citidin difosfato de colina; Cytidine 5'-(choline diphosphate); Cytidine 5'-(cholinyl pyrophosphate); Cytidine 5'-diphosphocholine; Cytidine 5'-diphosphoric choline; Cytidine-5'-diphosphocholine,Launched,glutathione transferase stimulant|membrane permeability enhancer,ACHE|SLC1A2,neurology/psychiatry|ophthalmology,stroke|Alzheimer's disease|senile dementia|Parkinson's Disease|attention-deficit/hyperactivity disorder (ADHD)|glaucoma,citicoline,
CC1(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)cc2)O1,Landiolol,Landiolol; Landiololum,Launched,adrenergic receptor antagonist,ADRB1,cardiology,cardiac arrythmia,landiolol,
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1[C@@H](O)[C@@H](O)[C@@H]2O,Estetrol,15α-hydroxyestriol; Estétrol; Estetrol; Estetrolum; Oestetrol,Phase 3,selective estrogen receptor modulator (SERM),ESR1,,,estetrol,
OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(OCCOC4CC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,Bexagliflozin,"(2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-(2-(cyclopropyloxy)ethoxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; Bexagliflozin; D-glucitol, 1,5-anhydro-1-C-(4-chloro-3-((4-(2-(cyclopropyloxy)ethoxy)phenyl)methyl)phenyl)-, (1s)-",Phase 3,solute carrier family member inhibitor,,,,bexagliflozin,
CC1=NN(c2ccccc2)C(=O)C1,Edaravone,"1-phenyl-3-methyl-5-oxo-2-pyrazoline; 2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one; 3-methyl-1-phenyl-2-pyrazolin-5-one; 3-methyl-1-phenyl-5-pyrazolone; 3-methyl-1-phenylpyrazol-5-one; Edaravone; Methylphenylpyrazolone; Norphenazone; Phenyl methyl pyrazolone; Phenylmethylpyrazolone",Launched,nootropic agent,BCL2,neurology/psychiatry,stroke,edaravone,
CSc1nc2cc(Oc3cccc(Cl)c3Cl)c(Cl)cc2[nH]1,Triclabendazole,Triclabendazole,Launched,microtubule inhibitor,DNMT1,infectious disease,tapeworm,triclabendazole,
O=C(O)CNC(=O)c1ncc(-c2cccc(Cl)c2)cc1O,Vadadustat,"Glycine, N-((5-(3-chlorophenyl)-3-hydroxy-2-pyridinyl)carbonyl)-; N-(5-(3-Chlorophenyl)-3-hydroxypyridine-2-carbonyl)glycine; Vadadustat",Phase 3,hypoxia inducible factor prolyl hydroxylase inhibitor,,,,vadadustat,
CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1,Fexinidazole,Fexinidazole,Phase 3,,,,,fexinidazole,
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,Brigatinib,Brigatinib,Launched,ALK tyrosine kinase receptor inhibitor|EGFR inhibitor,ALK|EGFR,oncology,non-small cell lung cancer (NSCLC),brigatinib,
CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1,Propiverine,Propiverina; Propiverine,Launched,acetylcholine receptor antagonist,CHRM1,urology,urinary incontinence,propiverine,
CN1CCOC(c2ccccc2)c2ccccc2C1,Nefopam,Nefopam,Launched,cyclooxygenase inhibitor,,neurology/psychiatry,pain relief,nefopam,
Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)n[nH]c1=O,Doravirine,Doravirine; Doravirinum,Launched,non-nucleoside reverse transcriptase inhibitor,,,,doravirine,
C[C@]12C(=O)OC(=O)[C@@]1(C)[C@@H]1CC[C@H]2O1,Cantharidin,"1,2-Dimethyl-3,6-epoxyperhydrophthalic anhydride; Cantharidin; Cantharidine; Cantharone; exo-1,2-cis-Dimethyl-3,6-epoxyhexahydrophthalic anhydride; Kantharidin",Launched,protein phosphatase inhibitor,,dermatology,blisters,cantharidin,
CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)CN5CCCC5)cc(F)c4C[C@H]3C[C@@H]12,Eravacycline,Eravacyclina; Eravacycline; Eravacyclinum,Launched,antibacterial,,,,eravacycline,
CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,Rucaparib,Rucaparib,Phase 3,PARP inhibitor,PARP1|PARP2,,,rucaparib,
O=C(O)CN(CC(=O)O)CC(O)CN(CC(=O)O)CC(=O)O,Diaminopropanol tetraacetic acid,DAPT; Diaminohydroxypropanetetraacetic acid,Preclinical,gamma secretase inhibitor,,,,DAPT,
COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1,Betrixaban,"Betrixaban; N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide; N-(5-chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide",Launched,coagulation factor inhibitor,KCNH2,hematology,deep vein thrombosis (DVT),betrixaban,
CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1,Siponimod,Siponimod,Launched,sphingosine 1-phosphate receptor modulator,S1PR1,neurology/psychiatry,multiple sclerosis,siponimod,
O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O,Relebactam,Relebactam; Relebactam anhydrous,Launched,beta lactamase inhibitor,,,,relebactam,
CCO[C@H](COc1ccc(C(F)(F)F)cc1)CSc1ccc(OCC(=O)O)c(C)c1,Seladelpar,"((4-(((2R)-2-ETHOXY-3-(4-(TRIFLUOROMETHYL)PHENOXY)PROPYL)THIO)-2-METHYLPHENYL)OXY)ACETIC ACID; (4-(((2R)-2-ETHOXY-3-(4-(TRIFLUOROMETHYL)PHENOXY)PROPYL)SULFANYL)-2-METHYLPHENOXY)ACETIC ACID PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) AGONIST,ANTIHYPERLIPIDAEMIC; (R)-2-(4-((2-ETHOXY-3-(4-(TRIFLUOROMETHYL)PHENOXY)PROPYL)-THIO)-2-METHYLPHENOXY)ACETIC ACID; ACETIC ACID, (4-(((2R)-2-ETHOXY-3-(4-(TRIFLUOROMETHYL)PHENOXY)PROPYL)THIO)-2-METHYLPHENOXY)-; ACETIC ACID, (4-(((2R)-2-ETHOXY-3-(4-(TRIFLUOROMETHYL)PHENOXY)PROPYL)THIO)-2-METHYLPHENOXY)- ((4-(((2R)-2-ETHOXY-3-(4-(TRIFLUOROMETHYL)PHENOXY)PROPYL)THIO)-2-METHYLPHENYL)OXY)ACETIC ACID; ACETIC ACID, 2-(4-(((2R)-2-ETHOXY-3-(4-(TRIFLUOROMETHYL)PHENOXY)PROPYL)THIO)-2-METHYLPHENOXY)-; Seladelpar",Phase 3,PPAR receptor agonist,,,,seladelpar,
O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,Bromperidol,Bromperidol,Launched,dopamine receptor antagonist,DRD2,neurology/psychiatry,schizophrenia,bromperidol,
COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21,Remimazolam,Remimazolam,Phase 3,benzodiazepine receptor agonist,GABBR1,,,remimazolam,
CN(C)c1cc(CNCC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,Omadacycline,Amadacycline; Omadacycline,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,pneumonia,omadacycline,
N[C@@H]1c2cccnc2[C@H](OC(=O)N2CCC(n3c(=O)[nH]c4ncccc43)CC2)CC[C@H]1c1cccc(F)c1F,Rimegepant,Rimegepant,Launched,calcitonin antagonist,CALCA,,,rimegepant,
NC(=O)c1nc(F)cnc1O,Favipiravir,Fapilavir; Favilavir; Favipiravir,Phase 3,RNA polymerase inhibitor,,,,favipiravir,
O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1,Taurolidine,Taurolidine,Launched,apoptosis stimulant,,infectious disease,catheter-related bloodstream infection,taurolidine,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C,Lynestrenol,Lynestrenol,Launched,progestogen hormone,,endocrinology,contraceptive,lynestrenol,
COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21,Copanlisib,"2-AMINO-N-(7-METHOXY-8-(3-(MORPHOLIN-4-YL)PROPOXY)-2,3-DIHYDROIMIDAZO(1,2-C)QUINAZOLIN-5-YL(PYRIMIDINE-5-CARBOXAMIDE; 2-AMINO-N-(7-METHOXY-8-(3-MORPHOLIN-4-YLPROPOXY)-2,3-DIHYDROIMIDAZO(1,2-C)QUINAZOLIN-5-YL)PYRIMIDINE-5-CARBOXAMIDE; 5-PYRIMIDINECARBOXAMIDE, 2-AMINO-N-(2,3-DIHYDRO-7-METHOXY-8-(3-(4-MORPHOLINYL)PROPOXY)IMIDAZO(1,2-C)QUINAZOLIN-5-YL)-; Copanlisib",Launched,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,hematologic malignancy,follicular lymphoma,copanlisib,
Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,Fedratinib,Fedratinib,Launched,FLT3 inhibitor|JAK inhibitor,BRD4|JAK1|JAK2|JAK3|TYK2,hematologic malignancy,myelofibrosis,fedratinib,
CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,Mizolastine,Mizolastina; Mizolastine; Mizolastinum,Launched,histamine receptor antagonist,HRH1,allergy,urticaria|allergic rhinitis,mizolastine,
CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)Nc2noc(C)c2C)c(COCC)c1,Sparsentan,Sparsentan,Phase 3,angiotensin receptor antagonist,,,,sparsentan,
CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1,Mebeverine,Mebeverina; Mebeverine; Mebeverinum,Launched,acetylcholine receptor antagonist,CHRM1,gastroenterology,irritable bowel syndrome,mebeverine,
O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2ccn[nH]2)c1,Asciminib,Asciminib,Phase 2,Bcr-Abl kinase inhibitor,,,,asciminib,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NCCO)no2)cc1C#N,Ozanimod,Ozanimod; Ozanimodum,Phase 3,sphingosine 1-phosphate receptor agonist,S1PR1,,,ozanimod,
CCN(CC)Cc1ccc2cc(COC(=O)Nc3ccc(C(=O)NO)cc3)ccc2c1,Givinostat,Givinostat,Phase 3,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,,givinostat,
CCCc1cc(C(N)=S)ccn1,Protionamide,Prothionamide; Protionamida; Protionamide; Protionamidum,Launched,,,infectious disease,tuberculosis,protionamide,
COc1ccc2[nH]c3c(c2c1)CCN[C@]31CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H](O)[C@@H]3Cc5cc(C)c(OC)c(O)c5[C@H]([C@H]21)N3C)OCO4,Lurbinectedin,Lurbinectedin,Phase 3,DNA binding agent,,,,lurbinectedin,
CCOc1ccc(Cc2cc([C@@H]3O[C@H](SC)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,Sotagliflozin,Sotagliflozin,Phase 3,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,,,sotagliflozin,
NC(CO)C(=O)NNCc1ccc(O)c(O)c1O,Benserazide,benserazida; Benserazide; benserazidum,Launched,DOPA decarboxylase inhibitor,DDC,neurology/psychiatry,Parkinson's Disease,benserazide,
CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,Dinoprost,Dinoprost; dinoprosta,Launched,prostacyclin analog,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R,obstetrics/gynecology,labor induction,dinoprost,
Cc1ncc([N+](=O)[O-])n1CC(C)O,Secnidazole,1-(2­ hydroxypropyl)-2-methyl-5-nitroimidazole; 1-(2-methyl-5-nitro-1H-imidazol-1-yl) propan-2­ ol; Secnidazole,Launched,acetylcholinesterase inhibitor|microtubule inhibitor,,infectious disease,protozoan infection,secnidazole,
O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,Benperidol,Benperidol; Benperidolum,Launched,dopamine receptor antagonist,DRD2,neurology/psychiatry,schizophrenia,benperidol,
CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,Quizartinib,"N-(5-(1,1-Dimethylethyl)isoxazol-3-yl)-N'-(4-(7-(2-(morpholin-4-yl)ethoxy)imidazo(2,1-b)benzothiazol-2-yl)phenyl)urea; Quizartinib; Quizartinibum",Phase 3,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET,,,quizartinib,
O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,Oxatomide,Oxatomida; Oxatomide; Oxatomidum,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis,oxatomide,
CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1,Tazemetostat,Tazemetostat; Tazémétostat; Tazemetostatum,Launched,histone lysine methyltransferase inhibitor,EZH2,,,tazemetostat,
CC(C)c1cc(Oc2c(Cl)cc(-n3nc(C#N)c(=O)[nH]c3=O)cc2Cl)n[nH]c1=O,Resmetirom,"1,2,4-Triazine-6-carbonitrile, 2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-; 2-[3,5-Dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazine-6-carbonitrile; Resmetirom",Phase 3,thyroid hormone receptor agonist,,,,resmetirom,
CNc1ncc(-c2ccc3c(=O)c(C(=O)O)cn(C4CC4)c3c2C)cc1C,Ozenoxacin,Ozenoxacin; Ozenoxacino,Phase 3,antiinfective drug,,,,ozenoxacin,
CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,Darolutamide,Darolutamide,Launched,androgen receptor antagonist,AR,oncology,prostate cancer,darolutamide,
FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1,Pexidartinib,Pexidartinib,Launched,tyrosine kinase inhibitor,CSF1R|FLT3|KIT,,,pexidartinib,
C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21,Parthenolide,,Phase 1,NFkB pathway inhibitor,,,,parthenolide,
CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC,Lusutrombopag,Lusutrombopag,Launched,thrombopoietin receptor agonist,,,,lusutrombopag,
CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1,Levosalbutamol,(-)-Albuterol; (-)-Salbutamol; (R)-salbutamol; Levalbuterol; Levosalbutamol; R-salbutamol,Launched,adrenergic receptor agonist,ADRB2,pulmonary,bronchospasm,levalbuterol,
N[Pt]1(N)OCC(=O)O1,Nedaplatin,"(glycolato-O,O')diammineplatinum(II); CDGP; cis-Diammine (glycolato)platinum; cis-diammine(glycolato)platinum; cis-Diammine(glycolato)platinum(II); Nedaplatin",Launched,DNA inhibitor,,oncology,non-small cell lung cancer (NSCLC)|small cell lung cancer|esophageal cancer,nedaplatin,
CC(C)=CCC[C@](C)(O)[C@@H]1CC=C(C)CC1,Levomenol,(-)-alpha-Bisabolol; alpha-(-)-bisabolol; alpha-bisabolol; Bisabolol; Kamillosan; Levomenol; α-(−)-bisabolol,Launched,,,neurology/psychiatry|infectious disease,spasms|skin infections,levomenol,
Oc1ccc(Cl)cc1,Parachlorophenol,4-Chlorophenol; 4-chlorphenol; p-Chlorophenol; Parachlorophenol,Launched,antiinfective drug,,infectious disease,first-aid antiseptic,parachlorophenol,
O=c1ccc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2o1,Esculin,"6-(beta-D-Glucopyranosyloxy)-7-hydroxy-2H-1-benzopyran-2-one; 6-(beta-D-Glucopyranosyloxy)-7-hydroxy-cumarin; 6,7-Dihydroxycoumarin 6-glucoside; 6,7-Dihydroxycoumarin-6-O-glucoside; Aesculin; Aesculinum; Esculetin 6-O-glucoside; esculetin 6-β-D-glucoside; Esculina; Esculoside",Phase 1,antioxidant,,,,esculin,
C=CCOc1ccc(CC(=O)O)cc1Cl,Alclofenac,(4-Allyloxy-3-chlorphenyl)essigsäure; [4-(allyloxy)-3-chlorophenyl]acetic acid; 3-Chloro-4-(2-propenyloxy)benzeneacetic acid; Alclofenac; Alclofénac; Alclofenaco; Alclofenacum; Alclophenac,Launched,cyclooxygenase inhibitor,PTGS1,rheumatology,rheumatoid arthritis,alclofenac,
O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O,Inositol,"1,2,3,5/4,6-cyclohexanehexol; cis-1,2,3,5-trans-4,6-cyclohexanehexol; Inositol; L-myo-Inositol; Meat sugar; meso-Inositol; myo-inositol",Launched,insulin sensitizer,CDIPT,obstetrics/gynecology,polycystic ovary syndrom (PCOS),inositol,
CO[C@H]1C[C@H](O[C@@H]2[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(C)=O)[C@@H](C)C(=O)[C@]3(CO3)C[C@H](C)[C@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@H]2C)O[C@@H](C)[C@@H]1OC(C)=O,Troleandomycin,Oleandocetine; Oleandomycin triacetate; Oleandomycin triacetyl ester; Triacetyloleandomycin; Triacetyloleandomycinum; Tribiocillina; Troleandomicina; Troleandomycin; Troleandomycine,Launched,protein synthesis inhibitor,,infectious disease|pulmonary|otolaryngology,pneumonia|bronchitis|tonsillitis|sinusitis,troleandomycin,
CCN(CC)CCc1nc(-c2ccccc2)no1,Oxolamine,Oxolamina; Oxolamine; Oxolaminum,Launched,antitussive,,pulmonary,cough suppressant,oxolamine,
C=CCC(C(=O)NC(N)=O)C(C)C,Apronalide,Apronal,Preclinical,cytochrome P450 modulator,,,,apronal,
Cn1cc(S(C)=O)c(=O)c2ccc(F)cc21,Flosequinan,Flosequinan,Withdrawn,phosphodiesterase inhibitor,,,,flosequinan,
CN(C)C(=S)SSC(=S)N(C)C,Thiram,Tetramethylthiuram disulfide; Thiram; Thirame; Thiramum; Thiuram; Tiramo,Launched,,JAK2,ophthalmology,contact dermatitis,thiram,
CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C,Pramiracetam,Pramiracetam,Launched,acetylcholine receptor agonist,,neurology/psychiatry,senile dementia,pramiracetam,
O=C(O)c1ccccc1C(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1,Phthalylsulfathiazole,Phthalylsulfathiazole,Launched,dihydropteroate synthetase inhibitor,,infectious disease|gastroenterology,dysentry|colitis,phthalylsulfathiazole,
CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,Clothiapine,Clothiapine; Clotiapina; Clotiapine,Launched,,,neurology/psychiatry,psychosis,clotiapine,
CC(=O)OC1CN2CCC1CC2,Aceclidine,Aceclidina; Aceclidine; Aceclidinum,Launched,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,ophthalmology,glaucoma,aceclidine,
CC(=O)Nc1cc([As](=O)(O)O)ccc1O,Acetarsol,Acetarsol,Launched,,,gastroenterology,diarrhea,acetarsol,
NC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)O1,Dibekacin,Dibekacin; Dibekacina; Dibekacine; Dibekacinum,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections,dibekacin,
CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,Sultopride,Sultopride; Sultopridum; Sultroprida,Preclinical,dopamine receptor antagonist,,,,sultopride,
CNC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1,Micronomicin,Micronomicin,Launched,protein synthesis inhibitor,,infectious disease,gram-negative bacterial infections,micronomicin,
CCOc1ccc(NC(=O)CC(C)O)cc1,Bucetin,,Withdrawn,analgesic agent,,,,bucetin,
Cc1cc2c(cc1S(N)(=O)=O)S(=O)(=O)CCC2,Meticrane,Meticrane,Launched,diuretic,,cardiology,edema,meticrane,
CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1,Pimethixene,Pimethixene,Launched,antihistamine,,neurology/psychiatry|allergy,attention-deficit/hyperactivity disorder (ADHD)|anxiety|sleep cycle support|allergic rhinitis,pimethixene,
Cc1ccc2c(Cl)cc(Cl)c(O)c2n1,Chlorquinaldol,"2-methyl-5,7-dichloro-8-hydroxyquinoline; 5,7-dichloro-2-methyl-8-hydroxyquinoline; 5,7-dichloro-2-methyl-8-quinolinol; 5,7-dichloro-8-hydroxy-2-methylquinoline; 5,7-dichloro-8-hydroxyquinaldine; 5,7-dichloro-8-quinaldinol; Chlorchinaldol; Chlorquinaldol; Chlorquinaldolum; Clorquinaldol",Launched,other antibiotic,,infectious disease,fungal infection,chlorquinaldol,
ClC=C(Cl)Cl,Trichloroethylene,"1,1-dichloro-2-chloroethylene; acetylene trichloride; ethinyl trichloride; ethylene trichloride; Narcogen; TCE; trichlor; Trichloräthen; Trichloräthylen; trichloréthylène; Trichloroethene; Trichloroethylene; trichloroéthylène; trichloroethylenum; triciene",Preclinical,,,,,trichloroethylene,
CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O,Dihydroergocristine,"9,10-dihydroergocristine; DHEC",Launched,adrenergic receptor antagonist|prolactin inhibitor,ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7,neurology/psychiatry,senile dementia|cerebrovascular insufficiency,dihydroergocristine,
CCCCOc1ccc(CC(=O)NO)cc1,Bufexamac,2-(p-Butoxyphenyl)-acetohydroxamic acid; 4-Butoxy-N-hydroxybenzeneacetamide; 4-Butoxyphenylacetohydroxamic acid; Acide p-butoxyphenylacethydroxamique; Bufexamac; bufexamaco; bufexamacum; Bufexamic acid; p-Butoxyphenylacetohydroxamic acid,Withdrawn,cyclooxygenase inhibitor,HDAC10|HDAC6,,,bufexamac,
CCc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,Edoxudine,2'-Deoxy-5-ethyluridine; 5-Ethyl-2'-deoxyuridine; Edoxudine,Launched,DNA directed DNA polymerase inhibitor,,infectious disease,virus herpes simplex (HSV),edoxudine,
O=C(O)COc1nn(Cc2ccccc2)c2ccccc12,Bendazac,Bendazac; bendazaco,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry|rheumatology,muscle pain|joint pain,bendazac,
CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21,Metergoline,Metergolina; Metergoline; Metergolinum,Launched,dopamine receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,neurology/psychiatry|endocrinology,seasonal affective disorder|anxiety|hyperprolactinemia,metergoline,
NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,Cyclopenthiazide,,Launched,thiazide diuretic,,cardiology,hypertension|congestive heart failure,cyclopenthiazide,
Cc1ccccc1OCC(O)CO,Mephenesin,"3-(O-METHYLPHENOXY)-1,2-PROPANEDIOL; Mephenesin; TOLSEROL",Launched,muscle relaxant,,neurology/psychiatry,muscle relaxant,mephenesin,
CNC(C)Cc1ccccc1OC,Methoxyphenamine,2-Methoxymethamphetamine; Méthoxyphénamine; Methoxyphenamine; Methoxyphenaminum; Metoxifenamina,Launched,adrenergic receptor agonist,,pulmonary,asthma,methoxyphenamine,
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3cccc4c3CCC4)CS[C@H]12)c1csc(N)n1,Cefpirome,cefpiroma; Cefpirome; cefpiromum,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,cefpirome,
C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1,Diphemanil,Diphemanil cation; Diphemanil ion,Launched,acetylcholine receptor antagonist,CHRM3,neurology/psychiatry,spasms,diphemanil,
Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,Lidoflazine,Lidoflazina; Lidoflazine; Lidoflazinum,Launched,calcium channel blocker,SCN1A|SCN3A|SLC29A1,cardiology,coronary artery disease (CAD),lidoflazine,
O=C(NCCNCC(O)COc1ccc(O)cc1)N1CCOCC1,Xamoterol,Xamoterol; Xamoterolum,Phase 3,adrenergic receptor agonist,ADRB1,,,xamoterol,
COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,Acemetacin,Acemetacin; Acemetacina; Acemetacine; Acemetacinum; indometacin carboxymethyl ester; indometacin glycolic ester; indomethacin carboxymethyl ester; indomethacin glycolic ester,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,osteoarthritis,acemetacin,
CCO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3,Artemotil,Arteether; Artemotil; beta-Arteether; beta-Dihydroartemisinin ethyl ether; Dihydroartemisinin ethyl ether,Launched,,,infectious disease,malaria,artemotil,
CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,Enasidenib,"2-Methyl-1-(4-(6-(trifluoromethyl)pyridin-2-yl)-6-(2-(trifluoromethyl)pyridin-4-ylamino)-1,3,5-triazin-2-ylamino)propan-2-ol; Enasidenib",Launched,isocitrate dehydrogenase inhibitor,IDH1,hematologic malignancy,acute myeloid leukemia (AML),enasidenib,
CC(C)(C)[C@@H]1NC(=O)O[C@@H]2CCC[C@H]2OC/C=C/C(F)(F)c2nc3ccccc3nc2O[C@@H]2C[C@@H](C(=O)N[C@]3(C(=O)NS(=O)(=O)C4(C)CC4)C[C@H]3C(F)F)N(C2)C1=O,Glecaprevir,Glécaprévir; Glecaprevir; Glecaprevirum,Launched,serine protease inhibitor,,infectious disease,hepatitis C,glecaprevir,
COC(=O)c1cccnc1,Methyl nicotinate,"3-(Carbomethoxy)pyridine; 3-(Methoxycarbonyl)pyridine; 3-pyridinecarboxylic acid methyl ester; Heat spray; Methyl 3-pyridinecarboxylate; Methyl nicotinate; Methyl-nicotinate; Methylnicotinate; Nicotinic acid, methyl ester",Phase 2,,,,,methyl-nicotinate,
O=[N+]([O-])C(Br)(CO)CO,Bronopol,"2-Bromo-2-nitropropane-1,3-diol; 2-Nitro-2-bromo-1,3-propanediol; beta-Bromo-beta-nitrotrimethyleneglycol; Bronopol; Bronopolu; Bronopolum",Launched,,,obstetrics/gynecology,mastitis,bronopol,
O=C(c1ccccc1)C(O)c1ccccc1,Benzoin,"(+-)-Benzoin; 2-Hydroxy-1,2-diphenylethanone; Aerozoin; alpha-Hydroxy-alpha-phenylacetophenone; alpha-Hydroxybenzyl phenyl ketone; Benzoin extract (resinoid); Benzoylphenylcarbinol; Hydroxy-2-phenyl acetophenone; Phenyl-alpha-hydroxybenzyl ketone; phenyl-α-hydroxybenzyl ketone; Phenylbenzoyl carbinol; α-hydroxy-α-phenylacetophenone",Preclinical,,CES1,,,benzoin,
O=C(NCNC(=O)NC1C(=O)NC(=O)N1CO)NC1C(=O)NC(=O)N1CO,Imidurea,Imidazolidinyl urea,Preclinical,other antibiotic,,,,imidurea,
Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2,Cianidanol,"(+)-catechin; (+)-Catechol; (+)-Cyanidan-3-ol; (+)-Cyanidanol; (2R,3S)-(+)-Catechin; (2R,3S)-catechin; Catechin; Catechuic acid; Cianidanol; Cianidanolum; D-(+)-Catechin; d-Catechin; D-Catechol",Withdrawn,fatty acid synthase inhibitor,PTGS1,,,cianidanol,
CCCOC(=O)c1ccc(O)cc1,Propylparaben,"4-Hydroxybenzoic acid propyl ester; 4-Hydroxybenzoic acid, propyl ester; n-Propyl 4-hydroxybenzoate; n-Propyl p-hydroxybenzoate; n-propyl paraben; p-Hydroxybenzoic acid propyl ester; p-Hydroxybenzoic propyl ester; p-Oxybenzoesäurepropylester; Propyl p-hydroxybenzoate; Propyl paraben; Propyl parahydroxybenzoate; Propylparaben",Launched,,,,,propylparaben,
O=C/C=C/c1ccccc1,Cinnamaldehyde,(3E)-3-phenylprop-2-enal; (E)-3-Phenyl-2-propenal; (E)-3-Phenyl-propenal; (E)-3-Phenylpropenal; 3-phenylacrylaldehyde; Cinnamal; Cinnamaldehyde; trans-Cinnamaldehyde; trans-Cinnamic aldehyde; Zimtaldehyde,Preclinical,aldose reductase inhibitor|TRPV agonist,TRPA1,,,cinnamaldehyde,
N=C(Nc1ccccc1)Nc1ccccc1,Diphenylguanidine,"1,3-diphenylguanidine; DPG; DPG vulcanizer; Melaniline; N,N'-diphenylguanidine; s-Diphenylguanidine",Preclinical,,,,,diphenylguanidine,
COC(=O)c1ccc(O)cc1,Methylparaben,Methyl 4-hydroxybenzoate; methyl p-hydroxybenzoate; Methyl paraben; Methylparaben; p-Hydroxybenzoic acid methyl ester; p-Methoxycarbonylphenol; p-Oxybenzoesauremethylester,Launched,other antifungal,,dermatology,cosmetic,methylparaben,
N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,Ivosidenib,Ivosidenib,Launched,isocitrate dehydrogenase inhibitor,IDH1,hematologic malignancy,acute myeloid leukemia (AML),ivosidenib,
Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](CO)OC4=O)cc3F)cn2)n1,Tedizolid,Tedizolid; Torezolid,Launched,bacterial 50S ribosomal subunit inhibitor,,infectious disease,skin infections,tedizolid,
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)OCCl,Loteprednol,Loteprednol,Launched,glucocorticoid receptor agonist|phospholipase inhibitor,NR3C1,ophthalmology,conjunctivitis,loteprednol,
NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,Lypressin,"8-L-lysinevasopressin; Lypressin; Lysine vasopressin; Vasopressin pig; Vasopressin, 8-L-lysine",Launched,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2,endocrinology,central diabetes insipidus,lypressin,
O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1,Larotrectinib,Larotrectinib,Launched,tropomyosin receptor kinase inhibitor,NTRK1|NTRK2|NTRK3,,,larotrectinib,
Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,Dabigatran,Dabigatran,Launched,thrombin inhibitor,F2,neurology/psychiatry|hematology,stroke|systemic embolism|pulmonary embolism (PE)|deep vein thrombosis (DVT),dabigatran,
N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2O)cc1,Hydroxystilbamidine,"2-Hydroxy-4,4'-diguanylstilbene; 2-Hydroxy-4,4'-stilbenedicarboxamidine; Hidroxiestilbamidina; Hydroxystilbamidine; Hydroxystilbamidinum; Idrossistilbamidina; Oxistilbamidinum",Launched,,,,,hydroxystilbamidine,
NC(=O)OC[C@H](N)Cc1ccccc1,Solriamfetol,(2R)-2-amino-3-phenylpropyl carbamate; Solriamfetol,Launched,dopamine reuptake inhibitor,,neurology/psychiatry,narcolepsy,solriamfetol,
O=C(O)C[C@H]1CCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21,Etrasimod,Etrasimod,Phase 3,sphingosine 1-phosphate receptor antagonist,,,,etrasimod,
CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21,Ripretinib,Ripretinib,Phase 3,receptor tyrosine protein kinase inhibitor,,,,ripretinib,
O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1,Filgotinib,Filgotinib,Phase 3,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,,,filgotinib,
CC(C)(O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(CCNC(=O)c4ccc(O)c(O)c4Cl)CCCC3)CS[C@H]12)c1csc(N)n1)C(=O)O,Cefiderocol,Cefiderocol,Launched,antibacterial,,,,cefiderocol,
CC(C)n1c(=O)cc(N[C@@H](C)c2ccccc2)[nH]c1=O,Mavacamten,"6-(((1S)-1-Phenylethyl)amino)-3-(propan-2-yl)-1,2,3,4 tetrahydropyrimidine-2,4-dione; Mavacamten; MYK-461",Phase 3,myosin inhibitor,,,,mavacamten,
CC(C)n1nccc1-c1ncccc1COc1cccc(O)c1C=O,Voxelotor,Voxelotor; Voxélotor; Voxelotorum,Launched,hemoglobin modulator,,,,voxelotor,
Cc1ccc(NC(=O)[C@H]2CCCN(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NC3CCCC3)cc2)cc1C(F)(F)F,Avacopan,Avacopan,Phase 2,complement inhibitor,,,,avacopan,
COc1ccc(-n2nccn2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1,Daridorexant,ACT-541468; Nemorexant,Preclinical,orexin receptor antagonist,,,,nemorexant,
C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,Zanubrutinib,Zanubrutinib,Launched,Bruton's tyrosine kinase (BTK) inhibitor,,,,zanubrutinib,
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,Upadacitinib,Upadacitinib,Launched,JAK inhibitor,,,,upadacitinib,
COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1S(N)(=O)=O,Gefapixant,Gefapixant,Phase 3,purinergic receptor antagonist,,,,gefapixant,
C=CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1,Futibatinib,"1-((3S)-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl)-1H-pyrazolo(3, 4-d) pyrimidin-1-yl)-1-pyrrolidinyl)-2-propen-1-one; 1-[(3S)-3-{4-amino-3-[(3,5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl}pyrrolidin-1-yl]prop-2-en-1-one; Futibatinib",Phase 3,FGFR inhibitor,,,,futibatinib,
Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1,Avapritinib,Avapritinib,Launched,KIT inhibitor,,,,avapritinib,
Cc1cn2nc(-c3cc(=O)n4cc(N5CCNC6(CC6)C5)ccc4n3)cc(C)c2n1,Risdiplam,Risdiplam; Risdiplamum,Phase 2/Phase 3,RNA splicing inhibitor,,,,risdiplam,
CCCCCCOc1nsnc1C1=CCCN(C)C1,Xanomeline,Xanomeline,Phase 3,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7,,,xanomeline,
CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1,Trilaciclib,Trilaciclib,Phase 2,CDK inhibitor,,,,trilaciclib,
COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3ncc(F)cc23)nc1N,Vericiguat,Vericiguat; Vériciguat; Vericiguatum,Phase 3,guanylate cyclase stimulant,,,,vericiguat,
CCOCCOC(=O)/C=C/c1ccc(OC)cc1,Cinoxate,2-Ethoxyethyl-p-methoxycinnamate; Cinoxate; Cinoxato; Cinoxatum,Launched,,,dermatology,sunscreen lotion,cinoxate,
O=C1c2c(O)cccc2C([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2cc(CO)cc(O)c21,Alloin,"Aloin; Aloin, Cape; Aloin, curaco",Preclinical,angiogenesis inhibitor,,,,aloin,
C[C@]12CC[C@@H]3[C@H]4CC[C@@](C)(O)C[C@H]4CC[C@H]3[C@@H]1CC[C@@H]2C(=O)Cn1cc(C#N)cn1,Zuranolone,Zuranolone,Phase 3,GABA receptor agonist,,,,zuranolone,
Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3C)n1,Fezolinetant,Fezolinetant,Phase 2,neurokinin receptor antagonist,,,,fezolinetant,
Cc1cc(C)c(NC(=O)CN(CC(=O)O)CC(=O)O)c(C)c1Br,Mebrofenin,Mebrofenin; Mebrofenine; Mebrofenino; Mebrofeninum,Launched,,,radiology,diagnostic agent,mebrofenin,
CCN(CC)CCOC(=O)C(c1ccccc1)c1ccccc1,Adiphenine,Adiphenine,Launched,acetylcholine receptor antagonist,CHRNA1,neurology/psychiatry,spasms,adiphenine,
C/C=C/c1ccc(OC)cc1,Anethole,(E)-Anethole; Anise camphor; Isoestragole; trans-Anethole,Launched,glutathione transferase stimulant,,,,anethole,
C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1,Lazertinib,"2-PROPENAMIDE, N-(5-((4-(4-((DIMETHYLAMINO)METHYL)-3-PHENYL-1H-PYRAZOL-1-YL)-2-PYRIMIDINYL)AMINO)-4-METHOXY-2-(4-MORPHOLINYL)PHENYL)-; Lazertinib; N-(5-((4-(4-((DIMETHYLAMINO)METHYL)-3-PHENYL-1H-PYRAZOL-1-YL)PYRIMIDIN-2-YL)AMINO)-4-METHOXY-2-MORPHOLINOPHENYL)ACRYLAMIDE",Phase 1/Phase 2,tyrosine kinase inhibitor,,,,lazertinib,
CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1,Leniolisib,Cdz-173 free base; Cdz173 free base; Leniolisib,Phase 2/Phase 3,PI3K inhibitor,,,,leniolisib,
O=C(c1ccc(NS(=O)(=O)c2cccc3cccnc23)cc1)N1CCN(CC2CC2)CC1,Mitapivat,Mitapivat; Pkr-in-1,Preclinical,pyruvate kinase isozyme activator,,,,mitapivat,
C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1,Repotrectinib,"(3R,6S,)-45-FLUORO-3,6-DIMETHYL-5-OXA-2,8-DIAZA-1(5,3)-PYRAZOLO(1,5-A)PYRIMIDINA-4(1,2)-BENZENANONAPHAN-9-ONE; (7S,13R)-11-Fluoro-7,13-Dimethyl-6,7,13,14-Tetrahydro-1,15-Ethenopyrazolo[4,3-F][1,4,8,10]Benzoxatriazacyclotridecin-4(5H)-One; 1,15-ETHENO-1H-PYRAZOLO(4,3-F)(1,4,8,10)BENZOXATRIAZACYCLOTRIDECIN-4(5H)-ONE, 11-FLUORO-6,7,13,14-TETRAHYDRO-7,13-DIMETHYL-, (7S,13R)-; Repotrectinib",Phase 1/Phase 2,receptor tyrosine protein kinase inhibitor,,,,repotrectinib,
CC(=O)N[C@@H](CC(C)C)C(=O)O,L-Acetylleucine,"(s)-2-acetamido-4-methylpentanoic acid; Acetyl-l-leucine; Acetylleucine, (s)-; Acetylleucine, l-; L-leucine, n-acetyl-; Leucine, n-acetyl-, l-; N-acetyl leucine; N-acetyl-l-(-)-leucine; N-acetyl-l-leucine; N-Acetyl-Leucine; N-acetylleucine",Launched,,,neurology/psychiatry,vertigo,acetyl-l-leucine,
C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,Vorasidenib,"1,3,5-triazine-2,4-diamine, 6-(6-chloro-2-pyridinyl)-n2,n4-bis((1r)-2,2,2-trifluoro-1-methylethyl)-; Vorasidenib",Preclinical,isocitrate dehydrogenase inhibitor,,,,vorasidenib,
CCCCCCCCCCCCN1CCCCCC1=O,Laurocapram,"1-dodecylazacycloheptan-2-one; 1-dodecylhexahydro-2h-azepin-2-one; 1-n-dodecylazacycloheptan-2-one; 2h-azepin-2-one, 1-dodecylhexahydro-; Azone; N-dodecyl-.epsilon.-caprolactam",Phase 3,,,,,laurocapram,
CCCCCCCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,Perfluorohexyloctane,"1-(perfluorohexyl)octane; F6H8; NOV03; Tetradecane, 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-",Launched,,,,,perfluorohexyloctane,
Cc1cc(O)c(C(C)C)cc1Cl,Chlorothymol,"4-chlor-2-isopropyl-5-methylphenol; 4-chloro-5-methyl-2-(1-methylethyl)phenol; 4-chlorothymol; 6-chlorothymol; Phenol, 4-chloro-5-methyl-2-(1-methylethyl)-",Launched,,,,,chlorothymol,
O=C(Nc1ccccc1)c1ccccc1O,Salicylanilide,2-hydroxy-n-phenylbenzamide; N-phenylsalicylamide; Salinidol,Preclinical,other antibiotic,,,,salicylanilide,
CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,Megestrol,"17-hydroxy-6-methylpregna-4,6-diene-3,20-dione; Chronopil",Launched,progesterone receptor agonist,,oncology,breast cancer,megestrol,
,Cyclosporine,,Launched,calcineurin inhibitor,ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3,rheumatology|dermatology,rheumatoid arthritis|psoriasis,cyclosporin-A,88.0
,Ascorbic acid,,Launched,antioxidant,SLC23A1|SLC23A2,endocrinology,scurvy,ascorbic-acid,100.0
,Aspartic acid,,Launched,metallic radical formation stimulant,ACY1|ACY3|ADSS|ADSSL1|ASNS|ASPA|ASPH|ASRGL1|ASS1|CAD|DARS|DARS2|GOT1|GOT2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|LYZ|PAICS|RNASE1|SLC1A1|SLC25A12|SLC25A13,,,L-aspartic-acid,93.0
,Adenosine phosphate,,Launched,adenosine receptor agonist,ACSL1|ACSS1|ACSS2|ADCY1|ADK|CREB1|FBP1|HINT1|PDE4B|PDE4D|PIM1|PRKAA1|PRKAB1|PRKAB2|PYGL|TRPM4,,,adenosine-phosphate,100.0
,alpha-Linolenic acid,,Phase 3,omega 3 fatty acid stimulant,ELOVL4|FADS1|FADS2|FFAR1|FFAR4|PTGS2|SLC8A1|TRPV1,,,alpha-linolenic-acid,100.0
,Tyrosine,,Launched,protein synthesis inhibitor,,infectious disease|gastroenterology,gram-positive bacterial infections|colitis,tylosin,80.0
,Succinic acid,,Launched,,ALDH5A1|ASPH|BBOX1|HSD17B6|OXCT1|OXCT2|P3H1|P3H2|P3H3|P4HA1|P4HA2|PLOD1|PLOD3|SDHA|SDHB|SDHC|SDHD|SLC13A1|SLC13A2|SLC13A3|SLC25A10|SUCLA2|SUCLG1|SUCLG2|SUCNR1|TMLHE,,,succinic-acid,100.0
,Glutamic acid,,Launched,glutamate receptor agonist,AADAT|AASS|ABAT|ALDH18A1|ASNS|BCAT1|BCAT2|CCBL2|DNPEP|EARS2|ENPEP|EPRS|FOLH1|FPGS|FTCD|GAD1|GAD2|GATB|GCLC|GCLM|GGCX|GLS|GLS2|GLUD1|GLUD2|GLUL|GMPS|GOT1|GOT2|GPT|GPT2|GRIA1|GRIA2|GRIA3|GRIA4|GRID1|GRID2|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM1|GRM2|GRM3|GRM4|GRM6|GRM7|GRM8|LGSN|NADSYN1|NAGS|OPLAH|PFAS|PGCP|PSAT1|SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7|SLC25A18|SLC25A22|SLC7A11|TAT,,,L-glutamic-acid,93.0
,NADH,,Preclinical,,DRD2|DRD3|DRD4|GHSR|HTR2A|HTR2C,,,NADPH,89.0
,Folic acid,,Launched,folate receptor ligand,FOLR2|FOLR3|SLC19A1|SLC46A1,hematology,megaloblastic anemia,folic-acid,100.0
,Vitamin E,,Launched,LDL oxidation inhibitor|PKC inhibitor,ALOX5|DGKA|NR1I2|PPP2CA|PPP2CB|PRKCA|PRKCB|SEC14L2|SEC14L3|SEC14L4,,,vitamin-E,100.0
,Lipoic acid,,Launched,,,radiology,contrast agent,iopodic-acid,87.0
,Amphetamine,,Preclinical,histamine receptor antagonist,HRH3,,,impentamine,82.0
,Phentermine,,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3,cardiology,hypotension,mephentermine,92.0
,Indecainide,,Phase 1,antiarrhythmic,,,,pincainide,86.0
,Aminosalicylic acid,,Launched,cyclooxygenase inhibitor|prostanoid receptor antagonist,AKR1C1|ASIC3|PTGS1|PTGS2,dermatology|endocrinology|neurology/psychiatry,acne vulgaris (AV)|fever|pain relief,salicylic-acid,85.0
,Butabarbital,,Launched,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2,neurology/psychiatry,headache|muscle relaxant,butalbital,82.0
,Alclometasone,,Phase 1,DNA inhibitor,,,,clomesone,82.0
,Benzatropine,,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,ophthalmology,cycloplegia|mydriasis|amblyopia,atropine,80.0
,Cycloserine,,Launched,bacterial cell wall synthesis inhibitor,GRIN1,infectious disease,tuberculosis|tuberculosis,cycloserine-(D),92.0
,Tenofovir disoproxil,,Launched,nucleoside reverse transcriptase inhibitor,CYP1A2,infectious disease,human immunodeficiency virus (HIV-1)|hepatitis B,tenofovir-disoproxil,100.0
,Tranexamic acid,,Launched,antifibrinolytic|plasminogen activator inhibitor,PLG,hematology,hemophilia,tranexamic-acid,100.0
,Valproic acid,,Launched,benzodiazepine receptor agonist|HDAC inhibitor,ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,epilepsy|seizures|seizures,valproic-acid,100.0
,Calcium glucoheptonate,,Launched,,,,,calcium-gluceptate,90.0
,Methadone,,Preclinical,oxazolidine antiepileptic,,,,dimethadione,86.0
,Atenolol,,Preclinical,adrenergic receptor antagonist,,,,atenolol-(+),100.0
,Aminohippuric acid,,Launched,,SLC22A6,nephrology,renal diagnostic agent,4-aminohippuric-acid,95.0
,Megestrol acetate,,Launched,progesterone receptor agonist,NR3C1|PGR,neurology/psychiatry|endocrinology,anorexia|cachexia,megestrol-acetate,100.0
,Grepafloxacin,,Phase 3,antiinfective drug,,,,delafloxacin,80.0
,Meprobamate,,Launched,muscle relaxant,,neurology/psychiatry,anxiety|muscle relaxant,phenprobamate,83.0
,Beclomethasone dipropionate,,Launched,glucocorticoid receptor agonist,GPR97|NR3C1,allergy,allergic rhinitis,beclomethasone-dipropionate,100.0
,Phenylpropanolamine,,Withdrawn,adrenergic receptor agonist,,,,"""1S,2R-phenylpropanolamine""",86.0
,Zoledronic acid,,Launched,bone resorption inhibitor,FDPS|GGPS1,endocrinology,Paget's disease,zoledronic-acid,100.0
,Zolpidem,,Withdrawn,benzodiazepine receptor agonist,GABRA1,,,alpidem,80.0
,Cerivastatin,,Launched,dehydropeptidase inhibitor,DPEP1,,,cilastatin,82.0
,Meperidine,,Launched,flavanone glycoside,AURKB|CACNA1B,,,hesperidin,80.0
,Methscopolamine bromide,,Launched,cholinergic receptor antagonist,,gastroenterology,abdominal pain,butylscopolamine-bromide,85.0
,Sodium tetradecyl sulfate,,Launched,,PROC,dermatology,varicose veins,sodium-tetradecyl-sulfate,100.0
,Gallamine triethiodide,,Launched,acetylcholine receptor antagonist,CHRM2|CHRNA1,neurology/psychiatry,muscle relaxant,gallamine-triethiodide,100.0
,Aminocaproic acid,,Launched,plasminogen activator inhibitor,LPA|PLAT|PLG,hematology,fibrinolytic bleeding,aminocaproic-acid,100.0
,Anisotropine methylbromide,,Launched,acetylcholine receptor antagonist,CHRM5,ophthalmology,uveal tract inflammation,homatropine-methylbromide,86.0
,Alitretinoin,,Launched,retinoid receptor agonist|retinoid receptor ligand,ALDH1A1|ALDH1A2|GPRC5A|NR0B1|NR2C2|PPARD|RARA|RARB|RARG|RARRES1|RORB|RORC|RXRB|RXRG,hematologic malignancy,acute promyelocytic leukemia (APL),tretinoin,86.0
,Pyridostigmine,,Launched,acetylcholinesterase inhibitor|cholinesterase inhibitor,ACHE|BCHE,cardiology|neurology/psychiatry|ophthalmology|gastroenterology,hypotension|Alzheimer's disease|glaucoma|gastroparesis,physostigmine,81.0
,Azelaic acid,,Launched,tyrosinase inhibitor,AKR1D1|SRD5A2|TYR,dermatology,rosacea,azelaic-acid,100.0
,Acetohydroxamic acid,,Launched,urease inhibitor,MMP12,infectious disease,urinary tract infections,acetohydroxamic-acid,100.0
,Perflutren,,Launched,contrast agent,,radiology,contrast agent,perflubron,80.0
,Cinnarizine,,Launched,calcium channel blocker,,neurology/psychiatry|gastroenterology|ophthalmology,Meniere's disease|nausea|vomiting|Cogan's syndrome,cinnarazine,91.0
,Fenfluramine,,Launched,membrane permeability inhibitor,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9,neurology/psychiatry,anesthetic,enflurane,86.0
,Fluticasone propionate,,Launched,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A,dermatology,corticosteroid-responsive dermatoses,fluticasone-propionate,100.0
,Fluocinolone acetonide,,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,dermatology,seborrheic dermatitis,fluocinolone-acetonide,100.0
,Medroxyprogesterone acetate,,Launched,progesterone receptor agonist,ESR1|PGR,endocrinology,contraceptive,medroxyprogesterone-acetate,100.0
,Dextropropoxyphene,,Launched,antitussive,,pulmonary,cough suppressant,levopropoxyphene,82.0
,Pentazocine,,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief,phenazone,80.0
,Nafarelin,,Launched,gonadotropin releasing factor hormone receptor antagonist,GNRH1,,,alarelin,82.0
,Benzyl benzoate,,Launched,lipase inhibitor,LIPE,allergy,sweet itch,benzyl-benzoate,100.0
,Amphotericin B,,Launched,membrane permeability enhancer,,infectious disease,fungal infection,amphotericin-b,100.0
,Midazolam,,Phase 3,benzodiazepine receptor agonist,GABBR1,,,remimazolam,80.0
,Fludrocortisone,,Launched,glucocorticoid receptor agonist,ANXA1|NOS2|NR3C1|NR3C2,dermatology|neurology/psychiatry,eczema|psoriasis|seborrheic dermatitis|itching,hydrocortisone,83.0
,Mycophenolate mofetil,,Launched,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,transplant,organ rejection,mycophenolate-mofetil,100.0
,Flurbiprofen,,Launched,cyclooxygenase inhibitor,,rheumatology,rheumatoid arthritis|osteoarthritis,flurbiprofen-(+/-),100.0
,Apomorphine,,Launched,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|CALY|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A,neurology/psychiatry,Parkinson's Disease,(R)-(-)-apomorphine,92.0
,Adefovir dipivoxil,,Launched,DNA polymerase inhibitor,,infectious disease,hepatitis B,adefovir-dipivoxil,100.0
,Clodronic acid,,Launched,bone resorption inhibitor,SLC25A4|SLC25A5|SLC25A6,orthopedics|endocrinology|hematologic malignancy,osteoporosis|hyperparathyroidism|hypercalcemia|multiple myeloma,clodronic-acid,100.0
,Homatropine methylbromide,,Launched,acetylcholine receptor antagonist,CHRM5,ophthalmology,uveal tract inflammation,homatropine-methylbromide,100.0
,Mannitol,,Launched,diuretic,,neurology/psychiatry|ophthalmology|gastroenterology,intracranial pressure|intraocular pressure|constipation,mannitol-D,89.0
,Gadobenic acid,,Preclinical,,,,,capobenic-acid,86.0
,Potassium chloride,,Launched,,,pulmonary,asthma|bronchitis|emphysema,potassium-iodide,82.0
,Propiomazine,,Launched,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|HRH1|HTR2A|HTR2C,neurology/psychiatry,schizophrenia,promazine,86.0
,Nalidixic acid,,Launched,bacterial DNA gyrase inhibitor,,infectious disease,urinary tract infections,nalidixic-acid,100.0
,Mefenamic acid,,Launched,cyclooxygenase inhibitor,KCNQ1|PTGS1|PTGS2|TRPM3,endocrinology,primary dysmenorrhea (PD),mefenamic-acid,100.0
,Gadopentetic acid,,Launched,contrast agent,PGD,radiology,contrast agent,gadopentetic-acid,100.0
,Uracil mustard,,Launched,DNA synthesis inhibitor,,hematologic malignancy,non-Hodgkin lymphoma (NHL),uracil-mustard,100.0
,Candesartan cilexetil,,Launched,angiotensin receptor antagonist,,cardiology,hypertension|congestive heart failure|hypertension,candesartan-cilexetil,100.0
,Gentamicin,,Launched,bacterial 50S ribosomal subunit inhibitor,HSPA8,infectious disease|critical care,bone and joint infections|endocarditis|pelvic inflammatory disease|meningitis|pneumonia|urinary tract infections|sepsis,gentamycin,90.0
,Ethynodiol diacetate,,Launched,,ESR1|PGR,endocrinology,contraceptive,ethynodiol-diacetate,100.0
,Diazepam,,Phase 2,benzodiazepine receptor agonist,GABRA1,,,ripazepam,82.0
,Aminolevulinic acid,,Launched,oxidizing agent,ALAD,oncology|dermatology,glioma|actinic keratosis (AK),5-aminolevulinic-acid,95.0
,Penicillamine,,Launched,chelating agent,,metabolism|rheumatology|nephrology,Wilson's disease|rheumatoid arthritis|cystinuria,penicillamine-(D),93.0
,Benzphetamine,,Preclinical,,,,,benethamine,83.0
,Isosorbide dinitrate,,Launched,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3|NPR1,cardiology,angina pectoris|coronary artery disease (CAD),isosorbide-dinitrate,100.0
,Triazolam,,Launched,benzodiazepine receptor agonist,GABRA1,neurology/psychiatry,insomnia|anxiety,etizolam,82.0
,Etacrynic acid,,Launched,sodium/potassium/chloride transporter inhibitor,ATP1A1|SLC12A1,cardiology|gastroenterology|nephrology|rheumatology,hypertension|congestive heart failure|edema|hepatic cirrhosis|chronic renal failure|nephrotic syndrome,etacrynic-acid,100.0
,Cocaine,,Launched,HMGCR inhibitor,CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3,neurology/psychiatry,anesthetic,procaine,80.0
,Anileridine,,Preclinical,phosphatidylglycerophosphatase inhibitor,PTPMT1,,,alexidine,80.0
,Salicylic acid,,Launched,cyclooxygenase inhibitor|prostanoid receptor antagonist,AKR1C1|ASIC3|PTGS1|PTGS2,dermatology|endocrinology|neurology/psychiatry,acne vulgaris (AV)|fever|pain relief,salicylic-acid,100.0
,Meclofenamic acid,,Launched,cyclooxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2,rheumatology|neurology/psychiatry|endocrinology,joint pain|muscle pain|rheumatoid arthritis|primary dysmenorrhea (PD),meclofenamic-acid,100.0
,Hydrocodone,,Launched,glucocorticoid receptor agonist,ANXA1|NOS2|NR3C1|NR3C2,dermatology|neurology/psychiatry,eczema|psoriasis|seborrheic dermatitis|itching,hydrocortisone,80.0
,Edetic acid,,Phase 2,chelating agent,,,,pentetic-acid,83.0
,Methyl aminolevulinate,,Launched,oxidizing agent,FCGR1A|FECH,dermatology,actinic keratosis (AK),methyl-aminolevulinate,100.0
,Cyclacillin,,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections,cloxacillin,82.0
,Levobupivacaine,,Launched,sodium channel blocker,KCNA5|SCN10A,neurology/psychiatry,peripheral nerve block|caudal epidural block|lumbar epidural block,bupivacaine,85.0
,Cromoglicic acid,,Launched,immunosuppressant,KCNMA1|S100P,pulmonary|ophthalmology|allergy|gastroenterology,asthma|conjunctivitis|urticaria|ulcerative colitis,cromoglicic-acid,100.0
,Clobetasol propionate,,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,dermatology,corticosteroid-responsive dermatoses,clobetasol-propionate,100.0
,Isosorbide mononitrate,,Launched,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,cardiology,angina pectoris|coronary artery disease (CAD),isosorbide-mononitrate,100.0
,Mycophenolic acid,,Launched,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,transplant,organ rejection,mycophenolic-acid,100.0
,Etidronic acid,,Launched,bone resorption inhibitor,ATP6V1A|PTPRS,endocrinology|orthopedics,Paget's disease|heterotopic ossification,etidronic-acid,100.0
,Arbutamine,,Phase 2/Phase 3,melanin inhibitor,TYR,,,arbutin,82.0
,Proflavine,,Launched,vitamin B,BLVRB|RFK,gastroenterology,jaundice,riboflavin,80.0
,Sulfoxone,,Launched,dihydropteroate synthase inhibitor,,infectious disease,malaria,sulfadoxine,80.0
,Arsenic trioxide,,Launched,apoptosis stimulant,AKT1|CCND1|IKBKB|JUN|MAPK1|MAPK3|TXNRD1,gastroenterology,diarrhea,arsenic-trioxide,100.0
,Desflurane,,Launched,membrane permeability inhibitor,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9,neurology/psychiatry,anesthetic,enflurane,84.0
,Estazolam,,Launched,benzodiazepine receptor agonist,GABRA1,neurology/psychiatry,insomnia|anxiety,etizolam,82.0
,Encainide,,Phase 3,polarization inhibitor,SCN5A,,,acecainide,84.0
,Bromodiphenhydramine,,Launched,histamine receptor antagonist,HRH1,neurology/psychiatry,headache,diphenhydramine,86.0
,Arformoterol,,Launched,adrenergic receptor agonist,ADRB2,pulmonary,asthma|chronic obstructive pulmonary disease (COPD)|bronchospasm,formoterol,91.0
,Bismuth subsalicylate,,Launched,antacid,,gastroenterology,diarrhea,bismuth-subsalicylate,100.0
,Ceftizoxime,,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,respiratory tract infections|urinary tract infections|gonorrhea|pelvic inflammatory disease|intra-abdominal infections|bacterial septicemia|skin infections|bone and joint infections|meningitis,ceftizoxim,95.0
,Potassium cation,,Phase 2,,,,,antimony-potassium,88.0
,Butobarbital,,Launched,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2,neurology/psychiatry,headache|muscle relaxant,butalbital,82.0
,Cortisone acetate,,Launched,glucocorticoid receptor agonist,NR3C1,pulmonary|rheumatology|allergy|dermatology|ophthalmology|gastroenterology|infectious disease,asthma|rheumatoid arthritis|urticaria|osteoarthritis|psoriasis|allergic rhinitis|conjunctivitis|ulcerative colitis|meningitis,cortisone-acetate,100.0
,Glutethimide,,Launched,glucocorticoid receptor antagonist,CYP11A1|CYP19A1,endocrinology|oncology,Cushing's syndrome|breast cancer,aminoglutethimide,83.0
,gamma-Hydroxybutyric acid,,Launched,,,neurology/psychiatry,epilepsy,aminohydroxybutyric-acid,86.0
,Dextroamphetamine,,Launched,trace amine associated receptor agonist,TAAR1,ophthalmology,mydriasis,hydroxyamphetamine,80.0
,Ketazolam,,Launched,benzodiazepine receptor agonist,GABRA1,neurology/psychiatry,insomnia|anxiety,etizolam,82.0
,Prazepam,,Phase 2,benzodiazepine receptor agonist,GABRA1,,,ripazepam,82.0
,Tiaprofenic acid,,Launched,cyclooxygenase inhibitor,PTGS2,rheumatology,rheumatoid arthritis,tiaprofenic-acid,100.0
,Amyl Nitrite,,Preclinical,atrial natriuretic peptide receptor agonist,,,,amyl-nitrite,100.0
,Isopropamide,,Launched,radiopaque medium,,radiology,contrast agent,iopromide,86.0
,Camphor,,Phase 2,,,,,camphor-(+),100.0
,Pantothenic acid,,Launched,coenzyme A precursor,,,,pantothenic-acid,100.0
,Propylene glycol,,Launched,,,,,propylene-glycol,100.0
,Flufenamic acid,,Preclinical,chloride channel blocker,AKR1C3|ANO1|AR|GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|PANX1|PANX2|PANX3|PKD2L1|PTGS1|PTGS2|TRPC5|TRPM2|TRPM5,,,flufenamic-acid,100.0
,Aminobenzoic acid,,Launched,food preservative,DAO|HRSP12|PRDX5|RAB9A,infectious disease,tinea pedis,benzoic-acid,83.0
,gamma-Aminobutyric acid,,Preclinical,benzodiazepine receptor agonist,GABBR1|GABBR2|GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2|GATM|KCTD12|KCTD16|KCTD8|SLC6A1,,,gamma-aminobutyric-acid,100.0
,Cholic Acid,,Launched,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B,gastroenterology|neurology/psychiatry|genetics,bile acid synthesis disorders|peroxisomal disorders|Zellweger syndrome,cholic-acid,100.0
,Fusidic acid,,Launched,bacterial 30S ribosomal subunit inhibitor,,dermatology,acne vulgaris (AV),fusidic-acid,100.0
,Lauric acid,,Phase 3,bacterial permeability inducer,GPR84|HNF4A|LTF|LY96|PLA2G2A|TLR4,,,lauric-acid,100.0
,Glycolic acid,,Launched,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B,gastroenterology|neurology/psychiatry|genetics,bile acid synthesis disorders|peroxisomal disorders|Zellweger syndrome,cholic-acid,83.0
,Pidolic acid,,Launched,,ADAM28|AMY1A|AMY2A|AMY2B|ANG|CCL8|HCRT|IGLC1|KRTAP5-2|TFF2|VEGFA,dermatology,xerosis cutis,pidolic-acid,100.0
,Flavin adenine dinucleotide,,Preclinical,,ACAD8|ACADM|ACADS|ACOX1|AIFM1|CYB5R1|CYB5R3|DAO|DLD|DPYD|ERO1LB|FDXR|GCDH|GFER|GSR|IL4I1|IVD|MAOA|MAOB|NOS1|NQO1|NQO2|POR|TXNRD1|XDH,,,flavin-adenine-dinucleotide,100.0
,Acetic acid,,Launched,5 alpha reductase inhibitor,GAST,dermatology,wound healing,acexamic-acid,83.0
,Propyl alcohol,,Phase 2,apoptosis stimulant|farnesyltransferase inhibitor,FNTA,,,perillyl-alcohol,80.0
,Stearic acid,,Preclinical,Bruton's tyrosine kinase (BTK) inhibitor,BTK,,,terreic-acid-(-),83.0
,Deoxycholic acid,,Launched,biliverdin reductase A activator|G protein-coupled receptor agonist,FPR1|GPBAR1,endocrinology,submental fat,deoxycholic-acid,100.0
,Propanoic acid,,Withdrawn,thyroid hormone inhibitor,,,,iopanic-acid,85.0
,Benzoic acid,,Launched,food preservative,DAO|HRSP12|PRDX5|RAB9A,infectious disease,tinea pedis,benzoic-acid,100.0
,Palmitic Acid,,Preclinical,,,,,palmitoleic-acid,90.0
,Hexamidine,,Launched,local anesthetic,,otolaryngology|infectious disease|dental|gastroenterology,pharyngitis|meningitis|laryngitis|gingivitis|ulcerative colitis,hexetidine,80.0
,Fructose,,Phase 3,fructose diphosphate stimulant,,,,fosfructose,84.0
,Oleic Acid,,Launched,folate receptor ligand,FOLR2|FOLR3|SLC19A1|SLC46A1,hematology,megaloblastic anemia,folic-acid,90.0
,Citric acid,,Preclinical,coagulation factor inhibitor,AKR1B1|ANG|APRT|BHMT|C8G|CA4|CPB1|CS|CTDSP1|GNMT|HGS|HS3ST3A1|IL4I1|ITPA|LSM6|MDH2|MIF|PDE5A|PKD2L1|PLEKHA1|RNASE1|RNASE3|SRC|TNFSF13B|UCK2,,,citric-acid,100.0
,Taurocholic acid,,Launched,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B,gastroenterology|neurology/psychiatry|genetics,bile acid synthesis disorders|peroxisomal disorders|Zellweger syndrome,cholic-acid,81.0
,Lactic acid,,Preclinical,coagulation factor inhibitor,AKR1B1|ANG|APRT|BHMT|C8G|CA4|CPB1|CS|CTDSP1|GNMT|HGS|HS3ST3A1|IL4I1|ITPA|LSM6|MDH2|MIF|PDE5A|PKD2L1|PLEKHA1|RNASE1|RNASE3|SRC|TNFSF13B|UCK2,,,citric-acid,82.0
,Lactose,,Launched,laxative,,gastroenterology,portal-systemic encephalopathy (PSE),lactulose,88.0
,Benoxaprofen,,Launched,prostaglandin inhibitor,PTGS1|SLC5A8,rheumatology,rheumatoid arthritis|osteoarthritis,fenoprofen,82.0
,Oxeladin,,Launched,antitussive,,pulmonary,cough suppressant,oxelaidin,94.0
,Rapacuronium,,Launched,acetylcholine receptor antagonist,CHRM2|CHRM3|CHRNA1|CHRNA2,critical care|neurology/psychiatry,endotracheal intubation|muscle relaxant,pancuronium,87.0
,Cyproterone acetate,,Launched,androgen receptor antagonist,ADORA1|AR,oncology,prostate cancer,cyproterone-acetate,100.0
,Clevidipine,,Launched,calcium channel blocker,CACNA1B,cardiology,hypertension,cilnidipine,82.0
,Ingenol mebutate,,Launched,PKC activator,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,dermatology,actinic keratosis (AK),ingenol-mebutate,100.0
,Migalastat,,Launched,glycosyl transferase inhibitor,UGCG,hematology,Gaucher disease,miglustat,84.0
,Silver sulfadiazine,,Launched,PABA antagonist,,critical care,sepsis,silver-sulfadiazine,100.0
,Iodine,,Launched,adrenergic receptor agonist,,cardiology,hypotension,midodrine,80.0
,Sodium stibogluconate,,Launched,tyrosine phosphatase inhibitor,PTPN6,infectious disease,leishmaniasis,sodium-stibogluconate,100.0
,Levoketoconazole,,Launched,sterol demethylase inhibitor,KCNA10,dermatology,seborrheic dermatitis,ketoconazole,86.0
,Obeticholic acid,,Launched,FXR agonist,NR1H4,gastroenterology,primary biliary cholangitis,obeticholic-acid,100.0
,Arzoxifene,,Launched,selective estrogen receptor modulator (SERM),ESR1|ESR2,orthopedics|endocrinology,osteoporosis|menopause,bazedoxifene,82.0
,Oxymetholone,,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C,otolaryngology,nasal congestion,oxymetazoline,80.0
,Armodafinil,,Launched,adrenergic receptor agonist,,neurology/psychiatry,fatigue,adrafinil,80.0
,Ceftaroline fosamil,,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections|pneumonia,ceftaroline-fosamil,100.0
,Ethanolamine oleate,,Launched,immunostimulant,F12|FABP4|FFAR1|FFAR4|PLD2,gastroenterology,esophageal varices,ethanolamine-oleate,100.0
,Dabigatran etexilate,,Launched,thrombin inhibitor,F2,neurology/psychiatry|hematology,stroke|systemic embolism|pulmonary embolism (PE)|deep vein thrombosis (DVT),dabigatran-etexilate,100.0
,Potassium Iodide,,Launched,,,pulmonary,asthma|bronchitis|emphysema,potassium-iodide,100.0
,Fospropofol,,Launched,benzodiazepine receptor agonist,FAAH|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|SCN2A|SCN4A,neurology/psychiatry,anesthetic,propofol,84.0
,Fosaprepitant,,Launched,tachykinin antagonist,TACR1,gastroenterology,nausea|vomiting,aprepitant,87.0
,Benzyl alcohol,,Launched,local anesthetic,,infectious disease,virus herpes simplex (HSV),benzyl-alcohol,100.0
,Carglumic acid,,Launched,carbamoyl phosphate synthase activator,CPS1,metabolism,hyperammonemia,carglumic-acid,100.0
,Chenodeoxycholic acid,,Launched,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist,HSD11B1|NR1H4,cardiology|gastroenterology,cerebral cholesterosis|gallstones,chenodeoxycholic-acid,100.0
,Desoxycorticosterone acetate,,Preclinical,progestogen hormone,NR3C2,,,deoxycorticosterone-acetate,98.0
,Hydroxyprogesterone caproate,,Launched,progesterone receptor agonist,AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR,obstetrics/gynecology,spontaneous preterm birth,17-hydroxyprogesterone-caproate,95.0
,Phenyl aminosalicylate,,Launched,,,infectious disease,tuberculosis,phenyl-aminosalicylate,100.0
,Pyrithione,,Withdrawn,psychoactive drug,,,,pyrithyldione,87.0
,Unoprostone,,Withdrawn,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R,,,dinoprostone,87.0
,Chloramphenicol succinate,,Launched,protein synthesis inhibitor,,infectious disease,gram-negative bacterial infections,chloramphenicol-sodium-succinate,88.0
,Hyaluronic acid,,Launched,,C1QBP|CD44|HABP2|HAPLN1|HAPLN3|HAPLN4|HMMR|ICAM1|NCAN|VCAN,rheumatology|urology,osteoarthritis|interstitial cystitis (IC),hyaluronic-acid,100.0
,Acetylcarnitine,,Launched,,,,,N-acetylcarnosine,81.0
,Gabapentin enacarbil,,Launched,adrenergic receptor agonist,CACNA1G,neurology/psychiatry,restless leg syndrome|postherpetic neuralgia,gabapentin-enacarbil,100.0
,Gadoxetic acid,,Launched,contrast agent,PGD,radiology,contrast agent,gadopentetic-acid,84.0
,Fluticasone furoate,,Launched,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A,dermatology,corticosteroid-responsive dermatoses,fluticasone-propionate,83.0
,Dimethyl fumarate,,Launched,nuclear factor erythroid derived|like (NRF2) activator,KEAP1,neurology/psychiatry,multiple sclerosis,dimethyl-fumarate,100.0
,Glycerol phenylbutyrate,,Phase 1,sigma receptor ligand,,,,glycerol-phenylbutyrate,100.0
,Levomilnacipran,,Launched,serotonin–norepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,rheumatology,fibromyalgia,milnacipran,85.0
,Iopanoic acid,,Withdrawn,thyroid hormone inhibitor,,,,iopanic-acid,96.0
,Fluclorolone acetonide,,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,dermatology,seborrheic dermatitis,fluocinolone-acetonide,86.0
,Etidocaine,,Launched,histamine receptor agonist,EGFR|SCN10A|SCN5A|SCN9A,neurology/psychiatry|dermatology|hematology,itching|eczema|hemorrhage,lidocaine,84.0
,Canrenoic acid,,Launched,PARG inhibitor,ANO1,gastroenterology,constipation,tannic-acid,80.0
,Tedizolid phosphate,,Launched,protein synthesis inhibitor,,infectious disease,skin infections,tedizolid-phosphate,100.0
,Sodium oxybate,,Launched,,,,,sodium-ascorbate,80.0
,Podophyllin,,Launched,microtubule inhibitor|tubulin polymerization inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,infectious disease,genital warts,podophyllotoxin,85.0
,Benzoyl peroxide,,Launched,oxidizing agent,,dermatology,acne vulgaris (AV),benzoyl-peroxide,100.0
,Coenzyme M,,Phase 2,,AASS|ACADS|ADH1A|ADH1B|ADH1C|ADH4|ADH5|ADH7|AKR1B1|AKR1C1|AKR1C2|AKR1C3|AKR1C4|ALDH1A1|ALDH1A2|ALDH1A3|ALDH1B1|ALDH2|ALDH3A1|ALDH3A2|ALDH3B1|ALDH3B2|ALDH4A1|ALDH5A1|ALDH6A1|ALDH7A1|ALDH9A1|AMT|BDH1|BLVRA|BLVRB|CDO1|CYB5R3|CYP17A1|CYP4A11|DHCR7|DHFR|DLAT|DLD|EHHADH|GAPDH|GAPDHS|GLUD1|GLUD2|GPD1|GSR|H6PD|HADH|HADHA|HIBADH|HMGCR|HMOX1|HMOX2|HPGD|HSD11B1|HSD11B2|HSD17B1|HSD17B10|HSD17B2|HSD17B3|HSD17B4|HSD17B7|HSD17B8|HSD3B1|HSD3B2|IDH3A|IDH3B|IDH3G|IMPDH1|IMPDH2|LDHA|LDHAL6A|LDHAL6B|LDHB|LDHC|MDH1|MDH2|ME1|ME2|ME3|MSMO1|MT-ND1|MT-ND2|MT-ND3|MT-ND4|MT-ND4L|MT-ND5|MT-ND6|MTHFD1|MTHFD2|NDUFA1|NDUFA10|NDUFA11|NDUFA12|NDUFA13|NDUFA2|NDUFA3|NDUFA4|NDUFA4L2|NDUFA5|NDUFA6|NDUFA7|NDUFA8|NDUFA9|NDUFAB1|NDUFB1|NDUFB10|NDUFB2|NDUFB3|NDUFB4|NDUFB5|NDUFB6|NDUFB7|NDUFB8|NDUFB9|NDUFC1|NDUFC2|NDUFS1|NDUFS2|NDUFS3|NDUFS4|NDUFS5|NDUFS6|NDUFS7|NDUFS8|NDUFV1|NDUFV2|NDUFV3|NNT|NQO2|NSDHL|OGDH|PDHA1|PDHA2|PDHB|PHGDH|PYCR1|PYCR2|QDPR|RDH5|SORD|TSTA3|TYR|UGDH,,,coenzyme-I,90.0
,Colfosceril palmitate,,Launched,pulmonary surfactant,,pulmonary,respiratory distress syndrome (RDS),colfosceril-palmitate,100.0
,Paraldehyde,,Preclinical,cyclooxygenase inhibitor,PTGS2,,,asaraldehyde,87.0
,Eslicarbazepine acetate,,Launched,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures,eslicarbazepine-acetate,100.0
,Zucapsaicin,,Launched,TRPV agonist,CFTR|TRPV1,neurology/psychiatry|rheumatology,muscle pain|rheumatoid arthritis,capsaicin,90.0
,Potassium citrate,,Launched,mineralocorticoid receptor antagonist,NR3C2,cardiology,edema,potassium-canrenoate,81.0
,Gadoteric acid,,Launched,contrast agent,PGD,radiology,contrast agent,gadopentetic-acid,84.0
,Iothalamic acid,,Preclinical,radiopaque medium,,,,iothalamic-acid-d3,91.0
,Uridine triacetate,,Launched,,,nephrology,orotic aciduria,uridine-triacetate,100.0
,Sodium citrate,,Launched,nitric oxide donor,,critical care,poison antidote|cyanide poisoning,sodium-nitrite,86.0
,Lorpiprazole,,Launched,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7,neurology/psychiatry,depression|schizophrenia|bipolar disorder,aripiprazole,83.0
,Dexibuprofen,,Launched,cyclooxygenase inhibitor,,neurology/psychiatry|rheumatology|otolaryngology|obstetrics/gynecology|endocrinology|dental,headache|muscle pain|rheumatoid arthritis|backache|common cold|menstrual pain|fever|toothache,ibuprofen,86.0
,Dexketoprofen,,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2|SLC5A8,rheumatology,rheumatoid arthritis|osteoarthritis,ketoprofen,87.0
,Tolfenamic acid,,Launched,cyclooxygenase inhibitor|prostanoid receptor antagonist,,neurology/psychiatry,migraine headache,tolfenamic-acid,100.0
,Bisoxatin,,Launched,vitamin B,ACACA|ACACB|HLCS|MCCC1|MCCC2|PC|PCCA|PCCB|SLC5A6,,,biotin,80.0
,Methylene blue,,Launched,guanylyl cyclase inhibitor|nitric oxide production inhibitor,ACHE,hematology,methemoglobinemia,methylene-blue,100.0
,Strontium ranelate,,Launched,bone formation stimulant|bone resorption inhibitor,CASR,orthopedics|rheumatology,osteoporosis|osteoarthritis,strontium-ranelate,100.0
,Phenylacetic acid,,Phase 2,chelating agent,,,,pentetic-acid,80.0
,Bismuth subcitrate potassium,,Launched,,,gastroenterology,duodenal ulcer disease,bismuth-subcitrate-potassium,100.0
,Tenofovir alafenamide,,Launched,nucleoside reverse transcriptase inhibitor,,infectious disease,hepatitis B,tenofovir-alafenamide,100.0
,Butylscopolamine,,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI,neurology/psychiatry|gastroenterology,motion sickness|vomiting|nausea,scopolamine,81.0
,Ioxaglic acid,,Launched,radiopaque medium,,radiology,contrast agent,ioxaglic-acid,100.0
,Zinc sulfate,,Preclinical,,,,,sulfanilate-zinc,86.0
,Iopodic acid,,Launched,,,radiology,contrast agent,iopodic-acid,100.0
,Alatrofloxacin,,Launched,bacterial DNA gyrase inhibitor,,infectious disease,gram-negative bacterial infections,balofloxacin,85.0
,Tyropanoic acid,,Withdrawn,thyroid hormone inhibitor,,,,iopanic-acid,81.0
,Metrizoic acid,,Launched,radiopaque medium,,radiology,contrast agent,metrizoic-acid,100.0
,Piperonyl butoxide,,Launched,cytochrome P450 inhibitor,,infectious disease,lice,piperonyl-butoxide,100.0
,Tannic acid,,Launched,PARG inhibitor,ANO1,gastroenterology,constipation,tannic-acid,100.0
,Fluprednisolone,,Launched,glucocorticoid receptor agonist,NR3C1|NR3C2|SERPINA6,ophthalmology|dermatology|infectious disease,conjunctivitis|rosacea|punctate keratitis|shingles|iritis|cyclitis,prednisolone,89.0
,Sodium acetate,,Launched,,,,,sodium-ascorbate,80.0
,Iocetamic acid,,Launched,radiopaque medium,,radiology,contrast agent,iocetamic-acid,100.0
,Sodium carbonate,,Launched,,,,,sodium-ascorbate,81.0
,Glycerin,,Phase 3,tumor necrosis factor release inhibitor,TNF,,,glycitein,82.0
,Sodium fluorophosphate,,Launched,,PYGM,dental,cavities,sodium-monofluorophosphate,92.0
,Cetyl alcohol,,Launched,local anesthetic,,infectious disease,virus herpes simplex (HSV),benzyl-alcohol,81.0
,Simethicone,,Launched,,,dermatology,cosmetic,dimethicone,91.0
,Methyl salicylate,,Launched,,,endocrinology|neurology/psychiatry,fever|pain relief,methyl-salicylate,100.0
,Dexchlorpheniramine maleate,,Launched,histamine receptor antagonist,,allergy|cardiology,allergic conjunctivitis|allergic rhinitis|urticaria|angioedema,dexchlorpheniramine,83.0
,Phenyl salicylate,,Launched,antiseptic,,urology,interstitial cystitis (IC),phenyl-salicylate,100.0
,Potassium nitrate,,Launched,mineralocorticoid receptor antagonist,NR3C2,cardiology,edema,potassium-canrenoate,81.0
,Potassium bicarbonate,,Launched,mineralocorticoid receptor antagonist,NR3C2,cardiology,edema,potassium-canrenoate,83.0
,Undecylenic acid,,Launched,other antifungal,,infectious disease,tinea pedis|tinea corporis,undecylenic-acid,100.0
,Sodium iodide,,Preclinical,,ACHE,,,propidium-iodide,83.0
,Calcium gluconate,,Launched,,,,,calcium-gluceptate,86.0
,Potassium hydroxide,,Launched,,,pulmonary,asthma|bronchitis|emphysema,potassium-iodide,80.0
,Phenyltoloxamine,,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,endocrinology|cardiology,pheochromocytoma|hypertension,phentolamine,86.0
,Rose bengal,,Launched,contrast agent|immunostimulant,,radiology,diagnostic agent,rose-bengal,100.0
,Menthyl salicylate,,Launched,,,endocrinology|neurology/psychiatry,fever|pain relief,methyl-salicylate,97.0
,Panthenol,,Launched,,,gastroenterology,paralytic ileus,dexpanthenol,86.0
,Chromium picolinate,,Launched,insulin sensitizer,,endocrinology,diabetes mellitus,chromium-picolinate,100.0
,Dihydroergocornine,,Launched,adrenergic receptor antagonist|prolactin inhibitor,ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7,neurology/psychiatry,senile dementia|cerebrovascular insufficiency,dihydroergocristine,86.0
,Brilliant green cation,,Launched,,,infectious disease,antiseptic,brilliant-green,81.0
,Boric acid,,Phase 2,,DHODH,,,orotic-acid,86.0
,Dipyrithione,,Withdrawn,psychoactive drug,,,,pyrithyldione,80.0
,Sinapultide,,Preclinical,cholecystokinin agonist,,,,sincalide,80.0
,Cetalkonium,,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections,cefalonium,86.0
,Etafedrine,,Launched,calcium channel blocker,,neurology/psychiatry,muscle relaxant|spasms,ethaverine,80.0
,Levoleucovorin,,Launched,folate receptor ligand,,oncology,osteosarcoma,leucovorin,83.0
,Normethadone,,Launched,progesterone receptor agonist,PGR,obstetrics/gynecology,endometriosis,norethindrone,80.0
,Nomegestrol,,Launched,progesterone receptor agonist,,oncology,breast cancer,megestrol,90.0
,Momelotinib,,Launched,EGFR inhibitor,EGFR|NR1I2,oncology,non-small cell lung cancer (NSCLC)|pancreatic cancer,erlotinib,80.0
,Capmatinib,,Phase 3,RET tyrosine kinase inhibitor,CSK|KDR|KIT|RET,,,apatinib,89.0
,Bempedoic acid,,Launched,AMPK inhibitor,ACLY,,,bempedoic-acid,100.0
,Nirogacestat,,Preclinical,notch signaling inhibitor,,,,crenigacestat,80.0
,Sarecycline,,Preclinical,antitumor agent,,,,sancycline,86.0
,Telotristat ethyl,,Launched,tryptophan hydroxylase inhibitor,TPH1,gastroenterology,diarrhea,telotristat-ethyl,100.0
,Deutetrabenazine,,Launched,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,infectious disease|neurology/psychiatry,cholera|Huntington's disease,tetrabenazine,90.0
,Dopexamine,,Launched,dopamine receptor agonist,DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4,cardiology|neurology/psychiatry,ventricular arrhythmias|depression|headache|tremors,dopamine,89.0
,Betulinic Acid,,Phase 1/Phase 2,apoptosis stimulant|NFkB pathway inhibitor,GPBAR1,,,betulinic-acid,100.0
,Piritramide,,Phase 2,H+/K+-ATPase inhibitor,ATP4A,,,picartamide,82.0
,Oxetacaine,,Launched,local anesthetic,,neurology/psychiatry,local anesthetic,oxethazaine,86.0
,Perazine,,Launched,benzodiazepine receptor agonist,GABRB3,infectious disease,gastrointestinal roundworms,piperazine,89.0
,Lactitol,,Launched,laxative,,gastroenterology,constipation,lacitol,93.0
,Dihydralazine,,Launched,vasodilator,,cardiology,hypertension,hydralazine,92.0
,Methylprednisone,,Launched,glucocorticoid receptor agonist,NR3C1,endocrinology|rheumatology|dermatology|infectious disease|allergy|hematology|neurology/psychiatry|gastroenterology,hypercalcemia|thyroiditis|ankylosing spondylitis|bursitis|osteoarthritis|psoriatic arthritis|seborrheic dermatitis|mycosis|allergic rhinitis|psoriasis|anemia|multiple sclerosis|ulcerative colitis|enteritis,methylprednisolone,94.0
,Oteseconazole,,Launched,sterol demethylase inhibitor,,infectious disease,vulvovaginal candidiasis,terconazole,83.0
,Macimorelin,,Phase 2,growth hormone secretagogue receptor agonist,GHSR,,,tabimorelin,82.0
,Amitriptylinoxide,,Launched,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin–norepinephrine reuptake inhibitor (SNRI),ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4,neurology/psychiatry,depression,amitriptyline,87.0
,Norflurane,,Launched,membrane permeability inhibitor,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9,neurology/psychiatry,anesthetic,enflurane,84.0
,Clobetasone,,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,allergy,allergic rhinitis,beclomethasone,80.0
,Gluconic Acid,,Phase 1,,,,,glucaric-acid,85.0
,Mandelic acid,,Launched,,,,,mandelic-acid,100.0
,Dibenzepin,,Preclinical,norepinephrine reputake inhibitor,,,,dibenzepine,95.0
,Calcium lactate,,Launched,,,,,calcium-gluceptate,85.0
,Perboric acid,,Preclinical,Bruton's tyrosine kinase (BTK) inhibitor,BTK,,,terreic-acid-(-),80.0
,Etofamide,,Launched,mycolic synthesis inhibitor,,infectious disease,tuberculosis,ethionamide,80.0
,Benziodarone,,Launched,chloride channel blocker,ABCC1,rheumatology,gout,benzbromarone,80.0
,Carbocromen,,Launched,,,hematology,hemorrhage,carbazochrome,83.0
,Tromantadine,,Launched,antiviral|RNA synthesis inhibitor,,infectious disease,influenza A virus infection,rimantadine,87.0
,Pheneticillin,,Launched,bacterial cell wall synthesis inhibitor,,,,phenethicillin,96.0
,Ioxitalamic acid,,Launched,radiopaque medium,,radiology,contrast agent,ioxaglic-acid,83.0
,Potassium gluconate,,Launched,,,,,sodium-gluconate,80.0
,Sodium aurotiosulfate,,Launched,,,gastroenterology,constipation,sodium-picosulfate,82.0
,Magnesium gluconate,,Launched,,,,,sodium-gluconate,80.0
,Calcium levulinate,,Launched,,,,,calcium-levofolinate,89.0
,Muzolimine,,Launched,mucus protecting agent,,gastroenterology,peptic ulcer disease (PUD)|gastroesophageal reflux disease (GERD),zolimidine,80.0
,Anethole trithione,,Launched,glutathione transferase stimulant,,dental,xerostomia,anethole-trithione,100.0
,Gamolenic acid,,Phase 2,cyclooxygenase inhibitor|prostanoid receptor agonist,PTGS1|PTGS2,,,gamma-linolenic-acid,82.0
,Dimazole,,Phase 1,sigma receptor antagonist,SIGMAR1,,,rimcazole,82.0
,Fenofibric acid,,Launched,cytochrome P450 inhibitor,CLCN1|PPARA,cardiology,dyslipidemia,fenofibric-acid,100.0
,Amylmetacresol,,Launched,,INS,,,metacresol,83.0
,Bismuth subgallate,,Launched,nitric oxide synthase inhibitor,NOS1,gastroenterology,internal deoderant,bismuth-subgallate,100.0
,Valproate bismuth,,Preclinical,,,,,bismuth-oxalate,81.0
,Piperaquine,,Launched,benzodiazepine receptor agonist,GABRB3,infectious disease,gastrointestinal roundworms,piperazine,86.0
,Testosterone enanthate,,Launched,contraceptive agent,,endocrinology,contraceptive,norethisterone-enanthate,83.0
,Estradiol acetate,,Launched,estrogen receptor agonist,ESR1,endocrinology|obstetrics/gynecology,menopause|vaginal atrophy,estradiol-acetate,100.0
,Estradiol benzoate,,Preclinical,contraceptive agent,ESR1,,,estradiol-benzoate,100.0
,Estradiol cypionate,,Launched,estrogen receptor agonist,ESR1,endocrinology,hypoestrogenism|menopause,estradiol-cypionate,100.0
,Estradiol valerate,,Launched,estrogen receptor agonist,ESR1,oncology|endocrinology|obstetrics/gynecology,prostate cancer|hypoestrogenism|menopause|vaginal atrophy,estradiol-valerate,100.0
,Isopropyl myristate,,Launched,,,dermatology,cosmetic,isopropyl-myristate,100.0
,Racemethionine,,Launched,methyltransferase stimulant|phosphodiesterase inhibitor,,neurology/psychiatry,depression|attention-deficit/hyperactivity disorder (ADHD),ademetionine,85.0
,Potassium carbonate,,Launched,mineralocorticoid receptor antagonist,NR3C2,cardiology,edema,potassium-canrenoate,87.0
,Nomegestrol acetate,,Launched,progesterone receptor agonist,PGR,endocrinology,contraceptive,nomegestrol-acetate,100.0
,Baloxavir marboxil,,Launched,endonuclease inhibitor,,infectious disease,influenza A virus infection,baloxavir-marboxil,100.0
,alpha-Tocopherol succinate,,Launched,,,,,D-alpha-tocopheryl-succinate,93.0
,D-alpha-Tocopherol acetate,,Launched,antioxidant,,endocrinology,vitamin E deficiency,alpha-tochopheryl-acetate,90.0
,Pentetic acid,,Phase 2,chelating agent,,,,pentetic-acid,100.0
,Sodium bisulfite,,Launched,,,gastroenterology,constipation,sodium-picosulfate,82.0
,Fosnetupitant,,Launched,tachykinin antagonist,TACR1,gastroenterology,nausea|vomiting,netupitant,87.0
,Acetyl sulfisoxazole,,Launched,folic acid antagonist,,infectious disease|otolaryngology,meningitis|urinary tract infections|otitis|trachoma,sulfisoxazole-acetyl,100.0
,Medronic acid,,Launched,bone resorption inhibitor,,radiology,skeletal imaging agent,medronic-acid,100.0
,Butylparaben,,Preclinical,DNA synthesis inhibitor,,,,butyl-paraben,96.0
,Dimercaptosuccinic acid,,Launched,chelating agent,DNMT1,neurology/psychiatry,metal toxicity,dimercaptosuccinic-acid,100.0
,Linoleic acid,,Phase 3,oxidative stress inducer,FABP4|FFAR1|FFAR4|HNF4A|KCNB1|PPARG|TRPM8,,,linoleic-acid,100.0
,Chloric acid,,Launched,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B,gastroenterology|neurology/psychiatry|genetics,bile acid synthesis disorders|peroxisomal disorders|Zellweger syndrome,cholic-acid,87.0
,Oxidronic acid,,Preclinical,uricase inhibitor,,,,oxonic-acid,88.0
,Tetramethylthiuram monosulfide,,Preclinical,,,,,tetramethylthiuram-monosulfide,100.0
,Aripiprazole lauroxil,,Launched,serotonin receptor agonist,,neurology/psychiatry,schizophrenia,aripiprazole-lauroxil,100.0
,Isoeugenol,,Launched,androgen receptor antagonist,AR,dental,toothache,eugenol,82.0
,Monomethyl fumarate,,Launched,,,neurology/psychiatry,multiple sclerosis,monomethyl-fumarate,100.0
,L-Lactic acid,,Phase 2,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK,,,ellagic-acid,80.0
,DL-alpha-Tocopherol,,Launched,antioxidant,,endocrinology,vitamin E deficiency,alpha-tochopherol,89.0
,DL-alpha tocopheryl acetate,,Launched,antioxidant,,endocrinology,vitamin E deficiency,alpha-tochopheryl-acetate,92.0
,Sodium ascorbate,,Launched,,,,,sodium-ascorbate,100.0
,Magnesium ascorbate,,Launched,,,,,sodium-ascorbate,80.0
,Potassium acetate,,Phase 3,,,,,acesulfame-potassium,81.0
,Sodium borate,,Phase 2,HDAC inhibitor,BCHE|FFAR2|FFAR3|HDAC1|HDAC2|HDAC3|HDAC8,,,sodium-butyrate,86.0
,Lithium citrate,,Launched,,,neurology/psychiatry,bipolar disorder|depression,lithium-citrate,100.0
,Lithium carbonate,,Launched,,,neurology/psychiatry,bipolar disorder|depression,lithium-citrate,81.0
,Mometasone furoate,,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,mometasone-furoate,100.0
,Chromium gluconate,,Launched,insulin sensitizer,,endocrinology,diabetes mellitus,chromium-picolinate,81.0
,Chromium nicotinate,,Launched,insulin sensitizer,,endocrinology,diabetes mellitus,chromium-picolinate,89.0
,Hydrocortisone acetate,,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,hydrocortisone-acetate,100.0
,Hydrocortisone butyrate,,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses|eczema,hydrocortisone-butyrate,100.0
,Hydrocortisone cypionate,,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,hydrocortisone-acetate,83.0
,Hydrocortisone phosphate,,Launched,,,pulmonary|gastroenterology|hematologic malignancy|ophthalmology,asthma|nausea|vomiting|multiple myeloma|contact dermatitis|enteritis|colitis,hydrocortisone-phosphate,100.0
,Hydrocortisone probutate,,Launched,,,pulmonary|gastroenterology|hematologic malignancy|ophthalmology,asthma|nausea|vomiting|multiple myeloma|contact dermatitis|enteritis|colitis,hydrocortisone-phosphate,83.0
,Hydrocortisone valerate,,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,hydrocortisone-valerate,100.0
,Eslicarbazepine,,Phase 3,voltage-gated sodium channel blocker,SCN5A,,,licarbazepine,93.0
,Segesterone acetate,,Launched,progesterone receptor agonist,PGR,,,segesterone-acetate,100.0
,Prednisolone phosphate,,Launched,glucocorticoid receptor agonist,NR3C1,allergy|pulmonary|ophthalmology|infectious disease|rheumatology|endocrinology|neurology/psychiatry|gastroenterology|hematology,allergic rhinitis|asthma|contact dermatitis|mycosis|lupus|hypercalcemia|thyroiditis|congenital adrenal hyperplasia|multiple sclerosis|ulcerative colitis|enteritis|thrombocythemia|pneumonia|meningitis|psoriatic arthritis|rheumatoid arthritis,prednisolone-sodium-phosphate,86.0
,Prednisolone tebutate,,Launched,anti-inflammatory agent,,,,prednisolone-tebutate,100.0
,Methylprednisolone aceponate,,Launched,anti-inflammatory agent|glucocorticoid receptor agonist,NR3C1,endocrinology|rheumatology|infectious disease|allergy|pulmonary|gastroenterology|dermatology|neurology/psychiatry|hematology,congenital adrenal hyperplasia|thyroiditis|hypercalcemia|rheumatoid arthritis|bursitis|epicondylitis|allergic rhinitis|asthma|ulcerative colitis|enteritis|osteoarthritis|psoriasis|multiple sclerosis|anemia,methylprednisolone-aceponate,100.0
,Methylprednisolone hemisuccinate,,Preclinical,glucocorticoid receptor agonist,NR3C1,,,prednisolone-hemisuccinate,90.0
,Prednisone acetate,,Launched,glucocorticoid receptor agonist,NR3C1,ophthalmology|dermatology|infectious disease,conjunctivitis|rosacea|punctate keratitis|shingles|iritis|cyclitis,prednisolone-acetate,95.0
,Dexamethasone acetate,,Launched,glucocorticoid receptor agonist,,endocrinology|rheumatology|allergy|gastroenterology|hematology|neurology/psychiatry|dermatology,hypercalcemia|rheumatoid arthritis|psoriatic arthritis|osteoarthritis|allergic rhinitis|ulcerative colitis|anemia|multiple sclerosis|enteritis|lupus|dermatitis herpetiformis (DH)|nephrotic syndrome|psoriasis,dexamethasone-acetate,100.0
,Drostanolone propionate,,Launched,androgen receptor modulator,AR,oncology,breast cancer,dromostanolone-propionate,96.0
,Chlorphenesin carbamate,,Launched,muscle relaxant,,neurology/psychiatry,spasms,chlorphensin-carbamate,98.0
,Paramethasone acetate,,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,betamethasone-acetate,86.0
,Chloramphenicol palmitate,,Launched,protein synthesis inhibitor,,infectious disease|endocrinology,meningitis|fever|cholera,chloramphenicol-palmitate,100.0
,Betamethasone phosphate,,Launched,,,rheumatology,rheumatoid arthritis,betamethasone-phosphate,100.0
,Estramustine phosphate,,Launched,DNA synthesis inhibitor|microtubule inhibitor,ESR1|ESR2|MAP1A|MAP2,oncology,prostate cancer,estramustine-phosphate,100.0
,Sodium metavanadate,,Preclinical,,,,,sodium-orthovanadate,82.0
,Cefamandole nafate,,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections|urinary tract infections|respiratory tract infections,cefamandole-nafate,100.0
,Racephedrine,,Launched,adrenergic receptor agonist,ACHE|ADRA1A|ADRB2|SLC18A2|SLC6A2,cardiology|pulmonary|neurology/psychiatry|endocrinology,hypotension|asthma|narcolepsy|obesity,ephedrine,86.0
,Diroximel fumarate,,Phase 3,anti-inflammatory agent,,,,diroximel-fumarate,100.0
,Vibegron,,Phase 3,adrenergic receptor agonist,ADRB3,,,amibegron,82.0
,Ritlecitinib,,Phase 3,JAK inhibitor,JAK1,,,itacitinib,82.0
,Abrocitinib,,Launched,JAK inhibitor,JAK1|JAK2,rheumatology,rheumatoid arthritis,baricitinib,82.0
,Aprocitentan,,Launched,endothelin receptor antagonist,EDNRA|EDNRB,endocrinology,contraceptive,macitentan,82.0
,Pemigatinib,,Phase 2,EGFR inhibitor,EGFR,,,pelitinib,80.0
,Vamorolone,,Launched,membrane integrity inhibitor,,infectious disease,onychomycosis,amorolfine,80.0
,Tovorafenib,,Launched,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,oncology,renal cell carcinoma (RCC)|thyroid cancer|hepatocellular carcinoma (HCC),sorafenib,80.0
,Resorcinol monoacetate,,Launched,antiseptic,,,,resorcinol-monoacetate,100.0
,Colchiceine,,Launched,microtubule inhibitor,GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,rheumatology|endocrinology,gout|fever,colchicine,95.0
,Prednisolone acetate,,Launched,glucocorticoid receptor agonist,NR3C1,ophthalmology|dermatology|infectious disease,conjunctivitis|rosacea|punctate keratitis|shingles|iritis|cyclitis,prednisolone-acetate,100.0
,Ethyl salicylate,,Launched,,,endocrinology|neurology/psychiatry,fever|pain relief,methyl-salicylate,97.0
,Pralsetinib,,Launched,ALK tyrosine kinase receptor inhibitor,ALK|MET,oncology,non-small cell lung cancer (NSCLC),alectinib,80.0
,Thenyldiamine,,Launched,antihistamine,,neurology/psychiatry,itching,thonzylamine,80.0
,Indocyanine green,,Launched,contrast agent,SLCO1B1,cardiology,vascular imaging agent,indocyanine-green,100.0
,Foscarbidopa,,Launched,aromatic L-amino acid decarboxylase inhibitor,DDC,neurology/psychiatry,Parkinson's Disease,carbidopa,86.0
,Prasterone enantate,,Preclinical,,,,,prasterone-acetate,86.0
,Foslevodopa,,Launched,dopamine precursor,DRD1|DRD2|DRD3|DRD4|DRD5|GPR143,neurology/psychiatry,Parkinson's Disease,levodopa,84.0
,Durlobactam,,Launched,beta lactamase inhibitor,,infectious disease,skin infections|intra-abdominal infections|gynecologic infections,sulbactam,80.0
,Pirtobrutinib,,Launched,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,hematologic malignancy,chronic lymphocytic leukemia (CLL)|mantle cell lymphoma (MCL)|Waldenstrom's macroglobulinemia (WM),ibrutinib,82.0
,Lomifylline,,Phase 2,interleukin receptor antagonist|STAT inhibitor,,,,lisofylline,82.0
,Enmetazobactam,,Launched,beta lactamase inhibitor,,infectious disease,pneumonia,tazobactam,83.0
,Benzgalantamine,,Launched,acetylcholinesterase inhibitor,ACHE|BCHE|CHRNA1|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB1|CHRNB2|CHRNB3|CHRNB4|CHRND|CHRNE|CHRNG,neurology/psychiatry,senile dementia,galantamine,85.0
,Chlorisondamine,,Preclinical,,,,,chlorindione,81.0
,Latanoprost acid,,Launched,prostanoid receptor agonist,PTGFR,ophthalmology,ocular hypertension|glaucoma,latanoprost,81.0
